An investigation of the role of Neuronal PAS Domain Protein 2 (NPAS2) in peripheral circadian clocks by Masterson, Mitchell
Masterson, Mitchell (2021) An investigation of the role of 
Neuronal PAS Domain Protein 2 (NPAS2) in peripheral 
circadian clocks. PhD thesis, University of Nottingham. 
Access from the University of Nottingham repository: 
http://eprints.nottingham.ac.uk/65675/1/MM%20final%20Thesis%20-%20Corrected.pdf
Copyright and reuse: 
The Nottingham ePrints service makes this work by researchers of the University of 
Nottingham available open access under the following conditions.
This article is made available under the University of Nottingham End User licence and may 
be reused according to the conditions of the licence.  For more details see: 
http://eprints.nottingham.ac.uk/end_user_agreement.pdf
For more information, please contact eprints@nottingham.ac.uk
An investigation of the role of 
Neuronal PAS Domain Protein 2 
(NPAS2) in peripheral circadian 
clocks 
Mitchell Masterson, BSc. 
 
Submitted to the University of Nottingham for the degree of 
Doctor of Philosophy 
 
March 2021




Circadian cycles are 24-hour biological oscillations, observable in an array of 
physiological and behavioural systems including the sleep wake cycle, metabolism, 
cardiovascular activity, and cognition. The core circadian clock, located in the suprachiasmatic 
nucleus (SCN) of the brain, is entrained by environmental light and is responsible for 
entrainment of oscillators in other tissues, known as peripheral clocks. Light entrainment via 
the SCN is not the only signal that can entrain circadian cycles, they can also be entrained by 
other cues such as time of feeding (reflecting environmental food availability), which acts to 
entrain peripheral cycles without requirement of the SCN. The molecular underpinnings of 
these peripheral clocks, responsible for this entrainment and various tissue-specific circadian 
effects, are incompletely understood. In these studies, we focused on investigation of the 
functional role of the transcription factor NPAS2 in liver and fibroblast peripheral clocks. 
NPAS2 is a bHLH-PAS domain transcription factor and heterodimeric partner of 
BMAL1 that forms part of the positive arm of the core circadian feedback loop. Expression of 
either NPAS2 or its more well characterised paralog CLOCK have been shown in mouse gene 
KO studies to be required for functional circadian cycles. Constitutive KO of the NPAS2 gene 
in mice has also been found to severely delay circadian entrainment to time of feeding and 
enhance the entrainment to light but the precise role of NPAS2 in this entrainment is unclear. 
As feeding entrainment of behaviour is closely associated with the entrainment of peripheral 
clocks it is unknown if this effect is due to the loss of NPAS2 in the peripheral tissues or in the 
core clock in the constitutive KO. We aimed to investigate the function of NPAS2 in the 
molecular feedback cycle in peripheral clocks, and how it contributes to circadian behavioural 
entrainment. As loss of NPAS2 expression has also been found to impair long term fear 
conditioning performance we investigated the potential contribution of the liver peripheral 
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clock to this, and latent inhibition of fear conditioning. 
To investigate NPAS2 function we utilised both cellular and mouse models. For cellular 
studies in NIH3T3 fibroblasts, NPAS2 or CLOCK genes were targeted using CRISPR-Cas9 
editing. Clonal lines were selected that showed loss of expression/function as confirmed by 
allele genotyping, western blots and RT-qPCR. It was observed that ablation of NPAS2 in 
NIH3T3 cells resulted in alterations in rhythmic expression of other core clock genes, including 
CRY2 and both REV-ERBα and REV-ERBβ genes of the negative arm of the feedback loop. 
Indeed, robust increases of the endogenous REV-ERBα and REV-ERBβ genes were observed, 
suggesting that NPAS2 may negatively regulate these genes.  
A liver-specific NPAS2 cKO mouse model was used to investigate expression of select 
core clock genes in liver and brain tissues, and also correlate this with behavioural effects of 
the loss of NPAS2 in the liver. In this mouse model we observed modulated expression levels 
of the REV-ERB genes in the liver across circadian time points. Interestingly however, we also 
observed significant changes in rhythmic expression of selected core clock genes in brain 
samples that included tissue from the prefrontal cortex and from other cortical (including motor 
cortical) and subcortical regions of the liver-specific cKO mice. We observed the appearance 
of variance in expression of BMAL1 at different times of day and the loss of similar time 
variance in the expression of REV-ERBβ. This raises the novel suggestion that ablation of 
NPAS2 in the liver clock can influence rhythmic gene expression in the brain. 
In contrast to the constitutive KO model, we found no effect of loss of liver NPAS2 on 
light entrainment but observed an enhancement of restricted feeding entrainment, although this 
effect was restricted to female mice. This suggests a sex-specific mechanism is involved in 
feeding entrainment and that loss of NPAS2 in the liver is beneficial for food entrainment. 
Investigation of fear conditioning and latent inhibition identified no effect of the loss of NPAS2 
in the liver although a genotype independent sex effect on fear conditioning supports further 
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sex-specific investigation.  
These findings suggest a systemic effect of loss of NPAS2 expression within the liver, 
influencing behavioural cycles and gene expression in separate tissues. This suggests the liver 
peripheral clock contributes to circadian behavioural cycles and entrainment of other tissues 
and that NPAS2 contributes to these activities of the liver clock. The mechanism behind this 
effect is unknown but it may be through effects on endocrine or metabolite signalling. The 
potential exists to breed mice with a brain specific NPAS2 KO in the future to complement 
these findings and investigate the specific effect of loss of NPAS2 from the central clock. 
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Chapter 1: Introduction 
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1.1 Circadian cycles 
Circadian cycles allow organisms to anticipate daily changes and pre-emptively 
respond with variating behaviour and physiology. These cycles match the organism to the 
24-hour daily cycles of the environment due to the Earth’s rotation. Circadian cycles are seen 
in many biological processes and behaviours in multicellular organisms. These biological 
circadian cycles include cycling of behaviour, physiology, and metabolism to match optimum 
timing within the day and provide a survival advantage (Xie et al., 2019, Panda et al., 2002b). 
External stimuli, known at zeitgebers, such as light (sunlight or artificial) and feeding can 
induce entrainment of these cycles to environmental time. Importantly, these zeitgebers entrain 
the cycles but are not responsible for them. In the absence of stimuli, i.e., in constant 
environmental conditions, circadian cycles persist with a period length (time taken for one 
repetition of the cycle) of approximately 24 hours. Any daily cycles in behaviour or physiology 
which do not persist in the absence of zeitgebers are not true circadian cycles, just responses to 
cycling stimuli. The capacity for entrainment allows adaptation of an organism’s daily cycles 
with seasons and with changes in location on the earth (Panda et al., 2002b). 
In mammals the suprachiasmatic nucleus (SCN) is the key brain region responsible for 
orchestrating circadian cycles throughout the organism. The SCN is located just above the optic 
chiasm at the base of the hypothalamus and is formed of an identical pair of regions, each with 
a core and shell subdivision. The SCN responds to information about changes in ambient light 
absorbed by the retina, received through the retinohypothalamic tract (RHT), to synchronise 
its output rhythms. The SCN then acts to synchronise the rest of the body. It does this through 
a combination of neuronal (primarily GABA) and hormonal signals, control of body 
temperature and by influencing behaviour (Takahashi et al., 2008). 
Evidence to support the role of the SCN in circadian rhythms comes from a variety of 
sources. Ablation of the SCN in rats results in complete arrhythmicity of adrenal corticosterone 
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rhythm (Moore and Eichler, 1972) and sleep-wake cycles (Mistlberger, 2005) but 
food-entrained rhythms survive (Krieger et al., 1977). Transplantation of a functional SCN into 
animals with an ablated SCN also restores the circadian behavioural cycles (Ralph et al., 1990). 
Even outside of the brain SCN structure, isolated SCN neurons from rats continue to cycle in 
their expression of action potentials for several weeks in ex vivo culture (Welsh et al., 1995). 
These findings have cemented the SCN as a key tissue responsible for circadian cycles in 
mammals. 
 
1.2 Circadian study methods in vitro and in vivo 
Molecular mechanisms relevant to circadian cycles can be studied, at least partly, 
outside of in vivo systems. Cells growing in vitro retain circadian cycles, although in most cell 
types the cells all cycle individually, without synchronisation from the SCN and nervous 
system. This means that no significant cycling can be observed in cell cultures without manual 
synchronisation or investigation of a single cell (Balsalobre et al., 1998). The exception to this 
is that some specific cell types, such as SCN and some other neuronal cells, do synchronise to 
each other in culture due to cell-cell communication, and in co-cultures can even synchronise 
the cycles of other cells (Allen et al., 2001). 
The NIH3T3 mouse fibroblast cell line is frequently used in circadian studies and can 
be synchronised by use of multiple different shock treatments (Nagoshi et al., 2005). These 
treatments act by inducing the expression of genes involved in resetting circadian cycles in vivo 
through pathways such as the MAP kinase cascade (Akashi and Nishida, 2000) and action at 
the glucocorticoid receptor (Balsalobre et al., 2000). One of the treatments used to synchronise 
cell cultures is a serum shock, in which the cells are exposed to a high concentration of serum 
in the culture medium, factors present in the serum stimulate the expression of circadian genes 
by the cells at a specific time and the cells are then cultivated in serum free medium for a short 
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time while they cycle in synchrony (Allen et al., 2004). Treatment with forskolin (Menger et 
al., 2007), dexamethasone (Balsalobre et al., 2000), tetradecanoylphorbol acetate (Akashi and 
Nishida, 2000) or heat treatment have also been used to synchronise circadian cycles (Tsuchiya 
et al., 2003). The HEK293 human kidney cell line is not as commonly used in circadian studies 
but it has been shown that the cells can be synchronised by use of dexamethasone treatment or 
serum shock (Cox, 2012).  
Once cells are induced to cycle in synchrony in vitro, gene and protein expression can 
be investigated in samples harvested at various time points to follow rhythmic expression. The 
circadian cycles can also be investigated by use of bioluminescence. A luciferase reporter under 
the control of a circadian gene promotor, such as that for PER2, will cause cycling of this 
luminescent reporter which can be monitored, allowing detailed assessment of the cycling 
behaviour including period length (Welsh and Kay, 2005). After synchronisation, cultured cells 
will slowly desynchronise from each other over time. This means that rhythmic measurements 
taken from cycling cell cultures will dampen as more time passes from when the cells were 
synchronised. 
To study circadian cycles in vivo rodents can be kept under specific light/dark cycles, 
typically 12 hours of light and 12 hours of dark per day (12h:12h LD) or constant darkness 
(DD). Generally, the mice are raised in LD before being changed to DD for the period of the 
study. Mice then present their endogenous free-running circadian cycles in their cycles of 
activity. The free-running behavioural periods present slightly shorter than 24 hours, as the 
animals require resynchronisation to retain consistently accurate 24-hour cycles (LeGates and 
Altimus, 2011). The light cycle can be modified to shift earlier or later to investigate 
entrainment or mimic jetlag and light pulses allow close investigation of entrainment by time 
of presentation (LeGates and Altimus, 2011).  
Most commonly, wheel running is used as a measure of the animals’ activity and at 
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points where the wheel is spinning the animal is considered to be active, and inactive otherwise 
(Siepka and Takahashi, 2005). Since wheel running is an elective behaviour it should be noted 
that the animal may be active but not running in its wheel. This means there are periods when 
the animal is considered inactive as no wheel turns are recorded even though it is awake. The 
introduction of a running wheel to a rodent can also impact on a number of behavioural 
parameters, however it remains a robust assay for circadian periods (Bains et al., 2017).  
To assess sleep-wake cycles the surgical implantation of electrodes for 
electroencephalography (EEG) and electromyography (EMG) can be used. These monitor 
electrical activity and the readings can be used to identify periods of neural activity reflecting 
sleep and wakefulness (Oishi et al., 2016). This provides very accurate measures of the 
sleep-wake cycle at the cost of requiring surgical procedures. 
General home cage activity can be recorded by use of a camera placed at the roof of the 
mouse containment chamber. Cameras are used in combination with a red or infra-red light, 
which rodents are insensitive to, meaning the behaviour of the mice can be recorded while 
normal lights are off. Video tracking software can then maintain tracking location of each 
mouse and be used to produce data about distance travelled and time spent active or inactive, 
assessing sleep-wake states at a basic level without the need for electrode implantation (Pack 
et al., 2007, Fisher et al., 2012). General activity can also be recorded by IR beams through 
cages, interruption of these beams by the mouse allows placement of the mouse’s location in 
the cage allowing similar data to be produced (Brown et al., 2016).  
The molecular circadian cycle can be studied in animal models by sacrificing animals 
at specific time points and tissues harvested for analysis. Sacrificing groups of animals at each 
time point to give reliable molecular data does however require a great number of animals for 
appropriately powered experiments which can often restrict the number of time-points used 
(Zhang et al., 2014). 
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1.3 The molecular feedback cycle 
The genetic basis for the circadian clock was initially identified in drosophila flies. 
Modifications of the per locus were identified to be associated with modified circadian 
behaviour (Konopka and Benzer, 1971). Within wild type flies the expression of the mRNA of 
per and its protein product were both shown to exhibit 24 hour cycles in expression showing 
the rhythmic expression contributes to behavioural circadian cycles (Baylies et al., 1987). 
Following this, loops of the complex feedback system of clock proteins responsible for 
the mammalian circadian rhythms were identified. Components that have been identified as 
central to the mammalian circadian system are NPAS2 (neuronal PAS domain protein 2), 
CLOCK (circadian locomotor output cycle kaput) and BMAL1 (brain and muscle ARNT-like 
1) which make up the positive arm of the circadian feedback loop. NPAS2 and CLOCK are 
paralogs, and either can heterodimerise with BMAL1 to form similarly acting NPAS2:BMAL1 
and CLOCK:BMAL1 dimers (hereafter referred to as CLOCK/NPAS2:BMAL1 when 
referring to both dimers). CLOCK/NPAS2:BMAL1 dimers bind to the E-box element, a 
genetic sequence (CANNTG) conserved between flies and mammals, and act as transcription 
factors (Gekakis et al., 1998). This binding also mediates nucleosome removal, opening 
chromatin to facilitate the binding of other transcription factors or transcriptional repressors to 
exposed regions of DNA sequence. This means the binding of CLOCK/NPAS2:BMAL1 can 
positively or negatively influence expression of various genes (Trott and Menet, 2018).  
CLOCK/NPAS2:BMAL1 action is negatively regulated by proteins whose expression 
is induced by the dimer’s transcription factor activity, the interactions of these positive and 
negative arms are responsible for the 24-hour cycles of circadian rhythms. Transcription of the 
period proteins (PER1, PER2 and PER3) and the cryptochrome proteins (CRY1 and CRY2) is 
activated by the activity of CLOCK/NPAS2:BMAL1 (Jin et al., 1999, Kume et al., 1999) and 
as the concentration of each of the proteins increases PER:CRY heterodimers form in the 
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cytoplasm and translocate to the nucleus to negatively regulate CLOCK/NPAS2:BMAL1 
transcription factor activity. As PER and CRY proteins are degraded and not replaced due to 
lack of transcription the repression of CLOCK/NPAS2:BMAL1 is relieved, beginning the 
cycle again (Shearman et al., 2000). The mechanism of PER and CRY negative regulation 
within the nucleus is different between the two gene families. CRY proteins bind to the E-box 
element associated CLOCK:BMAL1 and inhibit the transcription of genes by forming a stable 
promotor associated complex. PER proteins mediate repression of expression however, by 
removing CLOCK/NPAS2:BMAL1 from the E-box element in a CRY dependant manner (Ye 
et al., 2014). This feedback is considered the major driver of circadian rhythm although other 
feedback loops have been identified.  
A second negative feedback loop involves the nuclear receptors REV-ERBα (NR1D1) 
and REV-ERBβ (NR1D2), whose expression is induced by CLOCK/NPAS2:BMAL1 through 
E-box association. These REV-ERB proteins repress BMAL1 and NPAS2 transcription, in 
competition with the ROR nuclear receptors (RORα, RORβ, and RORγ) which are activators 
of transcription at RORE sites (Sato et al., 2004, Preitner et al., 2002, Takeda et al., 2011). A 
representation of the core feedback loops is shown in Figure 1.1. 
A paralog of BMAL1, BMAL2 is also able to dimerise with CLOCK and NPAS2 to 
function as a transcription factor, however, in BMAL1 KO models BMAL2 is unable to 
compensate for this loss (Bunger et al., 2000), as BMAL1 KO mice also show a knockdown of 
BMAL2 expression levels. In these mice it has been shown manipulation increasing expression 
of BMAL2 expression in BMAL1 KO mice was sufficient to recover circadian cycles (Shi et 
al., 2010). It is not as well identified how BMAL2 contributes to normal circadian cycles or if 
it differs significantly from BMAL1. 
 




Figure 1.1:  The transcriptional-translational feedback of the mammalian circadian clock.  
At the core of the circadian clock is the transcription factor activity of the CLOCK:BMAL1 
or NPAS2:BMAL1 dimer acting at E-boxes.  The PER and CRY proteins inhibit 
CLOCK/NPAS2:BMAL1 transcription factor activity, thereby inhibiting their own 
expression. The REV-ERB and ROR proteins have opposing effects on transcription at RORE 
sites influencing both BMAL1 and NPAS2 expression. These loops in combination with an 
array of other genes are responsible for ~24-hour circadian cycles in almost all  cells .  
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Both NPAS2 and CLOCK also associate with the CLOCK interacting protein, circadian 
(CIPC) which is responsible for phosphorylation of the proteins required for normal function 
and is another possible level of circadian control (Yoshitane and Fukada, 2009). The circadian 
feedback loop is more complex than detailed here to permit the consistency of the 24-hour 
cycles and entrainment. Including these genes, more than 20 genes are considered to be ‘core 
clock genes’ which play a role in the regulatory network in mammals to produce circadian 
cycles (Takahashi et al., 2008). 
 
1.4 Clock-controlled genes 
The cycles of expression and activity of core clock proteins induce the cycling of 
physiological processes by modification of clock-controlled gene expression and protein 
activity. Genes which display a 24-hour cycle, including some of those which make up the 
molecular clock, are referred to as clock-controlled genes (CCGs). There is no clearly defined 
separation of CCGs from genes which make up the molecular circadian clock as a large amount 
of CCGs have an impact on the cycling of the cell clock (Pett et al., 2016, Li and Zhang, 2015). 
It has been observed that a significant fraction of the transcriptome is made up of CCGs within 
mouse tissues, 43% of protein coding genes and 32% of noncoding RNAs have been identified 
to present rhythmic expression depending on the tissue (Zhang et al., 2014). 
The cycles of CCG expression are controlled by the core molecular clock in multiple 
ways. At the transcription level most significantly genes with an E-box promotor are induced 
to cycle through CLOCK/NPAS2:BMAL1 transcription factor action, while ROR and 
REV-ERB proteins have their nuclear receptor activity and CRY proteins can act as 
co-repressors for nuclear hormone receptors (Kriebs et al., 2017) all influencing gene 
transcription. 
Circadian gene expression is also influenced at the epigenetic level. Dynamic changes 
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in chromatin structure are required to facilitate gene transcription and, as such, modification of 
chromatin is also an important step in circadian output. Chromatin modification is mediated by 
post-translational modifications of histones, commonly acetylation, regulated by histone 
acetyltransferases (HATs) which acetylate the histones and the opposing histone deacetylases 
(HDACs) which remove acetyl groups. Circadian rhythms of histone acetylation at promotor 
regions of CCGs have been shown to contribute to rhythmic gene expression (Etchegaray et 
al., 2003, Partch et al., 2014) and the specific histone modifications of H3K4me1, H3K4me3, 
H3K9ac, H3K27ac, and H3K36me3 all show diurnal variation (Vollmers et al., 2012). 
CLOCK/NPAS2:BMAL1 dimers have been shown to interact with the HATs CREB binding 
protein (CBP), p300 and the CBP-associated factor PCAF as well as HDACs including SIRT1. 
There are some differences in association between the two dimers, such as PCAF preferentially 
associating with the NPAS2:BMAL1 dimer in the vasculature clock (Curtis et al., 2004). 
Various HDACs also associate with other circadian genes such as SIN3-HDAC with the PER 
proteins (Duong et al., 2011) and HDAC3 with REV-ERBα (Feng et al., 2011), providing 
another level of circadian input to histone acetylation. It has also been reported that, without 
requiring recruitment of other proteins, CLOCK can itself act as a HAT, identified due to 
sequence similarity to ACTR, a member of the p160 family of transcriptional coactivators, also 
reported to have weak HAT activity (Chen et al., 1997). The HAT activity of CLOCK is 
dependent on heterodimerisation with BMAL1 and the major modification it is responsible for 
is H3K14ac (Doi et al., 2006, Aguilar-Arnal and Sassone-Corsi, 2015). The histone acetylation 
performed by CLOCK is opposed by the deacetylase activity of SIRT1 (Nakahata et al., 2008). 
As well as lysine acetylation of histones, a variety of non-histone proteins can be 
acetylated reversibly as a post-translational modification, as part of the circadian control 
circuitry at the protein activity level. Acetylation can modulate protein functions, such as 
enzymatic activity, DNA binding capacity, protein:protein interactions or protein stability 
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(Masri et al., 2013). Reversible lysine acetylation has been shown to occur on both BMAL1 
and PER2 modifying their function. CLOCK is responsible for the acetylation of BMAL1 on 
lysine 537 when associated and this acetylation appears to be required for normal circadian 
function (Hirayama et al., 2007). It is unknown if this acetylation occurs when NPAS2 and 
BMAL1 are associated or if another HAT is recruited to perform this function. The activity of 
the HDAC SIRT1 is responsible for deacetylation of the BMAL1 acetylation performed by 
CLOCK, modulating transcription factor function (Nakahata et al., 2008) and deacetylation of 
PER2, promoting degradation (Asher et al., 2008). In the liver various metabolic enzymes show 
circadian patterns of acetylation, several of which are dependent on the CLOCK protein (Masri 
et al., 2013).  
 
1.5 The peripheral circadian clock 
As detailed above the core circadian clock in mammals is that of the SCN, which is 
responsible for entrainment of all other oscillators. In terms of circadian cycles peripheral 
clocks refers to all oscillators which are not the SCN, including other regions of the brain. 
While almost all cells present circadian cycles, tissues with clear circadian involvement in their 
function include the vasculature, liver, kidneys, cardiac muscle, and the gastrointestinal system. 
Between tissues there is variation in the expression patterns of circadian genes and variation in 
which genes show rhythmic expression (Yeung et al., 2018). For example, PER2 expression 
peaks 4-8 hours later in the liver compared to the SCN (Panda et al., 2002a). This variation is 
due to tissue-specific differences in chromatin accessibility and the activity of tissue-specific 
factors, including enhancers which associate with the CLOCK/NPAS2:BMAL1 dimer 
(Beytebiere et al., 2019).  
Advancing or delaying the light cycle causes the rodent SCN to rapidly reset to the new 
timings while peripheral clocks can take longer than a week to resynchronise depending on the 
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tissue (Yamazaki et al., 2000). Melatonin and glucocorticoids have both been identified as 
acting to synchronise peripheral clocks to the SCN.  
Melatonin synthesis is directly regulated by SCN inhibitory neuronal signals when 
exposed to light. In darkness this inhibition is alleviated and melatonin synthesis is facilitated 
(Korf et al., 2003). Melatonin receptors are found widely in peripheral tissues permitting 
entrainment through G protein-coupled receptor signalling. Melatonin signalling modifies the 
expression of certain core circadian genes, however, the exact mechanism by which the action 
at the receptor influences the circadian cycle has not been elucidated (Vriend and Reiter, 2015, 
Chen et al., 2020). Melatonin can also interact directly with RORα in the nucleus which may 
present a process for the entrainment of circadian cycles of gene expression (Carlberg, 2000). 
Showing the entrainment capabilities of melatonin, time restricted provision of melatonin to an 
ex vivo rat adipose culture has been shown to synchronise circadian cycles in the cells (Alonso-
Vale et al., 2008). 
Glucocorticoids are a group of steroid hormones which show a circadian peak of 
secretion around the time of activity onset and have been shown to synchronise peripheral 
clocks (Balsalobre et al., 2000). Expression of glucocorticoids are influenced by the SCN via 
direct neuronal connection to the hypothalamus–pituitary–adrenal axis (Son et al., 2011). 
Glucocorticoids act via binding to the glucocorticoid receptor which also presents circadian 
expression mediated by the action of CRY1 and 2 (Lamia et al., 2011). The activity of the 
glucocorticoid receptor at glucocorticoid response elements (GREs) has been identified to 
regulate the expression of the PER genes (Yamamoto et al., 2005, So et al., 2009) influencing 
the circadian cycle. In the liver similar activity at a GRE influences expression of HNF4α which 
then regulates the expression of other circadian genes (Reddy et al., 2007). The glucocorticoid 
receptor also regulates REV-ERBα expression without a GRE via interaction with the 
CLOCK:BMAL1 dimer at the E-box preventing transcription (Murayama et al., 2019). While 
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this was identified specifically at the REV-ERBα E-box with the CLOCK:BMAL1 dimer a 
similar effect may also modulate expression of other CLOCK/NPAS2:BMAL1 gene targets. 
The synthetic glucocorticoid dexamethasone can synchronise circadian cycles in cultured cells 
and is used in in vitro circadian research as detailed above in section 1.2 (Balsalobre et al., 
2000). These functions are responsible for synchronising peripheral clocks to light cycles, the 
most common zeitgeber. Time of feeding is however another potent zeitgeber, especially in 
peripheral clocks. 
 
1.6 Food entrainment 
Time of feeding as a time cue in mice can be investigated through restriction of the 
times of food provision. In mice housed under a restricted feeding (RF) paradigm the peripheral 
oscillations of the liver, kidney, heart, and pancreas are entrained to the timing when feeding 
occurs, while the SCN is not. This peripheral entrainment leads to activity immediately prior 
to food provision on following days known as food-anticipatory activity (FAA) and overrides 
SCN control, showing the circadian clock network is controlled at multiple levels (Damiola et 
al., 2000, Carneiro and Araujo, 2009). This shows that these tissues are guided in their circadian 
pattern by the SCN but are not solely controlled by it. Under conditions where food is not 
restricted to a specific time the behavioural effect of the SCN means that eating times match 
the lighting pattern, this provides another mechanism of SCN entrainment of peripheral clocks. 
The circadian cycles of the cells can be affected by metabolic state through multiple 
processes which likely contribute to food entrainment. The cellular redox state in the form of 
NAD+ and NADH levels affect the transcription factor activity of the 
CLOCK/NPAS2:BMAL1 dimer through direct interaction with CLOCK and NPAS2, NADH 
enhances DNA association while NAD+ inhibits it (Rutter et al., 2001). The activity of the 
HDAC SIRT1 is NAD+ dependent providing another route for metabolic state to influence 
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circadian cycling (Asher et al., 2008). The protein poly(ADP-ribose) polymerase 1 (PARP-1) 
which inhibits CLOCK/NPAS2:BMAL1 DNA association also participates in phase 
entrainment to metabolic state, though modulation of activity by NAD+ association (Asher et 
al., 2010).  
The nutrient status of cells reflected in the AMP:ATP ratio can feed into circadian 
cycles through influencing adenosine monophosphate-activated protein kinase (AMPK) which 
can phosphorylate and destabilise CRY1 (Lamia et al., 2009). Both REV-ERBs have also been 
shown associate with haem which is required for their function. The activity of the proteins 
does not seem to be affected by the redox state of the haem; however, the levels of free haem 
may reflect the cellular metabolic state (Raghuram et al., 2007). 
This peripheral entrainment is also associated with the food entrainable oscillator 
(FEO). The appearance of food anticipatory activity (FAA) while animals are under restricted 
food provision, as well as robust food entrained molecular rhythms across tissues, are observed 
effects of the FEO. FEO function is fully independent of the SCN, not requiring a functioning 
SCN and behavioural cycles entrained by feeding can be completely out of sync with SCN 
cycles (Mistlberger, 2020). As the shift in behavioural cycles requires that the influence of 
feeding needs to reach the brain it was assumed that a specific brain clock was the eventual 
endpoint for the information on the metabolic state and this region would then be responsible 
for synchronising behavioural cycles. However, the FEO has not been identified as a specific 
tissue despite various attempts (Pendergast and Yamazaki, 2018).  
The noted complexity of the pathways which can allow entrainment to metabolic state 
means identification of individual contributors to the FEO are heard to identify, as any loss can 
be compensated for by other pathways. It has been found that knocking out BMAL1 in the 
brain leads to desynchronisation of peripheral tissues and a restricted food schedule restores 
synchrony in the liver and kidney tissues specifically (Izumo et al., 2014). This shows that the 
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liver and kidney clocks respond to feeding signals independent of entrainment signals from the 
clocks in the brain while other tissues still rely on them. This suggests the liver and kidneys 
may play a role in FEO entrainment. It is possible that the FEO itself, as has currently been 
identified, is a reflection of the communication between circadian cycles of multiple tissues 
and brain regions rather than a distinct tissue region. This peripheral clock communication, 
including to the brain, is made up of hormonal and afferent neuronal communication, as well 
as the influence of blood glucose and other signals more directly affected by food restriction 
(Carneiro and Araujo, 2009). 
 
1.7 Clinical relevance of circadian cycles in humans 
Investigation into circadian cycles has the potential to be of value in a variety of ways. 
Jetlag is an obvious example of disruption of circadian cycles with negative symptoms 
associated with loss of sleep due to desynchrony to the environment, as well as internal 
desynchrony due to different rates of entrainments of different tissues (Yamazaki et al., 2000). 
Another circadian disruption comes in the form of night shifts. In modern society humans are 
easily able to function at any time, regardless of the environmental daily cycles, and various 
industries employ workers who work night shifts. Even in ordinary life however, the use of 
electric lights late into the evening and night can impact normal circadian cycles. Long term 
disruption of circadian cycles has been associated with various health conditions (James et al., 
2017). In shift workers with an established history of night work an elevated risk has been 
noted of type 2 diabetes (Vetter et al., 2018, Knutsson and Kempe, 2014), metabolic syndrome 
(Wang et al., 2014), various cancers (Straif et al., 2007, Erren et al., 2008), heart disease 
(Pimenta et al., 2012), stroke (Hermansson et al., 2007) and various mood disorders such as 
depression and anxiety (Kalmbach et al., 2015). Another contribution of circadian research is 
the field of chronotherapeutics. This aims to utilise knowledge of circadian cycles to identify 
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optimal timing of treatments to minimise toxicity or adverse events and enhance treatment 
efficacy (Ballesta et al., 2017).  
Disturbed circadian rhythms are also presented in seasonal affective disorder (SAD). 
During winter months people diagnosed with SAD have been shown to have disturbed or 
damped circadian rhythms and morning bright light is often recommended as a treatment to 
help entrain the circadian cycles. A polymorphism in NPAS2, 471 Leu/Ser which is located 
outside of the conserved motif domains, has been identified to have a recessive effect on 
susceptibility to SAD with the leucine allele increasing susceptibility (Johansson et al., 2003). 
In addition to cognitive decline people with Alzheimer’s disease (AD) have also been 
found to present abnormal circadian cycles. At evening or night, a characteristic agitation and 
disruption in activity and sleep is commonly noted, known as sundowning. The daily cycles of 
body temperature are also often shifted in people with AD (Volicer et al., 2001). Amyloid β, 
which is responsible for the build-up of amyloid plaques, varies in concentration in the 
interstitial fluid and cerebrospinal fluid with time of day with a higher concentration at wakeful 
hours and lower concentration during sleep hours showing a potential circadian influence in 
AD development (Kang et al., 2009). Mouse models of AD can be generated by genetic 
modifications that lead to plaque formation such as APPswe/PS1dE9 mice (Jankowsky et al., 
2004). The BACE1 and BACE2 genes, which are also linked to AD, have been found to be 
CCGs and their rhythmic expression is altered in the APPswe/PS1dE9 mouse strain (Ma et al., 
2016). Within this strain it is also of note that in LD conditions a higher activity was seen at 
night compared to the wild type mice, and blunting of circadian variation in the clock proteins 
CRY1 and CRY2 in the medulla/pons was seen, even before amyloid plaques began to form. 
The mice also showed reduced responsiveness to the change from LD to DD potentially 
suggesting a failure in circadian entrainment in the AD model (Oyegbami et al., 2017). 
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1.8 The significance of NPAS2 in circadian cycles 
This thesis will focus specifically on NPAS2. NPAS2 as introduced above is a 
transcription factor, part of the positive arm of the core circadian feedback loop. In the brain 
NPAS2 is expressed primarily in the forebrain and also hippocampal regions, notably 
pyramidal neurons of CA1, cortex, striatum, amygdala, and thalamus (Garcia et al., 2000, Zhou 
et al., 1997) and within the striatum NPAS2 is preferentially expressed within neurons 
expressing the dopamine D1 receptor (Ozburn et al., 2015). Outside of the brain NPAS2 is 
present in almost all tissues (Papatheodorou et al., 2019, Smith et al., 2018). NPAS2 and 
CLOCK are very similar proteins sharing 50% identity in their overall amino acid sequences, 
notably they share high similarity within their helix-loop-helix and PAS functional domains 
(King et al., 1997), shown in Figure 1.2. NPAS2 is able to associate with interacting proteins 
such as HATs and generally act with functional similarity to CLOCK despite lacking the 
intrinsic HAT domain (Curtis et al., 2004). 
The CLOCK gene has been heavily investigated, however, relatively little is known 
about the function of NPAS2. This is due historically to an initial CLOCK mutant mouse model 
lacking exon 19 (CLOCKΔ19) used to investigate the protein’s function. This mouse model 
showed that the CLOCK protein was integral for the circadian clock, as these mutants develop 
a significantly longer circadian cycle and blunted molecular rhythms, thus identifying CLOCK 
as the first mammalian circadian gene (Vitaterna et al., 1994). However, it was found that the 
modified CLOCK protein, while unable to associate with CIPC preventing transcription factor 
activity, was still able to associate with BMAL1 making this a dominant negative mutation 
(Gekakis et al., 1998, Zhao et al., 2007).  
 




Figure 1.2:  Functional domains of NPAS2 and identity and similarity comparison to CLOCK.  
The areas of high similarity are the bHLH-PAS domain (including the PAS domain C-terminal or PAC),  and the terminal activating domain 
(TAD) responsible for association with the CIPC. There is  no observable similarity of the HAT domain of CLOCK with any of the amino acid 
sequence in NPAS2 following the TAD. Comparisons were performed using the LALIGN software (Madeira et al. ,  2019).   
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In mice with a homozygous CLOCK KO, rather than mutation, behavioural cycles 
remain and were shorted by only ~20 minutes (Debruyne et al., 2006). It was found that the 
capacity of the NPAS2 protein to act as an alternate dimerisation partner for BMAL1 could 
almost fully compensate for loss of the CLOCK protein. This suggests NPAS2 can compensate 
for CLOCK due to their overlapping function, overturning previous findings that CLOCK was 
crucial for circadian cycling (Debruyne et al., 2006, Debruyne, 2008). The expression of 
NPAS2 is upregulated in CLOCK KO mice in both neural and peripheral tissues (Debruyne et 
al., 2006, Landgraf et al., 2016), likely a compensatory mechanism in response to the loss of 
CLOCK. It should be noted that compensatory mechanisms, such as this, can be caused by the 
influence of the KO in development and can diminish the apparent role of the knocked-out 
gene (El-Brolosy and Stainier, 2017). 
It had initially been suggested that NPAS2 is not expressed in the SCN despite enriched 
expression in the brain as NPAS2 transcripts could not be detected by in situ hybridisation 
(Shearman et al., 1999, Debruyne et al., 2006). However, following the discovery of the 
redundancy of CLOCK it was shown by quantitative reverse transcription PCR (RT-qPCR) 
that NPAS2 mRNA transcripts were present in the SCN (Kennaway et al., 2006) and NPAS2 
was able to compensate for the loss of CLOCK through action in the SCN, independent of other 
tissues (DeBruyne et al., 2007a). NPAS2 or CLOCK KO mice under DD showed circadian 
cycles which only slightly vary from wild type mice while mice with both CLOCK and NPAS2 
knocked out showed a loss of circadian cycles (DeBruyne et al., 2007a), see Figure 1.3.





Figure 1.3:  Actograms of wheel running activity in circadian gene mutant mice,  adapted 
from DeBruyne et  al.  (2007a).  
Plots are shown for wheel running activity in CLOCK-deficient (Clock−/−), NPAS2-deficient 
mice (Npas2−/−) and 3 different double KO (Clock−/−; Npas2−/−) mice. In the plots each 
horizontal line represents 48h; the second 24h period is plotted both to the right and below 
the first.  Vertical bars represent periods of activity. Animals were initially housed in a 12-
h light, 12-h dark cycle (LD) and were then transferred to constant darkness (DD),  grey 
shading indicates darkness. Single CLOCK or NPAS2 KO mice retained some maintenance of 
circadian cycles even under constant darkness due to compensatory effects, however,  
double KO mice showed variable arrhythmicity in their behaviour.  
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Following these findings it was initially reported that NPAS2 could compensate for 
CLOCK in the SCN but not in peripheral clocks, shown by a loss of rhythmicity of luciferase 
under a PER2 promotor in ex vivo liver identical in CLOCK and CLOCK/NPAS2 KO mice 
(DeBruyne et al., 2007b). However, in a separate report it was shown that loss of NPAS2 or 
CLOCK function individually had little impact on the cycling expression of factor VII, a 
protease involved in blood coagulation, but KO of both abolished this pattern (Bertolucci et 
al., 2008) showing peripheral circadian gene expression due to NPAS2 in the mouse liver. 
More recently, CLOCK deficient in vitro fibroblasts and ex vivo liver, lung, kidney and adrenal 
explants were all shown to exhibit NPAS2 dependant rhythmicity, while this cycling was 
impacted by the loss of CLOCK the cells do not behave arrhythmically without CLOCK, 
showing NPAS2 compensation (Landgraf et al., 2016).  
While it is now commonly accepted that NPAS2 and CLOCK are similar genes it is of 
interest that there seem to be differences between the two genes that have not been fully 
explored. In the NPAS2 or CLOCK KO mice mentioned above, there were subtle differences 
between the SCN gene expression profiles suggesting different affinities for different circadian 
promotors between the CLOCK:BMAL1 and the NPAS2:BMAL1 heterodimers (Debruyne et 
al., 2006, DeBruyne et al., 2007a). This is despite the disrupted circadian cycles of behaviour 
seen in the mice being very similar between the two KO models. Chromatin 
immunoprecipitation sequencing (ChIP-seq) analysis in mouse liver has identified ~5900 
BMAL1, ~4600 CLOCK and ~2300 NPAS2 unique DNA binding sites (Koike et al., 2012). 
This suggests a difference of the NPAS2:BMAL1 and CLOCK:BMAL1 DNA binding. This is 
explored in more detail in Chapter 3, section 3.1.2. 
 
1.9 Role of NPAS2 in entrainment mechanisms 
While NPAS2 KO mice under constant darkness present mostly unmodified rhythmic 
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behaviour due to the presence of CLOCK, changes in zeitgeber entrainment in these mice have 
been observed. NPAS2 KO mice adapt faster when the light schedule is shifted earlier 
compared to wild type mice with a more significant shift initially and a faster rate of 
adjustment. Entrainment due to RF was found to be compromised in the NPAS2 KO mice, with 
lower body weight, food intake and anticipatory locomotor activity compared to wild type mice 
when food is restricted under DD conditions to a six-hour window, during what had previously 
been light conditions. However, the mice did eventually show a shifted behaviour cycle in 
response to RF (Dudley et al., 2003).  
These findings suggest that NPAS2 plays a role in entrainment of the FEO to food as a 
zeitgeber, this explains the deficit in food entrainment and a decreased contribution of the 
feeding zeitgeber or the FEO to the circadian cycles would permit faster entrainment to light 
as a zeitgeber or the SCN. This may reflect a role of NPAS2 in multiple different broad 
processes; entrainment of the molecular clock to the metabolic conditions and circadian 
signalling from entrained peripheral tissues to the brain, either outputting or responding to this 
signalling. NPAS2 as noted above interacts with NAD+/NADH meaning NPAS2 can play a 
role in entrainment of circadian cycles to the cells metabolic state. As a transcription factor, 
when molecular cycles of peripheral tissues are entrained by RF, NPAS2 activity may be 
required to appropriately output signals to entrain brain regions responsible for behavioural 
cycles. Finally, it may be that the signalling received at brain tissues to synchronise the 
circadian cycle act via influencing NPAS2 activity within the core circadian feedback loop. 
Investigation of these specific differences would likely require tissue collections over a 
significant number of time points on each of the days as the mice entrain to the zeitgeber which 
has not been performed. As the mice are still able to entrain eventually to RF there is clearly 
still some overlap of CLOCK and NPAS2 function. However, CLOCK is insufficient to 
completely compensate for NPAS2 in this function. 
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In contrast, mice with a conditional KO of NPAS2 in the neonatal liver showed less 
weight loss than wild types in male mice when feeding was restricted in a similar fashion under 
LD conditions (O’Neil et al., 2017) suggesting potentially faster entrainment in these mice. 
The mechanism of the process behind this has not yet been established. 
 
1.10 Cognition and circadian cycles 
As well as its role in behavioural circadian cycles, NPAS2 has been shown to have a 
role in memory and learning. This is not unexpected as memory and cognitive performance 
present physiological circadian cycles, observed as improvement at certain times of day. 
Human cognition is initially impaired following the transition from sleep to wakefulness but 
improves rapidly in the first 20 minutes and then continuing to improve at a slower rate over 
2-4 hours from waking. Cognition is generally highest in the first 8 hours awake with an 
afternoon dip or slump after 8 hours followed by improved cognition right before habitual 
bedtime (Wertz et al., 2006, Wright et al., 2012). Mice have been observed to show improved 
acquisition of memory for maze navigation (Hoffmann and Balschun, 1992) and contextual 
fear conditioning (Valentinuzzi et al., 2001) in the dark phase of a light-dark lighting pattern 
when, as nocturnal animals, they are more active. However, it has been shown that mice acquire 
tone-cued fear conditioning more rapidly when trained in the light rather than dark phase 
(Chaudhury and Colwell, 2002). While circadian variation in performance in various cognitive 
tasks is often observed, differences in the phase of peak performance between tasks and breeds 
of mice have been reported, and other nocturnal rodents have been found to show different 
performance peaks to mice (Snider et al., 2018). This shows the complexity of circadian 
influence within cognitive tasks. Mouse performance in learned behavioural tasks such as the 
Morris water maze and contextual fear conditioning is also compromised when sleep is 
disrupted (Gerstner et al., 2009).  
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In humans long term memory performance is better during daylight hours and working 
memory shows clear circadian variation which follows diurnal body temperature fluctuation 
(Goel et al., 2013). Chronic disruption of circadian cycles leads to decreased cognitive 
performance in humans and mice. This is seen in mice subjected to shifting light cycles 
(Krishnan and Lyons, 2015), flight crews who routinely cross time-zones (Cho et al., 2000) 
and shift workers (Marquie et al., 2015). Working a night shift also has a noticeable temporary 
effect on short term memory (Meijman et al., 1993). 
 
1.11 Roles of NPAS2 and other circadian genes in cognition 
Mice with a functional NPAS2 KO under LD conditions were identified to perform 
similarly to mice in behavioural tests except for deficits in the long-term (24 hours later) cued 
and contextual fear task while short-term memory (half an hour later) remained intact. These 
mutant mice showed no change in Morris water maze performance or passive avoidance and 
step-down avoidance (Garcia et al., 2000). It was also noted that these mice showed no change 
in anxiety (open field, light/dark conflict, and elevated plus maze) (Garcia et al., 2000), but 
following this NPAS2 deficient mice have been shown to have decreased anxiety-like 
behaviour in the same tests (Ozburn et al., 2017). Using siRNA to knockdown NPAS2 in the 
nucleus accumbens also has the effect of reducing anxiety behaviours and also reducing 
expression of the GABAa alpha 1 subunit likely altering the GABAA receptor subunit 
composition which may alter inhibitory neurotransmission (Ozburn et al., 2017).  
The effect of NPAS2 loss on fear conditioning suggests a specific role in long-term 
memory consolidation within this task, possibly as part of the role in circadian gene expression. 
The specific details of the mechanism of this effect have not however been identified. Cued 
and contextual fear conditioning have both been shown by to rely on the hippocampus (Maren 
et al., 1997), although lesions of the hippocampus in some reports is not associated with 
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modified cued fear conditioning behaviour (Kim and Fanselow, 1992, Phillips and LeDoux, 
1992, Sanders et al., 2003). This suggests the impact was not a hippocampal defect however, 
performance in the Morris water maze, which requires hippocampal function (Vorhees and 
Williams, 2006), was unaffected.  
The amygdala, which is essential for emotional responses, plays a role in both cued and 
contextual fear conditioning in acquisition, storage, and expression (Phillips and LeDoux, 
1992, Marschner et al., 2008), so this may be a site of interest in the mechanism of how loss of 
NPAS2 induces deficits in fear conditioning performance. Dopamine signalling has also been 
shown to be required for both cued (Fadok et al., 2009) and contextual fear conditioning 
(Ikegami et al., 2014). Within the nucleus accumbens NPAS2 mRNA expression has been 
shown to be highly enriched specifically in dopamine receptor D1 (Drd1) containing neurons 
(Ozburn et al., 2015). Knockdown of NPAS2 gene expression, specifically in the nucleus 
accumbens, disrupted diurnal mRNA expression of the dopamine receptors 
Drd1, Drd2 and Drd3 (Ozburn et al., 2015). Based on this it may be that an effect of loss on 
NPAS2 on dopamine signalling pathways is responsible for behavioural changes in NPAS2 
mutant mice. 
Other circadian genes also have an impact on cognition which should be noted. PER1 
and PER2 KO mice exhibit defects in hippocampal-dependant learning tasks (Wang et al., 
2009). BMAL1 KO and CLOCK dominant negative mutant mice have shown deficiencies in 
habituation while mice deficient in CRY1/2 have shown facilitated habituation, however at the 
circadian level all these mutant mice are similarly arrhythmic, showing unique roles of 
individual proteins above simply the interaction of circadian cycles with memory (Kondratova 
et al., 2010).  
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1.12 Aims & Objectives 
The aim of this project was to first establish models of peripheral clocks with modified 
NPAS2 expression and second to use these models to investigate the role and function of 
NPAS2 in the circadian cycles of gene expression and behaviour. Two models were used, an 
in vitro cell culture and an in vivo mouse model. These models were intended to complement 
each other, with a cell model allowing more detailed molecular investigation than can be 
feasible in a mouse colony without exceptionally large numbers of mice, while the mouse 
model allows for investigation of behavioural effects and function within an organism. 
The experimental aims can be summarised as: 1; Establish cells with modified NPAS2 
expression. 2; Investigate expression of core circadian genes in modified cultured cells. 3; 
Investigate expression of core circadian genes in liver specific NPAS2 KO model mice. 4: 
Investigate circadian behavioural entrainment in the liver specific NPAS2 KO model mice. 5; 
Investigate latent inhibition of fear conditioning in liver specific NPAS2 KO model mice. 
The cell culture model involved generation of mutant cells by use of CRISPR-Cas9 
technology (Aim 1; Chapter 2). Due to relative ease of generation of modified cell models 
multiple were generated within this project. This allowed investigation of the NPAS2 gene as 
well as its paralogue CLOCK as a comparison of effects on a similar gene. Modification of 
these cells was confirmed by reduced protein expression levels and sequencing of the targeted 
region of the genome.  
These modified cells were used to investigate the effect of modified expression of the 
core circadian genes on the expression of other genes of the circadian feedback loop (Aim 2, 
Chapter 3). Gene expression was investigated both under normal cell culture conditions and 
after circadian synchronisation to investigate any impact on rhythmic expression of core 
circadian genes. Having been established, the cells can be used in future research to investigate 
other potential effects, such as protein modifications and expression of various core clock genes 
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which may be of interest. 
A liver-specific functional NPAS2 conditional KO mouse model colony was 
established in Nottingham. This previously generated model was floxed for NPAS2 and 
crossed for Cre expression in the liver to specifically KO functional gene expression in the 
liver. This mouse model was used in investigation of effect on core circadian gene expression 
in both the liver tissue as well as brain tissues to investigate the effect of the functional loss of 
NPAS2 in the liver (Aim 3, Chapter 4). 
As constitutive NPAS2 mice have been identified to present modified entrainment to 
zeitgebers, entrainment was investigated in the liver-specific conditional KO mice (Aim 4, 
Chapter 5). The response in activity to light pulses and restricted feeding was investigated to 
identify the impact of the loss of NPAS2 in the liver on these entrainment processes. 
Performance in cued fear conditioning, which constitutive NPAS2 KO mice have shown 
deficits in (Garcia et al., 2000), and latent inhibition of fear conditioning was investigated to 
identify any potential effect on cognition of modification in a peripheral clock (Aim 5, Chapter 
6). It is intended that this work will be complemented by development of a brain specific 
functional NPAS2 KO which can be produced by crossbreeding with mice which express a 
different tissue specific Cre. These two mouse models will allow comparative investigation of 
the effect of brain and non-brain peripheral tissue NPAS2 KO. 
Together the in vitro and in vivo models can present a valuable resource for 
investigation of the NPAS2 gene and aid in understanding of its role in peripheral circadian 
cycles, as well as investigation of the contributions of peripheral clocks to overall circadian 
behaviour. 
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Chapter 2: CRISPR-Cas9 editing of 
circadian genes in mouse and human cells 




2.1.1 CRISPR-Cas9 modification 
To study NPAS2 function in cell models we employed a genome editing approach using 
CRISPR-Cas9. CRISPR-Cas9 technology employs short (20 bp) guide RNAs (sgRNAs) to 
target the Cas9 nuclease to a specific target sequences that have an adjacent protospacer 
adjacent motif (PAM) (Ran et al., 2013b). The Cas9 enzyme contains two domains with 
nuclease activity (RuvC and HNH domains) that target opposing strands to achieve 
double-strand DNA cleavage near the PAM site. This activates the cells endogenous error 
prone non-homologous end joining repair pathway (NHEJ) which attempts to repair the 
double-strand break leading to insertions and deletions (indels) at the cleavage site.  
In addition to editing events at the intended target site, studies have shown that partial 
mismatches in the sgRNA/DNA hybrids can be tolerated and lead to off-target mutations. To 
reduce the frequency of off-target events, we used the Cas9 nickase (spCas9n) variant 
harbouring the D10A mutation, in which the RuvC domain is inactivated. This enzyme 
introduces just a single strand break at the sgRNA target sequence. Single strand breaks 
produced with this enzyme are repaired without mutation of the DNA sequence by the high-
fidelity base excision repair pathway (BER) (Ran et al., 2013a, Shen et al., 2014). Therefore, 
to achieve genome editing with Cas9n, pairs of guides were designed to target opposing strands 
at the target locus. The two single strand breaks generate a staggered cut that can be recognised 
as a double-strand break leading to NHEJ (See Figure 2.1). As the sgRNA pairs target distinct 
sequences, the likelihood of off-target events occurring on opposing strands at another locus is 
reduced by over 100-fold relative to wild type Cas9 (Ran et al., 2013a, Chiang et al., 2016, 
Shen et al., 2014). The orientation of the sgRNA target sequences, referred to as PAM-in or 
PAM-out designs, can alter the efficacy of editing with PAM-out showing higher efficiency of 
editing (Ran et al., 2013a).  




Figure 2.1:  Schematic representation of Cas9n targeting.  
sgRNA guide pairs are used to target opposing strands of the target sequence. Indels are 
generated randomly between these guides due to non-homologous end joining (NHEJ).  
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After we initiated this project, studies by Yan et al. (2017) using the D10A Cas9 in 
HEK293 cells showed that editing is more efficient with PAM-out designs with spacings of 
40-70 base pairs between nicks, and that efficiency of targeting drops dramatically if nick 
distances are too close (<25 bp) or too distant (>85 bp) (Yan et al., 2017). All guide pairs 
designed for this work were PAM-out designs, with spacings between the PAMs of 50-80 
bases. The D10A Cas9 has been shown to have a median deletion size of 36 nucleotides 
(Bothmer et al., 2017), so all nicks are targeted close to the region where modification was 
desired. Primers for PCR genotyping analysis were designed to amplify >100 bp fragments so 
that the primer binding sites would be less likely to bind within the indel region. 
2.1.2 Clonal expansion 
To generate modified cells, we relied on transient transfection of the Cas9 and sgRNA 
in a single expression vector, pSpCas9n(BB)-2A-GFP, also known as PX461. Different 
approaches are possible here; a polyclonal population can be selected with a mixture of targeted 
and untargeted cells with different indels. However, we chose to isolate and characterise 
clonally expanded cells, taking advantage of the eGFP gene on the PX461 vector. GFP+ cells 
are more likely to also express Cas9 protein and can be isolated using flow-assisted cell sorting 
(FACS). While antibiotic selection is also available that can facilitate selection of targeted 
clones, this may result in integration of the vector and sustained expression of the Cas9 protein, 
leading to higher incidence of off-target events. 
2.1.3 Gene targeting 
To enhance the chances of successful gene targeting of NPAS2 and other circadian 
genes, it was decided to embark on this study using the well-characterised human HEK293 
embryonic kidney and murine NIH3T3 fibroblast cell lines. Circadian cycling has also been 
experimentally induced in both cell types using serum shock (Cox, 2012, Allen et al., 2004).  
Our preferred strategy was to target regions incorporating the start codon, where indels 
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could disrupt the start codon and thereby translation, or close by in the first coding exon, where 
indels could produce frame shift mutations, leading to a premature stop codon and early 
truncation of coding sequence or nonsense-mediated decay. Due to the random nature of indels 
generated by CRISPR-Cas9 technology, this process included screening many clones to 
successfully select those that showed reduced or absent expression of each target gene. 
2.1.4 Aims 
The main objectives for this chapter were to generate and characterise modified clonal 
cells derived from NIH3T3 and HEK293 cells. As well as NPAS2, the other two genes which 
make up the positive arm of the circadian transcription-translation feedback loop, BMAL1 and 
CLOCK, were targeted for mutation. This strategy was to enable later comparisons to be made 
regarding the requirement of different circadian gene components for circadian regulation 
using RT-qPCR or reporter genes, and for follow-on studies, such as RNA-seq transcriptomics. 
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2.2 Materials & Methods 
2.2.1 Sources of general chemicals and reagents 
All general laboratory reagents were purchased as analytical grade quality from either 
Fisher Scientific or Sigma-Aldrich unless otherwise stated. Sterile Phosphate Buffered Saline 
(PBS) solution was prepared using tablets purchased from OXOID Ltd. All solutions were 
made in distilled water; purified by passage through a Millipore Elix® Essential 3 Water 
Purification System. The pH of solutions where specified was maintained by checking the pH 
with a pH meter (Jenway 3510), calibrated against standards of known pH. Sterilisation was 
achieved either by filtration through 0.2 µm filters, or via autoclaving at 121 °C for 20 minutes, 
as appropriate. 
2.2.2 Bacterial preparation and culture 
2.2.2.1 Bacterial strains & culture materials 
The Escherichia coli strain DH5α (Hanahan, 1983) is a recA deficient strain used to 
propagate plasmid vectors and was cultured in the lab after initial purchase from Stratagene. 
Luria-Bertani bacterial growth medium (LB medium) was purchased from Fisher. Plates were 
made using LB medium with added 2% w/v bacteriological agar which had been autoclaved at 
121 °C for 20 minutes. Solid medium was melted in a microwave for 5-10 minutes at full 
power. Where appropriate ampicillin was added to molten medium to a final concentration of 
100 µg/ml. Approximately 20 ml was poured into each petri dish to cover the surface and 
allowed to solidify at room temperature. Plates were stored at 4ºC for up to 1 month.  
Ampicillin was prepared as a 1000x stock solution made as 100 mg/ml in 50% ethanol, 
50% sterile dH2O. Stored in aliquots at -20 °C.  
2.2.2.2 Preparation of competent cells (Escherichia coli) 
Escherichia coli DH5α cells were streaked on an antibiotic-free LB agar plate and 
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incubated at 37 °C overnight. A single colony was used to inoculate a 10 ml volume of LB 
medium (antibiotic-free) and cultured overnight at 37 °C, with shaking. This was then used to 
set up a 300 ml total volume culture in the same medium and was incubated at 37 °C, with 
shaking until the optical density (measured at 600 nm; OD600) reached 0.5. Cultures were 
chilled on ice and all further work was performed at 4 °C. The culture was centrifuged for 10 
minutes, 4,000 rpm at 4 °C in separate 50 ml tubes and the supernatants removed. Each pellet 
was washed in 8.3 ml of 0.1 M MgCl2, before the centrifugation was repeated. The supernatants 
were discarded, and each pellet was resuspended in 8.3 ml of 0.1 M CaCl2. These suspensions 
were incubated on ice for a minimum of 20 minutes, before repeating the centrifugation. The 
supernatants were removed, and all pellets were resuspended together in a total of 8.6 ml of 0.1 
M CaCl2. 1.4 ml 100% glycerol was added to the suspension, inverted 5 times and 200 µl 
volumes were aliquot into microcentrifuge tubes. These were snap frozen immediately in liquid 
nitrogen and stored at -80 °C.  
2.2.2.3 Bacterial transformations 
Escherichia coli DH5α cells were utilised in all bacterial transformations. An aliquot 
of these heat-competent cells was allowed to thaw on ice for a maximum of 10 minutes after 
removal from storage at -80 °C. 50 ng of intact vector/plasmid, or 10 µl of ligation products 
was added to 50 µl of cells. The mixture held on ice for 30 minutes, then heat shocked at 42 °C 
for 2 minutes, before being placed on ice for a further 5 minutes. Pre-warmed LB medium was 
added to a final volume of 1 ml and each sample was cultured at 37 °C for 1 hour with shaking, 
before centrifugation for 2 minutes at 7,000 rpm. 900 µl of the supernatant was removed, the 
pellet was resuspended in the remaining liquid and (in the case of ligation mixes) the entire 
volume was plated on LB agar supplemented with 100 µg/ml ampicillin. Each agar plate was 
incubated overnight at 37 °C. For each transformation experiment, a negative control of 50 µl 
volume of DH5α cells, without added DNA, was included. When transforming ligation mixes, 
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additional controls included cut vector only (to ascertain background), insert only (to confirm 
no contaminating plasmid DNA) or vector/insert mix without ligase. Single Amp-resistant 
colonies were selected from plates for growth in LB-Amp broth for miniprep or maxiprep 
purification of the plasmid at 37 °C, with shaking. A positive control transformation using 50 
ng of undigested PX461 vector was used to test the competence of the DH5α cells. This 
transformation mix was diluted 1:10, 1:100 and 1:1000 before plating, meaning the plates 
would grow colonies as transformed by 5, 0.5 and 0.05 ng. The colony counts of these plates 
were then used to calculate the transformation efficiency of the bacteria using Formula 2.1. 




Formula 2.1:  Calculation of the transformation efficiency of competent bacteria  
2.2.3 Computational design of sgRNAs 
For each gene targeted for CRISPR-Cas9 modification the sequence of the genome was 
acquired from the Ensembl database (Zerbino et al., 2018, Cunningham et al., 2019). A specific 
region of the sequence where a mutation was desired was submitted to the MIT CRISPR design 
tool (Hsu et al., 2013) which identifies pairs of specific 23 base guide sequences ending in 
NGG, one on the forward and one on the reverse strand, in close proximity to each other. The 
design tool provides several guide pairs, and a single guide pair was selected based on locus in 
the genome and scoring provided by the tool. Later in the project alternative resources such as 
CHOPCHOP (Labun et al., 2019) or genome browser CRISPR track were also used due to the 
shutdown of the MIT CRISPR design tool.  
The selected CRISPR-Cas9 sgRNA oligonucleotide sequences of 20 bases, not 
including PAM sequences, were ordered with the reverse complement with some additions. 
For sequences in which the first nucleotide was not guanine, a single guanine was added to the 
5’ end and a complementary cytosine added to the complementary strand. This was because a 
guanine at the 5’ end of a sgRNA enhances its transcription when under the control of a U6 
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promoter, as in PX461 (Iijima et al., 2006, Chiang et al., 2016). In addition, “5’-CACC-3’” and 
“5’-AAAC-3’” sequences were added to the 5’ ends of the respective forward and reverse 
sgRNA oligonucleotide sequences to form overhangs complementary to those formed by BbsI 
restriction digestion in PX461.  
 
2.2.4 Molecular biology techniques 
2.2.4.1 Sources and composition of reagents 
All restriction enzymes, T4 polynucleotide kinase, calf-intestinal alkaline phosphatase 
and T4 DNA ligase enzymes and their relevant buffers were purchased from either Roche or 
New England Biolabs (NEB). Thermostable Taq DNA polymerase, along with reaction buffer, 
supplements and dNTPs were purchased from NEB. The 1 Kb Plus DNA Ladder was 
purchased from Invitrogen. Monarch® DNA gel extraction kits were purchased from NEB, 
Nucleospin® plasmid kits (miniprep kits) from Macherey-Nagel and plasmid maxi kits 
(maxiprep kits) from QIAGEN Ltd. The GenElute™ mammalian genomic DNA miniprep kits 
were purchased from Sigma-Aldrich. Oligonucleotides and primers were purchased from 
Sigma-Aldrich as lyophilised and desalted pellets. These were resuspended in sterile water to 
a 100 µM concentration and stored at -20 °C. The PX461 plasmid was a gift from Feng Zhang 
and generated plasmids are noted in the appendix Table A.2. 
Agarose gel loading dye (10x) = 3.9 ml glycerol, 500 μl 10% (w/v) SDS, 200 μl 0.5 M 
EDTA, 0.025 g bromophenol blue & made up to a total volume of 10 ml with dH2O. Used at a 
final concentration of 1x. 
Tris-borate-EDTA (TBE) = 40 mM Tris-base, 40 mM boric acid, 0.5 mM EDTA 
(pH8.0) and made up to 1 L with dH2O.  
2.2.4.2 Annealing of oligonucleotides 
100 µM CRISPR-Cas9 sgRNA single stranded oligonucleotides were individually 
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phosphorylated in the T4 Polynucleotide kinase reaction mixture shown in Table 2.1, incubated 
at 37 °C for 60 minutes. The mixture was then incubated at 65 °C for 20 minutes to inactivate 
the enzyme. 
Table 2.1: Oligonucleotide phosphorylation reaction composition 
100 µM Oligonucleotide 2 µl 
10 x T4 DNA ligase buffer 2 µl (to make 1 x) 
T4 Polynucleotide kinase 10 Units (1 µl) 
dH2O To a total volume of 20 µl 
 
Once complete, 5 µl of each complementary top and bottom oligonucleotide reaction 
mix were combined and made up to a total volume of 50 µl with sterile dH2O. These mixtures 
were then placed in a thermocycler to heat the mixture to 95 °C for 3 minutes, then cooled by 
1 °C each minute until a temperature of 25 °C was reached and held for additional 5 minutes 
at 25 °C to ensure correct annealing. The annealed and phosphorylated oligonucleotides were 
stored at -20 °C until required for ligation.  
2.2.4.3 Restriction digestions 
The PX461 Cas9 expression vector was digested with the BbsI restriction enzyme using 
NEBuffer 2.1 at 37 °C for 2 hours. Typical restriction enzyme digestions are shown in Table 
2.2. The digestion reaction was then run on an agarose gel and extracted to purify the uncut 
vector from the excised fragment. 
Table 2.2: Restriction digestion reaction composition 
10 x Buffer 2.0 µl (to make 1 x) 
Uncut PX461 vector 1 µg 
BbsI enzyme 10 Units (1 µl) 
dH2O To a total volume of 20 µl 
 
The BbsI restriction enzyme cuts the PX461 vector so that non-compatible ends are 
produced, which means that the vector would be unable to self-ligate without inclusion an 
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insert. The cut vector was dephosphorylated at the 5’ end by incubation with 1 μl TSAP (1 Unit) 
for 1 hour at 37 °C. The cut vectors were stored at -20 °C until required. 
2.2.4.4 Agarose gel electrophoresis 
Analysis and visualisation of PCR products and restriction enzyme digestions was 
performed via agarose gel electrophoresis. 0.8%-2% Agarose gels were made by mixing the 
relevant mass of agarose (w/v) required for the desired percentage agarose gel with 1 x TBE 
buffer, then heating in a microwave oven until agarose was dissolved and a clear liquid was 
formed (~3 minutes at full power). 1 µl of a 10 mg/ml ethidium bromide solution was added 
per 50 ml of liquid agarose, before pouring and allowing it to solidify at room temperature. 10 
µl of the desired DNA ladder was loaded and all samples to analyse were mixed with the 
necessary volume of 10 x agarose gel loading dye to make a final concentration of 1 x loading 
dye, prior to loading in the gel. All agarose gels were run at 90 V in 1 x TBE buffer for the 
necessary length of time that would ensure good DNA band separation of the desired size, 
generally 1 hour. DNA bands were visualised and imaged using either a BIO-RAD Universal 
Hood II UV transilluminator or a Fujifilm LAS-4000 system.  
2.2.4.5 Purification of DNA from an agarose gel 
Desired band(s) of DNA were excised from the agarose gel under low power UV 
illumination using a sterile scalpel blade, removing as much agarose as possible and avoiding 
prolonged UV exposure of the DNA. DNA fragments were purified using the Monarch® DNA 
Gel Extraction Kit, following the manufacturer’s instructions. The concentration of DNA in 
the eluate was determined using a NanoDrop 1000 Spectrophotometer. Purified DNA was 
stored at -20 °C until required. 
2.2.4.6 Ligation of DNA fragments 
Phosphorylated and annealed sgRNA linear dsDNA fragments were ligated to BbsI 
digested PX461 to generate Cas9 targeting constructs for the genetic regions of interest. A 
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typical ligation reaction is described in Table 2.3.  
For each set of ligation reactions, a negative control was included to indicate the level 
of background undigested/re-ligated vector. This negative control contained all the reagents, 
with exception of the linear DNA insert. Since all ligations were of the same size insert, this 
process was not varied. Each sample was vortexed, centrifuged and allowed to ligate overnight 
at 4 °C. Following this, the products were stored at -20 °C until used for bacterial 
transformation (see 2.2.2.3).  
Table 2.3: Ligation reaction composition 
Linear DNA Insert 2 µl (1:3 insert:vector) 
PX461 vector 100 ng 
10 x T4 DNA ligase buffer 2 µl (to make 1 x) 
T4 DNA ligase 3 Units (1 µl)  
dH2O To a total volume of 20 µl 
 
2.2.4.7 Small-scale purification of vectors & plasmids from bacteria (miniprep) 
For the small-scale purification of ligated vector from bacterial colonies, a miniprep 
was performed. A 10 ml volume of LB supplemented with 100 µg/ml ampicillin was inoculated 
with a single bacterial colony from the relevant transformation plate. This was then allowed to 
grow at 37 °C overnight, with shaking. The culture was pelleted by centrifugation at 4,000 rpm 
for 10 minutes at 4 °C. Plasmid DNA was then recovered from the pellet by alkaline lysis and 
affinity purification using the NucleoSpin® Plasmid kit (Machery-Nagel) according to the 
manufacturer’s protocol for low copy plasmids and the eluate DNA concentration determined 
using a NanoDrop 1000 Spectrophotometer. Purified plasmids were stored at -20 °C. 
2.2.4.8 Sequencing of DNA 
DNA was sequenced to identify that vectors purified from colonies had been ligated to 
correctly form PX461-sgRNAs and also to analyse the genetic sequence of targeted cells. 
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Plasmid or PCR DNA was sequenced by Source Bioscience Ltd using an Applied BioSystems 
3730 DNA Analyzer and PeakTrace™ software. The volumes and concentrations used for 
sequencing as advised by Source Bioscience Ltd are shown in Table 2.4. Vectors were taken 
from miniprep stocks (see 2.2.4.7) and sequenced using a human U6 forward primer, whereas 
PCR products were taken from agarose gel purified stocks (see 2.2.4.5) and were sequenced 
using designed primers (See appendix section A.6, page 296 for primer details).  
Table 2.4: The volume and concentration of vectors, plasmids, PCR products and 
primers for DNA sequencing 
 Vector or plasmid PCR product 
DNA 5 µl (100 ng/µl) 5 µl (10 ng/µl) 
Primer 5 µl (3.2 pmol/µl) 5 µl (3.2 pmol/µl) 
 
2.2.4.9 Large-scale purification of vectors & plasmids from bacteria (maxiprep) 
For the large-scale purification of PX461-gRNAs from bacteria, a maxiprep was 
performed. A 10 ml volume of LB supplemented with ampicillin (final concentration of 
100 µg/ml), was inoculated with a single bacterial colony from a transformation plate made 
using the purified and sequenced PX461-gRNAs. This was then allowed to grow at 37 °C, with 
shaking, until the culture visually became turbid. This was then used to set up a 300 ml total 
volume culture in the same medium and was incubated at 37 °C overnight, with shaking. The 
Qiagen Plasmid Maxi Kit protocol was followed, with the exception of the centrifugation steps, 
which were all performed at 6,500 rpm for 50 minutes at 4 °C. The purified PX461-gRNAs 
was re-dissolved in 200 µl dH2O and the concentration determined using a NanoDrop 1000 
Spectrophotometer before storage at -20 °C ready for transfections into cultured cells. 
2.2.4.10 Extraction of genomic DNA from mammalian cells and tissue 
Genomic DNA was purified from mammalian cultured cells using the GenElute™ 
Mammalian Genomic DNA Miniprep Kit. Cells were harvested as described in 2.2.5.2, the 
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suspension was transferred to 15 ml tubes and centrifuged at room temperature at 1,500 rpm 
for 5 minutes. The supernatant was discarded and the pellet resuspended in 1 ml 1 x PBS, 
before repeating the centrifugation. Again, the supernatant was removed, and the pellet stored 
at -20 °C for <1 week and genomic DNA was then purified by use of the extraction kit 
following the manufacturer’s instructions. Genomic DNA was stored at -20 °C until required. 
The concentration of DNA was determined using a NanoDrop 1000 Spectrophotometer. 
2.2.4.11 Polymerase chain reaction (PCR) 
PCR was utilised for genotyping of modified clones. Typical reaction mixtures and 
cycling protocols, as recommended by NEB, are shown in Table 2.5 and were performed in an 
Applied Biosystems 2720 thermal cycler. The Taq reaction buffer used includes MgCl2 at a 
concentration of 15 mM for a 1.5 mM concentration in the final reaction. The annealing 
temperature was set at 5 °C below the lowest Tm of the primer pair(s). If the PCR reaction 
conditions were altered it is noted in the respective results section. PCR products were stored 
at -20 °C until use. 
 
Table 2.5: Reagents used and composition of typical PCR reactions, along with typical 
thermocycler settings 
 
 Reagents Cycle 
 
DNA template 50 ng 95 °C – 30 seconds 
 
10 x standard Taq reaction buffer with 
MgCl2 
5 µl (to make 1 x) 95 °C – 10 seconds 
 
10 µM Forward primer 1 µl (to make 0.2 µM) 55-65 °C – 30 seconds 
      x 35           
cycles 
10 µM Reverse primer 1 µl (to make 0.2 µM) 68 °C – 1 min/kb 
 
10 mM dNTP mix 1 µl (to make 0.2 mM) 68 °C – 10 minutes 
 
Taq DNA polymerase 0.25 µl (1.25 units)  
 
Nuclease-free sterile dH2O To 50 µl final volume  
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2.2.5 Mammalian cell culture 
2.2.5.1 Sources of cell culture material and composition of reagents 
All cell culture reagents were purchased from Lonza or Gibco and all plasticware was 
obtained from Corning. Lipofectamine™ 2000 Transfection Reagent was purchased from 
ThermoFisher.  
2x HBS solution = 50 mM HEPES, 280 mM NaCl, 1.5 mM Na2HPO4 in dH2O, pH 
adjusted to 7.07 using 1 M HCl. Filter sterilised and stored at -20 °C until use.  
RIPA lysis buffer = 50 mM Tris base, 1% NP-40, 0.1% SDS, 150 mM NaCl, 
cOmplete™ mini protease inhibitor, pH adjusted to 8 using 1 M HCl. 
2.2.5.2 Culturing of adherent cells 
The human embryonic kidney (HEK293) and mouse fibroblast (NIH3T3) cells were 
typically maintained in Dulbecco’s Modified Eagle Medium (DMEM). This medium was 
supplemented with either 10% (v/v) heat-inactivated fetal calf serum (FCS) for HEK293 cells 
or 10% (v/v) heat-inactivated newborn calf serum (NBCS) for NIH3T3 cells plus 1% (v/v) 0.2 
M L-glutamine and 1% (v/v) Penicillin/Streptomycin antibiotics. Cells were cultured in sterile 
plastics at 37 °C, 5% CO2 and passaged when at approximately 80% confluency. When cells 
were passaged and/or collected the medium was aspirated, and cells washed with 1 x PBS. 
HEK293 cells were then suspended in fresh medium while NIH3T3 cells were incubated for 5 
minutes at 37 °C in 1 x trypsin and suspended in fresh medium. At this point, the cell suspension 
was diluted and split into other sterile plasticware and/or collected into 15 ml tubes if being 
used for other processes. 
2.2.5.3 Cryopreservation of cells  
For cryopreservation cells were collected into tubes in a media suspension as described 
in 2.2.5.2. A small volume of the cell media suspension was loaded onto a haemocytometer 
(Hawksley, BS.748) and counted under a light microscope. A volume containing the 
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appropriate number of cells was then centrifuged at 600 x g for 5 minutes to pellet the cells 
(1x106 cells/ml for NIH3T3 and 3 x 106 cells/ml for HEK293). These were then resuspended 
in freezing media (DMEM with 10% (v/v) DMSO and 20% (v/v) FCS for HEK293 or NBCS 
for NIH3T3) and moved to labelled cryovials. The vials were then stored at -20 ̊C until frozen 
solid. The cryovials were then placed at -80 C̊ overnight in bubble wrap to ensure slow freezing 
and then transferred to liquid nitrogen for long term storage.  
2.2.5.4 Resuscitation of frozen cells  
To recover cells from liquid nitrogen storage, cells were thawed at 37 C̊ and transferred 
into 10 ml of pre-warmed medium. The suspension was mixed thoroughly, and the cells 
pelleted by centrifugation at 600 x g for 5 minutes to remove residual DMSO which can impede 
growth. Cells were then resuspended in fresh media and incubated at 37 ̊C, 5% CO2. The day 
after cell plating the media was changed to remove dead and unattached cells, followed by 
another change of media after 24 hours. Cells were passaged at least three times after 
resuscitation, to ensure they have fully recovered, before use in experiments.  
2.2.5.5 Calcium phosphate-mediated transfection of HEK293 cells 
HEK293 cells were seeded at a density of 5 x 105 cells per well in a 6 well plate, 24 
hours prior to transfection. On the day of transfection, the culture medium was replaced 3-4 
hours before transfection. An aliquot of 200 µl 2 x HEPES Buffered Saline (HBS) solution, 
along with a separate mixture of 25 µl 2M calcium chloride solution & 1 µg of each 
vector/plasmid to be transfected, made up to a total volume of 200 µl with sterile dH2O was 
prepared for each sample. The calcium chloride & DNA mixture was added in a dropwise 
fashion to the HBS solution, whilst gently vortexing the aliquot of HBS. This mixture was 
incubated at room temperature for 20 minutes, before being added to the relevant cells in a 
dropwise fashion. The cells were incubated for 16 hours at 37 °C, 5% CO2. After incubation, 
the cells were washed three times with PBS, and then fresh medium was added. The cells were 
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then analysed for expression of the plasmid construct via fluorescent microscopy for GFP 
reporters after a further 24 hours and harvested for cell sorting within a further 36 hours.  
2.2.5.6 Lipofectamine-mediated transfection of NIH3T3 cells 
NIH3T3 cells were seeded at a density of 1.5 x 105 cells per well in a 6 well plate, 24 
hours prior to transfection. On the day of transfection, the manufacturer’s protocol for 
lipofectamine 2000 transfection was followed. The cells were then analysed for expression of 
the plasmid construct via fluorescent microscopy after 36 hours from transfection and were 
harvested for cell sorting as described for cell passaging within 72 hours. 
2.2.5.7 Flow-Assisted Cell Sorting of GFP+ cells 
Cell sorting of GFP+ single cells was achieved by the in-house fluorescence-activated 
cell sorting (FACS) facility using a FACSAria Cell sorter. Cell emission at 510 nm upon 
excitation using a 488 nm laser was used for analysis of GFP expression. To prepare transfected 
cells for FACS, they were harvested as for passaging in 2.2.5.2 and centrifuged at 600 x g for 
5 minutes, prior to pellet resuspension in 500 µl of media appropriate for the cell type. These 
volumes were then transferred to separate BD Falcon FACS tubes with cellstrainer caps to 
remove clumps of cells and were kept on ice prior to sorting. Individual GFP expressing cells 
were sorted into 96 well plates containing 100 µl prewarmed media appropriate for the sorted 
cell type. An extra 100 µl of media was added after single-cell seeding. 
 
2.2.6 Biochemical techniques 
2.2.6.1 Sources and composition of biochemical reagents 
The SDS-PAGE molecular weight protein marker, Color Prestained Protein Standard, 
Broad Range, 11–245 kDa was purchased from NEB. Nitrocellulose transfer membrane was 
purchased from Bio-Rad. The N,N,N,N-tetramethylethylenediamine (TEMED) was purchased 
from Sigma-Aldrich. 30% (w/v) ProtoGel acrylamide mix from National Diagnostics. The 
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developing solution used for imaging was Pierce™ ECL Western Blotting Substrate from 
ThermoFisher, used according to manufacturer’s instructions. 
SDS-PAGE loading buffer (4x) = 2.0 ml 1 M Tris-HCl pH 6.8, 0.8 g SDS, 4.0 ml 100% 
glycerol, 0.4 ml 14.7 M β-mercaptoethanol, 1.0 ml 0.5 M EDTA and 8 mg bromophenol blue, 
made up to 10 ml with dH2O. 
Ponceau S solution = 0.1% (w/v) Ponceau S in 5% (v/v) acetic acid. Made up to a total volume 
of 1 L with dH2O. 
5% milk blocking solution = 5% (w/v) Marvel 0% fat milk powder in 1x PBS.  
Tris-glycine-SDS (TGS) buffer (10x) = 250 mM Tris base, 2 M glycine, 35 mM SDS, pH 8.3. 
Transfer buffer = 48 mM Tris base, 39 mM glycine, 0.037% (w/v) SDS, 20% (v/v) methanol. 
10% Ammonium persulphate (APS) solution = 10% (w/v) APS in dH2O. Stored at -20 °C until 
use. 
10% Sodium dodecyl sulphate (SDS) solution = 10% (w/v) SDS in dH2O.  
PBST = 1× PBS containing 0.1% (v/v) Tween 20. 
2.2.6.2 Protein extraction from mammalian cell extracts 
Mammalian cell-free extracts were prepared using RIPA buffer. HEK293 cells were 
harvested as described for passaging in 2.2.5.1, the suspension was transferred to 15 ml tubes 
and centrifuged at room temperature at 600 x g for 5 minutes. The supernatant was discarded 
and the pellet resuspended in 1 ml ice cold 1 x PBS, before repeating the centrifugation. The 
pellet was then resuspended in ice cold RIPA buffer. When harvesting NIH3T3 cells the 
medium was aspirated, and cells washed with ice cold 1 x PBS before being scraped into ice 
cold RIPA buffer. Cell suspensions in RIPA buffer were then stored at -80 °C until sonicated. 
The samples were defrosted and sonicated for 3 cycles of 30 second bursts in a Diagenode 
Bioruptor® before spinning down of the cell lysate and collection of the supernatant. The 
protein samples could then be stored at -80 °C until required or progressed directly into 
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Bradford assays to determine total protein concentration for SDS-PAGE and western blotting. 
2.2.6.3 Antibodies 
The primary antibodies mouse anti-CLOCK (sc-271603) and mouse anti-BMAL1 (sc-
365645) were from Santa Cruz Biotechnology. Rabbit anti-NPAS2 (HPA019674) was from 
Atlas Antibodies. Mouse and rabbit anti-β actin (A5441 and A2066 respectively) were from 
Sigma-Aldrich. Primary antibody dilutions are detailed on western blot figures where they are 
used. Horseradish peroxidise (HRP) conjugated secondary antibody chicken anti-mouse (sc-
2954, used at 1:5000) and secondary goat anti-rabbit (sc-2004, used at 1:2000) were purchased 
from Santa Cruz Biotechnology. 
2.2.6.4 Protein concentration determination 
Protein concentrations were determined using the Bradford assay method. Reactions 
were set up consisting of 2 µl of protein extract, 800 µl dH2O & 200 µl of Sigma-Aldrich 
Bradford dye in cuvettes. The samples were mixed thoroughly and left to stand at RT for 15 
minutes. The absorbance of each sample was then read at 595 nm and the concentration 
calculated relative to a standard curve created from reads of diluted Bovine Serum Albumin 
(BSA) standards of known concentrations, performed at the same time.  
2.2.6.5 Sodium-dodecyl-sulphate polyacrylamide gel electrophoresis (SDS-PAGE) 
SDS-PAGE gels were made as either 5% stacking, 6% resolving, 12% resolving 
two-part gel or 5% stacking, 12% resolving gel. The two-part gels were prepared as shown in 
Table 2.6, for a 12% gel all volumes for the 12% section were doubled. 
The prepared protein extracts, which corresponded to 100 µg of protein made up to 
equal volumes with distilled water and SDS protein loading dye, were incubated for 5 minutes 
at 100 °C to denature the protein and resolved on a 6/12% or 12% SDS-PAGE gel ran at 180 
V with 1 x TGS buffer.  
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Table 2.6: Reagents used and composition of SDS-PAGE gels. All volumes are in ml and are 
enough for one gel. 
 5% Stacking gel 6% Resolving gel 12% Resolving gel 
dH2O 3.40 2.6 1.6 
30% (w/v) Acrylamide 0.83 1.0 2.0 
1.5 M Tris pH 8.8 - 1.3 1.3 
1.0 M Tris pH 6.8 0.63 - - 
10% SDS solution 0.05 0.05 0.05 
10% APS solution 0.05 0.05 0.05 
TEMED 0.005 0.004 0.002 
 
2.2.6.6 Western blotting 
After removal from the gel apparatus and rinsing in transfer buffer, Proteins were 
transferred from SDS-PAGE gels onto a nitrocellulose membrane overnight at 30 V, 4 °C, with 
an ice block in the chamber and filled with transfer buffer. The membrane was covered with 
1% Ponceau S solution for one minute, washed three times with dH2O and checked by eye for 
successful protein transfer. Non-specific antibody binding was blocked by adding 5% milk to 
the membrane for 1 hour at room temperature, with agitation. The membrane was then 
incubated overnight at 4 °C, with agitation in 5% milk containing the primary antibody (typical 
concentration 1:500 see results for details). To remove excess antibody, the membrane was 
washed in PBST three times for 5 minutes each, with agitation at room temperature, then 
incubated for 1 hour with agitation at room temperature in 5% milk containing the secondary 
antibody (typical concentration 1:5,000). The washes with PBST were repeated to remove 
excess antibody. Developing solution was added to the nitrocellulose membrane and incubated 
at room temperature for 1 minute. The membrane was wrapped in clear plastic and excess 
developing solution removed. A Fujifilm LAS-4000 system was used immediately to detect 
and image the chemiluminescent signal. Exposure times are detailed in the legends for the 
specific western blots. The prestained protein marker (Color Prestained Protein Standard, 
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Broad Range, 11–245 kDa) was also imaged as a reference of molecular weight. The imaged 
membranes were then stored at 4 °C sealed in PBS and could be reprobed and imaged if 
required. 
The molecular weight (MW) of the protein was calculated by use of a logarithmic 
regression analysis of migration distance. Briefly the migration distance of three of the known 
MW bands of the standard close to the band of interest were measured using ImageJ and a 
standard curve was made using the log of the distance travelled. This standard curve was then 
used to calculate the MW weight of the bands of interest using the migration distance calculated 
in ImageJ.  
 
2.2.7 Generation and identification of modified cells process 
2.2.7.1 Design of sgRNAs for targeting of murine and human circadian genes 
CRISPR-Cas9 nickase-mediated genome editing (as discussed in the introduction 
section 2.1.1) requires the targeting of SpCas9n to proximal 20mer sequences on opposing 
strands of the target locus (Ran et al., 2013a). The generated single strand breaks on opposing 
strands invokes repair by the non-homologous end joining repair pathway leading to indels. 
Transcripts were compared using the Ensembl (Cunningham et al., 2019, Zerbino et al., 2018), 
RefSeq (O'Leary et al., 2016), and UniProt (Consortium, 2019) databases and sequences were 
acquired from the Ensembl database. Guide sequences were designed as described in section 
2.2.3 to target CLOCK, BMAL1 and NPAS2 sequences in human kidney cells (HEK293) and 
CLOCK and NPAS2 sequences in mouse fibroblast cells (NIH3T3). Details of the design 
process for the specific genes are included below in section 2.3 and detailed sequence 
information for the guides is included in the appendix section A.6 (page 296).  
Our initial approach was to target indels close to or encompassing the initial ATG start 
codon (AUG in RNA) with the aim that sequence alterations disrupting the ATG should lead 
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to loss of expression. This was dependent on the availability of suitable guide sequences within 
the targeted region flanking the ATG. The alternative strategy, where required, attempted to 
introduce indels early in the coding sequence to produce premature stop codons or frame shifts 
leading to non-functional target proteins, the detailed process for each cell type below details 
the approach taken. 
2.2.7.2 Generation of Cas9 targeting constructs for circadian genes 
To generate Cas9 targeting vectors for BMAL1, CLOCK and NPAS2 in human and 
mouse cell models, the designed oligonucleotide guide sequences were annealed and 
phosphorylated (2.2.4.1) and maxiprep DNA of the PX461 vector was digested with BbsI 
enzyme and purified by running on an agarose gel (2.2.4.3-2.2.4.5). Complete digestion was 
validated by identification that the linearised vector was the correct predicted size of 9.22kb 
and ran differently to the uncut vector (Figure 2.2). The purified cut vector was ligated to the 
annealed phosphorylated oligonucleotides comprising the guide sequences and the ligations 
transformed into DH5α cells (2.2.4.6 to 2.2.4.7). While consistently no colonies were obtained 
using the vector only control, tens to hundreds of ampicillin resistant clones were obtained with 
the vector insert mix, indicating successful ligation. Sequencing of cultures from several clones 
from each ligation confirmed successful generation of the targeting constructs (2.2.4.8). These 
verified cultures were then subjected to maxiprep purification for mammalian cell transfection 
(2.2.4.9).  




Figure 2.2:  PX461 plasmid digestion 
A:  Agarose gel electrophoresis showing PX461 plasmid (1 mg), uncut or digested with BbsI.  
The linearised DNA runs with the band front at approximately the expected size of  9.2kb. 
B:  Schematic of  the BbsI cloning sites allowing insertion of the 20 bp guide sequences into 
the sgRNA scaffold.  BbsI digestion generates incompatible ends preventing self-ligation of 
the cut vector.  Design of annealed primers pairs is shown above. A schematic map of the 
PX461 vector is also shown detailing the FLAG-NLS-CAS9 and GFP coding sequences that 
are expressed under control of  a CMV promoter.  
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2.2.7.3 Transfection of cells with generated PX461 vector to target circadian genes 
For each target gene (human or mouse specific), the appropriate cell type was 
transfected with either the guide plasmid pairs or a single guide plasmid as a control (2.2.5.5 
or 2.2.5.6). The PX461 vector carries eGFP, so after 2-3 days, transfection efficiency was 
scored by fluorescence microscopy (for example see Figure 2.3) and if the cells are seen to 
achieve at least 10% transfection efficiency, they were harvested for cell sorting. GFP positive 
cells were selected using a FACSAria Cell sorter (2.2.5.7). For each condition, individual 
GFP+ cells were sorted in 2 x 96 well plates and clonally expanded over 2-3 weeks.  
 
 




Figure 2.3:  HEK293 cells transfected with PX461-Homo sapiens  CLOCK  sgRNA A and PX461-
Homo sapiens  CLOCK  sgRNA B 
A:  Under a blue light viewed through a green filter.  Cells  visible here express the eGFP and 
have been successfully transfected. B:  Under a white light showing total  cells most of which 
are not expressing eGFP. 
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2.2.7.4 Identification of mutant clones 
Identification of CRISPR-Cas9 targeted clones was performed to select specific 
mutants to use as models for research and characterise the specific mutations. This work was 
performed in collaboration with PhD student Ruby Chrisp. Surviving clones were named 
according to plate number and well position (e.g., 1E9). Once a sufficient number of cells were 
available (4-8 weeks) genomic DNA and protein extracts were collected for analysis of the 
control and targeted clones (2.2.4.10 & 2.2.6.2). Analysis of indels is detailed in section 2.3 
but for each gene target a similar process is followed. The genomic DNA was amplified by 
PCR using primers flanking the targeted genomic region to characterise mutations by change 
in product size on an agarose gel (2.2.4.11 & 2.2.4.4). Due to the variability of insertions and 
deletions expected for the mutations, changes in product size are to be expected with the alleles 
presenting as different bands due to unique indels. PCR analysis also aids checking of the 
number of alleles, which is required as HEK293 cells show variable pseudotriploid karyotype 
and NIH3T3 cells are near tetraploid (Lin et al., 2014, Leibiger et al., 2013). The extracted 
protein was used for western blotting to assess impact on level of protein expression (2.2.6.4-
2.2.6.6). Detection of changes in expression in the encoded proteins by western blots is reliant 
on the availability of high-quality antibodies, as well as knowledge of the different isoforms 
that may be expressed in each cell type or tissue. Sequencing of PCR products excised from 
the gels allowed complete identification of the induced mutation (2.2.4.8). These steps were 
necessary to enable selection of clones more likely to have gene inactivation in multiple alleles, 
rather than in-frame deletions/insertions etc. 
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2.3 Results of generation and characterisation of circadian 
gene edited clones 
2.3.1 Targeting NPAS2 gene expression in NIH3T3 fibroblasts 
The mouse NPAS2 gene is located on chromosome 1 and is made up of 21 exons, 20 of 
which are coding exons, and the major transcript is 4,234 bp (Figure 2.4 A). Only a single 
validated transcript is described for the mouse NPAS2 gene in the NCBI and Uniprot databases, 
encoding an 816-residue polypeptide (NM_008719.2). However, the Ensembl database lists 2 
more transcripts for mouse NPAS2 generated by alternative splicing, thus other isoforms may 
be expressed in the cells although the other two transcripts are a short mRNA coding for a very 
short 60aa polypeptide and a non-protein coding processed transcript. Given the make-up of 
the major known transcript, the guide pairs were designed to target exon 2 which codes for the 
AUG initiation codon (Figure 2.4 B and C).  
After transfection with the paired PX461 expression vectors encoding spCas9n-eGFP 
and specific sgRNAs, single GFP+ cells were isolated by FACs cell sorting and clonally 
expanded for analysis. Once clones had reached sufficient cell numbers, genomic DNA was 
extracted for PCR genotyping using the murine NPAS2 primers outlined in the appendix section 
A.5.1 (page 291). The karyotype of NIH3T3 cells is considered tetraploid albeit with 
imbalances due to genomic rearrangements (Leibiger et al., 2013) meaning that when targeting 
events are investigated, multiple alleles may be present depending on the targeted chromosome 
and the location within the chromosome.  




Figure 2.4: Targeting the mouse NPAS2  gene 
A:  Exon structure of the mouse NPAS2  gene from the Ensembl database.  B:  Sequence of the 
mouse NPAS2  exon 2 from the UCSC genome browser showing the initiation codon and 
encoded 11 amino acids. C:  sgRNA designs targeting opposite strands flanking exon 2 of 
Mus musculus  NPAS2 .  Guide pairs were selected close to the ATG in a PAM-out arrangement 
with a 59 bp spacing.  
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Indels in the NPAS2 exon 2 region were readily detected among the expanded clones 
(Figure 2.5) with at least three distinct alleles detected in some clones, as suggested by the 
number of distinct PCR products. In contrast, no obvious indels in this region were detected in 
controls (transfected with a single sgRNA vector). Some clones appeared to have amplified 
bands similar to expected size for unmodified NPAS2, such as the lower band of 1F3, which 
may mean not all alleles were targeted. However, gel electrophoresis is not sensitive enough 
to detect small alterations in targeted alleles. Nonetheless, several clones appeared to lack any 
unmodified product (242 bp) for example 1F12 clearly shows modification of sequence in the 
products. 
Several clones were selected for further investigation based on the absence of a PCR 
band consistent with the size expected for the wild type product. Cell-free extracts from these 
clones were used for western blotting to assess whether the targeted mutations were successful 
in reducing levels of NPAS2 expression. Initial western blot experiments, using a polyclonal 
antibody directed against NPAS2, identified bands that were inconsistent with the expected 
MW of the NPAS2 protein, indicating the antibody was not reliable (see appendix for more 
information, section A.3, page 287). We contacted several groups that had reported NPAS2 
western blots to request antibody samples, but personal communications indicated that none of 
the commercial antibodies available were specific. Indeed, the poor specificity of available 
NPAS2 antibodies precluded western blot confirmation in a KO model (O’Neil et al., 2017, 
pers. comms.).  




Figure 2.5: Genotyping mutations of murine NPAS2  
A: Schematic showing the targeted region of the NPAS2  gene. Blue arrows indicate the 
approximate positions of PCR analysis primers (F1 and R1, see section A.5.1).  B:  PCR 
genotyping gel of GFP+ NPAS2  NIH3T3 clones.  Clones transfected with single guide (Control,  
sgG9 and sgH6) all  produced a single product of the expected size (242 bp) for wild type 
alleles. Up to three distinct bands are present in some clones indicating targeting of 
multiple alleles. All clones apart from 2A9 harbour obvious indels.  Clones highlighted in 
green were selected for western blotting. (Note: the poor quality of the signal detection is 
due to this image being created using the Fujifilm LAS-4000 which used a less powerful UV 
bulb,  due to a temporary defect in the BIO-RAD Universal  Hood II  UV transilluminator that 
was later repaired.)  
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Based on the PCR genotyping data, several NPAS2 targeted clones (2G9, 1E9, 1F1 and 
2D10) were selected for further investigation of the nature of the targeting events. Multiple 
PCR bands from clones 2G9, 1E9, 1F1 and 2D10 and a single band from an sgControl were 
gel purified and sent for sequence analysis. Sequencing of the sgControl band confirmed only 
wild type sequence as expected, indicating successful HDR repair and no editing events in 
single guide controls. The single band detected in 2G9 contained a 23 bp deletion upstream of 
the ATG. Clone 2D10 yielded 3 or 4 PCR products, the lower 2 or 3 bands ran very closely 
together meaning only the larger band with a 31 bp insertion upstream of the ATG was clearly 
sequenced. Since the ATG was unaffected and a frameshift could not be expected these two 
clones were eliminated from further analysis. Clone 1E9 produced three observable PCR 
products, mixed sequence was obtained for the larger products, which indicated co-migration 
of similar sized PCR products, while the lower allele harboured a deletion of 118 bases 
including loss of the ATG. Clone 1F1 sequencing revealed clear deletions of 33 bp and 109 bp 
in the lower sized products, removing part of or the entire exon 2 region respectively, thus both 
alleles detected would be predicted to have lost the mRNA AUG start codon.  
The larger band detected in the 1F1 PCR is approximately 400 bp (A in Figure 2.6), 
suggesting an insertion in the sequence. However, sequence analysis of this product detected a 
mixed sequence. Surprisingly, deconvolution of the mixed sequence suggested that it consisted 
of both of the two smaller alleles 1F1.1 and 1F1.2 (see Figure 2.6.B). No other sequence was 
present. It is possible that during the PCR reaction overlap of sequence of these two products 
generated an artefactual recombined product. As such this is not a unique allele.  




Figure 2.6:  Sequencing murine NPAS2  mutations 
A:  PCR genotyping of clone 1F1 produced three distinct  bands A-C with no band at the 
wild-type position of 242bp. B:  Electropherograms showing a section of sequence analysis 
of  the isolated PCR products A-C,  clear sequence can be seen for B and C but for product A 
the read shows only a mix of B and C within the targeted region which becomes clear B 
sequence after the end of the C sequence.  C:  Sequence alignments of bands B (1F1.1) and C 
(1F1.2) to wild type sequence indicate two targeted alleles harbouring 33 bp and 109 bp 
deletions respectively.  
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Following this analysis, we obtained a different polyclonal NPAS2 antibody (Atlas 
antibodies; HPA019674), which detected multiple bands of varying size, but only one band 
between 80-135 kDa in NIH3T3 cell extracts, calculated to represent a protein of ~104 kDa, 
close to the predicted molecular weight of the NPAS2 main isoform (91 kDa). This band was 
assumed to be the NPAS2 protein based on no other proteins being observed in the correct 
range. Blots with this antibody showed variation of NPAS2 expression in selected clones 
including a strong reduction in the expression of endogenous NPAS2 protein in the clone 1F1 
compared to the wild type (WT) control. In contrast, western blot detection of β actin confirmed 
equal loading (Figure 2.7). As well as highlighting 1F1 as a candidate clone the variation of 
the protein in our NPAS2 modified lines also provides additional confidence that this is a true 
NPAS2 protein band observed. 
Similar western results were observed independently in our lab (Ruby Chrisp, pers. 
comm.). NPAS2 expression is not completely ablated which may indicate expression from an 
undetected allele or reinitiation from a downstream AUG. We did note that the band in Figure 
2.7 for 1F1 appeared to have travelled slightly further than other clones, possibly indicating a 
truncated product, calculated as ~101 kDa. Interestingly, the next available AUG that could 
potentially be used to initiate translation would generate a polypeptide lacking the N-terminal 
34 amino acids. This would truncate the NPAS2 protein within the bHLH domain, comprised 
within residues 1-77, required for DNA binding and BMAL1 association (Yoshii et al., 2013), 
and likely abrogate these functions. Thus, the NIH3T3-NPAS2-1F1 clone is likely to be 
deficient in functional NPAS2. 
 




Figure 2.7:  NPAS2 protein expression in targeted NIH3T3 clones 
Western blot of protein extracts from selected NPAS2  targeted NIH3T3 clones,  probed for 
NPAS2 (Atlas antibodies, HPA019674, batch: A115419, predicted MW 91 kDa, 1:1000 
dilution, 1000 sec exposure) and β actin (Sigma-Aldrich, A2066, batch: 018M4853V, 
predicted MW 42 kDa, 1:1000 dilution, 60 sec exposure) as a loading control.  A large 
number of bands were picked up by the NPAS2 antibody but the band closest to the 
estimated size for NPAS2 is  marked with an arrow. 1F1 is presented first next to the wild 
type control and a clear reduction in expression is visible in both 1F1 and 1E1 in the NPAS2 
band on the western. It  also appears that the putative NPAS2 band in 1F1 may have a 
slightly lower MW compared to other clones and control .  
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2.3.2 Targeting CLOCK gene expression in NIH3T3 fibroblasts 
The murine CLOCK gene is located on chromosome 5 and is made up of 23 exons, 20 
of which are coding exons, and the major transcript is 9,744 bp (Figure 2.8 A). Multiple 
isoforms are listed in the NCBI and Uniprot databases, but all share the same start codon, 
located within exon 4 of the major transcript (Figure 2.8 B). Based on this, guide pairs were 
designed to target exon 4 as shown below (Figure 2.8 C).  
After transfection with the paired PX461 expression vectors for the specific sgRNAs 
GFP+ cells were sorted by FACs and single clonal cells expanded for PCR genotyping, as 
described previously, using the murine CLOCK primers outlined in appendix section A.5.2 
(page 292)271. Indels in the CLOCK exon 4 region were detected in the expanded clones 
(Figure 2.9), with two to three distinct products detected in most clones (or in one case four 
products). No obvious indels were observed in the control clone transfected with a single 
sgRNA vector (sgG9). 
Several clones were selected for further analysis based on the absence of a PCR band 
consistent with the size expected for the wild type product (243 bp). However, most of the 
clones were lost at this stage due to growth failure or contamination, limiting those available 
for investigation to the three clones 2C1, 2H8 and also 1D12 which had not been included in 
the initial gel shown in Figure 2.9 B. 




Figure 2.8: Targeting the mouse CLOCK  gene  
A:  Exon structure of the mouse CLOCK  gene from the Ensembl database B:  Sequence of the 
mouse CLOCK  exon 4 from the UCSC genome browser showing the initiation coding and 
encoded 16 amino acids. C:  sgRNA designs targeting opposite strands flanking murine 
CLOCK  exon 4. Guide pairs were selected to flank the ATG in a PAM-out arrangement with a 
67 bp spacing.  




Figure 2.9:  Genotyping mutations of murine CLOCK  
A: Schematic showing the targeted region of the CLOCK  gene. Blue arrows indicate the  
approximate positions of PCR analysis primers (F2 and R2, see section A.5.2).  B:  PCR 
genotyping gel of GFP+ CLOCK  NIH3T3 clones. The control (sgG10) transfected with single 
guide produced a single product of the expected size (243 bp) for wild type alleles. Several  
distinct bands are present in some clones indicating targeting of multiple alleles. All  clones 
(with the possible exception of 1H2) harbour obvious indels. As detailed above most of 
these clones were lost before they could be carried forward for further testing. 
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A western blot was performed on cell-free extracts from these three clones using a 
monoclonal CLOCK antibody (Santa Cruz; sc271603) to assess whether the targeted mutations 
were successful in reducing levels of CLOCK expression. As shown in Figure 2.10 A, two 
bands were detected in the WT control, calculated as ~85 and ~95 kDa. The Uniprot database 
also describes 2 isoforms of murine CLOCK of 855 (96 kDa) or 825 (93 kDa) residues which 
may be what we observe. The antibody supplier (Figure 2.10 B) and other studies also reported 
the detection of multiple CLOCK bands 90-120 kDa, indicating expression of isoforms and 
posttranslational modifications that affect mobility (Lee et al., 2001). Clone 2H8 shows a clear 
reduction in the intensity of these bands but no change in β actin protein levels. While reduced 
CLOCK expression was also observed for clones 2C1 and 1D12, the loading control was also 
less in these, thus we could not make a confident conclusion as to whether CLOCK expression 
has been reduced in these clones, based on this western blot.  




Figure 2.10: CLOCK protein expression in targeted NIH3T3 clones 
A:  Western blot of protein extracts from selected CLOCK targeted NIH3T3 clones,  probed 
for CLOCK (Santa Cruz,  sc-271603, batch: I2917, predicted MW 93 kDa, 1:250 dilution, 600 
sec exposure) and β actin (Sigma-Aldrich, A2066, batch: 018M4853V, predicted MW 42 kDa, 
1:1000 dilution, 60 sec exposure) as a loading control . CLOCK expression is clearly reduced 
in 2H8 compared to the control.  While CLOCK seems to be reduced in 2C1 to a similar level 
and also in 1D12 to some extent,  the imbalanced intensity of  the β actin band means this is  
at least in part due to loading error. Multiple bands for CLOCK can be seen in the more 
intense lanes (WT and 1D12) potentially due to post translational modifications.  B:  
Supplier image showing multiple CLOCK bands detected with this antibody from human A-
673 (A) and mouse Sol8 (B) cell model lysates.  
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To further investigate the nature of targeting events in clones 2C1 and 2H8, PCR 
genotyping was performed for these clones and the sgControl (Figure 2.11 B), individual bands 
were gel-purified and sent for sequencing. Surprisingly, initial attempts to sequence 2H8 PCR 
products failed which we suspected might indicate indels spanning the region where the 
sequencing primer anneals. As this was the most promising candidate in terms of the western 
blot result, additional forward and reverse primers were designed the amplify the targeted 
region (Figure 2.11 C) Surprisingly, we continued to encounter poor yields, although the best 
yield was achieved using the F3,R3 primer set. We hypothesised that this might indicate some 
problems with Taq Polymerase amplification of the region.  
To investigate this, we decided to optimise the PCR conditions by varying the 
concentration of MgCl2 in the reaction, and/or adding 0.5M betaine. Magnesium ions are 
essential for Polymerase function, thus the presence of chelating agents or magnesium binding 
contaminants in the genomic DNA preps can hamper amplification or sequencing. Increasing 
the amount of MgCl2 in the reaction can counter this. Betaine facilitates amplification of DNA 
regions that are GC rich by disruption of secondary structures which can block polymerase 
action. As shown in Figure 2.11 D, addition of these reagents helped to optimise the 2H8 PCR 
product yield. Successful sequencing was then performed on products of the PCR reaction 
performed in the presence of 5 mM MgCl2 and 0.5M betaine. 




Figure 2.11:  Further genotyping of murine CLOCK  mutations 
A:  Schematic of the CLOCK  exon 4 targeted region showing forward and reverse primers,  
for more detail  see section A.5.2.  B:  PCR genotyping of NIH3T3  CLOCK  targeted clones using 
the F3 and R3 primers.  The control  (sgG10) produced a single product of the expected size 
(551 bp) for wild type alleles. C:  Comparison of PCR product yields using different  CLOCK 
exon 4 primer combinations.  For details on primers see section A.5.2 .  D:  Optimisation of 
the 2H8 PCR product yield in the presence of different concentrations of MgCl2  and /or 0.5M 
betaine. Primers F3 and R3 were used. 
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Sequencing of the sgControl band confirmed only wild type sequence while the two 
clones showed alterations in the targeted region. Clone 2C1 contained two distinct alleles with 
large insertions of 153 bp, introducing 51 in-frame amino acids after Val2, and 42 bp, 
introducing 7 in-frame amino acids after Val14 and a premature in-frame stop codon (Figure 
2.12). Expression of the first allele is likely to be unaffected while expression of the second 
allele would be inhibited explaining the reduced protein expression seen in the western blot. 
Taken together with the western blot result however, the 2C1 clone is not favourable as a 
CLOCK modified model, so investigation was focused on the 2H8 clone which appeared to 
show more significantly reduced protein expression.  
Sequencing of the two clear bands in clone 2H8 detected the presence of 3 alleles due 
to a mix of sequences in the lower band which could be individually identified after forward 
and reverse sequencing (see Figure 2.13). Allele 1 was found to have an insertion of 103 bp 
replacing 59 bp of the wild type sequence, resulting in complete deletion of exon 4. A potential 
open reading frame was generated that would produce a truncated 20 residue sequence 
unrelated to CLOCK. This allele is therefore likely to be non-functional. Allele 2 was found to 
have a 13 bp deletion generating a frameshift. If expressed this would destroy the exon 4 coding 
sequence after Serine 11, leading to an out of frame open reading frame that terminates at 108 
codons downstream (S11fs108*). Again, this is likely to be a non-functional allele. Allele 3 
has a 24 bp in-frame deletion that removes residues between Ser-6 and Arg-17, replacing this 
with a Tyr codon (S6-Y-R17). While this could produce a functional truncated product, it is 
possible that indels may also destabilise the gene transcription, mRNA transcript stability or 
protein stability, leading to loss of expression as is observed in the western blot.  
Based on these findings, we conclude that the NIH3T3-CLOCK-2H8 clone is strongly 
deficient in functional CLOCK expression.  




Figure 2.12:  Sequencing murine CLOCK  mutations in NIH3T3 clone 2C1 
Sequence analysis of the exon 4 region of two CLOCK  gene alleles. Allele 1 has a 153 bp 
in-frame insertion at codon Val-2 whereas Allele 2 has a 42 bp insertion at the codon Val-14 
which introduces an in-frame premature stop codon.  




Figure 2.13:  Sequencing murine CLOCK  mutations in NIH3T3 clone 2H8 
Sequence analysis of  the exon 4 region of three CLOCK  gene alleles.  Allele 1 has a 59 bp deletion and 153 bp insertion that disrupts CLOCK 
expression due to loss of the start codon. Allele 2 has a 13 bp deletion at codon Ser-11 generating a frameshift and an incorrect 108aa protein 
product (S11fs108*).  Allele 3 has a 24 bp deletion at codon Cys-7 which is an in-frame deletion (S6-Y-R17).
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2.3.3 Targeting CLOCK gene expression in HEK293 cells 
The human CLOCK gene is located on chromosome 2 and is made up of 22-24 exons 
depending on the specific transcript, 20 of which are coding exons, and the major transcript is 
10,470 bp (Figure 2.14 A). Multiple splice variant isoforms are listed in the NCBI, Uniprot and 
Ensembl databases but all coding transcripts share the same start codon, located within exon 4 
of the major transcript (Figure 2.14 B). No suitable target sequences for guides were available 
flanking the ATG in exon 4, therefore guides were designed to target exon 5, which is included 
in all isoforms, as shown below (Figure 2.14 C).  
After transfection with the paired PX461 expression vectors for the specific sgRNAs 
GFP+ cells were sorted by FACs and single cells clonally expanded for PCR genotyping, as 
described previously, using the human CLOCK primers outlined in appendix section A.5.3 
(page 292). The karyotype of the HEK293 cells is considered variable pseudotriploid (Lin et 
al., 2014) meaning that when targeting events are investigated, multiple alleles may be present. 
Indels in the CLOCK exon 5 region were detected in the expanded clones, with two to three 
distinct PCR products detected in most clones. No detectable indels were observed in the 
control clones transfected with a single sgRNA vector (sgF3 and sgG7) (Figure 2.15). 2D6 was 
specifically identified as potentially containing a wild type allele and a modified allele meaning 
it is potentially a heterozygous KO which could be a valuable model to have in combination 
with a homozygous KO. 




Figure 2.14:  Targeting the human CLOCK  gene 
A:  Exon structure of the human CLOCK  gene from the Ensembl database B:  Sequence of the 
human CLOCK  exon 5 from the UCSC genome browser showing the encoded 21 amino acids  
C:  sgRNA designs targeting opposite strands flanking exon 5 of Homo sapiens  CLOCK .  Guide 
pairs were selected targeting the second coding exon in a PAM-out arrangement with a 69 
bp spacing.  




Figure 2.15: Genotyping mutations of human CLOCK  
A:  Schematic showing the targeted region of the human CLOCK  gene. Blue arrows indicate 
the approximate positions of PCR analysis primers (F2 and R1, see section A.5.3).  B & C:  
PCR genotyping of GFP+ CLOCK  HEK293 clones. The controls (sgF3 and sgG7) transfected 
with single guides produced a single product of the expected size (205 bp) for wild type 
alleles. Several distinct bands are present in some clones indicating targeting of multiple 
alleles. All clones tested harboured obvious indels.  Notably 1C6 presented at least 5 
products.  This may be due to duplication of one of the primer binding sequences meaning 
multiple products are produced or the clonal expansion may be a mixture of two differently 
modified clones.  
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Initially all clones genotyped on the first gel were taken for further analysis to assess 
whether the targeted mutations were successful in reducing levels of CLOCK protein 
expression by western blot using the monoclonal CLOCK antibody detailed in 2.3.2. As shown 
in Figure 2.16 three bands for CLOCK were identified in all clones. Using the blot of Figure 
2.16 A the lower band was calculated to present the expected MW of ~95 kDa and the two 
higher bands to have MWs of ~122 and ~144 kDa. These larger bands are potentially due to 
isoforms or posttranslational modifications as noted for murine CLOCK. Clone 2A6 
consistently showed the lowest level of CLOCK expression (Figure 2.16 A-C), albeit in one of 
the blots poor detection of β actin (Figure 2.16 B) suggests suboptimal protein extraction. 
Reduced CLOCK expression was confirmed for clones 1G10 and 2A6 (Figure 2.16 C). 




Figure 2.16:  CLOCK protein expression in targeted HEK293 clones 
Multiple western blots of protein extracts from selected CLOCK targeted HEK293 clones, 
probed for CLOCK (Santa Cruz,  sc-271603, predicted MW 95 kDa batch: I2917, 1:250 
dilution, 500 sec exposure) and β actin (Sigma-Aldrich,  A2066, batch: 018M4853V, 
predicted MW 42 kDa, 1:1000 dilution, 60 sec exposure) as a loading control.  As above 
multiple bands are observed for CLOCK A: Expression appears most reduced in the 2A6 
clone. The other clones were excluded from further analysis .  B:  Expression appears most 
reduced in the 1G10 and 2A6 clones however these could not be compared to the control  
lane in which there appears to be an issue with the protein sample.  Only the upper band for 
CLOCK is  seen in this blot as well suggesting an issue with the antibody binding.  C:  Western 
blot of  extracted protein for the 1G10 and 2A6 clones.  Expression of CLOCK is  clearly 
reduced in both clones compared to the WT control. 
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To further investigate the nature of targeting events, PCR products from the clones 
1G10, 2A6 and 2D6 and an sgControl clone (Figure 2.17 A) were sequenced. Clone 2D6 was 
included due to the possibility, based on initial PCR genotyping and western blot results, that 
it may be a heterozygous KO. Sequencing of the sgControl band confirmed only wild type 
sequence as expected and modified sequences within the target region for alleles from the other 
clones (Figure 2.17). As was seen for the NPAS2 3T3 clone 1F1 in section 2.3.1 the higher 
band in both of 1G10 and 2A6 clones when sequenced was a mixture of the two lower bands, 
so does not represent a unique allele. 
Clone 2A6 presented two alleles, one with a deletion of 23 bases and the other with a 
deletion of 53 bases. 1G10 presented 2 alleles one with a deletion of 7 bases and the other with 
a deletion of 56 bases. All the deleted sequences from these two clones included splice 
junctions; loss of these may cause issues in mRNA splicing responsible for the reduced or 
altered expression. Deletions of the splice junction means it is difficult to predict what amino 
acid sequence the protein will have and possibly just that exon will be skipped. Neither allele 
of 2D6 showed wild type sequence meaning it was not of interest as a heterozygous clone, 
allele 1 had a deletion including the intron-exon junction and allele 2 a deletion at Glu-28 
generating a frameshift (E28fs30*). Based on this information we can conclude that the clones 
HEK293-CLOCK-1G10 and HEK293-CLOCK-2A6 are likely to have major CLOCK 
inactivation. 




Figure 2.17:  Sequencing human CLOCK  mutations 
A:  PCR genotyping of HEK293 CLOCK  targeted clones. The control (sgF3) produced a single 
product of  the expected size (575 bp) for wild type alleles. B:  Sequence analysis of the exon 
5 region of CLOCK  gene alleles present in HEK293 clones.  All  alleles sequenced excluding 
2D6 1 show splice junction mutations, it  is l ikely that these would cause differential  
splicing of the transcript as such the amino acid predictions would be inaccurate. The 2D6 
1 allele shows a deletion causing a frame shift  which will  lead to a premature stop codon 
and likely prevent functional CLOCK expression (E28fs30*). The highest of the three bands 
on the gel for both 1G10 and 2A6 were found to consist of mixed sequence of the alleles in 
the lower bands so was not a unique third allele similar to that shown above for NIH3T3-
NPAS2-1F1 in Figure 2.6.
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2.3.4 Targeting BMAL1 gene expression in HEK293 cells 
The human BMAL1 gene (also known as ARNTL-aryl hydrocarbon receptor nuclear 
translocator like) is located on chromosome 11 and is made up of 18-21 exons depending on 
the specific transcript, 16 of which are coding exons, and the major transcript is 2,776 bp 
(Figure 2.18 A). Multiple protein coding isoforms (at least 27) are listed across the NCBI, 
Uniprot and Ensembl databases. All identified isoforms utilise the same start codon in exon 5 
of the major transcript, however, multiple potential in-frame start codons exist, encoded in the 
first 20 amino acids (Figure 2.18 B). Guides were therefore designed to target within exon 5 
but downstream of these start codons with the intention of introducing a frameshift mutation 
(Figure 2.18 C). After transfection of HEK293 cells with the paired PX461 expression vectors 
for the specific sgRNAs GFP+ cells were sorted by FACs and single cells clonally expanded 
for PCR genotyping, as described previously, using the human BMAL1 genotyping primers 
outlined in appendix section A.5.4 (page 293). Indels in the BMAL1 exon 5 region were 
detected in the expanded clones, with three distinct products detected in most clones (Figure 
2.19). PCR amplification from wild type NIH3T3 cells showed an expected wild type product. 
Amplification from the single guide transfected clones produced this band and also a shorter 
product, which may indicate an indel caused by the single guide expression, or possible 
contamination with DNA from a targeted clone. 




Figure 2.18: Targeting the human BMAL1  gene  
A:  Exon structure of the human BMAL1  gene from the Ensembl database B:  Sequence of the 
start of  the human BMAL1  exon 5 from the UCSC genome browser showing the encoded 
amino acids and multiple in-frame start codons C:  sgRNA designs targeting opposite strands 
in exon 5 of Homo sapiens  BMAL1 .  Guide pairs were selected downstream of the ATGs in a 
PAM-out arrangement with a 54 bp spacing.  




Figure 2.19:  Genotyping mutations of human BMAL1  
A:  Schematic showing the targeted region of the human BMAL1  gene. Blue arrows indicate 
the approximate positions of PCR analysis primers (F2 and R1, see section A.5.4).  B:  PCR 
genotyping of GFP+ BMAL1  HEK293 clones. A WT control shows the expected size (240 bp) 
for wild type alleles. The clones transfected with single guides (sgD9 and sgF7) produced 
multiple products including one of the expected size suggesting contamination with one of 
the modified clones. Several distinct bands are present in most clones indicating targeting 
of multiple alleles. All  clones tested harboured obvious indels.  Clones highlighted in green 
were selected to be carried forwards for initial  western blotting.
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Several clones were taken for further investigation by western blot based on the absence 
of a PCR band consistent with the size expected for the wild type product. Cell-free extracts 
from these clones were used for western blotting to assess whether the targeted mutations were 
successful in reducing levels of BMAL1 protein expression using a monoclonal BMAL1 
antibody (Santa Cruz; sc-365645). A single band of ~69 kDa was detected in HEK293 control 
extracts, consistent with the predicted MW of the largest isoform (BMAL1b; 68.7 kDa) 
described in Uniprot. The western blot showed reduced band intensity in multiple targeted 
clones, with clones 1A9 and 2C9 appearing to show the most significant reduction, however 
some variation in β actin loading controls suggests this blot is not conclusive (Figure 2.20 A). 
A second blot including the two low expression clones and other potential clones identified 
2C9 and 1A9 remained the clones with the most notable reduction in BMAL1 expression 
(Figure 2.20 B). 




Figure 2.20:  BMAL1 protein expression in targeted HEK293 clones  
Western blots of protein extracts from selected BMAL1 targeted HEK293 clones,  probed for 
BMAL1 protein (Santa Cruz, sc-365645, batch: B2318, predicted MW 69 kDa, 1:500 dilution, 
1000 sec exposure) and β actin (Sigma-Aldrich, A5441, predicted MW 42 kDa, batch: 
11SM4835V, 1:1000 dilution, 60 sec exposure) as a loading control . A:  Expression of BMAL1 
can be seen to be reduced compared to the wild type control  in the clones 1A4, 1A9, 1C1 
and 2C9 while 2C6 shows increased expression. Some of the bands,  most noticeably 2C10, 
appear to show a smaller MW compared to the WT band. This may reflect isoforms or 
modified protein. The β actin loading control  varies a bit  across the blot meaning it is  hard 
to be fully confident in interpreting BMAL1 expression levels.  B:  Western blot showing 
reduced expression of BMAL1 in clones 1A9 and 2C9 as compared to the wild type control.  
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To further investigate the nature of targeting events in these clones, PCR genotyping 
was performed, as this first gel was performed concurrently it included all clones from the first 
western blot. Individual bands were gel-purified (excluding the 1A9 clone for which no 
products were produced) and then based on the western blot findings the three bands from 2C9 
were sent for sequencing. Sequencing of the unmodified cells revealed only the expected wild 
type sequence detailed in databases while sequencing of the 2C9 clone presented 3 distinct 
modified alleles (see Figure 2.21). The higher band showed a 38 base insertion introducing 13 
amino acids and generating a frame shift which leads to a premature stop codon occurring in 
exon 6 potentially resulting in a 73 amino acid protein (D22fs73*). The second band showed a 
29 base pair deletion and frame shift leading to a premature stop codon after 34 codons 
(P20fs34*). The third band showed a 46 base pair deletion leading to a frame shift the same as 
the first allele and reading frame which terminates 45 codons downstream (M16fs44*). These 
premature stop codons mean that either expression of non-functional protein or nonsense 
mediated decay of the transcripts would occur and there would be no expression of BMAL1 
protein. An attempt was made following this to amplify 1A9 products using alternate primers 
which was unsuccessful so 2C9 was chosen as the favoured clone. Based on this information 








Figure 2.21:  Sequencing human BMAL1  mutations 
A:  PCR genotyping of HEK293 BMAL1  targeted clones. The WT control shows a single 
product of  the expected size (240 bp) for wild type alleles. B:  Sequence analysis of the exon 
5 region of BMAL1  gene alleles present in the 2C9 clone. Allele 1 has a 38 bp insertions 
immediately after codon Thr-21 generating a frameshift and an incorrect 73aa protein 
product (D22fs73*). Allele 2 has a 29 bp deletion at codon Pro-20 generating a frameshift 
and an incorrect 34aa protein product (P20fs34*). Allele 3 has a 46 bp deletion at Met-16 
generating the same frameshift as in allele 1 and an incorrect 44aa protein product 
(M16fs44*).  
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2.3.5 Targeting NPAS2 gene expression in HEK293 cells 
The human NPAS2 gene is located on chromosome 2 and is made up of 21 exons, 20 
of which are coding exons, and the major transcript is 4,020 bp (Figure 2.22 A). Similar to 
mouse NPAS2 gene detailed in 2.3.1 there is only one validated transcript described for human 
NPAS2 gene in the NCBI and Uniprot databases encoding an 824 residue polypeptide with the 
start codon present in exon 2 (NM_002518.4, Figure 2.22 B) while the Ensembl database lists 
12 transcripts. These 12 transcripts are the one major transcript from NCBI and Uniprot, 6 non-
coding transcripts and 5 transcripts which code for much shorter proteins with under 300 
residues. The gnomAD database (Karczewski et al., 2020) indicates the longest isoform as the 
most abundant human transcript in sequencing studies (Figure 2.22 C). No suitable target 
sequences for guides were available flanking the ATG in exon 2, therefore guides were 
designed targeting downstream of the ATG within the same exon (Figure 2.22 D). 




Figure 2.22: Targeting the human NPAS2  gene  
A:  Exon structure of the human  NPAS2  gene from the Ensembl database B:  Sequence of the 
human NPAS2  exon 2 from the UCSC genome browser showing the encoded amino acids. C: 
NPAS2  exon RNA expression depiction from the GnomAD database D:  sgRNA designs 
targeting opposite strands in exon 2 of Homo sapiens  NPAS2 .  Guide pairs were selected 
downstream of the ATG in a PAM-out arrangement with a 51 bp spacing.  




After transfection with the paired PX461 expression vectors for the specific sgRNAs 
GFP+ cells were sorted by FACs and single cells clonally expanded for PCR genotyping, as 
described previously, using the human NPAS2 primers outlined in appendix section A.5.5 (page 
293). Indels in the NPAS2 exon 2 region were detected in the expanded clones, with two distinct 
products detected in most clones. No obvious indels were observed in the control clones 
transfected with a single sgRNA vector (sgD7, sgE2 and sgG3) (Figure 2.23). 
Several clones were taken for further investigation based on the absence of a PCR band 
consistent with the size expected for the wild type product. Western blots to assess whether the 
targeted mutations were successful in impacting levels of NPAS2 expression were performed. 
However, these blots used the initial NPAS2 antibody mentioned in 2.3.1 and detailed in the 
appendix (see section A.3, page 287) which was not specific for NPAS2.  
At this stage in the identification process the choice was made to focus on the NIH3T3 
targeted clones for inclusion in this PhD project due to the more advanced stage of 
identification and amenability to cycling experiments. 




Figure 2.23: Genotyping mutations of human NPAS2  
A:  Schematic showing the targeted region of the human NPAS2  gene. Blue arrows indicate 
the approximate positions of PCR analysis primers (F1 and R1, see section A.5.5).  B:  PCR 
genotyping of GFP+ NPAS2  HEK293 clones. The controls (sgD7, sgE2 and sgG3) transfected 
with single guides produced a single product of the expected size (233 bp) for wild type 
alleles. Several distinct bands are present in some clones indicating targeting of multiple 
alleles. Multiple clones such as 2F4 showed no modification from wild type sequence.  




These results show that we have successfully modified the genetic sequences of 
circadian regulator genes in cells leading to clearly reduced or ablated protein expression. 
Mutant clones for mouse NPAS2, mouse CLOCK, human BMAL1 and human CLOCK have 
been clearly identified. The NIH3T3-NPAS2-1F1 clone is likely a functional NPAS2 KO and 
is demonstrably at least a clone with significant reduction of NPAS2 expression. The NIH3T3-
CLOCK-2H8 clone is strongly deficient in functional CLOCK expression. The HEK293-
CLOCK-1G10 and 2A6 clones should have major CLOCK inactivation. The HEK293-
BMAL1-2C9 clone should have major loss of BMAL1 function. Mutants for human NPAS2 
have likely been produced but full characterisation was not completed due to time constraints 
and the decision to focus on the mouse NIH3T3 cells. 
These generated cells provide models that can be used for investigation of the role of the 
modified genes in gene expression and cell biology. Utilising comparable WT cells, changes 
in mutant cells can be investigated in gene and protein expression and the presentation of in 
vitro circadian cycles, among other factors which can be investigated in in vitro models which 
may be of interest. Within a similar timeframe of this project targeting genes within the 
modified cells could be used to produce double knockout models, this may be of interest to 
produce CLOCK;NPAS2 double KO cells. The modified NIH3T3 clones produced here are 
used in the following chapter, as models to investigate the impact of loss of the NPAS2 and 
CLOCK genes on the expression of core circadian genes.
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Chapter 3: Investigation of the roles of 
CLOCK and NPAS2 in expression of core 
circadian genes using mutant NIH3T3 
models




3.1.1 Modelling circadian cycling in cultured cells 
Cells in culture maintain circadian oscillations of core clock genes and clock-controlled 
genes (CCGs). However, the cultured cells are normally asynchronous, meaning gene 
expression analysis effectively gives an average across the circadian period (Nagoshi et al., 
2004). To model circadian gene expression in vitro cell cultures can be induced to synchronise, 
for example by treatments such as a brief serum shock in 50% horse serum which acts to reset 
the clocks of the cells all at the same time (Balsalobre et al., 1998). After replacement of the 
high serum media with serum free media cultured cells show a persistent circadian rhythm 
which gradually flattens over several days due to loss of synchrony within the culture. NIH3T3 
cells have in fact been shown to present circadian rhythmicity after simply prolonged culture 
at confluence when media changes always occurred at fixed times of day, without requiring a 
serum shock. This effect is likely due in part to the inhibition of cell division in confluent cells, 
which can modulate circadian rhythms, and some cell-cell communication along with a subtle 
repeated entrainment effect of media changes (O'Neill and Hastings, 2008). 
To facilitate the detection of circadian rhythms a circadian luciferase vector can be 
introduced into the cells, either by transient or stable transfection methods. The typical reporter 
utilises a modified luciferase cDNA (dLuc) which encodes a Luciferase destabilised by 
introduction of a hPEST destabilising sequence so that it is degraded rapidly in cells (Leclerc 
et al., 2000). This is useful in following circadian expression as long-term stability of the 
luciferase protein would interfere with observation of the circadian expression pattern. This 
luciferase system can be used to follow circadian cycling when expressed under the promotor 
of a circadian regulated gene (commonly PER2 or BMAL1) meaning luciferase expression is 
subject to circadian regulation. This can allow identification of the circadian period by 
collection of protein for luciferase assays at time points after synchronisation or detailed period 
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identification by real-time bioluminescence recordings of live cultures (Fang et al., 2017). 
3.1.2 NPAS2 in the circadian transcriptional feedback cycle 
NPAS2 is a core circadian gene and functions as part of the positive arm of the 
transcriptional feedback cycle. The NPAS2 protein acts as a transcription factor when 
dimerised with the BMAL1 protein by binding to genomic E-boxes, both the BMAL1 and 
DNA association are dependent on the NPAS2 bHLH domain (Hogenesch et al., 1998). 
CLOCK is a paralog of NPAS2 and an alternate dimerisation partner for BMAL1 (Gekakis et 
al., 1998). Circadian cycles are primarily maintained by the transcription of genes of the 
negative arm of the feedback loop through the positive arm activity at E-boxes. This includes 
the CRY and PER proteins which act to prevent the transcription factor activity of the 
CLOCK/NPAS2:BMAL1 dimer. Also involved in circadian maintenance are the REV-ERB 
and ROR genes, also under E-box promotors, which have opposing activity influencing the 
transcription of NPAS2 and BMAL1 (Shearman et al., 2000), for more details refer to section 
1.3 (page 26). The activity of both CLOCK and NPAS2 has been shown to be influenced by 
interactions with CO (Dioum et al., 2002) and NAD+/NADH (Rutter et al., 2001).  
While it has been proposed that NPAS2 and CLOCK have overlapping roles in gene 
expression in the SCN and are therefore at least partially redundant (Bertolucci et al., 2008), 
other studies using ChIP-seq of mouse liver samples have identified unique binding sites of 
CLOCK:BMAL1 and NPAS2:BMAL1 presented in Figure 3.1 (Koike et al., 2012). Most of 
the core circadian genes are identified as targets of both CLOCK and NPAS2 dimers, as would 
be expected, with the exception of a few genes (see Figure 3.1 legend for specific genes). 
However, the observation of subsets of genes that are specific targets for CLOCK:BMAL1 or 
NPAS2:BMAL1 heterodimers indicates differential recruitment to some gene regulatory 
regions. It remains unclear if this involves differences in DNA binding specificities or the 
involvement of additional cofactors. 




Figure 3.1:  Unique and overlapping target genes of BMAL1, CLOCK and NPAS2 
Based on ChIP-seq data from Koike et al.  (2012), image generated using Venny software 
(Oliveros,  2007).  The majority of genes fall  in the overlaps of CLOCK and BMAL1 with the 
circadian genes PER1 ,  PER2 ,  CRY2  and REV-ERBα  all  identified as target genes of all  three.  
Notably CRY1  and REV-ERBβ  were only identified as targets of CLOCK and BMAL1 and PER3  
was identified as a target of BMAL1 only.  The full gene lists as sorted in the diagram are 
included in the appendix (section A.7, page 305). Not all  binding sites necessarily suggest 
transcription factor activity at these sites however in genes targeted by both BMAL1 and 
either NPAS2 or CLOCK there is  an increased likelihood. 
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Another functional difference between CLOCK and NPAS2 has been reported in the 
subtle differences of circadian gene expression profiles in the SCN of NPAS2 and CLOCK KO 
mice. For example, the CLOCK KO was associated with a subtle phase shift but no change in 
expression levels of PER2 and a reduction in the amplitude of REV-ERBα expression while 
NPAS2 KO mice presented a reduction of PER2 cycling expression but no change in 
REV-ERBα expression pattern in the SCN (Debruyne et al., 2006, DeBruyne et al., 2007a). 
CLOCK also has intrinsic HAT activity, described in section 1.4 (page 29), which plays a role 
in regulation of gene expression and activity (Doi et al., 2006). In contrast NPAS2 has not been 
shown to perform any acetyltransferase activity and investigation of the amino acid sequence 
suggests NPAS2 lacks this HAT domain (see Figure 1.2, page 38) so is unable to perform these 
same activities without HAT recruitment. 
These observed differences between CLOCK and NPAS2 make it likely these genes 
have both overlapping and distinct functions, even in how they influence the core circadian 
feedback loop. 
3.1.3 Previous investigations of CLOCK and NPAS2 function in fibroblasts 
CLOCK and NPAS2 functions in gene expression have been investigated previously in 
various cell culture models, including fibroblast cells. For example Ramanathan et al. (2014) 
reported the effects of lentiviral shRNA knockdown of core circadian genes on cycling of a 
BMAL1-dLuc reporter in NIH3T3, a mouse fibroblast cell line. While suppression of CLOCK 
or BMAL1 lead to rapid arrhythmicity, knockdown of NPAS2 expression was reported to have 
no detectable effect on the circadian cycling period of the reporter in NIH3T3 cells nor in the 
adipocyte or hepatocyte cell lines tested. A caveat of this study is that the endogenous levels 
of NPAS2 protein were not determined; the efficacy of the shRNAs were identified by co-
transfection of FLAG-tagged NPAS2 expression vectors with the shRNA or control shRNA. 
This means that the reduction of protein expression presented only reflects the reduction of the 
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introduced FLAG-tagged NPAS2 which may not reflect endogenous levels in the control. The 
mRNA level of NPAS2 determined by RT-qPCR was only reduced to ~50% of the endogenous 
expression while the mRNA levels of CLOCK were reduced to ~40% or <10% in the two 
different shRNA models (Ramanathan et al., 2014) The reported effects were limited to the 
effect on the BMAL1-dLuc reporter and no investigation was performed on either the cycling 
or expression levels of the circadian genes. 
Primary dermal fibroblast cultures from NPAS2 constitutive KO mice showed an 
increase in expression of PER2. No change was observed in the expression of BMAL1, CLOCK, 
PER1, PER3 or CRY1-2 or in the circadian expression patterns and periods (Sasaki et al., 2020). 
3.1.4 Experimental aims and hypothesis 
The aim of this chapter was to investigate the effect of modification of the expression 
of NPAS2 and CLOCK on expression of core circadian genes in a cell culture model. As 
described in Chapter 2, mutant NIH3T3 CRISPR-Cas9 modified clones NIH3T3-NPAS2-1F1 
(ΔNPAS2) and NIH3T3-CLOCK-2H8 (ΔCLOCK) were developed for investigation of 
NPAS2 and CLOCK (2.3.1 & 2.3.2). The choice was made to focus on the NIH3T3 clones 
rather than the HEK293 clones as they are an easier experimental model to investigate circadian 
cycling due to the comparative ease of culturing the cells at confluence. While NIH3T3 cells 
can be cultured at confluence, due to contact inhibition preventing further growth, in HEK293 
cultures cell death occurs due to continued growth when cultured past confluency. While 
circadian cycling has still been shown to be induced in these cells more care needs to be taken 
and results can be affected by the increasing cell death at later time points (Cox, 2012). 
The expression of genes of the core circadian feedback loop were investigated in 
selected cells by RT-qPCR while in normal culture to investigate effects of the genetic 
modifications on the overall expression levels of the genes. As this measure cannot observe 
any effect on rhythmic expression of the genes a serum shock was also utilised to synchronise 
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the circadian cycles of the cells. The rhythmic expression of the genes and the influence of the 
modification of gene expression could then be investigated. 
It was hypothesised that we would see changes in gene expression either in the total 
levels consistent across each time point or in a time point specific manner. As both NPAS2 and 
CLOCK act with circadian rhythmicity it was assumed most likely that primarily time point 
specific effects would be observed. However, the investigation of asynchronous cells would 
provide some insight into effects on gene expression levels through a much faster and easier 
initial experiment. It was expected that we would not see effects such as a change in circadian 
period or any gross change in circadian cycle as in each cell type the other gene of 
CLOCK/NPAS2 would be present to compensate. Any change in circadian period was 
anticipated to be too subtle to be observed in the 6-hour window of these investigations. 
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3.2 Materials & Methods 
Chemicals, reagents, and methodologies were as described in Chapter 2, with the 
following additional details. 
3.2.1 Mammalian cell culture 
3.2.1.1 Culture and transfection 
NIH3T3 mutant clonal cells and the wild type (WT) NIH3T3 cells were cultured as 
described in section 2.2.5.2 (page 62). The ΔNPAS2 1F1 clones were identified to grow slower 
than the other cells so were passaged at 1:5 for general culture rather than the 1:10 used for the 
other cultured cells.  
3.2.1.2 Light microscopy 
Cell images were taken 1, 2 or 3 days after seeding 3x105 cells in 10 cm dishes (or 
6x105 cells for the ΔNPAS2 cells). The images were taken using a Celestron HD digital 
microscope imager attachment for a light microscope and Celestron Digital Imager HD 
software. 
3.2.1.3 Cell culture for RNA extraction (unsynchronised cells) 
Cells were seeded in triplicate at 3x105 cells in 10 cm dishes (or 6x105 cells for the 
ΔNPAS2 cells) and grown for 3 days before RNA extraction. At the time of collection, the 
cells were collected into 1.5 ml cold PBS and 400 µl was taken, the cells spun down at 600 x 
g for 5 minutes at 4 °C and the pellet taken for RNA extraction as described in section 3.2.2.2. 
3.2.1.4 Serum shock induction of circadian cycling 
To investigate circadian gene expression, cells were seeded at 2x104 (or 4x104 for the 
ΔNPAS2 cells) in triplicate in 5 x 12-well plates. The cells were cultured to full confluence (2 
weeks) in the plate, media changes were performed as required at a fixed time of day. The cells 
were then exposed to a serum shock; the media was removed, and the cells gently washed with 
0.5 ml warm PBS and the media replaced with 1 ml DMEM made up as 50% horse serum. The 
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cells were incubated for 2 hours at 37 °C before the serum was removed, the cells were washed 
with 0.5 ml of serum free media, 2 ml serum free media added and incubated at 37 °C. The 
cells were collected for RNA extraction by collection into the lysis buffer from the RNeasy kit 
after a wash with cold PBS at specific time points of 0, 6, 12, 18 and 24 hours after the end of 
the serum shock. Note that due to COVID-19 SOPs, it was not possible to extend the 
experiment beyond the 24-hour period. Samples in lysis buffer were stored at -80 °C until the 
RNA extraction was performed. This serum shock induction of cycling method was primarily 
based on the protocol used by Allen et al. (2004). 
3.2.2 Molecular biology techniques 
3.2.2.1 Sources and composition of reagents 
Primers for RT-qPCR were purchased from Sigma-Aldrich as lyophilised and desalted 
pellets. These were resuspended in sterile water to a 100 µM concentration and stored at -20 °C. 
Primers sequences were those previously designed (Oyegbami et al., 2017) or newly designed 
by use of the NCBI Primer BLAST software. The primers were designed to amplify across an 
exon-exon boundary preventing amplification of any genomic DNA. Primers are all between 
17 and 26 bases in length and amplify products between 60 and 150 bases with Tm values 
between 60 °C and 70 °C. All primer sequences are detailed in Table A.1 (page 296). The 
primers were validated through cDNA dilution series and agarose gel electrophoresis to 
confirm the expected size of products and no alternate products, these are detailed in the 
appendix, section A.4 (page 288). 
The RNA extraction RNeasy Mini kit and the QuantiTect Reverse Transcription kit were 
purchased from QIAGEN Ltd. The Brilliant II SYBR® Green QPCR Master Mix was 
purchased from Agilent Technologies. 
3.2.2.2 RNA extraction 
Total RNA was extracted from pelleted cultured cells using the QIAGEN RNeasy Mini 
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kit, ready for cDNA synthesis. Isolation of RNA was performed according to the manufacturer’s 
protocol and the RNA eluted from the column in 2 spins of 30 µl RNase free water for a total 60 µl 
volume and stored at -80 °C until required. The concentration of RNA was determined using a 
NanoDrop 1000 Spectrophotometer. 
3.2.2.3 Reverse transcription and cDNA to synthesis  
To produce cDNA from the RNA for RT-qPCR analysis the QuantiTect Reverse 
Transcription kit (QIAGEN Ltd) was used. To prepare extracted RNA for use as a template to 
synthesise cDNA, potential contaminating genomic DNA was removed following the 
manufacturer’s instructions. Samples were set up as shown in Table 2.3, mixed and incubated 
for 2 minutes at 42 °C, followed by immediate chilling on ice.  
Table 3.1: Composition of genomic DNA wipeout reactions 
7x gDNA Wipeout buffer  1 μl (1x)  
Template RNA  500 ng  
Sterile RNase-free water  To a total volume of 7 μl  
 
To synthesise cDNA, reverse transcription reactions were prepared using the produced 
genomic DNA-free RNA samples for a final volume of 10 µl, as shown in Table 3.2. These 
were incubated for 15 minutes at 42 °C, then for 3 mins at 95 °C to inactivate the Quantiscript 
Reverse Transcriptase enzyme. 15 μl of sterile dH2O was added to products of this reaction 
(1:2.5 dilution), thoroughly mixed and samples were stored at -20 °C until required. If more 
cDNA was required, for example when testing primers for standard curves, the reactions were 
scaled up appropriately. 
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Table 3.2: Composition of reverse transcription reactions 
Quantiscript Reverse Transcriptase  0.5 μl  
5x Quantiscript RT buffer  2 μl (1x)  
RT Primer mix  0.5 μl  
Genomic DNA wipeout reaction  7 μl  
Total volume  10 μl  
 
3.2.2.4 Quantitative reverse transcription PCR (RT-qPCR)  
To analyse gene expression RT-qPCR was performed using the cDNA generated by 
reverse transcription and Brilliant II SYBR® Green QPCR Master Mix from Agilent 
Technologies. The reaction mixture is detailed in Table 3.3 and the cycling protocol in Table 
3.4. All samples and reagents were kept on ice while the RT-qPCR reactions were prepared. 
The reactions were run on a Stratagene Mx3005P qPCR machine, programmed and data 
collected through the MXPRO software. In each plate for each gene ran, a no template control 
(NTC) was also included, with a reaction mix lacking cDNA but otherwise identical to that 
shown in Table 3.3, to check for contamination of the mastermix. The dissociation curves and 
amplification plots of each reaction were viewed in the MXPRO software to confirm no 
abnormal behaviour of the qPCR, such as multiple products. The software calculated an 
appropriate critical threshold for each run and quantified the cycle number at which the 
intensity of the fluorescence reached the critical threshold (Ct value). RT-qPCR analysis was 
performed in technical duplicates upon each of the biological triplicates, so a total of 6 readings 
were obtained for each data point. 18S rRNA (Rn18s) expression was used as a normalisation 
gene as various other genes which can be used in this capacity, such as GAPDH, have been 
identified to show circadian variation which would influence the calculated results (Matsumura 
et al., 2014). 
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Table 3.3: Composition of RT-qPCR reactions 
Sterile dH2O  2 μl  
10 μM Forward primer  0.5 μl  
10 μM Reverse primer  0.5 μl  
Brilliant II SYBR® Green QPCR Master Mix 5 μl  
cDNA 2 μl 
Total volume  10 μl  
 
Table 3.4: Quantitative thermocycler setting for RT-qPCR experiments 
No. Cycles  Time  Temperature  
x 1  10 mins (initial denaturation)  95 °C  
x 40  
30 secs (denaturation)  95 °C  
1 min (primer annealing and extension)  60 °C  
x 1  melt curve analysis 60-95 °C 
 
Initially the qPCR testing for expression of 18S rRNA was performed on a 1:40 diluted 
sample of the RT produced cDNA, the low dilution was used as 18S rRNA is expressed at a 
high level so easily detected and saves on use of the cDNA. This read was used to calculate the 
amount to dilute the cDNA, to ensure all samples were appropriately comparable and that 
dilution of the samples to provide the volume required to investigate all genes would not dilute 
those genes below the limit of the detection. The diluted cDNA samples were then used for 
qPCR testing of 18S rRNA for use as a normalisation gene and all genes of interest.  
3.2.2.5 RT-qPCR analysis 
Each sample was run in duplicate for each qPCR transcript analysis. The paired Ct 
values were confirmed to not vary more than 1.5 Ct, any instance where a greater difference 
was seen the qPCR was repeated. Data for each transcript were normalised to 18S rRNA as an 
internal control using the 2−ΔCt method. The respective average 18S rRNA Ct values were taken 
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away from the transcript of interest Ct values and then converted to copy number as in Formula 
3.1. The copy numbers were then divided by the average copy number of the control samples 
(the expression of the gene in WT cells or the WT cells at 0 hours in the synchronised time 
point experiment) to give the relative change in expression and the mean of the technical 
duplicates used for statistical analysis.  
 
𝑁𝑜𝑟𝑚𝑎𝑙𝑖𝑠𝑒𝑑 𝑅𝑁𝐴 𝑒𝑥𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛 𝑙𝑒𝑣𝑒𝑙 =  2   
Formula 3.1:  Calculation used to analyse the relative gene expression of RT-qPCR targets.  
This formula can be explained as: 2 to the power of the negative value of (Ct of  gene of 
interest -  Ct of  18S rRNA normalisation gene). 
3.2.3 Statistical analysis 
Tests were performed in biological triplicate based on previous procedures used in the 
lab for investigation of gene expression as 3 replicates is generally accepted as sufficient to 
identify biologically relevant changes in gene expression. Statistical tests were performed by 
use of IBM SPSS Statistics for Windows, Version 26.0. Normality was confirmed by 
visualisation on a graph. The significance level was set at 0.05. Gene expression in the modified 
clones was compared individually to expression in the WT cells. Independent t-tests were used 
for comparison of the unsynchronised gene expression between cell types and two-way 
ANOVAs were used to investigate the effect of time and genotype on rhythmic gene 
expression. Significant interactions identified by ANOVA were followed up by pairwise 
analysis of simple main effects between the cell types at individual time points.  
 




3.3.1 Growth and morphology of CRISPR-Cas9 edited NIH3T3 cells 
Chapter 2 described the generation of CRISPR-Cas9 edited clones defective in 
expression of CLOCK and NPAS2. Due to their greater survival in synchronising procedures 
compared to HEK293 cells, we chose to take forward NIH3T3 modified clones for further 
analysis to assess the impact of NPAS2 or CLOCK deficiency on circadian gene regulation. 
Therefore, unmodified WT NIH3T3 cells, ΔNPAS2 1F1 and ΔCLOCK 2H8 cells were selected 
and maintained in culture. We noticed while passaging the three cell types that the ΔNPAS2 
1F1 cells took longer to reach confluency, as compared to the WT NIH3T3 or ΔCLOCK 2H8 
cells under normal culture conditions. To adjust for this, when passaging cells, the ΔNPAS2 
cells were passaged to 1:5 rather than 1:10 and for each seeding of a specific cell count double 
the cell number was used as described in the methods sections. Assessment of the three cell 
types in culture by light microscopy did not reveal any gross phenotypic effects on morphology 
over 3 days of culture (Figure 3.2). It was noted that ΔCLOCK 2H8 cells took longer to recover 
after passage, perhaps due to delayed adherence, but all three cell cultures reached comparable 
confluency on day 3. 




Figure 3.2:  Cell growth images 
Representative images of the cells on sequential growth days; note the ΔNPAS2 1F1 cells 
were seeded at a higher density (2x) to account for slower recovery.  All cultures showed 
similar confluency and appearance on day 3, despite the appearance of the ΔCLOCK 2H8 
cells on day one suggesting that they showed slower recovery from the passage procedure,  
in that the cells had not yet begun to extend filopodia as the other two cells had. 
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3.3.2 Expression of core circadian genes in unsynchronised edited NIH3T3 
cells 
To investigate the effect of the modified expression of NPAS2 and CLOCK on 
circadian regulation in NIH3T3 cells, mRNA expression levels of several core circadian genes 
were determined (Figure 3.3). As most circadian genes show rhythmic expression over a 
24-hour period, expression levels detected in asynchronous cultures reflect the average gene 
expression across the cycling period. 
Expression levels of PER1, PER2, CRY1, CRY2, CLOCK, BMAL1, REV-ERBα and 
REV-ERBβ genes in the ΔCLOCK and ΔNPAS2 cells were compared individually to their 
expression levels in WT cells. The ΔNPAS2 cells showed significantly increased expression 
levels of REV-ERBα and CLOCK and reduced expression of BMAL1 compared to WT cells 
(Table 3.5 and Figure 3.3). These results suggest a possible negative regulation of REV-ERBα 
and CLOCK expression by NPAS2, and a positive effect on BMAL1 expression levels. Some 
increase in the expression of PER1 and REV-ERBβ was also observed, although not reaching 
significance.  
In contrast, no significant changes were observed in the expression of these genes in 
the ΔCLOCK cells compared to the WT cells, at least under conditions of unsynchronised 
culture (Table 3.5). However, it should also be noted that the ΔCLOCK cells are a knockdown 
rather than KO model (see section 2.3.2, page 82). Thus, a more complete KO may be required 
to observe robust effects.  




Figure 3.3:  Expression of circadian genes in asynchronous NIH3T3 cells  
Mean relative gene expression (±SEM) of ΔNPAS2 cells (red),  ΔCLOCK cells (green) 
compared to WT NIH3T3 cells (black).  Relative expression values are based on RT-qPCR 
reads after 2 - Δ Ct  transformation based on 18S reads, relative to the WT sample for each 
gene. The significance of independent t-test comparisons between WT and the ΔNPAS2 cells 
are shown (*=p<0.05, **=p<0.01),  identical t-tests were also performed comparing the WT 
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Table 3.5: Independent t-testing of expression of each gene in WT cells compared to 
modified ΔNPAS2 and ΔCLOCK cell lines 
Gene WT compared to ΔNPAS2 cells WT compared to ΔCLOCK cells 
PER1 t(4)=0.973, p=0.120 t(4)=-0.006, p=0.996 
PER2 t(4)=-0.092, p=0.931 t(4)=-0.663, p=0.543 
CRY1 t(4)=1.352, p=0.248 t(4)=1.117, p=0.326 
CRY2 t(4)=0.846, p=0.445 t(4)=-0.035, p=0.974 
REV-ERBα t(4)=3.728, p=0.020* t(4)=-0.416, p=0.698 
REV-ERBβ t(4)=1.942, p=0.124 t(4)=-0.678, p=0.535 
CLOCK t(4)=3.402, p=0.027* t(4)=-0.798, p=0.470 
BMAL1 t(4)=-5.185, p=0.007* t(4)=-0.410, p=0.703 
 
 
We also see that the levels of the CLOCK transcript appear unchanged in the ΔCLOCK 
cells. Note that the qPCR primers amplify a sequence from exons 15-16 of the CLOCK mRNA 
so will detect the modified transcripts from both alleles. While the modification clearly reduced 
protein levels (see Figure 2.10, page 86) the modification would not necessarily cause reduced 
expression of the transcript. In summary, this initial analysis of core clock genes in 
unsynchronised cells revealed that depletion of NPAS2 coincided with increased expression of 
REV-ERBα (>3-fold) and CLOCK (2-fold) transcripts as detected by RT-qPCR. This result 
suggests a possible role for NPAS2 in negative regulation of REV-ERBα and CLOCK 
expression in NIH3T3 cells. In contrast, depletion of NPAS2 resulted in a reduction (>2 fold) 
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3.3.3 Rhythmic expression of core circadian genes in synchronised edited 
NIH3T3 cells 
Having established that we could detect changes in transcript levels of core clock genes 
(REV-ERBα, BMAL1, CLOCK) between the WT and the ΔNPAS2 cells in asynchronous 
conditions, the next goal was to assess how circadian expression of key genes was altered in 
these cultured cells after serum shock. Based on the data from the analysis of gene expression 
in asynchronous cells it was decided to focus on the expression of 6 genes. REV-ERBα, BMAL1, 
CLOCK (based on the significant change in gene expression in the ΔNPAS2 cells). REV-ERBβ, 
PER1 (based on the sub-significant but observable change in expression in the ΔNPAS2 cells) 
and CRY1 (based on the observable change in the ΔCLOCK cells) were also included, in 
addition to 18S rRNA gene as a normalisation control. 
3.3.3.1 Circadian expression of genes in WT NIH3T3 cells 
Firstly, the expression of the genes across the time points in WT NIH3T3 cells was 
assessed to identify if we observe the expected rhythmic expression of genes to confirm to the 
model (Figure 3.4, Table 3.6). Looking at transcript levels of the 6 circadian genes, only 
REV-ERBα and REV-ERBβ showed robust and statistically significant circadian patterns, 
peaking at 18 hrs post serum shock. This pattern of expression is consistent with results from 
Osland et al. (2011) using serum shocked NIH3T3 cells, in which REV-ERBα expression 
peaked at 18 hours and 42 hours post shock. 




Figure 3.4:  Expression of circadian genes in WT NIH3T3 cells following serum shock 
synchronisation. 
Mean relative expression (±SEM) is  shown for each of the genes of investigated; BMAL1  
(black),  CLOCK  (red),  REV-ERBα  (green).  REV-ERBβ  (blue),  CRY2  (violet) and PER1  (cyan).  
Clear circadian peaks are seen in the expression of both REV-ERBs peaking at 18 hours.  
CLOCK  and BMAL1  both show antiphasic expression to the REV-ERB  transcripts with highest 
expression seen at 6 hours for CLOCK  and 0 hours for BMAL1 .  PER1  shows decreased 
expression after 0 hours and CRY2  does not present a notable variation across the time 
















Table 3.6: One-way ANOVA testing of time point effect on gene expression in serum 
shocked WT NIH3T3 cells 
Gene Effect of time point 
PER1 F(4,10)=9.707, p=0.00179* 
CLOCK F(4,10)=2.528, p=0.107 
BMAL1 F(4,10)=2.377, p=0.122 
CRY2 F(4,10)=0.743, p=0.584 
REV-ERBβ F(4,10)=4.300, p=0.028* 
REV-ERBα F(4,10)=5.639, p=0.012* 
 
The significant variation across time points observed for PER1 expression is likely 
primarily due to 10-fold higher expression of the transcript initially after the serum shock 
compared to all other time points. This initial induction of the expression of PER genes has 
been reported in other serum shock synchronised cultured cells and is likely part of the response 
responsible for entrainment in cultured cells (Balsalobre et al., 1998). Although a subtle 
increase of PER1 expression is observed at 18 hours, levels remained substantially lower than 
the expression at 0 hours. This pattern is consistent with that in the report by Osland et al. 
(2011) who noted no circadian expression of PER1 in NIH3T3 cells once the initial peak of 
expression is passed. 
No statistically significant effect of time was identified on expression of CLOCK. 
Despite this a potentially antiphasic expression pattern compared to the REV-ERBs can be seen, 
peaking at 6 hours within the time frame of the experiment. BMAL1 showed no significant time 
point variation but showed a potentially antiphasic expression pattern as compared to the 
REV-ERBs, with lowest expression observed at the 18-hour time point. Again, these results for 
CLOCK and BMAL1 are consistent with the observations in the Osland et al., 2011 study, albeit 
they had more time points. 
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In the Osland study, CRY2 expression levels displayed a modest and less clear 
oscillation over time, being low at 6 hrs and highest at 18 hrs. The CRY2 expression oscillations 
in WT NIH3T3 cells observed here were also modest and while they did not show a significant 
time point effect, we still observe subtle rhythmic fluctuations in expression. 
Thus, across all genes investigated we concluded that at least for several of the genes 
in this study, circadian oscillation patterns were observed that were consistent with previous 
studies and confirm the efficacy of serum shock in synchronising cell autonomous circadian 
clocks. 
3.3.3.2 Effect on circadian expression of genes in ΔNPAS2 NIH3T3 cells 
We next assessed the role of NPAS2 in regulating circadian oscillations of these genes 
shown in Figure 3.5. Results of the analysis are presented in Table 3.7. Significant interaction 
effects of genotype x time point on the expression of REV-ERBs and CRY2 were identified 
suggesting an impact of the loss of NPAS2 on the rhythmic expression of these genes. These 
interactions were investigated through post hoc pairwise analysis, the findings of which are 
shown on the respective graphs of Figure 3.5 and detailed in Table 3.8. Significant main effects 
of the loss of NPAS2 expression on BMAL1 and CLOCK expression were observed suggesting 
an impact of NPAS2 loss on the general expression of these genes without an effect on the 
rhythmic expression. However, no significant effect of NPAS2 expression on PER1 was 
observed. 




Figure 3.5:  Expression of circadian genes in serum shock synchronised cells 
Mean relative gene expression (±SEM) in ΔNPAS2 cells (red),  ΔCLOCK cells  (green) 
compared to WT NIH3T3 cells (black).  Relative expression values are based on RT-qPCR 
reads after 2 - Δ Ct  transformation based on 18S  reads, relative to the WT sample at time point 
zero for each gene. Note PER1  expression at 0 hours varies hugely from the other t ime 
points hence the split axis.  The results of statistical analysis of main effects are shown in 
Table 3.7 and Table 3.9. The significance of pairwise post hoc comparisons of cell types at 
specific  time points are shown (**=p<0.01, ***=p<0.001, details in Table 3.8 and Table 
3.10).  
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Table 3.7: Factorial ANOVA comparison of gene expression in serum shock synchronised 
WT and ΔNPAS2 cells 
Gene Genotype Time Genotype x time interaction 
BMAL1 F(1,20)=13.643, p=0.00144* F(4,20)=3.442, p=0.027* F(4,20)=1.518, p=0.235 
CLOCK F(1,20)=47.83, p<0.00001* F(4,20)=3.015, p=0.042* F(4,20)=2.574, p=0.069 




CRY2 F(1,20)=10.46, p=0.004* F(4,20)=5.95, p=0.003* F(4,20)=2.96, p=0.045* 









Table 3.8: Post hoc pairwise comparison of gene expression in WT and ΔNPAS2 cells at 




CRY2  REV-ERBα REV-ERBβ 
0 p=0.050 p=0.00001* p=0.153 
6 p=0.810 p=0.971 p=0.157 
12 p=0.620 p=0.310 p=0.518 
18 p=0.001* p=0.00018* p<0.00001* 
24 p=0.458 p=0.306 p=0.108 
 
Significantly enhanced expression of REV-ERBα and REV-ERBβ in the ΔNPAS2 cells 
was observed at 18 hours after the serum shock (3-fold higher REV-ERBα & 8-fold higher 
REV-ERBβ expression compared to WT at 18 hours). This is consistent with our previous result 
in the asynchronous expression assay (Figure 3.3) showing that loss of NPAS2 causes an 
increase in the amplitude of REV-ERB cycles. This suggests that depletion of NPAS2 leads to 
a derepression of REV-ERB gene transcription primarily at times of peak REV-ERB expression. 
The circadian pattern peaking at 18 hours is seen for both genes, so the timing of the circadian 
pattern is not modified from WT cells. The expression of REV-ERBα is also significantly 
increased in the ΔNPAS2 cells immediately following the serum shock, while not obvious in 
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the WT data presented here, Osland et al. (2011) reported an initial early peak of REV-ERBα 
in serum shocked NIH3T3 cells so we are likely also observing an enhancement of this peak. 
For REV-ERBβ expression while the post hoc testing only identified a significant change at 18 
hours the expression at every time point is several times greater than in the WT cells suggesting 
that while the major effect occurs at the time of peak expression there is a persistent increase 
in expression of REV-ERBβ in the ΔNPAS2 cells. 
The expression of BMAL1 at time zero is 2-fold lower in the ΔNPAS2 cells and it 
appears that the rhythmic expression of BMAL1 seen in WT cells is lost with the loss of NPAS2, 
shown in Figure 3.5. Despite this, the statistical analysis identified that loss of NPAS2 caused 
a significant reduction of BMAL1 expression however there was not a significant interaction 
effect with time point. As such this data only confidently shows that NPAS2 depletion causes 
decreased BMAL1 expression but not loss of the rhythmic expression. This is likely due to the 
subtle change in BMAL1 expression across time points and variation in expression meaning 
that there was not a significant effect of time points observed in the WT cells by statistical 
analysis. 
Figure 3.5 shows that the expression of CLOCK is increased between 2- and 4-fold in 
the ΔNPAS2 cells at each of the 5 time points, supporting the observed significant main effect 
of NPAS2 expression without a significant time point interaction. This suggests loss of NPAS2 
significantly increases CLOCK expression across the cycle without a rhythmic effect. 
The expression of CRY2 was enhanced in the ΔNPAS2 cells specifically at the points 
of higher expression (0 and 18 hours) although a significant comparison is only seen at 18 
hours. This means that the circadian pattern of expression is more obvious than was observed 
in the WT cells where a significant time point effect was not observed. As for the REV-ERB 
transcripts this suggests that depletion of NPAS2 leads to a derepression of CRY2 gene 
transcription primarily at times of peak expression. 
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3.3.3.3 Effect on circadian expression of genes in ΔCLOCK NIH3T3 cells 
The role of CLOCK in regulating circadian oscillations of these genes was investigated 
and results are shown in Table 3.9. Significant interactions of genotype x time point on the 
expression of the CLOCK transcript were identified suggesting an impact of the reduction of 
CLOCK protein expression on the rhythmic expression of its own modified transcript, or an 
effect of the modification on transcript stability. This interaction effect was investigated 
through post hoc analysis, the results of which are shown on the CLOCK expression graph of 
Figure 3.5 and detailed in Table 3.10. Significant main effects of the knockdown of CLOCK 
expression on the expression of the BMAL1 and REV-ERBβ transcripts were observed 
suggesting an impact of reduced CLOCK on the general expression of these genes without an 
effect on the rhythmic expression. However, no significant effect of CLOCK expression on the 
expression of PER1, CRY2 or REV-ERBα was observed. 
As shown in Figure 3.5 the expression of CLOCK transcript in ΔCLOCK cells was 
~2-fold higher that WT cells at 18 hours, with the significant increase only observed at this 
time point. While the WT cells do not present a clear circadian pattern there is a peak at 6 
hours, which is lost in the ΔCLOCK cells with the 18-hour peak appearing instead, this may 
present a phase shift in the rhythmic expression of the CLOCK transcript. This suggests that 
the depletion of CLOCK protein causes a decrease in repressive functions affecting its own 
expression in a rhythmic manner. 
The expression of BMAL1 in the ΔCLOCK cells is similar to that seen in the ΔNPAS2 
cells, although the expression in asynchronous ΔCLOCK cells did not present the statistically 
significant decrease in expression observed in ΔNPAS2 cells (Figure 3.3). Both ΔNPAS2 and 
ΔCLOCK cells appeared to show loss of the rhythmic BMAL1 expression, however, as noted 
for ΔNPAS2 cells, statistical analysis did not identify a significant effect on the cycling 
behaviour. This means we observe that CLOCK depletion causes decreased BMAL1 




Due to the substantially elevated expression of the REV-ERBs in the ΔNPAS2 cells 
another graph was created to clearly show the WT and ΔCLOCK comparison, Figure 3.6. 
REV-ERBβ was identified by analysis to show a significant increase in expression in the 
ΔCLOCK cells without it being a time dependent effect. However, it appears that expression 
is increased primarily at the time of peak expression similar to the expression in ΔNPAS2 cells 
suggesting a similar effect of CLOCK depletion. No significant effect of depleted CLOCK 
expression was observed on REV-ERBα expression although a 0-hour peak, possibly as part of 
the serum shock response, is observed in the ΔCLOCK cells similar to the larger peak in 
ΔNPAS2 cells. 
The depletion of CLOCK expression was also not observed to significantly modify the 
expression levels of CRY2 or PER1 either overall or in a time specific manner. 
 
Table 3.9: Factorial ANOVA comparison of gene expression in serum shock synchronised 
WT and ΔCLOCK cells 
Gene Genotype Time Genotype x time interaction 
BMAL1 F(1,20)=9.127, p=0.007* F(4,20)=2.736, p=0.058 F(4,20)=2.269, p=0.098 
CLOCK F(1,20)=1.778, p=0.197 F(4,20)=1.897, p=0.150 F(4,20)=3.721, p=0.020* 
PER1 F(1,20)=0.106, p=0.748 F(4,20)=19.85, p<0.00001* F(4,20)=1.263, p=0.317 
CRY2 F(1,20)=0.385, p=0.542 F(4,20)=2.125, p=0.115 F(4,20)=1.573, p=0.220 
REV-ERBα F(1,20)=2.355, p=0.141 F(4,20)=7.474, p=0.00075* F(4,20)=0.947, p=0.458 
REV-ERBβ F(1,20)=4.755, p=0.041* F(4,20)=6.274, p=0.00193* F(4,20)=0.993, p=0.434 
 
   
138 
 
Table 3.10: Post hoc comparison of CLOCK transcript expression in WT and ΔCLOCK 
cells at individual time points based on a significant interaction effect identified by 
factorial ANOVA 











Figure 3.6: Expression of REV-ERB genes in serum shock synchronised ΔCLOCK cells  
Mean relative expression (±SEM) of REV-ERBα  and REV-ERBβ  transcripts in serum shock 
synchronised ΔCLOCK cells (green) compared to WT NIH3T3 cells (black). Data is the same 
as that in Figure 3.5 without the data of ΔNPAS2 cells to allow clear comparison of the WT 
and ΔCLOCK cells.  Relative expression values are based on RT-qPCR reads after 2 - Δ C t  
transformation based on 18S  reads,  relative to the WT sample at time point zero for each 
gene.




3.4.1 Results summary 
In summary we have observed significant differences in the expression of various core 
circadian feedback genes between WT control cells and the ΔNPAS2 and ΔCLOCK cells. In 
unsynchronised cells it was identified that the expression of the REV-ERBα and CLOCK genes 
was significantly increased, and BMAL1 significantly decreased in the ΔNPAS2 cells 
compared to the WT cells (Figure 3.3). Investigating the expression after circadian 
synchronisation we identified significantly different expression of BMAL1, CLOCK, CRY2, 
REV-ERBα and REV-ERBβ genes between the ΔNPAS2 and WT cells. The increase in CRY2, 
REV-ERBα and REV-ERBβ expression coincided with the times of peak expression (Figure 
3.5). In ΔCLOCK cells, expression of REV-ERBα was similar to control levels, while BMAL1, 
CLOCK, and REV-ERBβ showed similar changes in expression to that in the ΔNPAS2 cells, 
although less substantial (Figure 3.5 & Figure 3.6). 
3.4.2 NPAS2 KO may influence the cell cycle in NIH3T3 cells 
Imaging of the cells identified no gross phenotypic effects in cell appearance. It was 
however noted in routine cell culture that the ΔNPAS2 clones take an increased amount of time 
to reach confluence (approximately 2x), although this has not been established experimentally. 
This may suggest loss of NPAS2 negatively influences cell growth. Various circadian genes 
have been linked to the cell cycle with various checkpoints affected by circadian timing which 
would influence cell growth (Farshadi et al., 2020). Upregulation of NPAS2 in hepatocellular 
carcinoma is associated with accelerated cell cycle progression (Yuan et al., 2017) and 
knockdown of NPAS2 in acute myeloid leukaemia cells supressed proliferation (Song et al., 
2018) suggesting the slowing of growth rate is an effect of the loss of NPAS2. However 
silencing NPAS2 has been reported to enhance the growth of DLD-1 colorectal 
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adenocarcinoma cells (Xue et al., 2014) and a primary fibroblast culture from NPAS2 KO mice 
showed enhanced proliferation (Sasaki et al., 2020) so it appears this may be a tissue-specific 
effect and more complicated than a direct effect of NPAS2. 
3.4.3 NPAS2 ablation impacts expression levels of REV-ERBα, CLOCK and 
BMAL1 in unsynchronised NIH3T3 cells 
Analysis of the expression levels of eight core clock components revealed significant 
changes in three genes in asynchronous ΔNPAS2 cells: REV-ERBα, CLOCK and BMAL1. 
While not reaching significance, expression levels of REV-ERBβ and PER1 also showed a 
tendency toward increased expression (Figure 3.3). The increase in CLOCK expression may 
be a compensatory mechanism to overcome loss of its paralog, similar to the increase in NPAS2 
observed in studies of CLOCK KO mice, although the mechanism is unknown (see below). 
The change in overall expression of REV-ERBα and REV-ERBβ was unexpected and was not 
observed in the CLOCK deficient cell line. To our knowledge, this is the first reported 
observation of potential negative regulation of REV-ERBα/β genes by NPAS2, although 
REV-ERBs are known repress expression of BMAL1 and NPAS2 genes through binding 
ROREs in their promoters (Ikeda et al., 2019). Thus, our results may indicate another aspect of 
the autoregulatory interactions of core clock genes. 
3.4.4 Serum shock model of circadian cycling in cell culture 
We demonstrated in this study the successful reconstitution of circadian 
synchronisation of several core clock components in NIH3T3 cells induced by serum shock. 
The results were largely consistent with other studies (Osland et al., 2011), with the most robust 
time dependent changes observed for the REV-ERBs and CRY2 which peak around 18 hours 
post shock (Figure 3.4). BMAL1 and CLOCK showed an antiphasic expression compared to 
REV-ERBs. No clear cycling of PER1 was observed over the time course of the experiment, 
despite an initial drop in PER1 expression post shock (Figure 3.4), similar to previous studies 
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(Osland et al., 2011). 
As shown in Figure 3.5, significant increases in the expression of both REV-ERB gene 
transcripts in the ΔNPAS2 cells were identified primarily at the time points of high expression, 
consistent with the observed modified expression in asynchronous cells. While in the ΔCLOCK 
cells an increase was observed in REV-ERBβ this change was very minor compared to the large 
change seen in the NPAS2 modified cells (2-fold compared to 8-fold increase). As such this 
may reflect an effect unique to NPAS2. 
Although CLOCK gene transcripts shows a very moderate cycling pattern (Figure 3.4, 
Figure 3.5) it was noticeable that in the ΔNPAS2 cells the overall expression level was 
increased, consistent with the data from unsynchronised cells. As noted above, this increase 
may potentially be a compensatory effect, similar to the compensatory increase in NPAS2 
expression which has been observed in the liver of CLOCK KO mice (Landgraf et al., 2016, 
Debruyne et al., 2006). It is noted that a decrease in expression of REV-ERBα is also reported 
in these mouse models which could be responsible for the increase in NPAS2 expression 
through loss of REV-ERB repression of NPAS2 transcription. This does not however explain 
the mechanism in our model, nor is the observed increase of both REV-ERBs and CLOCK 
contradictory as the REV-ERB proteins have been reported to not directly influence CLOCK 
expression due to the absence of a RORE site (Ikeda et al., 2019). Similarly, an increase in 
CLOCK transcript levels was noted in the ΔCLOCK cells (Figure 3.5), likely the response of a 
similar compensatory process. However, this is not associated with an increase in CLOCK 
protein expression based on the previously detailed western blot investigation of the cells 
(Figure 2.10). The analysis of the target sites identified by Koike et al. (2012), used to produce 
Figure 3.1 (details in appendix section A.7, page 305), found that BMAL1 alone has a binding 
site potentially influencing expression of the CLOCK gene. However, as the CLOCK gene was 
not reported to be a target of CLOCK or NPAS2 this is unlikely to reflect regulation of CLOCK 
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expression directly by BMAL1 activity and the change in expression is more likely due to 
indirect effects. 
BMAL1 showed reduced expression in both cell lines, primarily at the time points of 
higher expression in the WT cells meaning a loss of the variance of BMAL1 expression across 
time points (Figure 3.5). A similar decrease in cycling of BMAL1 transcript is observed in the 
liver and other peripheral clocks of CLOCK KO mice although cycling expression is still 
observed (Landgraf et al., 2016). In the SCN of NPAS2 KO mice rhythmic expression of 
BMAL1 is lost, however this effect is due to an increase in BMAL1 expression at lower 
expression time points rather than a decrease at the higher expression time points as seen in our 
cell model (DeBruyne et al., 2007a). As the REV-ERB proteins act to inhibit BMAL1 
expression the increased expression of REV-ERBs in both clones may be responsible for this 
effect, although the more substantial upregulation of the REV-ERBs in the ΔNPAS2 cells 
compared to the ΔCLOCK cells is not associated with a more substantial reduction of BMAL1 
expression.  
An increase in the expression of CRY2 was observed in the ΔNAPS2 modified cell line 
at the time of peak expression with a similar increase in the ΔCLOCK cells, although below 
significance (Figure 3.5). As CLOCK and NPAS2 both act as transcription factors for the CRY 
genes it is surprising that expression increases. However, this may suggest compensatory 
effects within the circadian cycles which then cause modifications in the expression patterns.  
3.4.5 Mechanisms of NPAS2 knockout influence on the expression of the 
REV-ERB genes 
Most notable of the gene effects is the substantial increase in expression of the 
REV-ERB transcripts in NIH3T3 cells with a KO of NPAS2. Possible mechanisms of this effect 
are shown in Figure 3.7. 
Firstly, this could be due to alleviation in the ΔNPAS2 cells of competition between 
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NPAS2 and CLOCK, both in association with BMAL1 and binding to genomic E-boxes. If in 
normal function the NPAS2:BMAL1 dimer is unable to induce transcription of the REV-ERB 
genes (Figure 3.7 A) or is a weaker activator of REV-ERB transcription (Figure 3.7 B) then 
loss of NPAS2 as a competitor will allow increased association of the CLOCK:BMAL1 dimer 
and lead to higher levels of transcription. This is unlikely as, while less substantial, we also 
observed increased REV-ERB expression in the ΔCLOCK cells. 
It may be a functional result of the compensation of loss of NPAS2, as noted above the 
ΔNPAS2 cells showed increased expression of the CLOCK transcript, if the levels of CLOCK 
expression are greater than the levels of NPAS2 and CLOCK expression combined in WT cells 
then this may enhance transcription of genes under E-box promotors, even if the 
NPAS2:BMAL1 and CLOCK:BMAL1 dimer are functionally similar, due to higher E-box 
occupation (Figure 3.7 C). 
Finally, the results we present here may instead be an indication of a more complex 
effect caused via influences on the expression and activity of various CCGs rather than a direct 
effect. If expression of other unidentified genes is modified in the ΔNPAS2 cells then these 
genes may influence expression of REV-ERB transcripts. Other genes could affect 
transcription, potentially through influencing CLOCK:BMAL1 activity at E-boxes or activity 
at other promotors (Figure 3.7 D) or some may influence stability of the REV-ERB transcripts. 
It should be noted that a combination of these effects may be responsible and any of these 
effects may occur only as a tissue-specific function, as circadian cycles are controlled in a 
variety of ways, including tissue-specific influences on CLOCK/NPAS2:BMAL1 activity 
(Yeung et al., 2018). The potential tissue specificity of this relationship is highlighted by the 
fact than in the SCN of constitutive NPAS2 KO mice the expression of REV-ERBα was 
unaltered (DeBruyne et al., 2007a). 




Figure 3.7:  Possible mechanisms responsible for the increased REV-ERB expression in cells 
with a functional KO of NPAS2. 
A:  Transcriptional repression, if  the NPAS2:BMAL1 dimer is  a  negative transcription factor 
of the genes then it will  compete for CLOCK:BMAL1 E-box association. B:  Competition, if  
the NPAS2:BMAL1 dimer is a  weaker activator of gene transcription then absence of NPAS2 
will alleviate competition for BMAL1 dimerisation for CLOCK allowing greater transcription 
through CLOCK:BMAL1 E-box association. C:  Compensation, the ΔNPAS2 cells  showed 
increased CLOCK transcript expression, if  the expression of CLOCK protein is  increased by 
more than the level of  NPAS2 is  decreased then this enhanced level  of CLOCK:BMAL1 dimer 
will increase E-box occupancy and gene transcription. D: Indirect mechanisms, other gene 
expression levels may be positively or negatively influenced by loss of NPAS2, this may then 
affect the levels of gene transcripts through influencing transcription or transcript 
stability.  
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3.4.6 Future work 
Effects on the expression levels of circadian genes have been identified, as follow up 
to this work it would be of value to perform rescue experiments, in which WT expression levels 
of the modified genes is restored via plasmid transfection. Reintroduction of the modified genes 
should change gene expression in the cells to levels similar to the WT cells. This would provide 
confidence that the findings are due to the gene modification effects, rather than any other 
change in the modified clones compared to the WT cells. 
Observation of any effect on the circadian period of gene expression would not be 
expected to be observed here, due to the large time windows utilised. As loss of CLOCK or 
NPAS2 individually would likely only be associated with a subtle modification to the circadian 
cycles, substantially closer time points would be required to observe the effect. Alternatively 
using live luciferase recording the period of luminescence, as introduced in section 3.1.1, would 
reflect the circadian period and could be used to identify any change in period length. 
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Chapter 4: Establishing the 
NPAS2fl/fl/Alb-cre liver knockout mouse 
model and investigating gene expression 
changes in the liver and brain regions




4.1.1 Circadian rhythms in the liver 
The core circadian transcription feedback loops are described in Chapter 1 (section 1.3, 
page 26). As addressed in section 1.5 (page 31), genes with rhythmic expression may exhibit 
differences in amplitude and phase across different tissues and some core clock genes and 
clock-controlled genes (CCGs) show rhythmic expression only in certain tissues (Yan et al., 
2008). This is due primarily to the impact of tissue-specific factors (Yeung et al., 2018).  
In the liver, circadian cycles play a significant role in metabolism, including rhythmic 
synthesis of cholesterol and bile acids (Ferrell and Chiang, 2015, Zhou et al., 2016). The liver 
is one of the peripheral oscillators which can be decoupled from the SCN cycles though 
preferential entrainment to restricted feeding (RF) schedules (Damiola et al., 2000) showing 
the sensitivity of liver circadian cycles to metabolic state. Liver-specific BMAL1 deletion 
causes loss of circadian transcription in the liver and also inhibits the oscillation of blood 
glucose levels leading to hypoglycaemia in the fasting phase (Lamia et al., 2008), showing the 
importance of the liver in metabolic circadian cycles and homeostasis. In mouse models which 
should only express a functioning clock in the liver due to constitutive KO of BMAL1 and 
reconstituted BMAL1 liver expression, it has been observed that the functioning genetic clock 
in the liver is not enough to fully restore the normal liver cycles of all rhythmic genes and even 
the cycling which does occur is quickly lost upon placement in constant darkness (Koronowski 
et al., 2019). The inverse has also been observed; even in liver-specific circadian KO models, 
the circadian cycling of some genes is retained in the liver tissue but lost when the liver is 
cultured ex vivo, while unmodified mice retain rhythmic expression of liver genes (Kornmann 
et al., 2007). This suggests liver cycles are dependent both on the contribution of circadian 
signals produced from other tissues as well as the internal circadian cycles for complete normal 
function. 
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Communication to other tissues of the circadian state of the liver has been shown to be 
performed by the liver-derived ketone body β-hydroxybutyrate. In mice under RF conditions, 
β-hydroxybutyrate production by the liver contributes to behavioural entrainment and artificial 
introduction of β-hydroxybutyrate to the brain, in a time restricted manner, causes a similar 
entrainment effect to that of RF (Chavan et al., 2016). Cycling levels of blood glucose have 
also been identified to influence behavioural cycles through effects on the brain (Yi et al., 2006, 
Burdakov et al., 2005) 
4.1.2 NPAS2 in mouse models 
The function of NPAS2 has previously been studied in constitutive mouse KO models. 
In the SCN the loss of NPAS2 has been found to cause little change in expression of some core 
circadian genes, a subtle dampening in the amplitude of PER2 cycling and overall increase in 
BMAL1 were observed without noticeable change in PER1 or REV-ERBα expression 
(DeBruyne et al., 2007a). In the forebrain of NPAS2 KO mice, it has been reported that there 
was no change in the expression of CLOCK (which does not show cycling expression in the 
forebrain) (Dudley et al., 2003), while normal PER2 cycling of expression was lost (Reick et 
al., 2001). A study of liver expression of genes in constitutive NPAS2 KO mice identified 
increased expression of BMAL1 and decreased expression of PER1 without any change in the 
expression of CLOCK, CRY2 and REV-ERBβ (O’Neil et al., 2013). However, this study did not 
look at gene expression at time points or specify the time at which tissue collection was 
performed, so some effects may have been missed. 
4.1.3 Genetics of the NPAS2fl/fl/Alb-cre mouse model 
To investigate gene functions within specific tissues, conditional KO mouse models 
can be employed in which a mutation is introduced into the genome in a way which modifies 
gene expression only in specific tissues. To investigate the role of NPAS2 in peripheral clocks 
a liver-specific KO was utilised.  
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The NPAS2TM2AAGAA mouse model with floxed NPAS2 was developed by the Aagaard 
group as part of their work investigating the interaction of NPAS2 with the microbiome (O’Neil 
et al., 2017). This liver-specific KO model NPAS2TM2.1AAGAA was generated by use of the 
Cre-LoxP system. Two LoxP sites within the introns up and downstream of exon 3 were 
introduced (‘floxing’ the exon) which should not affect the expression of NPAS2 protein nor 
change its structure. The Cre recombinase protein can then induce recombination of the DNA 
at the two LoxP sites, removing the DNA sequence between the two sites. This means that Cre 
under a tissue-specific promotor can be used to excise the NPAS2 genomic sequence in any 
tissue of interest (Kim et al., 2018a). In the conditional liver-specific NPAS2 KO, Cre is 
expressed via the postnatal liver-specific Albumin promotor (cKO, NPAS2fl/fl/Alb-cre). This 
leads to KO of NPAS2 after development reducing potential compensatory effects. Mice with 
floxed NPAS2 but which lack the expression of Cre are used as controls from the same litters 
(Ctrl, NPAS2fl/fl). This removal of exon 3 leads to loss of the functional protein expression; any 
protein expression from the common ATG start codon would present a frameshift due to the 
loss of the exon. This modification may lead to expression of a reported shorter NPAS2 protein 
(ΔbHLH-NPAS2) through an alternate exon 2 ATG becoming an in-frame start codon. 
However, this protein lacks exon 3 and without this substantial region of the bHLH domain 
would be unable to dimerise with BMAL1 or act as a transcription factor (Garcia et al., 2000). 
As such it is a non-functional protein and will also not compete with CLOCK for BMAL1 
association. 
4.1.4 Experimental aims and hypothesis 
The liver-specific NPAS2 cKO mice were used to investigate the effect of loss of 
NPAS2 in a peripheral clock on circadian gene expression. As the mouse colony was 
established, various molecular tests were performed to investigate the model. Initially, 
establishment of the mouse genotypes using ear notches was required, both to confirm the 
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modifications to the genetic sequence, as had previously been reported for these mice, and 
establish genotyping procedures for use in maintenance of the breeding colony.  
To assess the tissue-specific functioning of Cre in the liver, genomic DNA was obtained 
from the brain and the liver of wild type C57BL/6, floxed control and Cre expressing cKO 
mice. In the liver, due to the Cre activity, genotyping should show the loss of the floxed region 
of NPAS2 while in the brain this genomic region should only present floxed sequence. In the 
control mice the floxed sequence should be present for both tissues, while for wild type mice 
both tissues will present the sequence without the LoxP insertion. 
Finally, the effect of loss of liver NPAS2 on the expression of genes that make up the 
core circadian feedback loop was investigated. This was performed using a total of 18 female 
mice aged 2-5 months. Samples were collected from the liver at the time of lights on, which is 
defined as zeitgeber time 0 (ZT0) and lights off (ZT12). These time points were chosen as they 
reflect times of high and low expression for several circadian transcripts in the liver, based on 
information from the circadian expression profiles database, CircaDB (Pizarro et al., 2013, 
http://circadb.hogeneschlab.org/). Gene expression in the prefrontal cortex (PFC) was also 
investigated as a non-SCN clock in the brain with identified circadian oscillation (Chun et al., 
2015) and one of the regions in the brain that clearly present NPAS2 expression (Reick et al., 
2001). Specifically, the expression of the genes REV-ERBα, REV-ERBβ, BMAL1 and CLOCK 
were investigated as these genes were identified to be influenced by the loss of NPAS2 in the 
modified cell models. Comparison of the gene expression levels between control and cKO mice 
was then used to inform conclusions as to how NPAS2 in the liver contributes to the circadian 
feedback loop.  
It was hypothesised that we would see similar effects on gene expression in the cKO 
liver to those in the modified cells, as both are NPAS2 KO models of peripheral clocks, and 
gene expression within the brain would be unaltered due to retained NPAS2 expression. 
   
152 
 
4.2 Materials and Methods 
4.2.1 In vivo methods 
4.2.1.1 Animals 
Mice were bred on site after establishment of the breeding colony using mice imported 
from the Baylor Institute, Texas. The control mice (NPAS2TM2AAGAA) are floxed on exon 3 of 
NPAS2 and cKO mice (NPAS2TM2.1AAGAA) are floxed and are also heterozygous for Cre under 
an albumin promotor. This means the cKO mice express Cre specifically within the liver, 
resulting in a functional KO of NPAS2. Breeding cages were set up with two females and one 
male, either the male or both females were cKO mice and the remaining were control floxed 
mice. Other than breeders, mice were single sex housed in cages of up to five mice. The mice 
were provided with ad libitum water and 2018 Rodent diet (Envigo). The mouse holding room 
was kept on a light cycle of 12h:12h LD with lights on at 7am and constant temperature 
(20±2 °C) and humidity (40–60%). Wild type C57BL/6 mouse tissues for genotype analysis 
were taken from mice purchased from Charles River Labs UK aged 3-6 months. 
4.2.1.2 Genotyping 
From the breeding colony ear notches were collected from all mice when weaned. The 
ear notches were either used for genomic extraction and PCR testing (performed as detailed 
below) or sent off in well plates to Transnetyx, Inc., Cordova, TN, USA. Transnetyx provides 
automated genotyping services of the ear notch tissue using our established primer sequences. 
4.2.1.3 Tissue collection 
Liver and brain tissues were collected for genotype validation (5.1.1) and for 
investigation of mRNA expression (4.3.3); all mice were culled by cervical dislocation and 
tissue collected and placed directly onto dry ice before storage at -80 °C until needed. Sections 
were made to collect the PFC of the brain for gene expression analysis. These sections likely 
also included other cortical and subcortical regions of the brain including the motor cortex 
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while excluding the SCN. For genomic analysis a more general section encompassing a wider 
range of cortical and subcortical regions was made (see Figure 4.1). It should be noted that the 
brain region collected is likely to have included cortical regions outside of the PFC and some 
subcortical regions. 
For investigation of gene expression, tissues were collected from female mice aged 2-5 
months at lights on (ZT0) and lights off (ZT12). 
 




Figure 4.1:  Brain sections for tissue collection  
Sectioning of mouse brain used for tissue investigation.  A:  PFC sectioning used for 
investigation of gene mRNA expression levels. B:  General  brain section used for 
investigation of genomic DNA modifications.  
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4.2.2 Molecular biology techniques 
Chemicals, reagents, and methodologies for molecular investigation were as described 
in Chapters 2 and 3, with the following additional details. 
4.2.2.1 Composition of reagents 
RNA agarose gel loading dye = 1 ml deionised formamide, 0.3 mg bromophenol blue, 
0.3 mg xylene cyanol, 10 µl 1 M Tris-HCl pH 7.5-8.0. Stored at -20 °C. 
4.2.2.2 Genomic extraction 
Genomic DNA was purified from tissue using the GenElute™ Mammalian Genomic 
DNA Miniprep Kit. The tissue was cut minced on ice and digested in lysis solution T and 
genomic DNA extracted following the manufacturer’s instructions for mammalian tissue. The 
concentration of DNA was determined using a NanoDrop 1000 Spectrophotometer. 
4.2.2.3 Agarose gel electrophoresis 
RNA agarose gels were performed similarly to DNA agarose gels as detailed in Chapter 
2 (see 2.2.4.4). 1% agarose gels for RNA electrophoresis were made with 3 µl of 10 mg/ml 
ethidium bromide solution per 50 ml of liquid agarose rather than the 1 µl used for DNA gels. 
Prior to loading in the gel 0.2 µl RNA was added to 10 µl RNA agarose gel loading dye and 
incubated for 3 minutes at 70 °C to denature secondary structure. The gel was run for 1 hour at 
90V or longer, as required for clear separation. 
4.2.2.4 RNA extraction 
For gene expression analysis, total RNA was extracted using Trizol (Sigma). The PFC 
brain sections and sections of the livers weighing ~100 mg were minced on ice immediately 
upon removal from -80 °C using cold tools. The tissue was immediately moved into 
preprepared 1 ml cold Trizol reagent and sonicated in cold water for a maximum of 3 x 15 
second bursts as required to disrupt the tissue, using a Diagenode Bioruptor®. The RNA 
isolation was then performed according to the manufacturer’s protocol, briefly this involved 
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separation of the RNA by addition of chloroform and taking the phase containing the RNA, 
precipitation of the RNA by addition of isopropanol, washing the RNA using 75% ethanol and 
resuspension in 30 µl or 200 µl of RNase free water for PFC and liver samples respectively. 
4.2.2.5 RT-qPCR 
Reverse transcription of RNA and RT-qPCR was performed exactly as detailed for 
cDNA from cultured cells in Chapter 3 (section 3.2.2.3, page 120). The primers used for 
analysis are the same used for investigation of gene expression in the NIH3T3 cells (validation 
in appendix A.4, page 288, sequences in appendix Table A.1, page 296). Reads were 
normalised to individual 18S reads and the average of the specific gene expression in control 
mice at ZT0. Fold changes were calculated by dividing the reads at ZT12 by the average read 
at ZT0 for both genotypes individually. 
4.2.3 Experimental design and statistical analysis 
A power calculation using a Cohen's f of 0.908, based on a pilot study of genotype 
effect on gene expression in the liver of control and cKO mice, was performed in G power, for 
an ANOVA with an alpha value of 0.05 and power of 0.9 with 4 groups and a numerator df of 
1. This large effect size was considered appropriate to identify biologically relevant influences 
on gene expression. Based on this a required total of 16 mice was calculated, equal to four mice 
per group. Due to greater availability within the litter more control mice were available for 
tissue collection and a total of five control mice were used at each time point.  
Statistical analysis was performed using SPSS software as detailed in Chapter 3, section 
3.2.3 (page 123). For investigation of the effect of the between-subjects factors of time and 
genotype on relative gene expression two-way ANOVAs were used. For investigation of fold 
changes across time-points independent t-tests were used to investigate the between-subjects 
factor of genotype. 




4.3.1 Validation of genotyping primers 
To identify the genotypes of the mice for breeding and experimentation two genomic 
regions were investigated by PCR amplification. The inclusion of the inserted LoxP site shows 
that the mice are floxed for NPAS2. A region of genomic DNA where the LoxP site was inserted 
5’ of NPAS2 exon 3 was amplified by PCR. This amplification produces products of different 
sizes, depending on the presence or absence or the LoxP site and will always produce a product 
if the PCR was successful for either genotype. The size of the product then identifies the 
genotype of the mouse with respect to the floxing. A second PCR test was designed for 
amplification of a region of the integrated Cre recombinase sequence, this PCR will only 
produce a product if Cre transgene is present. As genotyping is performed on the ear notches, 
the recombination events are not expected as they would be liver-specific, so there should be 
no modification of the NPAS2 exon 3 region. 
Using DNA from characterised mice without the LoxP insertion, with or without Cre 
genetic sequence, three different primer pairs all designed to amplify different arbitrary 
sequences within the Cre gene were tested (Cre1, Cre2 & Cre3) and the NPAS2 LoxP primers 
(LoxP) were tested as internal controls (Figure 4.2 A). The use of an internal control is required 
for the Cre genotyping, due to a failure of PCR in a Cre positive sample and the absence of Cre 
appearing indistinguishable on a gel. Use of the LoxP amplification as the internal controls cuts 
down on the number of PCR tests required for genotyping. Based on the gel shown in Figure 
4.2 A it was identified that the 408 bp product from the primers designated ‘Cre2’ showed most 
clear amplification in combination with primers to amplify the 5’ LoxP site. Although the 
presence of observable primer dimers in the agarose gel also rose noticeably compared to the 
PCRs of only one primer pair it did not affect clear determination of the genotype. An exemplar 
gel showing genotyping of some mice from the breeding colony is presented in Figure 4.2 B 
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showing the larger LoxP product (246 bp) and the presence of Cre as identified by testing using 
the Cre2 primers. In amplification from DNA including the Cre genomic sequence, the LoxP 
product is fainter, suggesting the combined PCR amplification was less efficient, however it 
can still be seen and in this colony there should only be the LoxP inserted sequence present, 
meaning it purely acts as an internal control for the Cre negative samples. 




Figure 4.2:  Agarose gels of mouse genotyping PCRs 
A:  Comparison of primers to genotype the presence of the Cre genomic sequence in 
combination with the LoxP primers. 3 different Cre primer pairs were used, Cre1 which 
amplifies a 100 bp product,  Cre2 which amplifies a 408 bp product and Cre3 which amplifies 
a 643 bp product. These were run in combination with the NPAS2  LoxP primer pair to  
validate that combination of both can be used to provide an internal positive.  In this gel  all  
PCRs were performed on genomic DNA lacking the inserted LoxP, meaning the LoxP primers 
amplify a product of  194 bp of unmodified NPAS2  sequence (see Figure 4.3).  The products 
of Cre1 primers are very small and hard to differentiate from primer dimers in the 
combination reaction and the products of Cre3 primers are barely visible and marked with 
a blue arrow. Cre2 primers however were able to amplify a product which appears very 
clearly on the agarose gel even when amplified in the combination reaction. B:  An example 
genotyping gel  of mice from the NPAS2 f l / f l/Alb-cre  breeding colony. The LoxP primers 
produce a 246 bp product validating the inclusion of the NPAS2  LoxP site.  The Cre2 primers 
detect the 408 bp Cre sequence in the mice with Cre expression allowing clear 
differentiation. 
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4.3.2 Validation of conditional KO of NPAS2 in liver 
The NPAS2fl/fl/Alb-cre mouse model should present a liver-specific loss of NPAS2 exon 
3. To validate that this modification occurred, genomic DNA was extracted from liver and 
brain tissue of both control and cKO mice, as well as wild type C57BL/6 mice. A PCR was 
performed using primers up and downstream of either of the introduced LoxP sites, these will 
present different products depending on the genomic sequence present, explained in Figure 4.3 
A. The agarose gel showed the expected 650 bp products for both wild type mouse tissues, as 
expected from amplifications of NPAS2 exon 3 lacking the inserted LoxP site. Amplification 
from both tissues of the control NPAS2fl/fl mouse produced the expected 825 bp product, 
including the LoxP insertion. In the tissue from a cKO NPAS2fl/fl/Alb-cre mouse the LoxP 
inserted 825 bp product was amplified from the brain DNA while the 220 bp product was 
amplified from the genomic DNA in the liver. This shows excision of the targeted region 
(including exon 3) in the liver specifically of mice expressing Cre under an albumin promotor. 
This work was performed by PhD student Ruby Chrisp. 




Figure 4.3: Confirmation of genetic modification in NPAS2 f l / f l/Alb-cre cKO mice 
A:  Details  of  primers and expected product sizes for genomic amplification of wild type,  
floxed and excised NPAS2  exon 3. B:  Agarose gel of PCR products amplified from genomic 
DNA from brains and livers of  specific genotype mice,  performed by PhD student Ruby 
Chrisp.  In both WT (NPAS+ / +) and floxed (NPAS2 f l / f l) mice both tissues present identical 
genomic DNA of the expected size and in mice expressing Cre under an Albumin promotor 
the 220 bp product amplified from the liver genomic DNA shows that Cre recombination 
has occurred while no recombination occurs in the brain.  
   
162 
 
4.3.3 RT-qPCR investigation of expression of core circadian genes in mouse 
tissues 
Based on the detection of changes in the transcript levels of both REV-ERBs, CLOCK 
and BMAL1 in ΔNPAS2 cell lines (see section 3.3.3.2, page 132), we assessed expression of 
these genes in female control and cKO mice. Gene expression was investigated at two time 
points; lights on (ZT0) and lights off (ZT12) to allow a measure of circadian effect. Gene 
expression was investigated in the liver as the tissue of interest with loss of NPAS2 expression 
in the modified mice, and the prefrontal cortex (PFC) as a non-SCN brain tissue. Along with 
the expression at the time points, the fold change in expression from ZT0 to ZT12 of each of 
the mouse genotypes was calculated and compared. 
4.3.3.1 Core clock gene expression in the liver of control and liver cKO mice 
Previously reported circadian expression of gene transcripts in the mouse liver are 
available in the circadian database CircaDB (Pizarro et al., 2013), this provides a normative 
base line against which the results can be compared. Note that ZT0 and ZT12 were used as 
time points here as they reflect peak and lowest expression of CLOCK and BMAL1 and 
differences should be observable in the expression of both REV-ERBs between those time 
points with higher levels at ZT12. However, these time points do not reflect peak expression 
of the REV-ERB transcripts, REV-ERBα expression is highest as ~ZT7 and lowest at ~ZT20 
while REV-ERBβ expression is highest at ~ZT9 and lowest at ~ZT0 (Pizarro et al., 2013). 
In control floxed mouse livers the investigated transcripts showed the expected 
comparison in expression between time points; CLOCK and BMAL1 both showed higher 
expression at ZT0 while the REV-ERBs showed higher expression at ZT12 (Figure 4.4). 
Analysis results are shown in Table 4.1.  
A significant effect of time was observed for all genes. Supported by the comparisons 
of the expression between the time points consistent with the expression patterns from 
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CircaDB, this suggests we observed the normal circadian patterns of gene expression. The only 
significant genotype effect observed is the reduction of expression of REV-ERBα in the livers 
of cKO mice. Thus, ablation of NPAS2 was found to have a significant impact on expression 
of REV-ERBα in mouse liver. 
 
Table 4.1: Factorial ANOVA comparison of gene expression in the liver of control and 
cKO mice 
Gene Genotype Time Genotype x time interaction 
BMAL1 F(1,14)=0.008, p=0.932 F(1,14)=131.064, p<0.00001* F(1,14)<0.001, p=0.991 
CLOCK F(1,14)=0.171, p=0.685 F(1,14)=54.666, p<0.00001* F(1,14)=1.494, p=0.242 
REV-ERBα F(1,14)=8.05, p=0.013* F(1,14)=39.862, p=0.00002* F(1,14)=0.170, p=0.686 
REV-ERBβ F(1,14)=0.004, p=0.953 F(1,14)=126.683, p<0.00001* F(1,14)=1.635, p=0.222 
 




Figure 4.4:  Liver gene expression in control and cKO mice 
Mean relative expression (±SEM) of core circadian gene transcripts in the livers of control  
floxed (black) and conditional liver NPAS2 KO female mice (red) housed under 12h:12h LD 
conditions at ZT0 and ZT12. Relative expression values are based on RT-qPCR reads after 
2 -Δ Ct  transformation based on 18S  reads,  relative to the ctrl  sample at  ZT0 for each gene. 
Statistical analysis is presented in Table 4.1.  A significant main effect of time was identified 
for the expression of all  4 genes,  a separate main effect of  genotype on REV-ERBα  expression 
was also identified.  No significant interaction effects were identified so pairwise 
comparisons were not investigated. 
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We also examined the fold change in expression of the four genes analysed from ZT0 
to ZT12 (Figure 4.5, Table 4.2). This analysis identified significant increases in the fold change 
in expression of both REV-ERB transcripts in cKO mice. This observed increase of time-based 
variance in REV-ERBα is due to the decreased expression of the transcript in the cKO mice 
being more substantial at ZT0. This means that even though expression was reduced compared 
to control mice at both time points the difference between expression at the two time points is 
greater in cKO mice. The increase in fold change expression of REV-ERBβ is due to expression 
levels showing a subtle increase at ZT12 and a subtle decrease at ZT0 compared to expression 
in control mice. This suggests the amplitude of the rhythms of the REV-ERB genes may have 
increased even though the data suggests that the highest expression level of REV-ERBα has 
decreased. Although not reaching significance, the fold change in CLOCK expression is also 
further from 1 suggesting an increase in variation in the cKO mice. 
 
Table 4.2: Independent t-testing of the effect of liver NPAS2 expression on the fold change 
in expression of circadian genes from ZT0 to ZT12 in the liver 
Gene 
Genotype fold change 
comparison 
BMAL1 t(7)=-0.233, p=0.823 
CLOCK t(7)=1.923, p=0.096 
REV-ERBα t(7)=-2.663, p=0.032* 








Figure 4.5:  Rhythmic fold change in liver gene expression in control and cKO mice 
Mean fold change (±SEM) in expression of circadian genes from ZT0 to ZT12 in the liver of 
control  and cKO mice.  Values higher than 1 reflect increased expression at  ZT12 and less 
than 1 decreased expression at ZT12. The significance of independent t-test comparisons 
between WT and the ΔNPAS2 cells  are shown (*=p<0.05, ***=p<0.001, details  in Table 4.2).  
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4.3.3.2 Core clock gene expression in the prefrontal cortex (PFC) of control and liver 
cKO mice 
Circadian expression of core circadian genes has been observed in the mouse PFC, and 
studies have shown that these cycles can be perturbed by circadian disorganisation (Otsuka et 
al., 2020). The reported gene expression patterns from this study provide a normative baseline 
of gene expression in the PFC. Both CLOCK and BMAL1 were reported to show no rhythmic 
fluctuation in expression across time while REV-ERBα showed peak expression at ~ZT12 and 
low at ~ZT0 (Otsuka et al., 2020), REV-ERBβ expression was not investigated but it is assumed 
the expression pattern would be similar to REV-ERBα as is seen in most tissues.  
We analysed the expression of four core circadian genes in the PFC of control and cKO 
mice at ZT0 and ZT12 (Table 4.3). Here we show that CLOCK and BMAL1 expression in the 
PFC of control and cKO mice showed no significant change between ZT0 and ZT12, as a small 
apparent increase in CLOCK expression at ZT12 compared to ZT0 did not reach significance 
(Figure 4.6). Both REV-ERBα and REV-ERBβ showed ~2.5-fold higher expression at ZT12 
compared to ZT0 (Figure 4.6). These observations are consistent with those previously reported 
(Otsuka et al., 2020). 
Table 4.3: Factorial ANOVA comparison of gene expression in the PFC of control and 
cKO mice 
Gene Genotype Time Genotype x time interaction 
BMAL1 F(1,14)=0.533, p=0.477 F(1,14)=8.079, p=0.013* F(1,14)=5.885, p=0.029* 
CLOCK F(1,14)=0.001, p=0.974 F(1,14)=0.029, p=0.868 F(1,14)=7.353, p=0.017* 
REV-ERBα F(1,14)=0, p=0.987 F(1,14)=2.84, p=0.114 F(1,14)=2.439, p=0.141 
REV-ERBβ F(1,14)=0.914, p=0.355 F(1,14)=2.364, p=0.146 F(1,14)=4.985, p=0.042* 
 




Figure 4.6:  PFC gene expression in control  and cKO mice 
Mean relative expression (±SEM) of core circadian gene transcripts in the PFC of control  
floxed (black) and conditional liver NPAS2 KO female mice (red) housed under 12h:12h LD 
conditions at ZT0 and ZT12. Relative expression values are based on RT-qPCR reads after 
2 -Δ Ct  transformation based on 18S  reads,  relative to the ctrl  sample at  ZT0 for each gene. 
The results of statistical analysis of main effects are shown in Table 4.3. The significance 
of post hoc simple main effect comparisons within genotype or time point are shown 
(*=p<0.05, **=p<0.01, details in Table 4.4).  
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A significant interaction of genotype x time was observed in the expression of the 
BMAL1, CLOCK and REV-ERBβ genes. These interaction effects were further investigated by 
post hoc pairwise comparison, the results of this analysis are shown on the graphs of Figure 
4.6 and in Table 4.4. These comparisons identified a significant change in BMAL1 expression 
across time points specifically in cKO mice and a change in REV-ERBβ expression specifically 
in control mice. A significant change between genotypes at specific times was observed at ZT0 
for BMAL1 and ZT12 for REV-ERBβ. The appearance or loss of the time point difference is 
the most interesting, with the change between genotypes at time points primarily a reflection 
of this. Despite the significant interaction effect on CLOCK expression no significant pairwise 
comparison was identified. It appears changes were too subtle to be identified as statistically 
significant, although from the graph it appears an inversion of the timing of higher expression 
is observed in the cKO mice. Further time points would be required to understand these effects 
in more detail. No significant effect was identified on the expression of REV-ERBα, however 
the observed expression pattern suggests loss of variation in expression from ZT0 to ZT12, 
similar to REV-ERBβ. 
Table 4.4: Post hoc pairwise comparison of gene expression levels in the PFC of control 
and cKO mice investigating the effect of genotype at each time point and the effect of time 
within each genotype 
Comparison BMAL1 CLOCK REV-ERBβ 
Ctrl:cKO @ 
ZT0 
p=0.043* p=0.079 p=0.382 
Ctrl:cKO @ 
ZT12 
p=0.250 p=0.073 p=0.041* 
ZT0:ZT12 in 
ctrl mice 
p=0.759 p=0.077 p=0.013* 
ZT0:ZT12 in 
cKO mice 
p=0.003* p=0.074 p=0.648 
 
The fold change in expression from ZT0 to ZT12 is shown in Figure 4.7, analysis results 
are presented in Table 4.5. This analysis identified significant changes in the fold change 
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expression of REV-ERBβ and CLOCK transcripts in cKO mice. Based on the fold change 
values this suggests we observe a loss of change in REV-ERBβ expression across timepoints 
but an inversion in the change in CLOCK expression across timepoints in cKO mice. It should 
be noted that the post hoc comparison analysis of CLOCK expression did not identify a 
significant effect of time in either control or cKO mice, and there is reported to be no rhythmic 
circadian expression of CLOCK in the PFC (Otsuka et al., 2020), as such this result will require 
further investigation. It is possible that the subtle effect observed is due to rhythmic expression 
of CLOCK in the other brain regions included in our investigation. 
Table 4.5: Independent t-testing of the effect of liver NPAS2 expression on the fold change 
in expression of circadian genes from ZT0 to ZT12 in the PFC 
Gene 
Genotype fold change 
comparison 
BMAL1 t(7)=2.057, p=0.079 
CLOCK t(7)=2.602, p=0.035* 
REV-ERBα t(7)=2.156, p=0.068 
REV-ERBβ t(7)=2.501, p=0.041* 
 
The fold change in the expression of REV-ERBβ was reduced to ~1 suggesting a loss 
of the circadian rhythmicity, supported by the findings of the relative expression shown in 
Figure 4.6 and addressed above. Although not reaching significance, the fold change in BMAL1 
expression is numerically reduced from 1, combined with the significant pairwise analysis of 
the expression levels data, this suggests a circadian pattern of BMAL1 expression in the cKO 
mouse PFC which is not seen in the PFC of control mice. In the inverse of this, the fold change 
in REV-ERBα expression is ~3 in the control mice but ~1 in the cKO. Taken together these data 
show a definite effect of loss of NPAS2 expression in the liver on rhythmic expression of core 
circadian genes in the PFC. This suggests both that expression of clock genes in the liver 
influences distant molecular tissue clocks and that NPAS2 contributes to this function of the 
liver. 




Figure 4.7:  Rhythmic fold change in PFC gene expression in control  and cKO mice 
Mean fold change (±SEM) in expression of circadian genes from ZT0 to ZT12 in the PFC of 
control  and cKO mice.  Values higher than 1 reflect increased expression at  ZT12 and less 
than 1 decreased expression at ZT12. The significance of independent t-test comparisons 
between control  and cKO mice are shown (*=p<0.05, details in Table 4.5).  




4.4.1 Results summary 
The expected genomic modifications were validated to occur within the liver tissue of 
the cKO mice but not in brain tissues (Figure 4.3). Investigation of gene expression found that 
in the liver of cKO mice the expression of REV-ERBα was decreased compared to the control 
mice (Figure 4.4). In the brain region investigated, genotype time interaction effects were 
identified on the expression of BMAL1, CLOCK and REV-ERBβ. A significant difference in 
the expression of BMAL1 between timepoints was only identified in cKO mice while a 
significant timepoint difference in REV-ERBβ expression was only observed in cKO mice 
(Figure 4.6).  
4.4.2 Model validation 
We have validated the NPAS2 cKO mouse model, showing liver-specific loss of 
NPAS2 exon 3 (Figure 4.3). A loss of exon 3 has been previously characterised, as this is 
utilised in the established constitutive KO mouse model, and while a truncated NPAS2 protein 
may still be expressed, this ΔbHLH-NPAS2 protein is unable to perform its normal function 
(Garcia et al., 2000). As such this mouse model shows functional KO of NPAS2 in the liver 
while in other tissues the gene is unaffected. These floxed mice also have the potential to be 
bred with alternative Cre expressing mice to produce various other tissue-specific KO models. 
4.4.3 Knockout of NPAS2 expression in the liver modulates liver expression 
of the REV-ERB genes 
In the liver of cKO mice, where NPAS2 function was lost, we observed significant 
effects on the fold change in expression between time points of both REV-ERB transcripts and 
a significant reduction in REV-ERBα expression irrespective of time point. This contrasts with 
the results in the cell culture model, where we observed increased expression of the transcripts 
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primarily at times of peak expression (see section 3.3.3.2, page 132). It is likely that the effects 
are modulated by unique tissue-specific factors between the liver and fibroblasts (Yeung et al., 
2018, Beytebiere et al., 2019), such as the nuclear receptor hepatocyte nuclear factor 4 alpha 
(HNF4α) which is expressed in hepatocytes but not fibroblasts (Qu et al., 2018) but could also 
be the effect of synchronisation signals from other unmodified tissues present in the in vivo 
model but absent in the cell culture model. 
Despite the differences it is still of note that in both models, where NPAS2 function is 
lost but CLOCK is unaltered, we see alterations in expression of the REV-ERB genes which 
results in an increase in variation of transcript expression across time. In the SCN constitutive 
NPAS2 KO was not associated with any change in REV-ERBα expression (DeBruyne et al., 
2007a) supporting the contribution of tissue specific factors to this effect in peripheral clocks. 
The reduction of REV-ERBα expression levels suggests that in the liver NPAS2 normally acts 
to induce REV-ERBα expression, hence, the loss of NPAS2 then inhibits expression. The effect 
on REV-ERBβ expression is more subtle, appearing as an increase at the time of high expression 
and a decrease at the time of low expression. 
The REV-ERB proteins have been shown to link circadian cycles and metabolism. 
Depletion of the expression of both REV-ERBs has been shown to derepress the expression of 
multiple metabolic genes and causes hepatic steatosis (Bugge et al., 2012). Interaction between 
NPAS2 and the REV-ERBs may be responsible for the metabolic importance of NPAS2, 
meaning it is of interest to identify what this change in expression can mean in terms of effects 
on the expression of other genes. 
Both BMAL1 and CLOCK transcripts in the liver retain their rhythmicity without 
significant changes in expression observed in the cKO mice. This again contrasts with the 
findings in the ΔNPAS2 cells which showed decreased BMAL1 expression and increased 
CLOCK expression. As the significant increase in expression of the REV-ERB transcripts is not 
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observed in this model it may be unsurprising to note that we have not observed the repression 
of BMAL1 expression which was likely to be, at least in part, due to increased repression though 
REV-ERB activity at RORE sites blocking BMAL1 transcription. Based on some of the 
hypotheses proposed in Chapter 3 (section 3.4.5, page 143), it may be that the increased 
CLOCK protein expression is required for the increased REV-ERB expression through elevated 
transcription rates. As such we are not able to identify one specific effect responsible for the 
difference from the cell models. Whatever specific effect is responsible, the difference between 
this data and that from Chapter 3 may be due to tissue-specific variation in factors influencing 
the circadian cycle or even the presence of external signals to the liver which would occur in 
the mouse organism (Hughes et al., 2009). An effect of entraining signals from other tissues is 
very likely especially in a model where the circadian clock in all other tissues is genetically 
unmodified. 
4.4.4 Distant clocks are influenced by the loss of NPAS2 expression in the 
liver 
NPAS2 expression in the PFC is not expected to be modified, supported by the 
genotyping investigation (Figure 4.3). Despite this, significant alterations in BMAL1, CLOCK 
and REV-ERBβ expression in the PFC of cKO mice were observed, while expression of 
REV-ERBα also appeared modified although the data did not reach statistical significance. This 
result suggests a correlation between loss of liver NPAS2 expression and altered rhythmic 
expression of core circadian genes in the PFC. This is surprising as based on our data, the 
circadian cycles in the liver appear to have only changed subtly and under LD we would expect 
most tissues to retain entrainment to the light cycles via the SCN, without any modulation by 
the liver circadian clock. Importantly, in the liver, despite the observed changes, the pattern of 
time expression of the genes has remained, while in the PFC we saw loss of the time point 
variation of REV-ERBβ (and also REV-ERBα), the appearance of time point variation of 
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BMAL1 and the inversion of the fold change across time points of CLOCK. Expression of 
BMAL1 was shown by Otsuka et al. (2020) to be constant without circadian rhythmicity in the 
PFC which our data from control mice also shows. The appearance of cycling BMAL1 protein 
levels in cKO mice will influence the core circadian cycle and many more cycling genes than 
the ones tested here will likely show modified expression patterns in the PFC of cKO mice. 
The specific changes in gene expression may provide part of an explanation of the 
effects observed. A possible mechanism is presented in Figure 4.8. As the expression of the 
REV-ERBs depends on BMAL1, we know that in the PFC the arrhythmic expression of BMAL1 
means another factor must play a role in the circadian REV-ERB expression. In Figure 4.8 this 
is presented as a repressor, such as PER2, the PER2 transcript has been reported show peak 
transcript expression a few hours after peak REV-ERBβ expression in the PFC (Otsuka et al., 
2020), making this a reasonable candidate. However, any cycling input affecting REV-ERBβ 
expression could reasonably fill this role including activators of expression. As such, the 
cycling BMAL1 expression in the cKO mice may then act counter to this regulation and act to 
balance it out, either due to similar phase expression to a repressor, or antiphasic expression to 
another activator. This then means that REV-ERB expression is constant. The reverse is also 
possible, in that the cycling expression of the REV-ERB proteins may contribute to the static 
expression of BMAL1, in conjunction with another circadian regulated factor. In Figure 4.8 this 
other factor is presented as an activator of BMAL1 expression, such as ROR, however as stated 
above, a repressor of expression could also fill this role. A loss of the variation of REV-ERBβ 
protein expression in the cKO PFC would mean the complementary patterns of repression of 
BMAL1 transcription, specifically by REV-ERB at RORE sites, is lost, leading to cycling 
expression. Potentially, any rhythmically expressed factors which affects the expression of 
BMAL1 and REV-ERBβ can fill the gaps in this model as long as the circadian patterns of that 
factor are not modified in the cKO mouse. This model was kept simple for clarity, it is more is 
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likely there are transcription effects by multiple different proteins with different cycles of 
activity resulting the observe gene expression. While this hypothesised model could explain 
some of the expression patterns and show how modulation of any circadian gene expression 
can modify the whole feedback system, it is still unclear what causes this change in the PFC.  
The apparent change in the expression of CLOCK is less clear due to the more subtle 
changes in expression levels meaning we do not directly observe a significant difference in 
expression between timepoints in ctrl or cKO mice (Table 4.4). However, it appears that we do 
see subtle time point variation in expression in control mice, although this was not observed 
by Otsuka et al. (2020). To further investigate this, more time points may be useful as we may 
be missing the times of peak and lowest expression which would be more useful in 
understanding the effect on the circadian cycles of the PFC.




Figure 4.8:  Hypothesised modifications to the feedback loop of RORE influenced BMAL1 expression 
A:  Hypothesised normal function of the feedback loop in the PFC of control mice. BMAL1 arrhythmically induces the expression of REV-ERBβ .  
The rhythmic expression of REV-ERBβ  is due to rhythmic activity of a  repressor of BMAL1 activity (X) such as the PER or CRY proteins. 
REV-ERBβ rhythmically represses the expression of BMAL1  induced by an activator of BMAL1  transcription (Y) such as RORα. The arrhythmic 
expression of BMAL1  is due to the synchronous rhythmic expression of Y to REV-ERBβ meaning transcription rates remain comparable at all  
times due to increased repression of activity at time of higher induction of transcription. B:  Hypothesised modified function of the feedback 
loop in the PFC of cKO mice. The rhythmic expression of BMAL1 would lead to rhythmic activation of transcription of REV-ERBβ  however 
synchronous rhythmic expression of X leads to comparable transcription rates of REV-ERBβ  at all  times.  This constant expression means that 
the rhythmic activation of transcription of BMAL1  by Y leads to rhythmic expression. 
   
178 
 
4.4.5 Communication of the liver and the PFC 
These results suggest that the loss of NPAS2 in the liver modifies circadian gene 
expression in the PFC. This could occur via nervous feedback through afferent nerves to the 
brain or hormonal/metabolite feedback, or a combination of these involving different tissues. 
No findings to date have identified circadian communication from the liver through any 
afferent nervous communication to the brain. Afferent nerves from the liver are however able 
to detect glucose levels and send signals which influence the initiation of food intake (Yi et al., 
2010), suggesting that afferent nervous connections from the liver to the brain may play a role 
in circadian entrainment to the liver clock. 
The liver plays a pivotal role in blood glucose circadian homeostasis due to its role in 
glucose uptake and forming the major site of glucose synthesis, with liver-specific BMAL1 
KO leading to perturbations of cycling blood glucose levels (Lamia et al., 2008). If the cKO 
mice show a modulation of the metabolic output from the liver, then blood glucose levels may 
influence the circadian cycles in the brain. Information in the form of metabolites or hormones 
in the bloodstream can reach the brain without having to cross the blood brain barrier via the 
circumventricular organs: organum vasculosum of the lamina terminalis (OVLT), the 
subfornical organ (SFO), the area postrema (AP) and the arcuate nucleus (ARC). If the 
metabolic state of cells in these brain regions are modified, then the molecular clocks can be 
entrained in response to this through several metabolic effects on the metabolic feedback loop 
(as detailed in section 1.6, page 33). These brain regions can then influence circadian cycles 
throughout the brain. The ARC specifically has been reported to detect circulating glucose 
levels and even communicate directly to the SCN among other regions (Yi et al., 2006) making 
this a region that may be part of this liver influence on brain circadian cycles.  
Elevated glucose levels within the brain have also been identified to influence 
melanin-concentrating hormone (MCH) and orexin neurons of the lateral hypothalamus (LH) 
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which exert opposing effects on arousal and metabolism. Glucose enhances the function of 
MCH neurons and has the opposite effect on orexin neurons (Burdakov et al., 2005). Despite 
the clear links between blood glucose levels and circadian cycles in the brain, in our model, 
our data does not suggest that normal metabolic liver function was modified in any way and 
no effects are noted on the mouse physiology, so it is not known whether blood glucose levels 
are affected. 
As noted in section 4.1.1, the liver-derived ketone body β-hydroxybutyrate can also 
entrain other tissues and contributes to behavioural entrainment to RF (Chavan et al., 2016). If 
the loss of NPAS2 in the liver influences β-hydroxybutyrate production, then this may be 
responsible for the modulation of the separate circadian cycles. 
Peripheral clocks have also been shown to be reset by hormones with circadian 
influence over their expression, notably insulin (Sato et al., 2014), glucagon (Sun et al., 2015), 
leptin (Wiater et al., 2013) and ghrelin (LeSauter et al., 2009) among others. Receptors for 
metabolic hormones like insulin, leptin and ghrelin allow the ARC to sense information from 
the periphery and signal it to the central nervous system (Buijs et al., 2006) and ARC leptin 
receptors have been found to contribute to circadian rhythmicity (Coppari et al., 2005). The 
liver can produce the hormone insulin-like growth factor 1 (IGF-1) which has been reported to 
influence circadian cycles in various tissues (Crosby et al., 2019). If the expression of IGF-1 is 
modified in cKO mice, then activity at the ARC may influence circadian cycles. Alternatively, 
indirect activity of IGF-1 at another tissue, such as the adipose, may influence leptin levels 
which could then affect brain circadian cycles. Any of these hypotheses would require further 
work to prove or invalidate them. 
4.4.6 Future work 
We have identified effects of the loss of NPAS2 in the liver on the expression of core 
circadian genes, both within the liver and also surprisingly within the PFC. Based on this data 
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across this chapter and Chapter 3 we have observed that loss of NPAS2 has effects on 
expression of the REV-ERB genes, however, the effects are different between the fibroblast cell 
culture and in vivo liver. As such it may be of interest to further characterise tissue-specific 
factors which influence NPAS2 activity. Since we are observing an effect on REV-ERB 
expression, part of a feedback loop which directly affects NPAS2 expression in normal 
conditions, it would be of interest to look at the expression of the ROR genes which act counter 
to REV-ERBs in this feedback loop. 
For some of the changes in expression we see, it is possible that the effect is due to 
change in either amplitude or timing of the cycle. For instance, in the PFC our data cannot 
conclusively tell the difference between non-rhythmic expression and rhythmic expression 
where both ZT0 and ZT12 fall between peak and lowest expression. Although, since this then 
requires a very specific pattern this is unlikely. To validate or investigate our findings in more 
detail, RT-qPCR investigation of gene expression at more time points would be useful. RNA 
seq analysis could be used to investigate all transcripts in the tissues at multiple timepoints. 
To further investigate the effect of the liver NPAS2 cKO, it may be of interest to 
investigate other tissues or brain regions to see if there is an effect on circadian cycles in other 
peripheral tissues. Investigation of the levels of blood glucose and β-hydroxybutyrate and 
metabolomics analysis of the serum and brain tissue throughout the day may provide insight 
into the cause of the modified gene expression in a separate circadian clock. 
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Chapter 5: Circadian behavioural 
entrainment in NPAS2fl/fl/Alb-cre liver 
knockout mice 




5.1.1 Entrainment of circadian cycles and free-running 
Circadian cycles are entrained by zeitgebers, meaning the cycles are synchronised to 
these signals to match the external environment (see section 1.1, page 22). Light is the primary 
zeitgeber which entrains and synchronises circadian cycles through the SCN (Takahashi et al., 
2008). However, a variety of other signals have also been shown to synchronise behavioural 
cycles. In addition to light, time of feeding is a powerful zeitgeber which synchronises 
peripheral clocks and ensures the animal is awake and active at the time when food is available. 
Entrainment by zeitgebers is a daily process of resynchronising behaviour, when an animal is 
isolated from zeitgebers and under constant conditions it is no longer subject to the process of 
entrainment. In the absence of rhythmic zeitgebers patterns of behaviour are dependent on the 
intrinsic circadian free-running period, which tends to be close to, but not exactly, 24 hours, 
causing behaviour to steadily fall out of external daily synchrony (Panda et al., 2002b). 
Light entrainment can easily be observed experimentally. Under normal light-dark 
cycling (LD) conditions, high activity at times of darkness is seen in nocturnal animals. When 
lighting cycles are modified, the entrainment to light can be seen in the shift of behavioural 
cycles, such that the active period of the animal occurs during the new dark phase. Acute shifts 
in behavioural cycles can also be caused by entrainment in response to short pulses of light 
when the animals are under constant darkness (DD) conditions in a time specific manner 
(LeGates and Altimus, 2011). 
Food entrainment is observed when food is restricted to a specific time of day within a 
mouse’s inactive phase. Under these conditions, rodents begin to show a period of activity in 
advance of the time of regular food provision. This is known as food anticipatory activity 
(FAA) (Richter, 1922). This FAA behaviour is controlled by the output of an incompletely 
identified circadian food entrainable oscillator (FEO), a biological clock entrained by food 
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availability, the output of which can be seen in FAA and molecular cycles in peripheral tissues 
(Mistlberger, 1994). The FEO is independent of the SCN, not cycling in synchrony nor 
requiring the function of the SCN, and has been shown to function even in the absence of 
canonical clock genes (Pendergast and Yamazaki, 2018).  
The FEO has not been identified as existing as a single oscillator within one organ and 
while it has been posited that the FEO is possibly formed from the activity of multiple entwined 
loci, it is still possible that a final common circadian clock for food anticipation exists 
(Mistlberger, 2020). The liver has been suggested as an important organ for circadian 
entrainment to food as it is entrained to times of food availability and has been associated with 
RF entrainment of circadian endocrine signals (Hara et al., 2001, Díaz-Muñoz et al., 2000). It 
has been shown that a liver-specific KO of PER2 abolishes FAA as does a constitutive KO. 
This abolition is not seen in a brain specific PER2 KO (Chavan et al., 2016), suggesting a fully 
functional circadian clock in the liver may be more important than in the brain for FEO 
entrainment. However, it should also be taken into account that there is conflicting information 
as to the role of PER2 in FAA; under different food restriction conditions and with running 
wheel availability PER2 constitutive KO mice show normal FAA (Pendergast et al., 2017). It 
has also been shown in mice with a brain specific BMAL1 KO, effectively knocking out 
circadian cycles in the brain, that while most tissues become asynchronous under DD, the 
introduction of restricted feeding (RF) is sufficient to resynchronise liver and kidney circadian 
cycles while other peripheral tissues remain unsynchronised (Izumo et al., 2014). Since this 
suggests liver is entrained by RF independently of the brain it is possible that the entrained 
liver clock contributes to entrainment of circadian cycles in the brain to RF. The entrained brain 
clock would then be responsible for entrainment of other peripheral tissues. 
These investigations of the responses of mouse models to the zeitgebers of light and 
food availability contribute to understanding the role of specific genes and tissues within 
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regular circadian maintenance. While the mechanisms of the core feedback loop are fairly well 
understood (e.g., how CRY and PER prevent the activity of the CLOCK/NPAS2:BMAL1 
dimer) it is less well characterised how this feedback loop is externally influenced in the 
processes of entrainment. Nor is it fully known, especially as noted in the case of the FEO, how 
different tissues contribute to the circadian timing of an organism. 
5.1.2 NPAS2 in circadian entrainment – studies in constitutive mouse 
models 
Constitutive NPAS2 KO mice in DD have been shown to have a reduced free-running 
period compared to WT mice (23.7 (WT) and 23.5 (NPAS2 KO)) based on wheel running 
behaviour (Dudley et al., 2003). This shortening of the free-running period was likely due to 
the impact of loss of NPAS2 within the core feedback cycle, but the retention of rhythmic 
activity shows that the core clock feedback loop was still functional in these mice. The delay 
due to loss of NPAS2 appears similar to the impact of the CLOCK KO on free-running cycles 
while knocking out both genes renders mice arrhythmic (DeBruyne et al., 2007a). This suggests 
a similar effect of loss of one of the BMAL1 dimerisation partners on free-running period and 
that the overlapping functions of CLOCK and NPAS2 are sufficient to retain circadian 
free-running behaviour with minimal effect in the absence of the other gene. 
The activity profiles of constitutive NPAS2 KO mice were also found to vary 
significantly from wild type mice; NPAS2 KO mice showed increased wheel-running activity 
and reduced sleep during the latter part of the dark phase of the LD cycle (ZT19-ZT22) (Dudley 
et al., 2003). This suggests a role of NPAS2 in the maintenance of normal activity patterns, as 
the normal circadian timings are, for the most part, retained it is likely that this is due to a role 
outside the SCN. 
Constitutive NPAS2 KO mice have been shown to have an enhanced response to light 
entrainment but are deficient in entrainment to food availability. While wild type mice exposed 
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to a phase advance of the LD cycle of 4 hours shifted their activity to match the new light cycle 
over a few days, NPAS2 KO mice activity shifted almost completely within the first day. This 
showed that behaviour was more efficiently synchronised by light signals in NPAS2 KO mice 
(Dudley et al., 2003). 
Although the NPAS2 KO model does not present increased expression of CLOCK as a 
compensatory protein, it was suggested that the contribution of CLOCK:BMAL1 to the 
circadian feedback cycle may be of greater importance for synchronisation to light in the SCN 
than NPAS2:BMAL1. According to this hypothesis the NPAS2 KO model favours entrainment 
to light as the feedback loop is entirely dependent on CLOCK:BMAL1 activity (Dudley et al., 
2003). This is somewhat supported by a reported decrease in phase delay response to early 
active phase light entrainment in CLOCK constitutive KO mice, however a substantial increase 
in phase advance in response to late active phase light entrainment was also observed 
(Debruyne et al., 2006). This suggests specific directionality of the influence of the core 
circadian genes in light entrainment. 
In contrast to light entrainment, the constitutive NPAS2 KO mice have been shown to 
have impairment in responding to time restricted food provision, although entrainment was not 
completely abolished. Under restricted feeding conditions NPAS2 KO mice showed a slower 
increase in FAA compared to wild type mice, taking three days longer to reach the peak activity 
level (Dudley et al., 2003). This suggests the phase shifting of FEO was less responsive to the 
restricted food entrainment in the KO mice. Although the mice were in constant darkness, the 
behavioural shift in KO mice still occurred faster than the shift due to the effect of free-running 
cycles alone and activity remained persistent after the shift to match the time of food 
availability. This shows that while entrainment was delayed, the FEO remained functional in 
these mice. 
This suggests NPAS2 plays a role in entrainment of the FEO in response to feeding, 
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most likely contributing to pathways through which the cellular metabolic state influences 
circadian cycles (see section 1.6, page 33). The mechanism of this may include the influence 
of the redox state on the NPAS2:BMAL1 heterodimer (Rutter et al., 2001) and the influence 
of haem on the REV-ERB proteins (Raghuram et al., 2007), which can modulate NPAS2 
expression. 
Taken together this data suggests that NPAS2 primarily plays a role in food rather than 
light entrainment. Inhibiting entrainment to light cycles (by SCN ablation) has been associated 
with improved entrainment of circadian cycles to timed feeding (Saini et al., 2013). Any 
reduction of entrainment to feeding times may be the direct cause of the faster light 
entrainment, due to a similar mechanism of decreased competing circadian entrainment. 
5.1.3 Restricted feeding response in conditional liver-specific NPAS2 
knockout mice 
The mouse model used in the following experiments, with a conditional KO of NPAS2 
in the neonatal liver, has previously been investigated under conditions of RF. These studies 
measured body weight of the mice and the response in the microbiome. It was observed that 
recovery of weight after initial weight loss when food was restricted to the light/inactive phase 
under LD was accelerated in males or unchanged in females compared to floxed controls 
(O’Neil et al., 2017). This enhanced weight loss recovery may suggest enhanced entrainment. 
However, these experiments did not measure behavioural activity. Without knowledge of how 
activity was affected, the change in weight loss and recovery may be due to other effects of the 
genetic modification, potentially impacts on the microbiome (the primary focus of the O’Neil 
paper). This is supported by the correlation of weight changes with specific microbiota genera 
which differed between WT and cKO mice after RF (O’Neil et al., 2017).  
5.1.4 Methods of investigation of circadian cycle entrainment 
For the experiments performed here various protocols were considered. Light based 
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entrainment of mouse circadian cycles is often investigated by use of light pulses. Single short 
pulses of light can induce circadian phase shifts depending on the time at which mice are 
exposed to the pulse. The use of multiple pulses at different circadian times allows the 
construction of a detailed phase response curve (PRC) detailing how light pulses at each time 
point influence phase shifts and potential genotype effects on specific directionality of 
entrainment (LeGates and Altimus, 2011, Banks and Nolan, 2011). See Figure 5.1 for an 
example PRC. 
The light pulse experimental protocol can be performed in one of two ways. Light 
pulses are performed at specific times within the behavioural cycle, either after several days in 
DD based on predicted activity onset or on the first day in DD after LD based on the timing of 
the lighting schedule. The first protocol can be more efficient as it allows for administration of 
successive pulses following the same protocol without days of reentrainment to LD while the 
second protocol removes the need for calculation immediately prior to the light pulse and does 
not subject mice to unique timed light pulses. These are referred to as Aschoff type I and type 
II protocols respectively (Jud et al., 2005). 




Figure 5.1:  An example phase response curve (PRC) for mice 
Created based on the phase response curve by LeGates and Altimus (2011).  A light pulse 
during the subjective day (CT0-12) does not induce a significant shift .  A light pulse in early 
subjective night (CT12-19) causes a phase delay and late in subjective night (CT19-24) a 
phase advance.  Investigation by light pulse allows identification of the pattern of the PRC 
and can show differences in phase shift based on where in the circadian cycle the light pulse 
is administered.
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The investigation of circadian entrainment to feeding is more constrained than 
investigation of light as unlike light, food is essential for survival, meaning most light 
entrainment procedures are impossible with food provision. Food entrainment by the FEO is 
often analysed by use of time restriction of food availability and monitoring daily activity for 
the development of entrained FAA. Under LD conditions this can appear as a distinct peak of 
activity or extension of previous activity to include the window prior to food provision while 
in DD mice phase shift so their active period begins in advance of food provision (see Figure 
5.2) (Takasu et al., 2012).  
Food restriction under DD will show the entrainment to the timing of food provision, 
however these results can be complicated by free-running meaning any change in free-running 
behaviour may be observed as an impact on RF entrainment. For example, a shorter 
free-running period would mean a mouse could shift faster to an earlier active phase as 
entrained by food (assuming no effect on the FEO). Testing RF under LD will not cause an 
obvious phase shift as the primary synchronisation of behaviour by the SCN to the light cycles 
remains intact. RF under LD can disassociate and desynchronise the FEO from the SCN cycles 
if the food is provided during the inactive light phase. The phase shifting of the FEO will 
present as the appearance of a FAA peak separate to the normal activity. This has the benefit 
of the peak during the light being isolated as a response of the FEO entrainment (Pendergast 
and Yamazaki, 2018). See Figure 5.2 for example potential actograms.




Figure 5.2:  Example actograms showing FAA 
These actograms show how behaviour patterns may look under RF while in LD (left) or DD 
(right) conditions.  Red arrows mark times of food provision and the background colours 
represent the lighting, yellow means l ights on and grey means lights off.  In the LD example 
activity is  not presented after food provision to keep the representation simple. This is very 
similar to what would be seen if activity were recorded for wheel running as the animal 
would stop wheel running to eat,  while for general activity low level  would be seen with 
peaks at the points of food provision and removal due to this process agitating or waking 
the mice.
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5.1.5 Aims, experimental justification and hypotheses 
The aim of these experiments was to investigate the impact of the liver NPAS2 cKO on 
circadian behaviour and entrainment. The investigations here are complimentary to those 
performed on constitutive NPAS2 KO mice by Dudley et al. (2003) to identify how their 
findings compare to those of the liver-specific cKO and address the specificity of the role of 
NPAS2 in liver peripheral clocks. Two behavioural experiments are detailed here; Experiment 
1 investigated the free-running behaviour of the mice while under DD conditions within the 
circadian cages. The aim of this experiment was to validate that circadian behaviour could be 
measured in the experimental set-up and also identify any potential change in free-running 
period length which would represent changes in the endogenous circadian function. 
Experiment 2 investigated the response of the mice to both light and food entrainment in 
repeated tests of the same mice throughout. The behaviour of the mice recorded across 
experiment 2 was also used to examine the circadian variation in locomotor activity under both 
LD and DD.  
Light pulse testing was performed following the Aschoff type II protocol which involves 
reentrainment to 12h:12h LD between light pulses. This was adopted as under our procedures 
4 mice are exposed to the same light pulse. This means any variance in free-running periods 
using an Aschoff type I protocol would mean some mice would have to be excluded from the 
analysis due to light pulse exposure occurring at different circadian times. This has been noted 
as a problem that required exclusion of up to 3 mice out of 5 in previously published studies 
(Morin and Studholme, 2014). The timing of the two different light pulses were chosen based 
on timings which should give a peak phase advance or delay based on phase response curves 
reported by LeGates and Altimus (2011). 
The RF procedure was performed under LD, isolating the influence of behavioural 
free-running on the experiment. Food availability was restricted to a comparably long 8-hour 
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window (compared to the 4-6-hour windows used more often in RF investigations) and 
included mash supplement due to concerns as to how food restriction would affect the health 
of these mice. These concerns were based on observation in prior experiments in our laboratory 
that both the control and cKO models showed substantial weight loss upon movement of the 
mice into the circadian cages (Ruby Chrisp, pers. comm.) and that NPAS2 constitutive KO 
mice showed a severe phenotype when food availability was limited to only 4 hours (2 deaths 
and 7 severe conditions out of 11 mice) (Dudley et al., 2003). 
We hypothesised that there would be no difference between our control and cKO mice 
in both free-running and daily patterns of locomotor activity as both of these are hypothesised 
to be primarily mediated within the SCN and other brain regions. While we anticipated no 
difference, it was still of interest to confirm these as a comparison to that observed in the 
constitutive KO model. 
It was hypothesised that there would be no effect of the liver NPAS2 cKO on 
entrainment to light (considered to be mediated by the SCN), but that there would be an 
attenuation of the food anticipatory response to RF (considered to be mediated by peripheral 
clocks including the liver). The cKO model used here should avoid some compensatory effects 
which may have occurred in the constitutive KO mice due to lack of NPAS2 expression in 
development. This means we may observe more substantial effects than in the constitutive KO 
due to the absence of these compensatory effects. 
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5.2 Materials and Methods 
5.2.1 Animals 
Mice were bred and housed as detailed in section 4.2.1.1 (page 152) prior to movement 
into circadian cages for experimentation. Mice were used at 3-6 months of age. Identical 
cohorts of 16 mice were used for each of the two experiments, 8 cKO and 8 control mice 
counter-balanced for sex (see section 5.2.6).  
5.2.2 Circadian cages 
Activity recording was performed in identical cages (16 cm x 19 cm x 26 cm) with the 
mice in semi-social isolation. There were four cages per chamber, (80 cm x 61 cm x 71 cm, 
ENV-018, MED Associates Inc., St Albans, VT, USA) shown in Figure 5.3. Each chamber 
contained a fluorescent strip bulb, under the control of a programmable timer, and an IR light 
(BW® 48 LED Illuminator Light), which is not visible to mice, remained on at all times for 
video capture. A camera at the roof of the chamber in conjunction with the Video Tracking 
Interface software (Version 1, MED associates inc) recorded the current tracking location of 
each individual mouse from each cage. This footage was converted into distance travelled (in 
cm), by the Activity Monitor software (Version 5, MED associates inc). Each chamber also 
contained a fan to provide air exchange, which also provided background noise (55dB). A radio 
in the room was also permanently on to provide background noise (~70 dB).  
Mice were provided ad libitum water and 2018 Rodent diet (Envigo) and weighed 
weekly to ensure general good health. This diet was supplemented with ~3.5 g 2019s Teklad 
mash (Envigo) twice weekly to counter substantial weight loss upon movement of mice into 
the circadian cages, which had previously been noted in these mice (Ruby Chrisp, pers. 
comm.). The 2019s mash is similar in nutritional makeup to the 2018 diet but is made into 
mash by soaking in water making it easier to eat. 
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Activity data was output from the Activity Monitor Software in multiple data bins of 
distance travelled in 10-minute periods. The data is formatted in Excel as required for analysis 
(see 5.2.5). 




Figure 5.3:  Circadian activity recording chamber 
Note the camera placed above the cages to record activity,  the strip white light and the grey 
IR lamp placed on the strip l ight fitting.  The IR lamp is  pointed away from the cages 
preventing glare and shadows as the reflection of the IR is sufficient for activity tracking.
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5.2.3 Experiment 1 – Free-running investigation 
The activity of mice was investigated while circadian free-running under constant 
darkness using data from experimentation performed by PhD student Ruby Chrisp. Mice were 
housed in the circadian cages shown in Figure 5.3 under cycling 12h:12h LD conditions (lights 
on 7am and off at 7pm) for 7 days to adjust to the housing. The lighting condition was then 
changed to DD for 10 days for activity to be recorded. 
5.2.4 Experiment 2 – Entrainment investigation 
Experiment 2 investigated light pulse and RF entrainment in the same mice. The light 
entrainment experimental procedure (section 5.2.4.1) was performed first and as soon as this 
procedure ended the RF entrainment procedure (section 5.2.4.2) immediately began. Activity 
recorded on days throughout this experiment were used for investigation of daily locomotor 
activity (see section 5.2.5.3). 
5.2.4.1 Light entrainment by light pulses 
Mice were housed in the circadian cages shown in Figure 5.3 under cycling 12h:12h 
LD conditions (lights on 7am and off at 7pm) for 6 days to adjust to the housing. The lighting 
condition was then changed to DD with a light pulse at CT16 (11pm), 4 hours into the active 
phase (LP1). Mice were kept in DD for 7 days for activity to be recorded and then the lighting 
was returned to LD and the procedure repeated with a light pulse at CT 20 (3am), 4 hours prior 
to the end of the active phase (LP2). The lighting cycles across days are shown in Figure 5.4. 




Figure 5.4: Lighting conditions of days for the light pulse experiment 
The lighting procedure follows that detailed above. Each row represents a single l ighting 
pattern for one day.  Yellow represents times that the l ights are on and grey times lights are 
off.   
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5.2.4.2 Restricted feeding entrainment 
The same mice used for light pulse testing (detailed above in 5.2.4.1) were used for the 
RF experiment. The mice were reentrained to a 12h:12h light:dark cycle following light pulse 
testing, with lights on at 6am and off at 6pm. After nine days in LD with ad libitum food, the 
food was removed from the cages at 5pm (ZT11). Food was provided within the light hours 
every day at 9am (ZT3) along with a ~1.5 g of 2019s Teklad diet (Envigo) and available for 8 
hours until 5pm (ZT11). This RF schedule was maintained for 9 days. While under RF mice 
were weighed every 2-3 days to monitor for maintenance of healthy weight. 




Figure 5.5:  Mouse experimental design for investigation of circadian behaviour 
Two identical  cohorts of  16 mice were used. The cohort in experiment 1 was used to 
investigate free-running. The other cohort was used in light and then RF entrainment 
investigation, performed sequentially.
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5.2.5 Activity analysis 
5.2.5.1 Actograms 
Activity is presented in double plotted actograms, produced by use of the ImageJ plugin 
software, ActogramJ, produced by Schmid et al. (2011). The actograms were normalised to 
total activity levels for the individual mice for comparison. For activity in RF entrainment 
average actograms were produced using the functionality of ActogramJ. The background 
highlighting shows time of lights on (yellow), lights off (grey) and food provision during RF 
(orange).  
5.2.5.2 Period estimates 
To generate period estimates the recorded data of distance travelled in 10 minute 
windows was analysed using online BioDare2 software (Zielinski et al., 2014) using 
FFT-NLLS analysis. In this analysis initially a Fast Fourier Transformation (FFT) is performed 
on the data to generate initial period values by fitting a complex cosine curve to the data set. 
These initial values are then improved on by the Non-Linear Least Squares (NLLS) iterative 
numerical search, adding cosine components until the addition of a cosine term does not 
improve the resulting fit significantly. The analysis ends having modelled the data by a sum of 
cosine functions, the cosine function with a period within the defined window of 18-34 hours 
is then used to give output values for activity period, amplitude, phase, and the relative 
amplitude error (RAE), a measure of rhythm robustness which increases from 0 to 1 as the 
cosine fit to the data nears statistical insignificance. If more than one function falls within this 
window then the function is manually selected, generally the function with the lowest RAE, 
supported by observation of the fit to the data. 
5.2.5.3 Daily locomotor activity 
Daily activity was investigated on days throughout experiment 2. Activity under LD 
was investigated using activity on 10 days, excluding days in which mice are habituating to the 
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cages (the first 4 days), resynchronising to the light cycle (the first day when the mice are 
returned to LD) or were weighed (various days throughout the experiment). Total daily activity 
under DD was investigated on a selection of 10 days within the light entrainment investigation, 
excluding those where the mice were exposed to a light pulse or weighed. Hourly daily activity 
under DD was investigated on a single day as the unsynchronised behaviour in DD will vary 
day to day so cannot be grouped for a meaningful analysis. The first day of darkness following 
light pulse 2 was used for this. For this activity investigation, in LD or DD, activity within the 
10-minute bins were summed to provide total activity within larger windows of 1, 12 and 24 
hours. 
5.2.5.4 Light pulse phase shifting 
The phase shifts caused by the light pulses were calculated using the ClockLab Analysis 
6 software (Actimetrics), this process in the software is shown in Figure 5.6. The software 
produced least squares regression lines from the activity onset times for the 6 days in LD prior 
to the light pulse and the 7 days following the light pulse. The phase shift was calculated by 
comparing the difference in the timings of each of these lines when extrapolated into the last 
day of LD. A positive value reflects a phase advance, and a negative value reflects a phase 
delay. 




Figure 5.6:  Example phase shift calculation in ClockLab 
Best fit lines are drawn based on activity onsets for the days prior to and the days following 
the l ight pulse.  Phase shift is  calculated based on the difference between the fit l ines on the 
last day of LD, marked with an arrow. Note that the onset of one of the later days in DD is  
excluded in this example (no red dot) due to the lack of clarity as to when this should fall  
based on the activity data.
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5.2.5.5 Restricted feeding - FAA measurement 
FAA was defined as activity within the window after lights turn on and before food 
provision that was not caused by a stimulus such as someone entering the room. For this reason, 
the 30 minutes immediately before food provision are not included in the FAA analysed time 
frame of 2.5 hours (ZT0-ZT2.5). Percentage FAA activity is calculated using the activity within 
this window as a percentage of the daily total distance travelled, from lights off to the next 
lights off, 6am-6am. 
Alternate measures of activity included FAA as above, without correction to the daily 
activity, and the time of onset of FAA prior to food provision. FAA onset prior to food was 
calculated as the number of minutes prior to food provision where activity was consistently 
recorded. This was the time of the earliest active data bin within the FAA window that was not 
separated from the time of food provision by two or more consecutive inactive bins (distance 
travelled < 50 cm). If no activity is recorded in the two bins prior to food provision the timing 
of activity onset prior to food provision was defined as zero. 
5.2.6 Experimental design 
The circadian set-up available limited the testing to cohorts of 16 mice simultaneously 
with the potential to repeat experiments to increase the n numbers. In both experiments the 16 
mice were made up of a balance of the two genotypes: 8 control mice and 8 cKO mice. Due to 
restrictions in availability of appropriately aged mice and the fact that there was hypothesised 
to be no sex difference on circadian behaviour (Krizo and Mintz, 2014, Kuljis et al., 2013) both 
experiments were counter-balanced for sex within each genotype. 
Experiment 1 (detailed in 5.3) investigated the functioning of the set up in excluding 
mice from zeitgebers and investigated the effect of genotype on the free-running period. No 
genotype effect on free-running period was predicted of a mutation in a peripheral clock so this 
experiment was considered an appropriately sized pilot study to identify if the free-running 
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period was of interest for further investigation. 
Based on calculations in G power, the 16-mouse cohort provides sensitivity for a 
Cohen’s d effect size of 1.745 or greater for t-tests investigating light pulse effect with an alpha 
of 0.05 and power of 0.9. For a mixed ANOVA investigating RF entrainment using the same 
alpha and power, non-sphericity correction of 1 and an estimated repeated measures correlation 
of 0.5, based on 10 within-subjects measurements G power identified a Cohen’s f effect size 
of 0.281.  
Based the reported investigation of entrainment by Dudley et al. (2003), the effect sizes 
were calculated using the G power software, and Formula 5.1 for F testing. For genotype 
influence on light entrainment Cohen’s d was identified as 0.805 and on RF entrainment the 
Cohen’s f effect size was 0.976. As such the group numbers used here are sufficient to identify 
a similar effect on RF entrainment but insufficient for a similar effect of light entrainment. It 
should be noted that the experiment investigating light entrainment performed here differs from 
the light entrainment protocol used in this publication and it was hypothesised that if liver 
NPAS2 cKO reflects the constitutive KO effect it would be more subtle. As such the 
experiments performed here were considered preliminary and power calculations can be used 




𝐹 × 𝑑𝑓 + 𝑑𝑓
 
Formula 5.1:  Calculation of partial eta squared from F and df values (Lakens,  2013) 
5.2.7 Statistical analysis 
Statistical tests were performed using SPSS software as described in Chapter 3, section 
3.2.3 (page 123). Where required, data was log transformed to meet the assumption of 
normality, detailed if performed in the results sections. For mixed repeated measures ANOVAs 
sphericity was assessed by Mauchly’s test of sphericity. If the assumption of sphericity was not 
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met Greenhouse-Geisser correction was used.  
Confirmation of the experimental result in free-running period and light pulse phase 
shift was performed by one sample t-test comparing the data for all mice to the ‘null’ value (24 
for free-running period, representing maintained daily entrainment, and 0 for phase shift, 
representing no shift). Investigation of the effects of the factors of sex and genotype on those 
measures were performed using two-way ANOVAs. 
Investigation of daily locomotor activity data was performed using mixed measures 
ANOVAs with between-subjects factors of genotype and sex and the within-subjects factors of 
time of day, lighting phase and lighting condition as appropriate. Day was included as a 
within-subjects factor to permit accurate modelling of the data but not analysed. 
Investigation of the activity profiles used hourly data and were analysed using mixed 
ANOVAs including the within-subjects factor of hour and the between-subjects factors of 
genotype and sex. For the LD hourly analysis, the between-subjects factor of day was included 
for modelling purposes. Due to the number of repeated measures being greater than the number 
of mice, Mauchly's test of sphericity was inappropriate, and Greenhouse-Geisser correction 
used. This also prevented Bayesian analysis of this data. 
Investigation of FAA data was performed by use of mixed ANOVAs and ANOCVA 
with within-subjects effect of day and between-subjects effects of genotype and sex and weight 
as a covariate where appropriate. Correlational mouse weight data was analysed using 
Pearson’s correlation coefficient. The FAA onset, calculated based on the discrete 10 minute 
bins of activity, is non-parametric data and was analysed in SPSS using generalised linear 
analysis, for repeated measures this takes the form of generalised estimating equations (GEE) 
which allows for mixed repeated measures analysis (Hardin, 2005). GEE was performed using 
an unstructured correlation matrix and modelling a linear response. Analysis of genotype effect 
within each day was performed using generalised linear modelling. 
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Frequentist testing was supported by Bayesian statistical testing. Frequentist testing 
cannot distinguish between a true null effect and insensitivity of the experiment whereas 
Bayesian analysis can identify whether data presents evidence in support of the null hypothesis. 
Bayesian tests were performed using the JASP software (Version 0.13.1) using default equal 
prior probabilities for all factors in each analysis. The analysis of effects was performed across 
matched models. BF values <1 are considered evidence against a model or factor while >1 are 
evidence for. BF values between 1/3 and 3 are considered inconclusive/weak evidence, 
unsuitable for drawing a conclusion however these values can identify whether the data is 
suggestive for or against an effect. Values between 3 and 10 represent substantial evidence, 
between 10 and 30 strong evidence and >30 decisive evidence in favour of a factor/model, with 
the inverse values having the same reliability as evidence against (Dienes, 2014). Where 
performed, Bayesian tests matching the frequentist tests were used (i.e., Bayesian ANOVA, 
Bayesian repeated measures ANOVA). 
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5.3 Free-running behaviour 
5.3.1 Results 
Average periods lengths of the mice under DD are presented in Figure 5.7. The average 
identified period was 23.88 hours (SEM = ±0.051) across all 16 mice. This was significantly 
different to 24 by one sample t-test t(15)=-2.369, p=0.032. This demonstrates that we observed 
the free-running periods and these mice were not entrained to 24-hour cycles.  
ANOVA showed no significant main effect of sex (F(1,12)=0.953, p=0.348) or 
genotype (F(1,12)=0.048, p=0.830) on the free-running period nor of a sex x genotype 
interaction (F(1,12)=1.673, p=0.220). A Bayesian ANOVA using default priors favoured the 
null hypothesis of no effect of sex or genotype (BF10=1.692 compared to the next best model; 
the individual effect of sex, indicating weak evidence). Individual effect analysis showed weak 
evidence suggestive of no effect of genotype (BFincl=0.380) and sex (BFincl=0.495) and the sex 
x genotype interaction (BFincl=0.402). This analysis suggests our data, while suggestive 
against, is unable to be used to confidently conclude as to the effect of genotype on free-running 
period. 
 




Figure 5.7: Free-running behavioural  period of control and cKO mice under DD   
Mean free-running period (±SEM) in constant darkness showing the effects of  genotype (A) 
and sex and genotype (B) within the same data. Experimentation performed by PhD student 
Ruby Chrisp.  




This experiment successfully validated the set-up and experimental process, as we were 
able to observe free-running behaviour (see Figure 5.7). 
Investigation of the factor of genotype within the ANOVA suggested no effect of the 
loss of liver NPAS2 on circadian behavioural period. This is in contrast to the shortened period 
previously observed in constitutive NPAS2 KO mice (Dudley et al., 2003). This suggests that, 
as predicted, the loss of NPAS2 in the liver may not have contributed to the effect observed in 
constitutive NPAS2 KO mice. 
This experiment is underpowered to appropriately investigate sex interaction effects. 
Although not significant, graphically we appear to observe a longer average free-running 
period in control male mice compared to control female mice. Within the female mice an 
increased period length appears to be observed in cKO mice compared to the control mice (see 
Figure 5.7 B). This is unexpected as it has been reported previously that there are no sex 
differences in period length of C57BL/6 mice (Krizo and Mintz, 2014, Kuljis et al., 2013), 
suggesting a difference may be specific to this floxed mouse strain. Using the same 
experimental set up in our laboratory we confirmed no sex influence on the DD free-running 
period in C57BL/6 mice (Ruby Chrisp, pers. comms.). More experimentation would be 
required to be confident of the small potential sex-specific genotype effect. 
In experiments using other liver-specific circadian gene KO models (PER2 and 
BMAL1) no difference in free-running period compared to WT mice was reported. In PER2 
liver-specific KO mice the period was observed to not vary significantly from WT mice while 
constitutive and neuronal PER2 KO shortens the period length (Chavan et al., 2016). In 
BMAL1 liver KO mice it has also been reported that the circadian behaviour was unaffected, 
however no period analysis is shown and visually the actograms for liver BMAL1 KO mice do 
appear to present a shorter free-running period (Lamia et al., 2008). In mice with a constitutive 
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BMAL1 KO, restoration of BMAL1 expression to the brain specifically recovers circadian 
behaviour. However, the period is still shorter than mice retaining constitutive BMAL1 
expression, showing a delaying effect of loss of circadian function in peripheral tissues outside 
of the brain on neural circadian rhythms (McDearmon et al., 2006). This is suggestive of an 
influence of peripheral clocks on between tissue clock entrainment to influence behavioural 
cycles. 
   
211 
 
5.4 Daily locomotor activity 
Using activity data recorded throughout experiment 2 we investigated daily locomotor 
behaviour in the mice. This behaviour can provide insight into effects on circadian patterns 
outside of zeitgeber influence due to the genetic modifications. 
5.4.1 LD results 
The collected activity data under LD allowed analysis of the daily activity and average 
hourly LD activity (see Figure 5.8). 
5.4.1.1 LD total daily activity 
Daily total activity is presented in Figure 5.8 A. Analysis was performed using log 
transformed data. A significant main effect of sex on total activity was identified 
(F(1,12)=27.542, p=0.00021). There was no significant effect of genotype (F(1,12)=0.088, 
p=0.772) nor an interaction effect of sex x genotype (F(1,12)=0.376, p=0.551). This supports 
previous reports that female mice show higher daily activity than males (Broida and Svare, 
1984) and suggests no genotype effect on total activity is observed. Bayesian mixed ANOVA 
identified a model with an independent effect of sex as the favoured model (BF10=229.0 
compared to the null model, indicating decisive evidence). Individual effect analysis showed 
decisive evidence for an effect of sex (BFincl=186.2) and weak evidence suggestive against an 
effect of genotype (BFincl=0.702) and a sex x genotype interaction (BFincl=0.776). 
5.4.1.2 LD dark phase activity 
As activity can be separated into high (dark) and low (light) activity phases based on 
the lighting cycles, analysis was performed to see if any genotype effect was associated with 
specific activity phases. 
Analysis of activity within the dark phase was performed using log transformed data. 
There was a significant effect of sex on activity (F(1,12)=30.511, p=0.00013). No significant 
effect was identified due to genotype (F(1,12)=0.106, p=0.750) nor an interaction effect of sex 
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x genotype (F(1,12)=0.093, p=0.765). Bayesian analysis favoured a model with an independent 
effect of sex (BF10=399.4 compared to the null model, indicating decisive evidence). Individual 
effect analysis showed decisive evidence for an effect of sex (BFincl=335.7) and weak evidence 
suggestive of no effect of genotype (BFincl=0.692) or a sex x genotype interaction 
(BFincl=0.775). These analysis results are similar to those for total daily activity, which was 
expected as activity in the dark phase will account for the significant majority of daily activity. 
5.4.1.3 LD light phase activity 
Analysis of activity within the light phase was performed as above on the log 
transformed data. There was no significant effect identified of sex (F(1,12)=1.991, p=0.184) or 
genotype (F(1,12)=0.333, p=0.575) but there was a significant sex x genotype interaction 
(F(1,12)=5.735, p=0.034). To follow up on the significant interaction effect, simple main 
effects analysis of the impact of genotype identified no significant effect within male (p=0.223) 
or female mice (p=0.057), but a simple main effect of sex was identified between male and 
female cKO mice (p=0.020) which was not observed in control mice (p=0.500). This suggests 
a sex effect on activity in the light phase specifically in the cKO mice. Bayesian analysis 
favoured the null model (BF10=1.557 compared to the next best model; sex effect only, 
indicating weak evidence). Individual effect analysis supported the frequentist analysis 
identifying substantial evidence in favour of a sex x genotype interaction (BFincl=3.022). 
However, the analysis found only weak evidence against the main effects of sex (BFincl=0.765) 
and genotype (BFincl=0.521). This suggests no effect of the main factors of sex and genotype 
however these data are inconclusive.  




Figure 5.8:  Home cage activity of mice under LD measured by total  distance travelled.  
A:  Mean total distance (±SEM) travelled within the 12-hour l ight and dark phases and the 
total  day, based on ten days of activity. B: Log transformation of the distance travelled data 
in A. A significant pairwise effect between sexes was observed in cKO mice on activity in 
the light phase (*=p<0.05).  C:  Activity profile  of  mean distance travelled (±SEM) within 
each hour.  
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5.4.1.4 LD hourly activity profile 
Average activity per hour over 10 days is presented in Figure 5.8 C. The pattern of most 
activity occurring in the dark phase can be clearly seen along with the clear sex difference in 
activity levels. Distance travelled data was log transformed after addition of 1 to each value 
due to the presence of multiple 0 values for hours in light where no movement was detected. 
Significant effects were identified of hour (F(6.663,79.951)=79.661, p<0.00001) and the 
interaction effect of hour x sex (F(6.663,79.951)=5.122, p=0.00010) (Greenhouse-Geisser 
corrected). No significant effects were identified due to the interaction of hour x genotype 
(F(6.663,79.951)=1.301, p=0.262), or the interaction of hour x sex x genotype 
(F(6.663,79.951)=1.593, p=0.153). Thus, the analysis suggests that the activity varies with 
hour of day and sex influences the presentation and pattern of this activity, but genotype does 
not. 
5.4.2 DD results 
As behavioural patterns are influenced by lighting conditions, locomotor activity was 
also investigated in conditions of constant darkness. Total activity per day and hourly activity 
were investigated (Figure 5.9).  
5.4.2.1 DD total daily activity 
The data for total 24-hour activity was log transformed for analysis. We identified a 
significant main effect of sex (F(1,12)=21.831, p=0.00054), but no effect of genotype 
(F(1,12)=0.116, p=0.740), nor a significant interaction effect of the two (F(1,12)=0.247, 
p=0.629). Bayesian analysis supported this, favouring a model with only an effect of sex 
(BF10=78.016 compared to the null model, indicating decisive evidence). Individual effect 
analysis showed decisive evidence for an effect of sex (BFincl=35.081) and weak evidence 
suggesting no effect of genotype (BFincl=0.414) or a sex x genotype interaction (BFincl=0.630). 
This analysis is similar to that of the LD data, showing that we see a sex effect but no genotype 
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effect on the amount of activity in DD, however for DD conditions the Bayesian analysis 
suggests that we are unable to conclude with confidence that there is no genotype effect on 
activity. 
5.4.2.2 DD hourly activity profile 
The hourly activity from a single day in DD is presented in Figure 5.9 C. The patterns 
of low and peak activity presenting a similar pattern to the behaviour under LD can clearly be 
seen, as well as the sex difference in activity levels. Analysis was performed using distance 
travelled data log transformed after the addition of 1 as for the LD hourly activity. Due to the 
variability of hour-to-hour activity, the only significant effect observed on activity was that of 
hour (F(6.931,2.020)=10.749, p<0.00001) with no significant interactions of hour x sex 
(F(6.931,2.020)=1.001, p=0.436), hour x genotype (F(6.931,2.020)=0.955, p=0.469) or hour x 
sex x genotype (F(6.931,2.020)=0.770, p=0.613) found. 




Figure 5.9:  Home cage activity of mice under DD measured by total  distance travelled 
A:  Mean total distance travelled (±SEM) within 24 hours based on 10 days of activity. B: 
Log transformation of the distance travelled data in A.  C:  Activity profile of mean distance 
travelled (±SEM) within each hour.  Note this is  based on activity from a single day rather 
than 10 days hence the SEM values are much greater than those shown in Figure 5.8.  
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While less obvious due to the larger variability, and again lacking a significant 
difference, similar daily patterns are presented under DD to that observed for the mice under 
LD. We see the peak of activity coincided with activity onset in cKO female mice while control 
female mice showed a later peak of activity. In male mice a single hour of very high activity 
with activity onset is observed in the control mice while a clear peak is not observed for the 
cKO mice. This suggests the influence of the loss of liver NPAS2 on the patterns of behaviour 
were a reflection of the rhythmic behaviour of the mice, independent of a lighting effect as we 
observed the same in LD and DD. 
5.4.3 Comparing LD and DD 
The data used above for the LD and DD total day activity analysis were compared 
together to interrogate the effect of the lighting on total activity, shown in Figure 5.10. Light 
acts to supress activity, as well as a zeitgeber, so we would expect to see reduced activity in 
LD compared to DD (Banks and Nolan, 2011). The data was log transformed for analysis. The 
analysis identified a significant main effect of the lighting condition on daily activity 
(F(1,12)=9.223, p=0.010), but no significant interaction effect of lighting condition x sex 
(F(1,12)=0.041, p=0.842), lighting condition x genotype (F(1,12)=0.12, p=0.735), or lighting 
condition x sex x genotype (F(1,12)=0.039, p=0.847). Bayesian analysis favoured a model with 
an effect of the factors lighting condition, and sex (BF10=5.89x103 compared to the null model, 
indicating decisive evidence). Individual effect analysis showed decisive evidence for an effect 
of lighting condition (BFincl=43.925), substantial evidence against interaction effects of lighting 
condition x genotype (BFincl=0.191) or lighting condition x sex (BFincl=0.189) and lighting 
condition x sex x genotype (BFincl=0.212). Taken together, this analysis shows a significant 
effect of lighting condition on activity as expected, with higher activity in mice under DD. The 
Bayesian analysis means we are confidently able to conclude no effect of the loss of liver 
NPAS2 on how total activity is changed by lighting condition. 




Figure 5.10 :  Effect of lighting condition on activity levels 
Mean total daily home cage activity (±SEM) of mice under LD and DD measured by distance 
travelled. The higher activity level  of  female mice can be clearly observed as well  as the 
subtle increase in total activity under DD compared to LD due to loss of light suppression 
of activity.  




Analysing general locomotor activity, we observed expected differences in patterns and 
levels of activity. Female mice were more active than male mice and mice were more active 
under DD conditions compared to LD, as has been previously reported (Broida and Svare, 
1984, Banks and Nolan, 2011). We observed no effect of liver NPAS2 on general activity levels 
under LD or DD for full day activity although we see a sex-specific genotype effect on 
behaviour within the light phase in LD conditions with a sex difference of higher activity in 
female mice only observed within cKO mice. Under other conditions we observe this sex 
difference without a genotype influence. The change in results of analysis of activity in the 
light phase is because we are unable to observe the sex difference in control mice. This 
appearance of a significant sex effect within cKO mice suggests subtle modulation of activity 
levels in the cKO mice, increased in female and decreased in male mice, enhancing the sex 
difference meaning it is observable even at low activity levels. We did not observe any 
significant simple main effect of genotype within the sex groups so are unable to conclude as 
to the differing genotype effect within sexes. 
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5.5 Investigation of light entrainment 
5.5.1 Results 
Example representative actograms for individual mice over the course of the light pulse 
experimentation are presented in Figure 5.11. These show activity patterns and also the lighting 
pattern mice were exposed to, including both light pulses. 
5.5.1.1 Light pulse 1 
The first light pulse at CT16 caused an average phase shift of -0.66 hours (SEM = 
±0.075) across all 16 mice (Figure 5.12 A). This shift was significantly different to zero by one 
sample t-test t(15)=-8.696, p<0.00001. This demonstrates a phase delaying effect of the light 
pulse on activity onset as predicted.  
ANOVA showed no significant main effect of sex (F(1,12)=0.433, p=0.523) or 
genotype (F(1,12)=1.261, p=0.283) on the phase shift nor of a sex x genotype interaction 
(F(1,12)=0.433, p=0.523). A Bayesian ANOVA using default priors favoured the null 
hypothesis of no effect of sex or genotype (BF10=1.486 compared to the next best model; the 
individual effect of genotype, indicating weak evidence). Individual effect analysis showed 
weak evidence suggestive of no effect of genotype (BFincl=0.673), sex (BFincl=0.497) and the 
sex x genotype interaction (BFincl=0.587). This analysis suggests our data is unable to be used 
confidently conclude as to the effect of genotype on light entrainment. 




Figure 5.11:  Activity of mice exposed to light pulse entrainment  
Representative double plotted actograms of individual mouse activity.  Lighting conditions 
are displayed in the background colour.  Yellow represents lights on and grey IR light only.  
The light pulses are short periods of l ight marked as small yellow sections on the actograms 
highlighted by a white arrow on the left of  the male control actogram. The actograms begin 
prior to the mice being placed in the cages and a burst of activity in the first light section 
can be seen when the mice were active having just been moved to a new environment.  




Figure 5.12: Phase shift  in activity onset due to light pulses 
A positive value reflects a phase advance and a negative value a phase delay.  A & B:  Mean 
phase shift (±SEM) in response to light pulse 1 showing the effects of genotypes (A) and 
sex and genotype (B) within the same data. C & D: Mean phase shift (±SEM) in response to 
light pulse 2 showing the effects of  genotypes (C) and sex and genotype (D) within the same 
data.  Note the change in scale of  the y axes.  
   
223 
 
5.5.1.2 Light pulse 2 
The phase shift following the second light pulse at CT20 caused an average phase 
advance of 0.028 hours (SEM = ±0.045) across all 16 mice (Figure 5.12 C). This data did not 
show a significant difference from zero by one sample t-test (t(15)=0.618, p=0.546) suggesting 
the light pulse at ZT20 was not able to produce an effect on activity onset as was seen for the 
light pulse at ZT16. 
5.5.2 Discussion 
The first light pulse induced a predicted delay in the onset of activity. No significant 
effect of the liver NPAS2 cKO was identified. While Bayesian analysis favoured the null 
model, suggestive of no genotype effect as predicted, this result was inconclusive. 
The second light pulse did not affect the phase of activity onset. The timings of the light 
pulses were based on a methods paper by LeGates and Altimus (2011) but it may be that for 
the delaying shift the light pulse would be more effective at a later time, such as ZT22, based 
on other publications by Schwartz and Zimmerman (1990) and Banks and Nolan (2011). 
This data suggests there is no effect of loss of NPAS2 in the liver on entrainment to 
light, however, the data supports further investigation to validate this, and we were unable to 
investigate phase advancing entrainment. 
Within this experiment the order of the light pulses was not varied. It is possible that 
different effects to those observed here would be seen in mice exposed to the light pulses in 
the opposite order due to a potential lasting effect of the first light pulse influencing the 
response to the second. Experiments of this nature, where possible within the mouse groups 
tested, would benefit from counterbalanced groups exposed to the light pulses in different 
orders due to this possibility.
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5.6 Investigation of feeding entrainment 
5.6.1 Results 
5.6.1.1 Food anticipatory activity 
The appearance of FAA in mice under an RF schedule can be seen highlighted in 
average actograms in Figure 5.13. Note average actograms after normalisation are presented 
here, rather than representative actograms, as mice under 12h:12h LD remain synchronised 
with each other making this possible. 
The mean FAA percentage of total activity across the days of RF are presented in Figure 
5.14. Analysis of the data found a significant main effect of number of days under RF (F(9, 
126)=3.898, p=0.0002) showing we observe RF entrainment. There was no significant effect 
of the interaction of days x genotype (F(9, 126)=0.789, p=0.627) suggesting no genotype effect 
on the entrainment. 




Figure 5.13:  Activity of mice under restricted feeding 
Average double plotted actograms for each genotype. Lights on or off are marked by yellow 
or grey,  the beginning of food restriction is marked with a red arrow and the times of food 
availability when food restriction was underway is  marked in orange. Note high activity 
was recorded when the food was provided or taken off each day due to this process being 
picked up by the tracking cameras as activity.  The actograms show the appearance of FAA 
active periods prior to food provision while the lights were on (highlighted in the cKO 
actogram) when the animals were inactive on previous days.  




Figure 5.14:  Food anticipatory activity 
A:  The mean percentage of daily activity which falls within the 2.5-hour FAA window 
(±SEM). B:  Rolling average of the recorded data for visualisation only.  Each data point here 
is the mean of the three values of the day and the two days either side except days 0 and 9 
which were the mean of two days. An upward trend is seen as the animals adjust to the 
feeding schedule. 
   
227 
 
Average actograms of mice split by sex and genotype groups are presented in Figure 
5.15. FAA percentage data including the factor of sex are presented in Figure 5.16. These data 
showed a significant main effect of number of days under RF (F(9, 108)=4.925, p=0.00002) 
and of the interaction of days x sex (F(8, 96)=5.046, p=0.00001), but not days x genotype (F(9, 
108)=0.997, p=0.447) or the interaction of all three (F(9, 108)=0.642, p=0.759).  
As there was an interaction, we split the data by sex for analysis. There was no 
significant effect of day for female mice (F(3.537, 24.760)=0.964, p=0.437) but there was for 
male mice (F(3.895, 27.267, p=0.009) (Greenhouse-Geisser corrected). This means that the 
behaviour change due to RF is only observed in male mice and we were not able to see an 
effect of RF on anticipatory behaviour in female mice even over 9 days. 
The male data was analysed using a Bayesian mixed factor ANOVA with equal prior 
probabilities for each model. The analysis determined that the data were best represented by a 
model using days under RF as the only factor (BF10=2.16x104 compared to the null model, 
indicating decisive evidence). Analysis of effects showed decisive evidence for the main effect 
of days under RF (BFincl=2.22x104), and substantial evidence against the effect of the 
interaction of number of days x genotype (BFincl=0.242). This supports the frequentist ANOVA 
in showing a clear effect of number of days under RF as expected. More importantly, the 
Bayesian analysis identifies that our data confidently implies no effect of an interaction of day 
x genotype in male mice rather than being underpowered to identify such an effect. We 
conclude that the liver-specific loss of NPAS2 expression does not have an effect on RF 
entrainment in male mice. This measure was however unable to identify RF entrainment in 
female mice.  
 




Figure 5.15:  Activity of male and female mice under restricted feeding 
Average double plotted actograms for each of the genotype and sex mouse groups.  Lights 
on or off  are marked by yellow or grey,  the beginning of food restriction is  marked with an 
arrow and the times of food availability when food restriction was underway is marked in 
orange. Note high activity recorded when the food was provided or taken off each day due 
to this process being picked up by the tracking cameras as activity.  




Figure 5.16:  Food anticipatory activity of male and female mice 
The mean percentage of daily activity  which fell  within the 2.5-hour FAA window (±SEM). 
A: All  data across days of RF.  B:  Rolling average of the recorded data to smooth out daily 
fluctuations as described in Figure 5.14. C & D:  Sex separated graphs of the data presented 
in A to allow clear visualisation of the behaviour of each sex group. Activity of  male mice 
showed the upward trend while the activity of female mice remained consistent across days 
with only minor fluctuation.  




The effect of the RF procedure on mouse weight is shown in Figure 5.17. It appears 
that the inclusion of mash and the 8-hour feeding window countered any weight loss and 
prompted weight to be put on by some mice under the procedure. Analysis of weight changes 
compared to initial weight by Pearson’s analysis showed a significant negative correlation 
(r=-0.854, p=0.00003) showing that mice with a lower weight put on more weight over the 
course of RF as shown in Figure 5.17 D. This effect is likely because the amount of wet mash 
diet was provided equally to all mice meaning lighter mice were provided much more per body 
weight. 
As weight is a potential confounding variable, the FAA percentage data was analysed 
by mixed measures ANCOVA with initial weight as a covariate. There was no significant 
interaction of initial weight x days under RF on presentation of FAA activity for all mice or 
sex separated data (all mice: F(1,11)=0.442, p=0.520, female mice: F(1,5)=1.133, p=0.336, 
male mice: F(1,5)=0.46, p=0.838). 




Figure 5.17:  The effect of  the restricted feeding procedure on mouse weights  
A:  Mean mouse weights (±SEM) over the RF procedure for each group distinct by genotype 
and sex B:  Mean weights relative to the weight when RF began (±SEM). C:  Mean weights 
relative to the day the mice were placed into the circadian cages (±SEM). The blue l ine 
marks the beginning of RF. D: Mean change in weight (±SEM) over the 10 days of RF 
compared to weight at the beginning of RF. Under RF significant weight loss was prevented 
in male mice and female mice increased weight.  This is  likely due to the initial  lower weight 
of  the female mice rather than a pure sex difference as higher initial  weight is  correlated 
with weight change. 
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5.6.1.3 Additional FAA measures investigated 
We were unable to see entrained FAA behaviour in female mice using the standard 
percentage activity measure, despite some FAA still appearing to be present in individual 
female mice actograms (Figure 5.15). We investigated two other measures to investigate 
whether these showed greater sensitivity to detect FAA in our data. First, the total activity in 
the FAA window without correction to total activity, as it was possible that the higher level of 
general total daily activity in female mice obscured the appearance of FAA when used as a 
percentage measurement. The second measure was the time of onset of activity prior to food 
provision which should shift earlier as the FEO is entrained to the feeding schedule (detailed 
in methods section 5.2.5.5). Note that the experiment ended on the tenth day meaning it could 
not be included in the FAA percentage analysis due to the lack of a full tenth day required for 
percentage calculation. However, when assessing the activity prior to food provision without 
respect to the full day, data from all 10 days can be included. The analysis of the raw FAA data 
is not detailed here as it showed similar data to that of the percentage FAA. Analysis identified 
no effect of day on female activity while this effect was still observed for male mice suggesting 
that the high level of daily activity in female mice was not obscuring an entrainment effect.  
For time of onset, data fluctuations and variability make this measure unclear 
graphically, however an upward trend can be seen in all groups when a rolling average is used 
(Figure 5.18). The GEE analysis showed a significant main effect on activity onset of number 
of days under RF (χ2(1)=62.921, p<0.00001) and the interaction of days x sex x genotype 
(χ2(1)=4.261, p=0.039) without significant interaction effects of days x genotype (χ2(1)=0.009, 
p=0.925) or days x sex (χ2(1)=0.409, p=0.523).  
To follow up on the significant interaction, the same analysis was performed on the 
male and female data individually. In male mice the analysis showed a significant effect of day 
(χ2(1)=32.002, p<0.0001) without a significant interaction effect of day x genotype 
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(χ2(1)=3.499, p=0.061) on the time of activity onset. This is consistent with the finding in male 
mice using the FAA percentage of activity measure as detailed in 5.6. 
Analysis of female mice identified a significant effect of day (χ2(1)=31.711, 
p<0.00001) and a significant interaction effect of genotype x day (χ2(1)=17.166, p=0.00003). 
This suggests both that we are observing the effect of RF entrainment, as well as a genotype 
effect on this entrainment. To further investigate this effect the GEE analysis was used to 
confirm that a significant effect of day was observed in both genotypes of female mice. A 
significant effect of day on activity onset was observed for both control (χ2(1)=13.298, 
p=0.00027) and cKO mice (χ2(1)=18.635, p=0.00002). This confirms that RF entrainment is 
still observed in both genotypes. 




Figure 5.18:  Time of activity onset as a measure of behavioural  response to restricted 
feeding.  
Onset is presented as the number of minutes prior to food provision from which consistent 
activity was observed.  A: Mean time of activity onset prior to food provision (±SEM) for 
each sex and genotype group B:  Rolling average of the time of activity onset data based on 
3 days C & D:  Mean onset data (±SEM) as presented in A showing only male (C) and female 
(D) data to allow clearer comparison. Significance of genotype comparisons within each day 
for female mice (from Table 5.1) are presented on figure D. 
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Post hoc analysis was performed comparing the effect of genotype on time of activity 
onset in female mice on each day, the results of these comparisons are shown in Table 5.1. 
These analyses identified significant genotype differences on days 5, 7 and 8. Looking 
at the data in Figure 5.18 D it can be seen that this is due to earlier activity onset in cKO mice 
on those days and the significance is lost in the later days as the control mice begin to present 
an earlier time of activity onset. This suggests faster entrainment of cKO female mice to the 
feeding schedule.  
 
Table 5.1: Post hoc comparison of genotype effect on activity onset timing in female mice 
in each day of restricted feeding entrainment using generalised linear modelling  
 
Day Genotype effect on activity onset 
0 χ2(1)=1.333, p=0.248 
1 χ2(1)=1.333, p=0.248 
2 χ2(1)=0.414, p=0.520 
3 χ2(1)=0.800, p=0.371 
4 χ2(1)=1.333, p=0.248 
5 χ2(1)=5.323, p=0.021* 
6 χ2(1)=2.400, p=0.121 
7 χ2(1)=8.308, p=0.004* 
8 χ2(1)=9.398, p=0.002* 
9 χ2(1)=0.135, p=0.713 
10 χ2(1)=0.364, p=0.546 




5.6.2.1 Genotype effects on RF entrainment 
In our initial investigation using percentage activity as a measure of the main genotype 
effect across both sexes we observed RF entrainment and analysis suggested no effect of the 
loss of liver NPAS2 on this entrainment. This is in contrast to the delayed RF entrainment 
previously observed in constitutive NPAS2 KO mice (Dudley et al., 2003). 
We found a significant effect of sex on the entrainment to RF as female mice did not 
display a change in percentage FAA over the experimental days. This means this data 
measurement could not be used to investigate a genotype effect in female mice. Based on 
Bayesian analysis, the data from male mice provides substantial evidence against an effect of 
genotype on entrainment to RF. It is concluded therefore that there is no significant effect of 
loss of liver expression of NPAS2 on behavioural response to RF in male mice specifically. 
Measurement of FAA based on the time of onset of activity showed that an earlier shift 
in activity onset across the repeated days exposed to RF was observed for both male and female 
mice. There was no main genotype effect found on this measure in males. However, an 
enhancement of entrained response to RF was observed in cKO female mice. This suggests 
that in female mice the RF entrainment was enhanced by the loss of NPAS2 expression in the 
liver when measured by time of onset of activity.  
The finding that we did not see delayed RF entrainment as reported in constitutive KO 
mice (Dudley et al., 2003) suggests that the previously reported effect is due to loss of NPAS2 
in other tissues or may be a developmental effect avoided in this model. It should be noted that 
the study performed by Dudley et al. (2003) was on male mice only and we have observed 
effects in female mice (and only in one measure). Since this experimentation observed this 
effect purely in female mice, there may also be a sex effect of the response in the constitutive 
model that remains unknown. 
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5.6.2.2 Sex differences 
Using activity as a measure of FAA we did not find a RF effect in female mice. It has 
been reported that female mice present a blunted FAA response compared to male mice. In 
published research measuring activity by cage activity female mice took longer to show high 
FAA than males although FAA was still observed after 7 days (Aguayo et al., 2018). Based on 
this it is possible that we would be able to observe FAA using the standard percentage of total 
day activity measure (presented in Figure 5.16) in females if they remained under RF for 
longer. However, our data for female mice does not appear to show even a subtle increasing of 
FAA so we are unable to conclude with confidence that it would develop given more time. It 
is possible that the effect would present in the percentage FAA measure for female mice under 
a stricter RF regimen. The longer window of food availability should not have prevented FEO 
entrainment as a change in activity would still be required for the mice to be active at an 
abnormal time to eat. It may however have prevented a significant presentation of FAA, as any 
active period within that window would have allowed the mice to eat. 
We found an RF effect in female mice using a measure of onset of FAA only, while in 
male mice both measures detected the RF effect. This suggests that we did not observe a change 
in female activity levels within the 2.5-hour FAA window but a clustering of the activity to the 
time immediately prior to food provision. The weakness of the percentage FAA measure 
appears to be the high background level of activity of female mice, even in the light phase. 
Using the onset of activity measure of FAA, our data shows a genotype effect 
specifically within female mice. We also observed the findings using this measure in male mice 
were consistent with those of the FAA percentage of activity measure. The enhancement of 
FEO entrainment within the cKO female mice suggests NPAS2 in the liver of control mice 
may act counter to the FEO entrainment in female mice specifically. Oestrogen signalling in 
female mice has been identified to influence timing of activity onset (Royston et al., 2014, 
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Hatcher et al., 2020). Ovariectomised females have also been shown to present enhanced 
4-hour RF entrainment (Li et al., 2015) which is posited as presenting a role of oestrogen, 
although a study where a restricted amount of food was provided at a set time each day 
observed no effect of ovariectomy on entrainment (Aguayo et al., 2018). While this data is 
contradictory it suggests that it may be that the loss of liver NPAS2 influences behaviour via 
an effect on oestrogen signalling. A potential mechanism of this, through an effect on the liver, 
would be modification of the metabolism of oestrogen. Oestrogen metabolism is performed 
primarily by the liver expressed cytochromes P450 enzymes CYP1A1, CYP1A2 and CYP3A4 
(homologous to CYP3A11, CYP3A16, CYP3A41A, CYP3A41B and CYP3A44 in mice) 
(Tsuchiya et al., 2005, Renaud et al., 2011). CYP1A1, CYP1A2 and CYP3A11 have all been 
identified to show rhythmic expression in the female mouse liver (Lu et al., 2013, Lin et al., 
2019). If loss of NPAS2 modulates the expression of these enzymes in the liver, then the 
modification of oestrogen metabolism may be behind a sex-specific effect. Alternatively, it is 
known that oestrogen can influence metabolism in the liver and the liver shows circadian 
expression of oestrogen receptors which are under an E-box promotor (Eagon et al., 1986, Cai 
et al., 2008). If NPAS2 influences the expression of the oestrogen receptors in the liver this 
may influence metabolic cycles specifically in female mice. This may then influence 
behavioural entrainment to RF. 
We found that loss of NPAS2 expression in the liver is not associated with a negative 
impact on weight loss recovery when the mice were kept under RF conditions. Our findings 
are consistent the observations of O’Neil et al. (2017) using these mice. A negative impact of 
weight loss recovery would be expected if the cKO mice took longer to develop FAA, 
regardless of any other metabolic associated effect, as slower FEO entrainment would cause 
extreme weight loss. This finding also suggests that the improved weight recovery in male mice 
observed by O’Neil et al. (2017) was not due to faster circadian entrainment compared to 
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controls, which the male mice did not present, but due to another mediating effect such as that 
on the microbiome. For female mice we did observe accelerated entrainment while O’Neil et 
al. observed no effect on weight recovery. This supports the weight recovery being independent 
of an effect on FEO entrainment. 
 




5.7.1 Results summary 
Investigations of the free-running periods, daily locomotor activity and entrainment of 
behavioural cycles to light pulses in control and cKO mice found no evidence for an effect of 
the cKO of NPAS2 in the liver. However, potential sex x genotype interactions were suggested 
by the results of these tests. In male mice we showed no effect of the cKO on entrainment of 
behavioural cycles to restricted feeding while in female cKO mice a significant enhancement 
of the entrainment to restricted feeding was observed. 
5.7.2 Free-running period 
We observed no effect of the liver cKO on free-running behaviour (based on general 
cage activity analysed by FFT-NLLS), although the data supports further investigation of a 
potential sex x genotype interaction effect with a potential lengthening of the free-running 
period in female mice. If supported this would suggest a contribution of the liver clock to 
behavioural period when food is available ad libitum under DD. A sex influence on this effect 
may suggests a contribution of oestrogen signalling in between clock entrainment as suggested 
in 5.6.2.2. 
5.7.3 Daily locomotor activity 
Overall activity is modulated by sex, but we found no evidence of a genotype effect on 
daily activity levels. We did observe that a significant sex difference in activity levels in the 
light phase was only observed in cKO mice. A sex-specific effect of the cKO on total daily 
activity is suggested by the data and may be of interest for further investigation. 
The investigation of daily activity patterns was underpowered, but the data suggested 
potential sex-specific effects of the cKO which may warrant further investigation. 
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5.7.4 Light and food entrainment 
We observed no effect of loss of liver NPAS2 on entrainment to either light or RF in 
male mice. This is in contrast to Dudley et al. (2003) using constitutive KO mice, who found 
inhibited RF and enhanced light entrainment. These findings suggest that these entrainment 
impairments following NPAS2 KO may not have been dependant on a role of NPAS2 in the 
liver. 
In female mice we observed the loss of NPAS2 expression in the liver enhanced 
behavioural entrainment to feeding when measured as time of onset of activity. Female mice 
were not used in prior studies of entrainment in constitutive KO mice, it is possible that a sex 
effect may have been observed if they were. A possible explanation of this effect is an influence 
of liver NPAS2 on oestrogen signalling in circadian cycles (see section 5.6.2.2).  
5.7.5 Future work 
Further investigation of free-running behaviour will provide further insight into the 
potential sex effect observed.  
While we were able to observe the effect of an early light pulse in the delaying shift in 
activity, we were unable to experimentally observe a light pulse induced phase advance. 
Repetition of the experimental procedure with light pulse performed at different times may be 
of interest to fully characterise the light response in the cKO mice, especially light pulses 
causing a phase advance. 
Under RF we were able to see entrainment influencing time of activity onset in female 
mice and an enhancement of the response in cKO females. While this effect was clearly 
observed it would be preferable to observe this effect in the more robust percentage FAA 
measurement. As such it may be useful to perform a similar experiment with a reduced window 
of food availability as this may encourage the appearance of this behaviour and we have seen 
that these mice do not appear to be at risk of severe weight loss. Investigation of this effect 
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may be aided by investigation of gene expression in tissues of animals under RF. Tissues 
collected at multiple times on multiple days would allow observation of the entrainment 
process but would require a large number of mice. Tissues collected after a substantial number 
of days where FAA is clearly presented could be compared to mice under normal ad libitum 
feeding to potentially provide insight. It would also be of interest to identify the effect on the 
expression of genes related to metabolism especially those also related to NPAS2 such as Shp 
(Lee et al., 2015)
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Chapter 6: Latent inhibition of cued fear 
conditioning in NPAS2fl/fl/Alb-cre liver 
knockout mice 




6.1.1 Circadian cycles and cognition 
Circadian cycles have been shown to impact on cognition, as detailed in Chapter 1 
sections 1.10 (page 43) and 1.11 (page 44). This can be observed in cycling patterns in the 
performance of cognitive tasks, performance is generally optimal within the first 8 hours of 
activity in humans and mice, however this does depend on the specific task. For example, mice 
showed improved performance in contextual fear conditioning in the dark phase of a 12h:12h 
LD cycling environment (Valentinuzzi et al., 2001) however performance in tone-cued fear 
conditioning is improved when mice are trained in the light phase (Chaudhury and Colwell, 
2002). Chronic disruption of circadian cycles leads to a deficit in cognitive function in both 
humans and animals (Krishnan and Lyons, 2015, Cho et al., 2000, Marquie et al., 2015) and 
KO of various core circadian genes has an impact on cognitive function in different ways 
(Wang et al., 2009, Kondratova et al., 2010) as detailed in section 1.11 (page 44). 
6.1.2 Role of NPAS2 in cognitive tasks – studies in constitutive KO mice 
Constitutive NPAS2 KO mice present defective long-term memory of cued and 
contextual fear conditioning, identified in male mice by Garcia et al. (2000). In this study mice 
were exposed to a repeated auditory cue and associated foot shock, to induce fear association. 
Either 30 minutes or 24 hours later, mice were exposed to the auditory cue (cued fear 
conditioning) or the conditioning cage (contextual fear conditioning) and freezing behaviour 
was assessed by overhead camera tracking. There was a clear conditioning effect but no 
genotype difference in freezing response to either cue or context when mice were tested after 
30 minutes. However, 24 hours after exposure, mice with a constitutive KO of NPAS2 showed 
reduced freezing behaviour in response to both the cue and context, compared to controls. This 
suggests a deficit in long-term memory consolidation of the conditioning in the NPAS2 KO 
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mice. The effect of loss of NPAS2 function on memory is proposed to be mediated outside of 
the hippocampus as NPAS2 KO mice also showed no change in performance in the Morris 
water maze (Garcia et al., 2000), which has been associated with hippocampal function 
(Vorhees and Williams, 2006), see section 1.11 (page 44). 
In a separate study, decreased anxiety-like behaviour has been demonstrated in NPAS2 
constitutive KO mice in elevated plus maze, light/dark box, and open field assays (Ozburn et 
al., 2017). In mice with a selective viral vector shRNA knockdown of NPAS2 specifically 
within the nucleus accumbens, similar anxiolytic effects on these tests were observed (Ozburn 
et al., 2017). This suggests the role of NPAS2 in the nucleus accumbens is important for 
anxiolytic effects. 
Within the nucleus accumbens NPAS2 expression is highly enriched in specifically 
Drd1 dopamine receptor containing neurons, identified by RT-qPCR of neurons sorted by 
FACS for Drd1 expression. This is broadly consistent with the finding that NPAS2 expression 
is also required for rhythmic expression of dopamine receptors (Ozburn et al., 2015). Dopamine 
signalling pathways have also been shown to be important for both cued and contextual fear 
conditioning (Fadok et al., 2009, Ikegami et al., 2014). This may suggest that the loss of NPAS2 
expression influences dopamine signalling, causing changes contributing to the observed 
behavioural phenotypes. 
6.1.3 Latent inhibition 
Latent inhibition (LI) is a process of learning to ignore irrelevant stimuli. The process 
is a measure of how past experience with a stimulus modulates the attention to, or readiness to 
form associations with, that stimulus (Lubow, 2005, Weiner and Arad, 2009). Experimentally 
LI is tested in mice by comparing two experimental groups. One group is pre-exposed to a 
stimulus such as a tone or light without consequence i.e., pre-exposed (PE) and one group is 
not pre-exposed to the stimulus i.e., non-pre-exposed (NPE). Both groups are then conditioned 
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to associate the stimulus with an outcome (e.g., footshock). LI is demonstrated as the PE group 
showing reduced fear conditioning to the stimulus compared to the NPE group.  
In rats, circadian modulation of LI of learning of taste aversion has been observed. Rats 
pre-exposed and conditioned at a different time of day to testing showed loss of LI effect 
(Manrique et al., 2004). This suggests LI of association of stimuli is enhanced by matching 
time of day context. As such the circadian system contributes to LI and modulation of the 
circadian system may affect LI performance.  
LI appears to rely on signalling within the nucleus accumbens, as shown by the 
disruption of LI by amphetamine when introduced both systemically and by microinjection to 
the NAc shell (Nelson et al., 2011). The Drd1 and Drd2 dopamine receptors play different roles 
in of LI. It has been shown that in mouse models with a KO of Drd1, normal disruption of LI 
induced by D-amphetamine was attenuated, while a Drd2 KO had no effect (Bay-Richter et al., 
2013). It has also been shown there are opposite effects of dosing with Drd1 or Drd2 receptor 
antagonists on LI, with Drd2 antagonists associated with increased LI effect and Drd1 
antagonists reduced LI effect (Diaz et al., 2015). This suggests a potential link between LI and 
NPAS2. 
The LI paradigm measures both contextual control of conditioning and cued 
conditioning. As constitutive NPAS2 KO models have shown a modulation of fear 
conditioning activity indicating an influence of the KO on associative learning, possibly via a 
circadian influence, it was hypothesised that an effect may also present in LI of this learning. 
It was therefore considered to be a useful assay to further evaluate the influence of the loss of 
NPAS2.  
6.1.4 Aims and Hypothesis 
The following experiment was intended to establish whether KO of NPAS2 in the liver 
affects cued fear conditioning and the influence of LI on the fear conditioning. This experiment 
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was planned as a control for future brain specific NPAS2 KO mice to compare roles of NPAS2 
both in and outside of the brain. It was hypothesised that there would be no effect of 
liver-specific KO of NPAS2 on either fear conditioning or LI of fear conditioning, as general 
brain function was predicted to be unaffected. It has however been noted that expression of the 
circadian genes within the brain are modified in the liver NPAS2 cKO mice (section 4.3.3.2, 
page 167), as such this investigation will inform whether this change affects LI of fear 
conditioning. 
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6.2 Materials and Methods 
6.2.1 Animals 
Mice were bred and housed as detailed in section 4.2.1.1 (page 152). Mice were used 
at 3-6 months of age. For mouse numbers see Table 6.1 below. 
6.2.2 Conditioning chamber set-up 
Training and testing occurred in six identical conditioning chambers (21.6 cm x 17.8 
cm x 12.7 cm, ENV-307W; Med Associates Inc., St Albans, VT, USA) housed in light and 
sound-attenuating boxes (ENV-022V, Med Associates Inc.). The conditioning chambers were 
composed of Plexiglas walls in the front and back, stainless steel sides, and a metal grid floor 
connected to a shock scrambler and generator. Each box contained a house light, a ventilation 
fan, mounted at the back to provide air exchange and background noise (69 dB), and a sonalert 
mounted on the right wall for delivering the conditioned stimulus (CS) (85 dB) (ENV-323AW, 
Med Associates Inc.). Each chamber was equipped with a removable drink spout located in the 
left wall of the chamber. The lick spout was connected to a lickometer (ENV-250, Med 
Associates Inc.) which recorded the number of licks. The chambers were interfaced with a PC 
computer running MED-PC software (SOF-735, Med Associates Inc.) to control stimulus 
presentation and record data. The software programs ran are detailed in the appendix (section 
A.8, page 316). 
6.2.3 Cued fear conditioning and latent inhibition of conditioning 
The LI protocol was based on that of Bay-Richter et al. (2009) and consisted of six 
stages: water restriction, pre-training, pre-exposure/no pre-exposure, conditioning, re-
establishment of drinking, and testing (summarised in Figure 6.1). Within this experimental 
protocol we were able to investigate fear conditioning and the LI separately to identify any 
specific effects as well as investigate the effect of extinction on both by inclusion of repeated 
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test days. Mouse testing in conditioning chambers commenced at approximately the same time 
within the morning each day. 
Water restriction (days 1-7) - Mice were placed on a 22-h water restriction schedule 7 
d before pre-training began. A daily ration of 2 h of water availability was provided in the home 
cages at the same time each morning.  
Pre-training (days 8-13) - Mice were placed in the conditioning chambers and allowed 
to drink freely from a water sipper for 15 min. The number of licks made and latency to lick 
was recorded. After the training, the mice were provided a daily ration of 1 hour of water 
availability in the home cages, the procedure of post-training water provision was followed for 
the rest of the procedure. 
Pre-exposure (day 14) - Mice were placed in the conditioning chambers without access 
to the water sipper. PE mice were given 60 presentations of an 85-dB 5 s tone with a 15 s 
interstimulus interval. NPE control mice were placed in the chambers for the same amount of 
time but received no pre-exposures to the tone. 
Conditioning (day 15) - Mice were placed in the experimental chambers without access 
to the water sipper. After 5 min, two tone-footshock pairings were presented. Each tone (CS) 
was of 5 s duration and was followed by a 1 s 0.38 mA footshock. There was a 2.5-minute 
interval between pairings and mice remained in the chamber for 5 minutes following the second 
tone-shock presentation. 
Rebaseline lick training (days 16-17) - Mice were placed in the conditioning chambers 
for 15 minutes and given free access to the water sipper to re-establish licking in the chamber 
prior to testing. The same software script was used as that for pre-training. 
Testing (day 18-21) - Mice were placed in the conditioning chambers with access to the 
water sipper. The number of licks and the time to complete licks 90-100 (lick time; LT) were 
recorded electronically. After the first 90 licks, the tone CS was presented until the mouse 
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reached lick 100. The measure in seconds (s) of time taken to complete licks 90-100 in the 
presence of the CS (LT) can be compared across to mice to investigate effects on conditioned 
suppression. Testing on following days investigated the effect of extinction on the acquired 
fear conditioning. Extinction was measured by repeating the test phase three days beyond the 
initial day to give a total of 4 test sessions. 




Figure 6.1:  Latent inhibition of fear conditioning experimental protocol 
Mice were placed on water restriction 7 days prior to, and throughout,  the experiment. Over 6 days pre-training the mice were habituated to  
the test chamber.  On the day of pre-exposure, the PE group were exposed repeatedly to the tone while the NPE group were simply placed in 
the chamber for the same amount of time. On the conditioning day all mice were exposed to two tone-footshock pairings. Two rebaseline lick 
training days then allowed restoration of normal drinking behaviour in the chambers. On the four test sessions mice were exposed to the 
tone immediately on reaching lick 90 and the tone continued until they reached l ick 100. Conditioning is measured as slowing or cessation 
of drinking during the tone presentation. LI is shown as reduced conditioning in the group of mice pre-exposed to the stimulus compared to 
the group not pre-exposed.
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6.2.4 Experimental design 
Mice were tested across two experimentally identical cohorts (Table 6.1). Sexes were 
pooled as previous work by our lab group identified no sex effect on fear conditioning and LI 
in WT C57BL/6 mice (Bay-Richter et al., 2013). The experiment was approximately counter-
balanced for sex and equally distributed between PE and NPE mice for each genotype as much 
as was possible with mouse numbers available. 
Power calculations were performed based on reported effect of mutation of the Disc1 
gene on LI which was investigated using a similar protocol (Haque et al., 2012). Based on the 
reported values, using Formula 5.1 and the G power software the Cohen’s f for the genotype 
effect on LI was determined as 0.287. Using an alpha value of 0.05, power of 0.9, 
non‑sphericity correction of 1 and an estimated repeated measures correlation of 0.5, G power 
analysis identified that an experiment would be suitably powered to identify a similar sized 
effect with a total of 36 mice based on a mixed model ANOVA of four groups across four 
repeats. Based on this at least 9 mice were used for each group, influenced by mouse 
availability.  
Table 6.1: LI mouse sample sizes 
Sex and 
genotype 
Cohort 1 Cohort 2 Total 
NPE PE NPE PE NPE PE 
♂ cKO 2 2 3 3 5 5 
♂ Ctrl 2 3 4 3 6 6 
♀ cKO 3 3 1 2 4 5 
♀ Ctrl 4 3 1 2 5 5 
 
The data was analysed to separately consider the behavioural outcomes of fear 
conditioning, LI, and extinction as these reflect separate behavioural mechanisms which, while 
we were able to investigate within one procedure, are of interest independently to evaluate the 
effect of the NPAS2 liver cKO. 




6.2.5 Statistical analysis 
Frequentist statistical tests were performed using SPSS software as described in 
Chapter 3, section 3.2.3 (page 123). For mixed repeated measures ANOVAs sphericity was 
assessed by Mauchly’s test of sphericity. Independent t-tests were used for investigation of the 
between-subjects factor of genotype, factorial ANOVAs are used for analysis of combinations 
of the between-subjects factors of genotype, sex, and pre-exposure on the first test day and 
mixed ANOVAs were used for investigations of extinction including the within-subject factor 
of test day. Due to the identification of non-normal distributions of the data, log transformations 
were used to generate normally distributed data for all analyses in this chapter. Matching 
Bayesian tests were performed in JASP to supplement frequentist tests and identify support for 
the null hypothesis as described in Chapter 5, section 5.2.7 (page 156). 




6.3.1 Latent inhibition of fear conditioning behaviour 
Fear conditioning was measured using the time taken (s) to complete licks 90-100 while 
being exposed to the CS tone stimulus (LT). The LI effect is observed as decreased log LT in 
PE mice as these mice do not form as strong fear association with the stimulus compared to the 
NPE groups (Figure 6.2).  
The results of the statistical analysis are presented in Table 6.2Error! Reference 
source not found.. Interaction effects which include the factor of pre-exposure condition 
reflect effects on the LI, while other factors and interactions reflect effects on fear conditioning. 
A significant effect of pre-exposure and a significant effect of sex were identified but there was 
no significant effect of genotype. No interaction of sex with genotype was identified and nor 
any significant effect of sex or genotype on LI (interaction terms including pre-exposure). 
Bayesian analysis favoured a model consisting of the factors of both pre-exposure and 
sex independently (BF10=12.848 compared to the null model, indicating strong evidence). 
Analysis of effects, shown in Error! Reference source not found., identified substantial 
evidence for the effect of pre-exposure. Substantial evidence was identified against a main 
effect of genotype suggesting no genotype effect on fear conditioning while evidence was 
inconclusive regarding interaction effects. 
This analysis shows a sex effect in fear conditioning behaviour. While the Bayesian 
investigation suggests only weak evidence for the effect of sex, taken together with the 
frequentist analysis, as it does still favour an effect, this conclusion stands. The analysis is 
suggestive against an interaction of sex x genotype. This experiment was not designed to 
explicitly test genotype and sex comparison, so was underpowered to investigate these 
interaction effects. However, it appears graphically that improved learning was seen in cKO 
male mice compared to control male mice in NPE groups (see Figure 6.2 BError! Reference 
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source not found.). 
The significant effect of the pre-exposure condition shows the LI of fear conditioning. 
The lower fear conditioning response in male ctrl mice means that the reduction of fear 
response in this group due to PE is less obvious as the behaviour most likely approaches a 
baseline. We observe no significance for a sex x pre-exposure interaction and the Bayesian 
analysis shows the data provides only weak evidence against the interaction, so we are 
restricted by the power of this study to conclude an effect of sex on the LI of fear conditioning. 
The analysis suggests we observe only weak evidence that liver-specific NPAS2 cKO does not 
influence LI of fear conditioning.  
Table 6.2: Results of frequentist and Bayesian three-way ANOVA analysis of LI of fear 
conditioned behaviour in mice and the effects of genotype and sex 
Effect Frequentist ANOVA Bayesian ANOVA Bayesian conclusion 
Pre-exposure F(1,33)=8.524, p=0.006* BFincl=6.894 
Substantial evidence 
for 
Genotype F(1,33)=0.057, p=0.812 BFincl=0.318 
Substantial evidence 
against 
Sex F(1,33)=4.959, p=0.033* BFincl=2.383 Weak evidence for 
Pre-exposure x  
Genotype 
F(1,33)=0.454, p=0.505 BFincl=0.459 
Weak evidence 
against 
Pre-exposure x  
Sex 
F(1,33)=0.632, p=0.432 BFincl=0.507 
Weak evidence 
against 
Genotype x Sex F(1,33)=0.356, p=0.555 BFincl=0.443 
Weak evidence 
against 
Pre-exposure x  
Genotype x Sex 









Figure 6.2: Latent inhibition of fear conditioned lick behaviour  
A&B: Log mean time taken to perform 10 licks (±SEM) while exposed to the conditioned 
stimulus (LT) of mice pre-exposed (PE, ○) and not pre-exposed (NPE, ●) to the stimulus. A: 
The effect of  pre-exposure condition and genotype. B: The effect of pre-exposure condition, 
genotype, and sex.  Decreased LT is apparent for all  PE groups in comparison to NPE except 
the male ctrl  mice,  due to lesser fear conditioning of male NPE mice.  
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6.3.2 Extinction of learned behaviour 
Extinction is the gradual loss of the learned fear response with repeated exposure of the 
conditioned stimulus without negative reinforcement. The extinction of fear conditioned 
behaviour in, both PE and NPE mice, is shown in Figure 6.3, the results of the analysis are 
presented in Table 6.3. The extinction due to test day showed a significant effect on log LT and 
significant effects of pre-exposure condition and sex were identified, without a significant 
genotype effect. No significant interaction effects were identified. Graphically we see the log 
LT decrease most obviously between the early days, as extinction of the fear conditioning 
occurs, and little change between day 3 and 4, as behaviour approaches a baseline. 
Bayesian analysis favoured a model of independent effects of day, sex, and 
pre-exposure (BF10=4.51x107 compared to the null model, indicating decisive evidence). 
Analysis of effects are shown in Table 6.3. The Bayesian analysis supports the frequentist 
identification of significant factors identifying substantial or stronger evidence in favour of 
those effects. Strong evidence against a genotype x test day interaction and substantial evidence 
against sex x day and sex x genotype x day interactions suggest sex and genotype had no effects 
on the extinction of the fear conditioning. Similarly substantial evidence against pre-exposure 
x sex x day and pre-exposure x genotype x sex x day was identified. For other factors and 
interactions only weak evidence against them was identified. Taken together the data confirms 
the occurrence of the extinction of the conditioned fear. However, the data is not conclusive 
but suggestive against any difference in fear conditioning, LI and LI influenced extinction of 
fear conditioning presentation in mice with a liver-specific NPAS2 cKO. 
 




Figure 6.3:  Latent inhibition and extinction of fear conditioned lick behaviour  
A&B:  Log mean time taken to perform 10 licks (±SEM) while exposed to the conditioned stimulus (LT) of mice pre-exposed (PE, ○) and not  
pre-exposed (NPE, ●) to the stimulus, showing the extinction of the learning over repeated days.  A: The effect of pre-exposure condition and 
genotype. B: The effect  of pre-exposure condition, genotype, and sex.  For almost all  groups the reduction in LT is  clearly observed on test 
day 1 in mice which were pre-exposed. As extinction of the training occurs over the test days the performance of NPE and PE mice becomes 
similar,  approaching a baseline.  The only group where this is not clearly apparent is  for the male ctrl  mice which as previously noted did not 
present as clear fear conditioning as that observed in the other groups.  
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Table 6.3: Results of frequentist and Bayesian mixed ANOVA analysis of extinction of 
fear conditioned behaviour in mice and the effects of genotype and sex 
 
Effect Frequentist ANOVA Bayesian ANOVA Bayesian conclusion 
Pre-exposure F(1,33)=6.604, p=0.015* BFincl=4.765 
Substantial evidence 
for 
Day F(1,99)=14.532, p<0.00001* BFincl=7.53x105 Decisive evidence for 
Genotype F(1,33)=0.425, p=0.519 BFincl=0.426 
Weak evidence 
against 
Sex F(1,33)=10.669, p=0.003* BFincl=24.459 Strong evidence for 
Pre-exposure x 
Day 















F(1,99)=0.297, p=0.827 BFincl=0.092 
Strong evidence 
against 
Sex x Day F(1,99)=0.672, p=0.571 BFincl=0.166 
Substantial evidence 
against 










Sex x Day 




Genotype x Sex 
F(1,33)=0.387, p=0.538 BFincl=0.556 
Weak evidence 
against 
Genotype x Sex 
x Day 




Genotype x Sex 
x Day  










6.4.1 Results summary 
Our data identified a significant effect of pre-exposure showing that we have 
demonstrated LI of fear conditioning. We also observed a significant effect of sex, this is likely 
due to lower baseline fear conditioning of male mice, clearly visible in NPE ctrl mice. This 
data is evidence against a main effect of genotype on fear conditioning but is inconclusive 
regarding a genotype x sex interaction. We observe only weak evidence that liver-specific 
NPAS2 cKO does not influence LI of fear conditioning. 
Investigation over repeated days similarly identified significant effects of pre-exposure 
and sex as well as a significant effect of the factor of day showing the effect of extinction. The 
data was found to provide evidence against sex, genotype and sex x genotype interaction effects 
on the extinction. 
6.4.2 Fear conditioning, LI, and extinction 
No difference was identified in either the fear conditioning or the LI response between 
genotypes. This supports loss of liver expression of NPAS2 having no effect on fear 
conditioning behaviour. This was expected but means we do see a successful experimental set 
up for use with any future brain specific tissue KO models using this floxed line and suggests 
that the disruptive effect of NPAS2 as reported by Garcia et al. (2000) were not due to effects 
within the liver. 
Extinction of the learning appeared as expected, with a greater decrease in log LT across 
the earlier days which became a much lesser decrease as the behaviour approached a baseline 
for lick speed. Mice with a lower initial log LT due to LI showed similar decreases of behaviour 
approaching a baseline the only difference observed being the log LT was lower on test day 1 
for pre-exposed mice. The extinction of the behaviour was not significantly modified in the 
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liver-specific NPAS2 cKO mice suggesting that NPAS2 in the liver and any effects on brain 
regions have no influence on the extinction effect. 
It should be noted that the experimental process used here was slightly different to that 
performed by Garcia et al. (2000) on constitutive NPAS2 KO mice where the impact was 
originally identified. The original experiment identified the fear conditioning through freezing 
behaviour, while we investigated fear conditioning via cessation of drinking behaviour. In the 
Garcia paper the fear conditioned behaviour was investigated 24 hours after conditioning while 
our experimental conditions investigate lick behaviour in the presence of the CS 72 hours after 
conditioning. This is due to two days of lick training after fear conditioning, required to prevent 
contribution of contextual fear effects of the test chamber on behaviour, and isolate the effect 
of the cue on drinking behaviour. 
6.4.3 Sex-specific effects 
In these data we identified a significant sex effect in fear conditioning with male mice 
showing reduced fear conditioning compared to female mice. Previous work from our lab using 
this experimental procedure had identified no sex difference in presentation of fear 
conditioning and LI of the conditioning in wild type C57BL/6 mice, so this sex effect was 
unexpected (Bay-Richter et al., 2013, O'Callaghan et al., 2014). Other fear conditioning 
protocols have however identified a sex difference in mouse behaviour with females showing 
more freezing when trained by cued and contextual fear conditioning (Borkar et al., 2020, 
Keiser et al., 2017), while other studies have shown with greater shock intensity male mice 
present greater freezing behaviour (Villasana et al., 2010).  
Possibly a difference in this colony compared to WT C57BL/6 mice means that the sex 
difference normally observed in freezing behaviour was observed in drinking behaviour for 
these experiments. While the modification introducing the LoxP sequences in the floxed 
control mice does not cause any change in gene expression, these mice are not from pure 
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C57BL/6 stock and have been bred as a separate colony for a large number of generations 
meaning some genetic drift and differences would be expected (Eraly, 2014). Variation in LI 
of fear conditioning has been recorded across different mouse strains (Lipina et al., 2011). As 
such it is fortunate that for our experimentation, we are able to compare litter mate mice as 
underlying differences would appear as an effect of the genetic modification if compared to a 
separate control colony. 
Experimentally our design was underpowered to identify sex interactions without 
additional cohorts. While Bayesian analysis was suggestive against a sex x genotype 
interaction, it was only weak evidence, and it appears that we do see a genotype effect within 
male mice when viewed graphically (Figure 6.2Error! Reference source not found. B). This 
appears to be an increase in log LT in cKO mice, bringing the behaviour closer to the baseline 
for female mice. It may be that this increased conditioning would be seen in genotypes for both 
sexes if the control female mice had a similar low fear conditioning behaviour as it may be that 
any increase in log LT in the cKO mice is lost due to a ceiling effect. This conclusion would 
require further experimentation however before it could be upheld. 
The potentially increased log LT reflects enhanced fear learning in the male cKO mice, 
this is the opposite effect to that observed in male constitutive NPAS2 KO mice which showed 
impaired fear conditioning (Garcia et al., 2000). 
As we have observed modified circadian gene expression within the brain, this 
suggested a pathway through which a liver-specific modification of circadian cycles can 
influence a memory test, an unexpected outcome. While we have only observed modification 
of circadian gene expression in the forebrain other brain regions may be similarly affected. As 
detailed in the introduction section 6.1.1, various circadian disruptions lead to deficits in 
cognitive function across a variety of tasks, and circadian influences in fear conditioning 
entrainment have been reported (Albrecht and Stork, 2017). 
   
263 
 
Investigation of the extinction of the learned behaviour and the effect of LI found that 
we observe no influence of sex or genotype on these, other than the noted effect on fear 
conditioning. The lack of change in extinction suggests the reduced fear conditioning in males 
was not due to faster extinction of the learning in the days between the training and testing, 
which was one possible mechanistic explanation behind the difference. 
Taken together these findings show we have found no significant evidence to support a 
role of the NPAS2 protein in the liver which influences fear conditioning behaviour. However, 
our findings suggest the possibility of a genotype effect within male mice specifically which 
our data is insufficient to conclusively support or oppose, which may warrant further 
independent investigation. 
6.4.4 Future work 
These data support further experiments using additional cohorts of male mice to further 
investigate a potential male specific effect of the cKO on fear conditioning. To support this 
molecular work, similar to that detailed in Chapter 4, in the tissues of male mice looking at 
more brain regions would also be useful. 
A modification of the procedure such that baseline female fear conditioning is lower 
could also be developed to investigate if a lower response in control mice permits observation 
of an increased response in the cKO mice irrespective of sex. This may however have presented 
in this experiment as a slower extinction of the learning in the female cKO mice or as an 
increase in the fear conditioning of cKO PE mice compared to control PE mice, neither of 
which were observed. This does not however rule out that a genetic effect may be seen in 
female mice under a different protocol. 
This potential sex-specific enhancement of LI does not appear to reflect the reported 
effects in constitutive NPAS2 KO mice but a novel effect of KO of NPAS2 liver expression 
influencing brain regions. If significantly identified it would also be of interest to further 
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investigate potential liver influences on circadian cycles in the brain, as suggested in section 
4.4.6 (page 179). It is also possible that other cognitive tasks, influenced by circadian cycles, 
are affected so it would be of interest to investigate how the mice perform in these assays. 
 




This project focused on investigating the functions of the transcription factor NPAS2 
in modulation of core clock gene transcription in vitro and also its contribution to the liver 
peripheral clock in vivo. Previous gene KO studies in mice have found that NPAS2 contributes 
to the maintenance of circadian cycles in the SCN and peripheral clocks (DeBruyne et al., 
2007a, Landgraf et al., 2016). NPAS2 appears to have both overlapping and distinct functions 
with its paralog CLOCK and ablation of both genes is required to fully abolish circadian cycles 
in vivo (DeBruyne et al., 2007a). NPAS2 has been proposed to play a role in restricted feeding 
entrainment (Dudley et al., 2003) although the mechanisms of this entrainment mechanism are 
poorly understood. Food entrainment of circadian behaviour is known to be closely linked to 
entrainment of peripheral clocks (Damiola et al., 2000), so it was unknown whether the role of 
NPAS2 in feeding entrainment was primarily within brain or peripheral tissues. As such we 
investigated the role of NPAS2 in peripheral tissue clocks. 
To investigate NPAS2 function in cells, CRISPR-Cas9 gene editing technology was 
used to genetically edit NIH3T3 fibroblast cells, producing clonal lines deficient in NPAS2 or 
CLOCK (see Chapter 2). Two clonal lines; NIH3T3-NPAS2-1F1 (ΔNPAS2) comprising a 
functional KO of NPAS2 and NIH3T3-CLOCK-2H8 (ΔCLOCK) exhibiting depleted CLOCK 
protein expression were utilised. Transient synchronisation of the control and edited cell lines 
was successfully achieved via the serum shock method and following release, RT-qPCR at 
multiple time points established the induction of oscillation in transcript levels of core clock 
genes (see Chapter 3). In ΔNPAS2 cells, expression of the REV-ERBα (NR1D1) and REV-
ERBβ (NR1D2) genes, were found to be significantly increased compared to control levels, 
with the increase coinciding with the time of peak expression. CRY2 and CLOCK also showed 
enhanced transcriptional oscillation in this experiment, whereas BMAL1 expression was 
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reduced compared to control levels. In ΔCLOCK cells, expression of REV-ERBα was similar 
to control levels, while BMAL1, CLOCK, and REV-ERBβ showed similar changes in expression 
to that in the ΔNPAS2 cells, although less substantial. The increase in REV-ERBβ expression 
especially was much more substantial in the ΔNPAS2 cells.  
To summarise, these results represent (to our knowledge) a novel observation that 
NPAS2 may function to repress transcription of REV-ERBα and REV-ERBβ genes (directly or 
indirectly) in some cellular contexts. Current models invoke a feedback loop where 
CLOCK:BMAL1 or NPAS2:BMAL1 activate REV-ERBα and REV-ERBβ expression, which 
in turn repress transcription of the NPAS2 and BMAL1 genes. Thus, the results from this study 
suggest the existence of an additional level of interplay involving context-dependent NPAS2-
mediated repression of REV-ERBα and REV-ERBβ. It will be important to investigate if this is 
also seen in other cell types and to establish the mechanism involved. 
It is important to state some of the limitations of these experiments, for example, we 
were unable to find clones in which CLOCK expression was completely ablated, thus low level 
of WT CLOCK was detectable in the ΔCLOCK cell line, which may explain the more moderate 
effects on core clock gene expression. In addition, the quality of available antibodies for 
NPAS2 is poor, although we were able to establish with reasonable confidence the absence of 
NPAS2 protein in the ΔNPAS2 cell line. It would also be important to see if the ‘derepression’ 
of REV-ERBα and REV-ERBβ upon NPAS2 ablation is observed in other cell lines, and to 
explore if this is a direct or indirect mechanism, e.g., due to the moderately increased CLOCK 
expression in ΔNPAS2 cells. 
We also established an in vivo model to investigate NPAS2 function, a liver-specific 
NPAS2 conditional KO mouse colony was established from NPAS2TM2AAGAA and 
NPAS2TM2.1AAGAA mice imported from the Baylor Institute generated by O’Neil et al. (2017) 
(see Chapter 4). This model was used for both analysis of core clock gene transcription in the 
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liver and brain and for behavioural studies. RT-qPCR of mRNA extracted from liver or PFC at 
opposite time points indicated that expression of REV-ERBα and REV-ERBβ expression was 
also altered in liver NPAS2 cKO mice, showing a trend towards reduced levels. A caveat here 
is that due to restricted mouse availability, influenced by COVID-19 work conditions requiring 
temporary colony downsizing, we were only able to analyse gene expression at two time points 
within the experiment. While the result suggests an opposing effect to that seen in the NIH3T3 
cells, it does again implicate NPAS2 in regulation of REV-ERBα and REV-ERBβ genes and 
may reflect tissue specific effects. Future studies should ideally incorporate additional time 
points to get a clearer picture of the circadian expression of the genes tested.  
The differences between the two models do highlight that the change in gene expression 
is likely a complex effect, involving mediating effects on the expression of other CCGs which 
then influence the expression of the circadian genes (see Figure 3.7 D), as without the influence 
of other factors NPAS2 should act as a transcription factor for the REV-ERB genes in a 
consistent manner across tissues. In both in vitro and in vivo models, it appears that the 
circadian expression patterns of the genes were unmodified, this is as expected as the timing 
of the circadian clock should be maintained as CLOCK is still expressed.  
In the in vivo model we found that the expression of core circadian genes in the brains 
of cKO mice were also altered with significant changes to the rhythmic expression of 
REV-ERBβ, CLOCK and BMAL1 observed in cKO mice (see Chapter 4). A similar change to 
that of REV-ERBβ expression was noted for expression of REV-ERBα, although this fell below 
the threshold for significance. These findings show both that the output of the liver circadian 
clock can influence the circadian clock in other tissues and that within the liver, NPAS2 
contributes to the output of synchronising signals in a way which cannot be fully performed 
when reliant on the expression of CLOCK alone. It is especially of note that in the liver, without 
NPAS2 contribution, we did not appear to observe a comparable change in rhythmic expression 
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to the effect we observed the PFC. This may suggest NPAS2 is closely involved at the level of 
output signalling, so the liver circadian cycles are maintained due to the presence of CLOCK, 
but without NPAS2 output signals are modified in such a way to have a more substantial effect 
in other tissues. Various potential mechanisms of how the liver might influence the PFC such 
as via an effect on liver glucose levels are presented in Chapter 4, section 4.4.5 (page 178).  
Investigation of the entrainment to feeding as a zeitgeber identified unanticipated 
sex-specific effects of the NPAS2 cKO (see Chapter 5). Through investigation of RF 
entrainment measured by time of FAA onset, this experiment suggested that the cKO of NPAS2 
in the liver enhanced FEO entrainment in female mice specifically but not any effect in male 
mice. As an overall effect, enhanced entrainment in cKO mice would suggest that NPAS2 in 
the liver either acts to delay circadian entrainment in the liver or that the modulation of 
circadian rhythms throughout the organism mean that the mice are more susceptible to 
entrainment to food timing. The sex-specificity of the effect may suggest that the underlying 
mechanism is more to do with the signalling between the liver and other tissues, as circadian 
rhythms have a noted association with oestrogen signalling (Royston et al., 2014, Hatcher et 
al., 2020) which may be responsible for the sex differences. 
Investigation of the free-running period, activity levels and patterns, and light 
entrainment were underpowered statistically to investigate sex effects, however, findings 
reported here support further investigation with respect to potential sex-specific differences. 
The lack of observed genotype effect was consistent with our predictions as these behaviours 
should rely more on circadian gene expression in the brain. However, as experiments in 
Chapter 4 found that the liver cKO is associated with modified circadian gene expression in 
the PFC of female mice, this change would provide a potential mechanism for an influence on 
these behaviours. 
Constitutive NPAS2 KO mice have previously been shown to present deficits in fear 
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conditioning (Dudley et al., 2003). To investigate the contribution of NPAS2 in peripheral 
clocks to this effect, experiments investigating fear conditioning, LI, and extinction were 
performed. Again, we observed unexpected sex differences. We found a significant sex 
difference due to male mice presenting reduced fear conditioning compared to female mice 
which had not been previously observed in our group using this procedure. While the 
experiment was underpowered to investigate sex interaction effects the data was suggestive of 
increased fear conditioning in NPAS2 cKO male mice compared to control male mice. A lower 
fear conditioning baseline in male mice may have permitted observation of an increase in fear 
conditioning, with a ceiling effect on the genotype contribution obscuring the effect in female 
mice. While an effect on a memory task of a liver-specific KO would not be expected, our 
findings suggest that circadian gene expression in the brain was modified in female mice. 
Taken together our findings present three conclusions: 1) Loss of NPAS2 function in 
peripheral clocks affects the expression of genes which are part of the core transcription 
feedback loop in a way which is not fully compensated for by CLOCK, especially the REV-ERB 
genes. This suggests specific unique functions of NPAS2 in peripheral clocks which are not 
seen in the SCN. 2) Loss of NPAS2 in the liver clock modulates the rhythmic expression of 
circadian genes in the brain, suggesting a possible role of NPAS2 in synchronisation of clocks 
between the liver and different tissues. 3) Circadian entrainment to restricted feeding is 
influenced by loss of NPAS2 in a sex-specific manner and sex-specific behavioural effects 
warrant further investigation for free-running behaviour and fear conditioning. 
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A.1 Generation of BET mutant triple negative breast 
cancer cells 
As part of a collaborative effort to investigate the role of the BET proteins in the 
hypoxia response in breast cancer, I was responsible for the generation of clones with modified 
BET protein expression. The BET proteins are epigenetic regulators containing the 
bromodomain. These function as coactivators for many transcription factors, including 
members of the bHLH-PAS family which includes HIF, AHR, NPAS, SIM and CLOCK 
proteins. It is likely that BET proteins are essential for control of circadian gene regulation, and 
interactions with REV-ERBs have been reported (Kim et al., 2018b) 
This work was part of collaborative study between our group and Dr Alan McIntyre, 
funded by Breast Cancer Now. Guides were designed for, and clones were produced, in which 
mutations were targeted in the bromodomain and extra-terminal proteins BRD2-4 in two breast 
cancer cell models, HCC1806 and MDA231, as part of research into tumour hypoxia. The BRD 
genes are of interest as the BET inhibitor JQ1, which has been shown impair tumour response 
to hypoxia and downregulate angiogenesis in breast cancer (da Motta et al., 2017) inhibits 




Materials and methods used are as those detailed in Chapter 2 with the exceptions 
shown below. Targeted clones were generated, and initial PCR analysis was performed. Based 
on this initial analysis specific clones were selected for western blotting investigation of protein 
expression which was performed in collaboration with Leonardo da Motta (pers. comms.). 
Based on western blotting specific clones were chosen and sequencing was performed to 
identify the specific mutations for the selected BRD3 and BRD4 clones. These processes were 
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performed following the methods sections in Chapter 2. 
A.1.1.1 Culturing of adherent cells 
The human breast cancer (MDA231 and HCC1806) cells were maintained in 
Dulbecco’s Modified Eagle Medium (DMEM). This medium was supplemented with 10% 
(v/v) heat-inactivated fetal calf serum (FCS) plus 1% (v/v) 0.2 M L-glutamine and 1% 
Penicillin/Streptomycin antibiotics. Cells were cultured in sterile plastics at 37 °C, 5% CO2 and 
passaged when at approximately 80% confluency. When passaging and/or collecting cells the 
medium was aspirated, and cells washed with 1 x PBS. Following this MDA-MB-231 cells 
were incubated for 5 minutes at 37 °C in 1 x trypsin and fresh media then added and HCC1806 
cells were incubated for 10 minutes at 37 °C in 2 x trypsin and fresh media then added. At this 
point, the cell suspension was diluted and split into other sterile plasticware and/or collected 
into 15 ml tubes if being used for other processes. 
A.1.1.2 Calcium phosphate-mediated transfection of MDA231 and HCC1806 cells 
For transfection MDA231 and HCC1806 cells were seeded at a density of 5 x 105 cells 
per well in a 6 well plate, 24 hours prior to transfection. Transfection was performed as detailed 
for HEK293 cells in section 2.2.5.5 (page 63). 
A.1.1.3 Cell sorting of transfected cells 
After harvesting cells were sorted by use of fluorescence-activated cell sorting (FACS) 
for GFP expression with single cells expressing GFP sorted into 96 well plates with prewarmed 
media. 
A.1.1.4 Targeting guides 
Guides were designed for the human BRD2-4 genes as described in section 2.2.3 (page 
55), sequences are detailed in Table A.1 (page 296) and targeting information is shown in the 
relevant following sections. BRD3 and 4 both have only one consensus start codon for all 
transcripts and guides were designed targeting the start codon in exon 2 for both genes. The 
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human BRD2 gene has multiple possible start codons. As such two pairs of guides were 
designed to target different start codons at different locations within the gene in exon 2 and 
exon 4. This then meant that targeted effects at the two sites had to be identified individually. 
 
A.1.2 Generated mutant clones 
A.1.2.1 BRD2 
The targeting information for BRD2 is shown in Figure A.1, two different sites within 
the gene were targeted. The mutant HCC1806 clone 2F5 and the MDA-MD-231 clone 1F11 
were selected due to the loss of BRD2 protein expression. Western blots showing the modified 
protein expression compared to single guide transfected control cells are shown in Figure A.2. 
Sequencing identification of these mutations has not been performed at this time. 




Figure A.1:  Targeting the BRD2  gene 
A:  Exon structure of the BRD2  gene from the Ensembl database,  note alternate splice 
variants exist utilising start codons in exons 3 and 4.  B:  Sequence of a  section of exon 2 of 
the BRD2  gene from the UCSC genome browser showing the initiation coding. C:  sgRNA 
designs targeting opposite strands of exon 2 of BRD2  and the following intron. Guide pairs 
were selected close to the ATG in a PAM-out arrangement with a 68 bp spacing.  D:  Sequence 
of a section of exon 4 of the BRD2  gene from the UCSC genome browser showing the 
alternate splice form initiation coding.  E:  sgRNA designs targeting opposite strands of exon 
4 of BRD2 .  Guide pairs were selected close to the ATG in a PAM-out arrangement with a 46 
bp spacing.  




Figure A.2:  BRD2 protein expression in targeted HCC1806 and MDA-MB-231 clones 
Western blot of protein extracts from BRD2  targeted clones performed by Leonardo da 
Motta.  Membranes were probed for detection of BRD2 (Cell  Signalling,  D89134, predicted 
MW 110 kDa) and β actin (Santa Cruz, sc-1615, predicted MW 42 kDa) proteins of  HCC1806 
(A) and MDA-MB-231 (B) clones.  Clones highlighted in green were chosen for future work 
due to the loss of BRD2 expression. 




The targeting information for BRD3 is shown in Figure A.3, targeting exon 2. The 
mutant HCC1806 clone 2E2 and the MDA-MD-231 clone 2D9 were selected as successfully 
targeted cells. Western blots showing the modified protein expression compared to single guide 
transfected control cells are shown in Figure A.4. The genetic sequence information is shown 
in Figure A.5. For both clones only one unique allele was identified, this may mean only one 
allele was present, which is not impossible for triple negative breast cancer cultured cells, or 
homologous repair was used between the chromosomes so two alleles are present, but both 
show the same sequence. 




Figure A.3:  Targeting the BRD3 gene 
A:  Exon structure of the BRD3  gene from the Ensembl database B:  Sequence of a section of 
exon 2 of the BRD3  gene from the UCSC genome browser showing the initiation coding.  C:  
sgRNA designs targeting opposite strands of exon 2 of BRD3 .  Guide pairs were selected close 
to the ATG in a PAM-out arrangement with a 41 bp spacing.  




Figure A.4:  BRD3 protein expression in targeted HCC1806 and MDA-MB-231 clones 
Western blot of protein extracts from BRD3  targeted clones.  Membranes were probed for detection of BRD3 (Cell Signalling, D89134, 
predicted MW 100 kDa) and β actin (Sigma-Aldrich, A2066, predicted MW 42 kDa) proteins of  HCC1806 (A) and MDA-MB-231 (B) clones. The 
selected clones of interest are highlighted in green both slowing loss of  BRD3 expression. 




Figure A.5:  Sequencing of modifications to the BRD3  gene in targeted clones 
A&B:  Agarose gel of  PCR products amplified using BRD3  F1,R2 primers (WT product size: 235 bp) showing a single product of reduced size  
compared to control unmodified DNA for HCC1806 clone 2E2 in A  and MDA-MB-321 clone 2D9 in B .  C:  Sequences of the target region deletions 
in the clones leading to frame shift mutations and premature stop codons. Deletion of 31 bases in clone 2E2 and 22 bases in clone 2D9. 




The targeting information for BRD4 is shown in Figure A.6, targeting exon 2. The 
mutant HCC1806 clone 1A11 and the MDA-MD-231 clone 2D6 were selected as successfully 
targeted cells. Western blots showing the modified protein expression compared to single guide 
transfected control cells are shown in Figure A.7. The genetic sequence information is shown 
in Figure A.8. For both clones only one unique allele was identified, as for the BRD3 clones. 
It makes sense that clones which showed most severe effects on protein expression would be 
cells which only have one allele of the target gene. Both selected clones still retain some 
expression by western blot despite the sequences identified suggesting that complete loss of 
the protein would occur. We observed a subtle difference in size of the band in 2D6 which is 
still larger than a change that an insertion of 4 amino acids would be responsible for. As such 
it may be that another variant of BRD4 may exist which is dependent on an alternate start codon 
in these modified clones. While transcript variants for BRD4 are listed on the Ensembl database 
which use alternate start codons these transcripts lack the majority of the BRD4 transcript and 
any protein produced from these transcripts would have a significantly reduced molecular 
weight compared to the consensus BRD4 protein, as such these are not responsible for the 
observed western blot bands and we may be observing a previously unreported isoform. If the 
western blot bands are due to functional BRD4 or a functional isoform we still see clear 
reduction in expression meaning the clones are still models which can be used for investigation 
of BRD4 function. 
 
 




Figure A.6:  Targeting the BRD4  gene 
A:  Exon structure of the BRD4  gene from the Ensembl database.  B:  Sequence of a  section of 
exon 2 of the BRD4  gene from the UCSC genome browser showing the initiation coding.  C:  
sgRNA designs targeting opposite strands of exon 2 of BRD4 .  Guide pairs were selected close 
to the ATG in a PAM-out arrangement with a 41 bp spacing.  




Figure A.7:  BRD4 protein expression in targeted HCC1806 and MDA-MB-231 clones 
Western blot of protein extracts from BRD4  targeted clones.  Membranes were probed for  
detection of BRD4 (Cell  Signalling, E2A7X, predicted MW 200 kDa) and β actin (Santa Cruz,  
sc-1615 in A ,  Sigma-Aldrich,  A2066 in B ,  predicted MW 42 kDa) proteins of  HCC1806 (A ,  
performed by Leonardo da Motta) and MDA-MB-231 (B) clones.  Clones selected for use are 
highlighted in green. Both selected clones retain the presence of a  protein band for BRD4 
although notably reduced. For 2D6 it also appears that the band is  of a slightly different 
size.  




Figure A.8:  Sequencing of modifications to the BRD4  gene in targeted clones 
A&B:  Agarose gel of  PCR products amplified using BRD4  F1,R2 primers (WT product size: 201 bp) showing a single product of reduced size  
compared to control  unmodified DNA for HCC1806 clone 1A11 in A  and a single product comparable to the control unmodified DNA project 
MDA-MB-321 clone 2D9 in B .  C:  Sequences of the target region modifications in the clones. In clone 1A11 25 bases were lost which includes 
the start codon and in clone 2D9 an insertion of 14 bases occurred which introduces a frame shift mutation. 
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A.2 Rhythmic expression of a PER2-dLuc reporter in 
serum shock synchronised NIH3T3 cells 
A.2.1 Introduction 
To assess the efficacy of serum shock in establishing circadian gene synchronisation in 
our cell model, I employed a luciferase reporter system previous described in the literature 
(Fang et al., 2015, Fang et al., 2017). This system involves a reporter plasmid carrying a 
destabilised luciferase gene under the control of the human PER2 promoter. After transient 
transfection of wild type NIH3T3 cells with the PER2-dLuc expression plasmid, stably 
transfected cells were isolated by selecting for cells resistant to the antibiotic (G418) marker 
carried on the plasmid. These cells were used to validate the serum shock synchronisation 
protocol. 
A.2.2 Methods 
The pGL[hPer2P/Luc2P/Neo] plasmid was a gift generously provided by Mingzhu 
Fang (Fang et al., 2017, Fang et al., 2015). This plasmid was used to transform bacteria which 
were grown for large-scale purification of the plasmid as detailed in Chapter 2 methods 2.2.4.9 
(page 60). A map of the plasmid is shown in Figure A.14. 
NIH3T3 cells were cultured and transfected with the pGL[hPer2P/Luc2P/Neo] plasmid 
as described for the Cas9n plasmid transfection in 2.2.5.6 (page 64). Three days after 
transfection the cell media was changed to media including 1 mg/ml of G418, selecting for 
cells expressing neomycin resistance from the transfected plasmid. The media was replaced 
every 3-4 days to maintain the G418. A control plate of untransfected cells was subjected to 
the same treatment to validate that complete cell death occurred (Fang et al., 2017). After 2 
weeks the cells were plated in duplicate well in 6 x 12-well plates for the serum shock 
procedure as detailed in 3.2.1.4 (page 118) including control cells exposed to a media change 
to serum free media when the 50% horse serum media was removed from the serum shocked 
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cells. Cells were collected into the lysis buffer of the luciferase reporter assay kit 0-, 6-, 12-, 
18-, 24- and 30-hours after the treatment and the lysate stored at -80 °C until the analysis was 
performed.  
The luciferase assays were performed in duplicate for each sample using the 
ThermoFisher Dual-Light™ Luciferase & β-Galactosidase Reporter Gene Assay System per 
the manufacturer’s protocol. The luminescence read was measured using a GloMax® 96 
Microplate Luminometer and the two technical replicates from each sample averaged together. 
The reads were corrected to the total protein mass of the assay volume based on the protein 
concentrations for the samples assessed by Bradford assay performed as described in 2.2.6.4 
(page 66). 
A.2.3 Results 
A clear rhythmic variation in luciferase activity was detected post serum shock, that 
showed an approximate 24-hour period, consistent with synchronisation and circadian 
regulation of the reporter, while cells exposed to only a media change saw an early induction 
of luciferase expression which then dropped and remained at a low level without circadian 
expression (Figure A.9). Thus, we concluded serum shock technique to have successfully 
induced synchronisation of circadian gene regulation in the stable WT cells. However, as the 
amplitude of dLuc activity was relatively modest, and due to the potential for variability in 
stable-expression clones due to different reporter integration sites, we did not consider this 
system would be sufficiently sensitive to enable us to ascertain subtle differences in circadian 
gene expression between wild type and ΔNPAS2 or ΔCLOCK cells. Thus, it was decided not 
to proceed further with this system.  
 




Figure A.9:  Expression of dLuc under a PER2  promotor following a serum-shock. 
Mean relative luminescence (±SEM). Bioluminescence assays were performed on protein 
collected from NIH3T3 cells stably transfected with a PER2-dLuc  expression vector 
following either a serum shock (green) or a media change (black). Samples were collected 
every 6 hours immediately following the treatment up to 30 hours.  The luminescence reads 
were normalised to total protein mass based on protein concentrations determined by 
Bradford assay.  In the serum shock data, the clearest marker of the circadian cycle is the 
low expression at 6 hours and 24 hours later at 30 hours marked on the graph. In the media 
change control,  while initial  induction of the dLuc expression by the media appears to 
occur, this is not then followed by cycling behaviour as the luminescence read drops and 
stays at  a constant low level. For points without error bars,  the SEM was within the size of 
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A.3 NPAS2 polyclonal antibody 
As introduced in Chapter 2 NPAS2 western blots were initially performed using a 
different polyclonal antibody directed against NPAS2 (Mouse anti-NPAS2, PACO0029654, 
Antibody Genie). Using this antibody however, multiple bands were identified that were 
inconsistent with the expected MW of the NPAS2 protein (see Figure A.10). Notably even the 
1F1 clone which is selected as the clone used for research due to the change in NPAS2 protein 
levels appears consistent with all other clones in band intensity. 
 
 
Figure A.10:  Western blotting of NPAS2 targeted NIH3T3 clones using a polyclonal NPAS2 
antibody 
Western blot  of protein extracts from selected NPAS2 targeted NIH3T3 clones,  probed for 
NPAS2 (Antibody genie,  PACO0029654, predicted MW 91 kDa, 1:500) and β actin (Sigma-
Aldrich,  A2066, batch: 018M4853V, predicted MW 42 kDa, 1:1000 dilution, 60 sec exposure) 
as a loading control.  The bands detected by use of the NPAS2 antibody do not reflect  the 
appropriate size,  the lower bands are not visible for all  clones as they are close to the edge 
of the membrane which was cut at ~58 kDa. All protein extracts show similar intensity of 
the bands identified by the NPAS2 antibody, notably including 1F1 which showed clear 
reduction of the NPAS2 band in Figure 2.7 (page 81).  
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A.4 RT-qPCR primer validation 
The various qPCR primers used in Chapters 3 and 4 before use were validated by 
investigation of the reaction efficiency and specificity of produced products. Primer sequences 
are detailed in Table A.1 (page 296). 
Dilution series were performed to validate the reaction efficiency shows a linear 
relationship with the cDNA concentrations. cDNA was produced from WT NIH3T3 cells and 
serial dilutions were used in qPCR for each of the primer sets following procedures presented 
in 3.2.2.4 (page 121). Graphs of the output values are presented in Figure A.11. The dilution 
series are not identical across all primer sets; for 18S rRNA, CLOCK, BMAL1 and REV-ERBβ 
amplification was observed for each of 4 dilutions from 1x to 0.001x however for the other 
genes, amplification was not observed at lower dilutions, so a more sensitive dilution series 
was used up to 0.01x, for some of these genes the most diluted sample remained below the 
detection limit so is also missing from the graphs. For each series the relationship between the 
Ct and relative quantity of cDNA was analysed by semi-log least squares fit using the prism 
software. The equation of the linear line on the graph and the R2 value is presented, R2 values 
greater than 0.98 reflect high correlation between the cDNA relative amount and the Ct 
showing the reaction efficiency does not change with cDNA concentration. 
To validate the primer specificity products from the highest concentration of the serial 
dilution qPCRs were ran on 2% agarose gels following the procedure in 2.2.4.4 (page 58). Gels 
with products for each of the primer sets are presented in Figure A.12. For all primer sets the 
expected product sizes, detailed in the figure legend are observed. 




Figure A.11:  cDNA dilution series RT-qPCR to test amplification by primer pairs 
For each primer set initially a 4-step dilution from 1 to 0.001 relative quantity was used, 
the expression levels of  some genes were too low for identification at these dilutions,  so a 
more sensitive dilution series was used. 




Figure A.12 :  Agarose gels of RT-qPCR products for specific primer pairs  
Three different gels showing the products of  qPCR using primers for the various circadian 
genes investigated. All expected product sizes were observed; 18S  rRNA: 93 bp, PER1:  116 
bp, PER2:  70 bp, CLOCK :  135 bp, BMAL1 :  154 bp, CRY1 :  60 bp, CRY2:  98 bp, REV-ERBα:  84 
bp, REV-ERBβ:  150 bp. 
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A.5 PCR genotyping 
Primers designed for PCR genotyping and sequencing of mutations introduced, use is 
detailed throughout Chapter 2 and section A.1. Not all primers included here were used as 
multiple were initially designed in case of issues with specific primers and some were designed 
specifically for sequencing. In all of the genomic sequence information below exon sequences 
are presented in capitals and introns in lower case PAMs are marked in blue highlight and ATG 
start codons where present are underlined. 
A.5.1 Murine NPAS2 
ATG PAM EXON intron 
FORWARD PRIMERs actgggttgaggtgtgcat  F1 
                acatgcctgtacctgatccc  F2 
REVERSE PRIMERs gcccgccatgttgagtttaa  R1 
                acttcactggtgaggtgcaaa  R2 
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A.5.2 Murine CLOCK 
ATG PAM EXON intron 
FORWARD PRIMER ccattaatgttttcttttctcacaagG  F1 
               ctcaagataatgttgtagaagtgttttaga  F2 
               tgcagccagtttgtagttacg   F3 
               tccccatccaaagatatttgct   FS 
               ggttgcttcttgtctgggtg   F4 
REVERSE PRIMER tgtcactgtattaaaccacccac   R1 
                   aaaccagtatgaaattatgtcactgt  R2 
               tgaaggcagtgatactcagct   R3 
               tttcaaaatggccttcactttt   RS 
               tcaaggaaacaagctcggga   R4 
 
















A.5.3 Human CLOCK 
PAM EXON intron 
FORWARD PRIMERs acaaaaatcatagggcataactgagttg  F1 
                ctgttgcttagtgagtctgct  F2 
                accgttactaaaagtttgaaacaag  F3 
                tcttgtttagcatgatgtgttc  FS 
REVERSE PRIMERs cacatagcttttggaaatcatttattcac R1 
                cagtttctgtttaagcaaagca  R3 
                tctaagttcttccaccttgct  RS 
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A.5.4 Human BMAL1 
ATG PAM EXON intron 
F1 or F2 with R1, F3 with R3 
FORWARD PRIMERs tccagATCATCCAATGGCAGA  F1 
                tctccaccacttttgagagct  F2 
                ctttccattctatcacatgcctg  F3 
                ggggtgtgagagatgcattag  FS 
REVERSE PRIMERs agaggaagacatgccccaaa   R1 
                aaggctccttcttgcttacaa  R3    
                tgtcgccacctagagttgg   RS 
 












A.5.5 Human NPAS2 
ATG PAM EXON intron 
FORWARD PRIMERs agaccaaaatgacaacaacctga F1 
REVERSE PRIMERs agagtgaaagccagcgagat   R1 
                aaaacccagaccactcagcc   R2 
 















FORWARD PRIMER ggttatgctggaccgggc  AF1 
               gaggccacccggactttccg  AF2 
               gagaggccccaaagagactg  AF3 
REVERSE PRIMER ccgctcagtactcccaaca  AR1 
               agtactcccaacacggcgcc  AR2 
               aaaaccgtcgctcaattccc  AR3 
 









FORWARD PRIMER tcggtagtctccctataagca  BF1 
               aattggggccgcagtttaag BF2 
REVERSE PRIMER actgtttctccccacctact BR1 
               agagctctgaagtcacatcact BR2 
 











FORWARD PRIMER gctttctcagggagcgtaga F1 
               ctccaagccgctgctgtgac  F2 
               ctttcccgacagcctctca  F3 
               gactggccttcctctctgtt  FS 
REVERSE PRIMER gcttgctggggttggaga  R1 
               gtttccagagcgtcttcacc  R2 
               caaattcccaaggccagagg  R3 
               agaacgtggctcttgggg  RS 
 
                















FORWARD PRIMER ggacttgtcattctgagcgg  F1 
               tgctgactgatatctcacggg  F2  
               ttcagtcaaagcatggggtg  F3 
               caacttggctagctaccgc  FS 
REVERSE PRIMER ggaagtttctagtccatcccc  R1 
               cctgggcctgtgttgtaga  R2 
               ccctgcccacactactcac  R3 
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A.6 Oligonucleotides, vectors and plasmids 
Table A.1: Oligonucleotides: primers and sgRNA sequences 
Name Gene Specifics Purpose Sequence 
U6 Promotor F Human U6 Promotor F Plasmid sequencing ACTATCATATGCTTACCGTAAC 
MuCLOCK sgRNA AT Mouse CLOCK Guide A Top Cas9n targeting CACCGCACATTATGTTTTCGTCTTG 
MuCLOCK sgRNA AB Mouse CLOCK Guide A Bottom Cas9n targeting AAACCAAGACGAAAACATAATGTGC 
MuCLOCK sgRNA BT Mouse CLOCK Guide B Top Cas9n targeting CACCGAAATGAGCTCAATTGTTGAC 
MuCLOCK sgRNA BB Mouse CLOCK Guide B Bottom Cas9n targeting AAACGTCAACAATTGAGCTCATTTC 
HuCLOCK sgRNA AT Human CLOCK Guide A Top Cas9n targeting CACCGCTGTCATCTCTAAAAGAAAG 
HuCLOCK sgRNA AB Human CLOCK Guide A Bottom Cas9n targeting AAACCTTTCTTTTAGAGATGACAGC 
HuCLOCK sgRNA BT Human CLOCK Guide B Top Cas9n targeting CACCGATGACAAGGACAAAGCGAAA 
HuCLOCK sgRNA BB Human CLOCK Guide B Bottom Cas9n targeting AAACTTTCGCTTTGTCCTTGTCATC 
HuBMAL1 sgRNA AT Human BMAL1 Guide A Top Cas9n targeting CACCGAGCTGGAAAGCAGGTCGGT 
HuBMAL1 sgRNA AB Human BMAL1 Guide A Bottom Cas9n targeting AAACACCGACCTGCTTTCCAGCTC 
HuBMAL1 sgRNA BT Human BMAL1 Guide B Top Cas9n targeting CACCGTGTGGATTGCAACCGCAAA 
HuBMAL1 sgRNA BB Human BMAL1 Guide B Bottom Cas9n targeting AAACTTTGCGGTTGCAATCCACAC 
HuNPAS2 sgRNA AT Human NPAS2 Guide A Top Cas9n targeting CACCGGACAGCTGCATCTTACCTCT 
HuNPAS2 sgRNA AB Human NPAS2 Guide A Bottom Cas9n targeting AAACAGAGGTAAGATGCAGCTGTCC 
HuNPAS2 sgRNA BT Human NPAS2 Guide B Top Cas9n targeting CACCGCAGAGCTCTCTGGCCCCCGG 
HuNPAS2 sgRNA BB Human NPAS2 Guide B Bottom Cas9n targeting AAACCCGGGGGCCAGAGAGCTCTGC 
MuNPAS2 sgRNA AT Mouse NPAS2 Guide A Top Cas9n targeting CACCGAAAAAGGAATCTGATGATAG 
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MuNPAS2 sgRNA AB Mouse NPAS2 Guide A Bottom Cas9n targeting AAACCTATCATCAGATTCCTTTTTC 
MuNPAS2 sgRNA BT Mouse NPAS2 Guide B Top Cas9n targeting CACCGAGACTGCATAGAAACTCTAA 
MuNPAS2 sgRNA BB Mouse NPAS2 Guide B Bottom Cas9n targeting AAACTTAGAGTTTCTATGCAGTCTC 
BRD2 sgRNA AT Human BRD2 Guide C Top Cas9n targeting CACCGGCATCTTGACCGCAAGGAAC 
BRD2 sgRNA AB Human BRD2 Guide C Bottom Cas9n targeting AAACGTTCCTTGCGGTCAAGATGCC 
BRD2 sgRNA BT Human BRD2 Guide D Top Cas9n targeting CACCGCGTTTCCGCGAGCCGCGTGT 
BRD2 sgRNA BB Human BRD2 Guide D Bottom Cas9n targeting AAACACACGCGGCTCGCGGAAACGC 
BRD2 sgRNA CT Human BRD2 Guide E Top Cas9n targeting CACCGTTAATAGTACCCATGTCCAT 
BRD2 sgRNA CB Human BRD2 Guide E Bottom Cas9n targeting AAACATGGACATGGGTACTATTAAC 
BRD2 sgRNA DT Human BRD2 Guide F Top Cas9n targeting CACCGACTTGAAAACAATTATTATT 
BRD2 sgRNA DB Human BRD2 Guide F Bottom Cas9n targeting AAACAATAATAATTGTTTTCAAGTC 
BRD3 sgRNA AT Human BRD3 Guide A Top Cas9n targeting CACCTCGTGGCGGTGGACATCCTC 
BRD3 sgRNA AB Human BRD3 Guide A Bottom Cas9n targeting AAACGAGGATGTCCACCGCCACGA 
BRD3 sgRNA BT Human BRD3 Guide B Top Cas9n targeting CACCAGTCGCCCCCGCGGGGATCC 
BRD3 sgRNA BB Human BRD3 Guide B Bottom Cas9n targeting AAACGGATCCCCGCGGGGGCGACT 
BRD4 sgRNA AT Human BRD4 Guide A Top Cas9n targeting CACCATCCCATCACATTCTTCACC 
BRD4 sgRNA AB Human BRD4 Guide A Bottom Cas9n targeting AAACGGTGAAGAATGTGATGGGAT 
BRD4 sgRNA BT Human BRD4 Guide B Top Cas9n targeting CACCACTAGCATGTCTGCGGAGAG 
BRD4 sgRNA BB Human BRD4 Guide B Bottom Cas9n targeting AAACCTCTCCGCAGACATGCTAGT 
MuNPAS2 F1 Mouse NPAS2 Exon2 F1 Primer - genotyping ACTGGGTTGAGGTGTGCAT 
MuNPAS2 R1 Mouse NPAS2 Exon2 R1 Primer - genotyping GCCCGCCATGTTGAGTTTAA 
MuNPAS2 F2 Mouse NPAS2 Exon2 F2 Primer - genotyping ACATGCCTGTACCTGATCCC 
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MuNPAS2 R2 Mouse NPAS2 Exon2 R2 Primer - genotyping ACTTCACTGGTGAGGTGCAAA 
MuCLOCK F1 Mouse CLOCK Exon4 F1 Primer - genotyping CCATTAATGTTTTCTTTTCTCACAAGG 
MuCLOCK F2 Mouse CLOCK Exon4 F2 Primer - genotyping CTCAAGATAATGTTGTAGAAGTGTTTTAGA  
MuCLOCK R1 Mouse CLOCK Exon4 R1 Primer - genotyping TGTCACTGTATTAAACCACCCAC 
MuCLOCK R2 Mouse CLOCK Exon4 R2 Primer - genotyping AAACCAGTATGAAATTATGTCACTGT 
MuCLOCK F3 Mouse CLOCK Exon4 F3 Primer - genotyping TGCAGCCAGTTTGTAGTTACG 
MuCLOCK FS Mouse CLOCK Exon4 FS Primer - genotyping TCCCCATCCAAAGATATTTGCT 
MuCLOCK R3 Mouse CLOCK Exon4 R3 Primer - genotyping TGAAGGCAGTGATACTCAGCT 
MuCLOCK RS Mouse CLOCK Exon4 RS Primer - genotyping TTTCAAAATGGCCTTCACTTTT 
MuCLOCK F4 Mouse CLOCK Exon4 F4 Primer - genotyping GGTTGCTTCTTGTCTGGGTG 
MuCLOCK R4 Mouse CLOCK Exon4 R4 Primer - genotyping TCAAGGAAACAAGCTCGGGA 
HuCLOCK F1 Human CLOCK Exon5 F1 Primer - genotyping ACAAAAATCATAGGGCATAACTGAGTTG 
HuCLOCK F2 Human CLOCK Exon5 F2 Primer - genotyping CTGTTGCTTAGTGAGTCTGCT 
HuCLOCK R1 Human CLOCK Exon5 R1 Primer - genotyping CACATAGCTTTTGGAAATCATTTATTCAC 
HuCLOCK F3 Human CLOCK Exon5 F3 Primer - genotyping ACCGTTACTAAAAGTTTGAAACAAG 
HuCLOCK FS Human CLOCK Exon5 FS Primer - genotyping TCTTGTTTAGCATGATGTGTTC 
HuCLOCK R3 Human CLOCK Exon5 R3 Primer - genotyping CAGTTTCTGTTTAAGCAAAGCA 
HuCLOCK RS Human CLOCK Exon5 RS Primer - genotyping TCTAAGTTCTTCCACCTTGCT 
HuBMAL1 F1 Human BMAL1 Exon5 F1 Primer - genotyping TCCAGATCATCCAATGGCAGA 
HuBMAL1 F2 Human BMAL1 Exon5 F2 Primer - genotyping TCTCCACCACTTTTGAGAGCT 
HuBMAL1 R1 Human BMAL1 Exon5 R1 Primer - genotyping AGAGGAAGACATGCCCCAAA 
HuBMAL1 F3 Human BMAL1 Exon5 F3 Primer - genotyping CTTTCCATTCTATCACATGCCTG 
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HuBMAL1 FS Human BMAL1 Exon5 FS Primer - genotyping GGGGTGTGAGAGATGCATTAG 
HuBMAL1 R3 Human BMAL1 Exon5 R3 Primer - genotyping  AAGGCTCCTTCTTGCTTACAA 
HuBMAL1 RS Human BMAL1 Exon5 RS Primer - genotyping TGTCGCCACCTAGAGTTGG 
HuNPAS2 F1 Human NPAS2 Exon2 F1 Primer - genotyping AGACCAAAATGACAACAACCTGA 
HuNPAS2 R1 Human NPAS2 Exon2 R1 Primer - genotyping AGAGTGAAAGCCAGCGAGAT 
HuNPAS2 R2 Human NPAS2 Exon2 R2 Primer - genotyping AAAACCCAGACCACTCAGCC 
BRD2 AF1 Human BRD2 Exon2 AF1 Primer - genotyping GGTTATGCTGGACCGGGC 
BRD2 AF2 Human BRD2 Exon2 AF2 Primer - genotyping GAGGCCACCCGGACTTTCCG 
BRD2 AR1 Human BRD2 Exon2 AR1 Primer - genotyping CCGCTCAGTACTCCCAACA 
BRD2 AR2 Human BRD2 Exon2 AR2 Primer - genotyping AGTACTCCCAACACGGCGCC 
BRD2 AF3 Human BRD2 Exon2 AF3 Primer - genotyping GAGAGGCCCCAAAGAGACTG 
BRD2 AR3 Human BRD2 Exon2 AR3 Primer - genotyping AAAACCGTCGCTCAATTCCC 
BRD2 BF1 Human BRD2 Exon4 BF1 Primer - genotyping TCGGTAGTCTCCCTATAAGCA 
BRD2 BF2 Human BRD2 Exon4 BF2 Primer - genotyping AATTGGGGCCGCAGTTTAAG 
BRD2 BR1 Human BRD2 Exon4 BR1 Primer - genotyping ACTGTTTCTCCCCACCTACT 
BRD2 BR2 Human BRD2 Exon4 BR2 Primer - genotyping AGAGCTCTGAAGTCACATCACT 
BRD3 F1 Human BRD3 Exon2 F1 Primer - genotyping GCTTTCTCAGGGAGCGTAGA 
BRD3 F2 Human BRD3 Exon2 F2 Primer - genotyping CTCCAAGCCGCTGCTGTGAC 
BRD3 R1 Human BRD3 Exon2 R1 Primer - genotyping GCTTGCTGGGGTTGGAGA 
BRD3 R2 Human BRD3 Exon2 R2 Primer - genotyping GTTTCCAGAGCGTCTTCACC 
BRD3 F3 Human BRD3 Exon2 F3 Primer - genotyping CTTTCCCGACAGCCTCTCA 
BRD3 FS Human BRD3 Exon2 FS Primer - genotyping GACTGGCCTTCCTCTCTGTT 
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BRD3 R3 Human BRD3 Exon2 R3 Primer - genotyping CAAATTCCCAAGGCCAGAGG 
BRD3 RS Human BRD3 Exon2 RS Primer - genotyping AGAACGTGGCTCTTGGGG 
BRD4 F1 Human BRD4 Exon2 F1 Primer - genotyping GGACTTGTCATTCTGAGCGG 
BRD4 F2 Human BRD4 Exon2 F2 Primer - genotyping TGCTGACTGATATCTCACGGG 
BRD4 R1 Human BRD4 Exon2 R1 Primer - genotyping GGAAGTTTCTAGTCCATCCCC 
BRD4 R2 Human BRD4 Exon2 R2 Primer - genotyping CCTGGGCCTGTGTTGTAGA 
BRD4 F3 Human BRD4 Exon2 F3 Primer - genotyping TTCAGTCAAAGCATGGGGTG 
BRD4 FS Human BRD4 Exon2 FS Primer - genotyping CAACTTGGCTAGCTACCGC 
BRD4 R3 Human BRD4 Exon2 R3 Primer - genotyping CCCTGCCCACACTACTCAC 
Cre F1 Cre F1 Primer - genotyping GCGGTCTGGCAGTAAAAACTATC 
Cre R1 Cre R1 Primer - genotyping GTGAAACAGCATTGCTGTCACTT 
Cre F2 Cre F2 Primer - genotyping GCATTACCGGTCGATGCAACGAGTGATGAG 
Cre R2 Cre R2 Primer - genotyping GAGTGAACGAACCTGGTCGAAATCAGTGCG 
Cre F3 Cre F3 Primer - genotyping CGGTCGATGCAACGAGTGATGAGG 
Cre R3 Cre R3 Primer - genotyping CCAGAGACGGAAATCCATCGCTCG 
NPAS2 LoxP 5'F NPAS2 LoxP site 5'F Primer - genotyping TGGCCAAAGTCTAGCAAAA 
NPAS2 LoxP 5'R NPAS2 LoxP site 5'R Primer - genotyping GGAACACACAAGGCACAGGTTA 
NPAS2 LoxP 3’R NPAS2 LoxP site 3’R Primer - genotyping GGATGAGTTCCAGGGGATTATG 
qPCR PER1 F Mouse PER1 F Primer - qPCR TCGAAACCAGGACACCTTCTCT 
qPCR PER1 R Mouse PER1 R Primer - qPCR GGGCACCCCGAAACACA 
qPCR PER2 F Mouse PER2 F Primer - qPCR  GCTCGCCATCCACAAGAAG 
qPCR PER2 R Mouse PER2 R Primer - qPCR GCGGAATCGAATGGGAGAATA 
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qPCR CLOCK F Mouse CLOCK F Primer - qPCR CGGCGAGAACTTGGCATT  
qPCR CLOCK R Mouse CLOCK R Primer - qPCR AGGAGTTGGGCTGTGATCA 
qPCR BMAL1 F Mouse BMAL1 F Primer - qPCR TGACCCTCATGGAAGGTTAGAA 
qPCR BMAL1 R Mouse BMAL1 R Primer - qPCR GGACATTGCATTGCATGTTGG 
qPCR CRY1 F Mouse CRY1 F Primer - qPCR ATCGTGCGCATTTCACATAC 
qPCR CRY1 R Mouse CRY1 R Primer - qPCR TCCGCCATTGAGTTCTATGAT 
qPCR CRY2 F Mouse CRY2 F Primer - qPCR CCATTATGAAGATGGCCAAGGA 
qPCR CRY2 R Mouse CRY2 R Primer - qPCR CTGCCCATTCAGTTCGATGATT 
qPCR REV-ERBα F Mouse REV-ERBα F Primer - qPCR TGGCATGGTGCTACTGTGTAAGG 
qPCR REV-ERBα R Mouse REV-ERBα R Primer - qPCR ATATTCTGTTGGATGCTCCGGCG 
qPCR REV-ERBβ F Mouse REV-ERBβ F Primer - qPCR GGAGTTCATGCTTGTGAAGGCTGT 
qPCR REV-ERBβ R Mouse REV-ERBβ R Primer - qPCR CAGACACTTCTTAAAGCGGCACTG 
 
Table A.2: Vectors and plasmids 





pSpCas9n(BB)-2A-GFP (PX461) N/A N/A Ampicillin 
A gift from Feng Zhang 
(Addgene plasmid #48140) 
PX461-Mus musculus CLOCK sgRNA A MuCLOCK sgRNA A BbsI (BpiI) Ampicillin Mitchell Masterson 
PX461-Mus musculus CLOCK sgRNA B MuCLOCK sgRNA B BbsI (BpiI) Ampicillin Mitchell Masterson 
PX461-Homo sapiens CLOCK sgRNA A HuCLOCK sgRNA A BbsI (BpiI) Ampicillin Mitchell Masterson 
PX461-Homo sapiens CLOCK sgRNA B HuCLOCK sgRNA B BbsI (BpiI) Ampicillin Mitchell Masterson 
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PX461-Homo sapiens BMAL1 sgRNA A HuBMAL1 sgRNA A BbsI (BpiI) Ampicillin Mitchell Masterson 
PX461-Homo sapiens BMAL1 sgRNA B HuBMAL1 sgRNA B BbsI (BpiI) Ampicillin Mitchell Masterson 
PX461-Homo sapiens NPAS2 sgRNA A HuNPAS2 sgRNA A BbsI (BpiI) Ampicillin Mitchell Masterson 
PX461-Homo sapiens NPAS2 sgRNA B HuNPAS2 sgRNA B BbsI (BpiI) Ampicillin Mitchell Masterson 
PX461-Mus musculus NPAS2 sgRNA A MuNPAS2 sgRNA A BbsI (BpiI) Ampicillin Mitchell Masterson 
PX461-Mus musculus NPAS2 sgRNA B MuNPAS2 sgRNA B BbsI (BpiI) Ampicillin Mitchell Masterson 
pGL[hPer2P/Luc2P/Neo] Per 2 promotor SacI/HindIII 
Ampicillin / 
Neomycin 
A gift from Mingzhu Fang 
(Fang et al., 2017) 
PX461-Homo sapiens BRD2 sgRNA A BRD2 sgRNA C BbsI (BpiI) Ampicillin Mitchell Masterson 
PX461-Homo sapiens BRD2 sgRNA B BRD2 sgRNA D BbsI (BpiI) Ampicillin Mitchell Masterson 
PX461-Homo sapiens BRD2 sgRNA C BRD2 sgRNA E BbsI (BpiI) Ampicillin Mitchell Masterson 
PX461-Homo sapiens BRD2 sgRNA D BRD2 sgRNA F BbsI (BpiI) Ampicillin Mitchell Masterson 
PX461-Homo sapiens BRD3 sgRNA A BRD3 sgRNA A BbsI (BpiI) Ampicillin Mitchell Masterson 
PX461-Homo sapiens BRD3 sgRNA B BRD3 sgRNA B BbsI (BpiI) Ampicillin Mitchell Masterson 
PX461-Homo sapiens BRD4 sgRNA A BRD4 sgRNA A BbsI (BpiI) Ampicillin Mitchell Masterson 
PX461-Homo sapiens BRD4 sgRNA B BRD4 sgRNA B BbsI (BpiI) Ampicillin Mitchell Masterson 
 
 




Figure A.13:  Map of the PX461 Cas9n vector 
The BbsI double restriction site where the guides are inserted is just prior to the blue marked gRNA scaffold after the U6 promotor.  




Figure A.14:  Map of the pGL[hPer2P/Luc2P/Neo] plasmid 
Image taken from Fang et al.  (2017). Important regions are the human PER2 promotor region (hPER2P) upstream of the dLuc gene (luc2P),  
the neomycin resistance gene (Neor) for selection in the mammalian cultured cells and the ampicillin resistance gene (Amp r) for selection 
in bacterial cell  culture for cloning.  
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A.7 Target genes of BMAL1, CLOCK and NPAS2 
identified by ChIP-seq 
Unique and overlapping target genes of BMAL1, CLOCK and NPAS2, gene lists behind Figure 
3.1. Based on ChIP-seq data from Koike et al. (2012) organised by use of Venny software 
(Oliveros, 2007). 
 
NPAS2: BC067010, Zyg11a, Aox3, Slc20a2, Sh3bp5l, Ppox, BC054353, AK202580, 
AK133333, Npsr1, 9230115E21Rik, Polr3b, Gm10451, Trpc7, Spatc1, Usp49, Syvn1, Rnls, 
Refbp2, Lcn12, Mybl2, AK076665, Cldn11, Pgrmc2, Ubxn2b, AK050144, AK142614, 
D4Bwg0951e, Faah, D4Ertd22e, Kif1b, Fam20c, Nxph1, Chchd3, AK215237, D6Ertd474e, 
Prr24, Opa3, Gsk3a, Plekhf1, Polr3e, Slc5a11, Mfhas1, Gm10649, Lipc, BC048403, 
2310004N24Rik, Serpina3k, Larp4b, Cmah, Gcm2, Bmp1, AK084954, Fgd4, AK015664, 
Ptprm, Il17b, Pkd2l1, Lgsn, Hibch, Cflar, Pdcd1, AK147021, Nr6a1, Abcb11, Trim69, Gss, 
Lbp, Pigt, Slc9a8, Trim55, AK076759, Grhpr, Alad, Orm1, Tle1, Btf3l4, AK148461, Rnf11, 
Luzp1, Arhgef19, Pex10, Ept1, Tfip11, P2rx7, Zkscan1, Kdelr2, BC044870, Gngt1, Cml5, 
Atp2b2, Anubl1, AK143902, AK156678, Zfp444, Mctp2, E230029C05Rik, Mrps31, 
BC035532, DQ704652, Gfod2, Smpd3, Dpep1, Agt, Ttc36, Med23, Ifi47, Zfp692-ps, Spag7, 
Abcc3, Fbxo47, Brca1, Baiap2, AK020496, AB349192, AK015341, C230035I16Rik, 
Hist1h4h, AK144747, Papd4, Bhmt2, Gcnt4, Itga1, Ints9, AK015937, C1qtnf3, Cyp2d40, 
Trmu, AK019614, Serpind1, Acat3, Fam120b, Chd1, Zfp40, BC003965, LOC100415784, 
Wac, Gata6, Mir1948, Apbb3, Zfp608, Grpel2, Zfp236, BC021614, 2010003K11Rik, 
AK048878, 9130011E15Rik, Apool, Gm7157, Rs1 
CLOCK: Cyld, Cdk5, AK040640, Cldn3, Espl1, C80913, Yap1, Rufy3, Cd9, Txn2, 
Ndufb3, Mrpl34, Ndufv1, AK054442, Ttll5, Klhl20, Ubxn1, Ogfod2, BC033430, Gldn, 
Slc33a1, Ethe1, AK005539, Rev1, Gtpbp1, Rpl3, Nenf, C85492, Gm10094, Pno1, AK037512, 
Alkbh7, AK020619, Zbtb7b, Pias1, AK017586, Agfg2, Papln, Rd3, 4933434E20Rik, Ergic3, 
Lpcat2b, Wdr45l, Vnn3, Proc, Atf6, Eif4ebp1, Blk, Tead4, Acp6, Spns1, Cxadr, Vaultrc5, 
Ptges, Radil, Ttc33, AK027935, DQ707749, AK050069, Gypc, Ppp4r2, Prtg, Slc22a6, Iars, 
Gtpbp4, Prss22, Grb10, AK146888, AK043285, C3, Mir721, Slc44a1, Skp2, Scd1, Lgr4, 
Pyroxd1, Cutc, Gsta4, AK149260, Crp, Uqcc, Evi5, Hmgcl, Slc26a11, Myoc, Il1rn, Alx4, 
Grem1, Kin, Nfam1, Erp44, Lrrn4, Zfp788, Coq6, Ints4, Apoa2, Dusp5, Taf6l, 
2410001C21Rik, Snx32, Diap3, Erlin1, Nop14, Plcz1, U09772, Gm826, Rfesd, Mep1b, 
Apobec1, AK158157, Kif13a, Polr3gl, Slc39a9, Mustn1, Ift140, H2-K2, Pacsin2, Pigr, Immt, 
Cdk17, Lpin2, Eri2, Rpap3, Skiv2l2, Prph, Fam78a, Tfrc, Chek2, Sp4, Rnf5, Slc17a1, Txnl4b, 
Ube2l6, Fabp5, AK133167, AK144274, Nfyc, Arhgap21, AK039014, Serpina12, 
1810031K17Rik, AK078979, Fbxw11, Rab18, 9930013L23Rik, Tspan15, Il12a, AK036551, 
C8b, Mir592, E2f7, Lrfn3, Stt3a, Atp6v0e, H2-Q10, Zcchc7, C2cd4a, Gm6792, Fam108c, 
Rhbdf2, Mrpl37, Acacb, Ldhd, Nudt2, Pecr, Myh14, 8430410K20Rik, 1700009P17Rik, 
B3galnt1, Cd1d1, Rnf186, Lins, Chid1, Morc2a, Mycn, Ankrd33b, Hnrnpul2, AK090268, 
Mpp4, 5830433M19Rik, Tbc1d2b, Pion, Zfp354b, Akr1b7, Themis, AK147070, Anp32b, 
Arhgap24, AK143758, AK043365, Cldn5, Rps2, Srsf7, Fam154a, Bag3, Acly, Gtf2f2, Wdr91, 
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Ablim3, Tlk1, 1700034H15Rik, Bahd1, Qprt, Mphosph6, Adamts7, Pole4, Gsta2, Gm16515, 
Tmem102, Ccdc43, Dsg2, N4bp2l1, Slc24a1, P4ha1, Atg2b, Morn4, Kcnq1ot1, Cnot1, 
AK085480, 1600002K03Rik, AK028549, Tat, Tsta3, Haus6, Morn3, Colec12, Tmem186, 
AK036616, Mir3065, Med18, Tmem150a, AK133650, Nrap, Mcart1, Chrna2, Ehbp1, Stom, 
Fxyd1, 2410006H16Rik, AK007214, Pi4k2a, Vcpip1, Stau1, BC029726, Umod, Slco2a1, 
Grsf1, Grm2, Ubxn11, Igf2bp3, Dera, Pcm1, AK035573, AK145139, Scp2, 1300017J02Rik, 
Rfk, Tmem185b, Commd9, AK076716, Taf2, Mir33, Srsf1, AK040684, Dnaja2, Sp2, 
4930579G24Rik, 4933406I18Rik, DQ564716, AK083606, Rps6kb1, Mir346, Copz1, 
Gm7550, Bambi, 2900060B14Rik, Pamr1, Alg6, Hps4, Cdkn2aip, Trim71, Zfp354c, Prrx1, 
9130409I23Rik, AK040173, Creld1, Qpctl, Gtf2a2, Ifi27l2b, Puf60, Olfr1423, Kif6, Gpr153, 
Golga7, Tmem107, Cgrrf1, Kng2, Necab1, Pnpla1, AK188812, Inadl, Fam151a, Cyp2b10, 
Ogt, Mir375, Spon2, Lphn3, C330005M16Rik, Hmox1, BC005537, Ccdc90a, Sall3, Fam107b, 
Cdk9, AK008166, Vgf, Mast3, Lrig3, Calml3, Med10, Pxt1, Capn10, Gclc, Ppm1l, Cep57, 
Dnaja3, Nfkbia, Ift57, Cdh26, Selenbp1, Ccin, Pax4, Tmem209, Hes7, Hexim2, Ifngr2, 
C030016D13Rik, Raly, Zc3hav1, C1ra, 2310033P09Rik, Wfikkn2, Timm9, Rgs6, Cdh6, 
Mir193b, AK029591, Veph1, Usp1, AK076709, Lig3, Myt1l, Med17, BC004004, Gabarapl1, 
Rock2, Taf4a, Ube2u, Ptch2, Tpk1, Hrg, Hdlbp, Fmn2, AK006766, Myl10, Anxa4, 
8430419L09Rik, Chd2, Ifitm2, Wdr18, AK041537, Dscam, AK208354, Rhod, Cep350, 
5730590G19Rik, Leap2, A230051G13Rik, DQ703913, Cd96, Fen1, Ubap2, Usp24, Gatc, 
AK006167, Hmg20b, AA987161, Kctd9, Rap2a, Mtm1, Tgs1, Sh3bp4, Smpdl3a, Dpys, 
AK011877, Shroom3, Tcerg1l, Nudcd3, Rnu12, Wnt8b, Txndc9, Csf1, Ank1, Cybrd1, 
Tuba3b, Med21, Wdr72, AK089981, Dcn, AK047676, Fam181a, BC068229, Rsph9, 
Tmem146, Kcnh6, Hk2, Pde4a, Tcam1, Prodh, Slc26a6, Fcho2, Atp5g2, AK192544, Nfatc3, 
Cx3cr1, Cirbp, Dnahc6, Hp1bp3, Ccdc126, Clip1, Terf2, AK077428, Sep-10, Mycl1, 
AK018911, Hpcal1, Olfr655, Dctn6, 1700071K01Rik, Mtrf1, DQ686437, Prdx3, 
2810008D09Rik, Unc45a, Rabep1, Greb1, Bicd2, Mrps6, Pkig, AK037419, Mphosph10, 
Smg7, Angel2, Acot11, Fbrsl1, Lnx2, Myst3, Tagln, Zfp521, Wwp2, Ky, Fez2, Hist4h4, 
Slc25a19, 3110001I22Rik, Zfp35, Efcab4b, BC019943, Fam73b, AK215842, Ahctf1, 
Tmem63a, Setmar, Sult2a6, Asf1b, Cpn2, Fndc3a, Ado, Abp1, Apoc1, Maff, Ppp1r10, Mir30a, 
Gpatch1, AK019722, Ifi35, Golt1a, Gpr37l1, Rgl1, Gnb2l1, Trp53, Erc2, AK132729, Zfp760, 
Atp5c1, Cog8, Ppil1, Zfp39, AK028012, 1700016K19Rik, Sntn, Poc1b, Phf20, Sik3, Robo1, 
1700034H14Rik, 5031425F14Rik, Epha7, 2610528J11Rik, AK087942, Plxna1, AK005115, 
Ptk2b, Cxcl13, Acer3, Ell2, Arl16, Hrk, Fam149b, Adam30, Tomm6, A730017L22Rik,  
BMAL1: Etfa, Hnrnph3, Nr2f2, Lss, A930001N09Rik, Vkorc1, Arrb2, Tdo2, 
D2Wsu81e, Mir1931, Mknk1, BC048393, Mapk8, Ninj1, Ccne1, Pgm2l1, Abcf1, 
2310016C08Rik, Xpot, Usp3, Acbd3, Ccne2, Trappc10, Macrod1, Eif5a2, Hspb8, Rnf19b, 
Rps6ka5, Clcn2, Ppfibp2, Pa2g4, AK086741, Aimp2, C230081A13Rik, AK017040, Stk40, 
Tlcd1, Ndel1, Ntpcr, Top1mt, Aph1c, Mafk, Parp1, AK019691, Galt, Hspbap1, Wdr89, 
Hnrnpf, Pex14, AK031221, Ptpn3, Srp14, Phf19, Ttc25, Triobp, Hexa, AK133925, Vps13a, 
Mir1943, BC024139, Chsy3, Ptplad1, AK053084, Tcfap4, Mtrr, Mir499, Slc30a1, Cpm, 
Lsm4, Ptprs, Ncl, Lcorl, Usp28, Nab2, AK144265, Pola2, Unc5b, Psmg3, Pepd, Kremen1, 
Ccnh, Rcbtb1, Btbd3, Mpped1, Fbxo15, BC050972, Fads6, Gm15348, Ccdc33, Edn3, Cbara1, 
DQ568657, Chchd8, Mccc2, Mbp, BC082591, Lactb2, F930015N05Rik, Polr2j, AK039686, 
Dhx29, AK052590, Znhit6, Agpat6, Irs1, AK030052, Tcfap2c, Mar-08, Fam26f, Mlec, Dact3, 
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Chst14, Pde9a, Acaca, Glul, Dnajc1, Naa30, Lrig1, Zbed4, Srsf11, AK005363, Bop1, Xylb, 
Acyp1, Dcp2, Fam164c, D17Wsu92e, Sigmar1, Elovl1, Nars2, Comtd1, Rassf5, 
4933400F21Rik, Clcn4-2, Acads, Elovl3, Naaa, Adamts1, 2810407C02Rik, Irgm1, Mirlet7c-
2, Zmym6, Stk24, Tanc2, Zfyve21, Nrtn, Pmf1, AK019366, Phf1, Zyx, Lipt1, Paqr3, Cdh15, 
Pcbd1, Bcl2l11, Hnrnpul1, Gpr137, Fzr1, Pih1d1, Smyd3, 1700029J11Rik, Polr3g, Rad51l1, 
Got1, AK006413, Pou2f1, Ccno, Rmrp, BC031361, Zfp623, Jazf1, Rps17, Ormdl3, Ptges2, 
Foxred2, Fam113b, Snhg10, Pus7l, Apitd1, Mgst1, 6030446N20Rik, Cd300lg, Dhps, Nudt6, 
BC048644, Rpl13a, Pfn1, Gm6772, Eprs, Rybp, Ccdc134, Cyp46a1, Mir30d, Sec11a, Lsm1, 
Tnfsf14, Cntd1, Pla1a, Lmx1a, Per3, Cops7a, Stub1, Nbas, Fbl, BC068281, Slc39a8, Egfr, 
Ptp4a2, Gpsm2, Mthfd1l, Camta1, Acat1, Cml2, Bckdha, Gtf2b, 2010305A19Rik, Rreb1, 
AK019719, Efna3, Ubtf, Zcchc24, Ubl3, Abca3, Lmf1, Cldn14, Nt5c3, Pvr, D15Ertd621e, 
Kctd3, Nop10, AK043303, Slc27a1, Stag1, Rsph1, Kctd13, Slc37a1, AK012595, Scara5, 
Setd1b, Adrbk2, AK085371, Kidins220, 4930583K01Rik, Btbd9, Spnb3, Gm5544, Atl3, Tle6, 
Nat15, Xpo4, Tmub1, Erap1, Il6ra, Prcp, AK090150, Naglu, Ddx31, Supt4h1, Hmgb1, Sep-
09, Vldlr, Dlc1, Bri3bp, Xkr9, Fam45a, Eif2c3, 1700018L24Rik, Irf8, Rhobtb2, Ntan1, 
4930471G03Rik, Laptm4a, C1qtnf6, Vwce, Idua, Rmnd5a, Rps6kc1, Fgl1, Dsc2, 
4930592I03Rik, Park7, D10Jhu81e, 1810063B07Rik, Rap1b, Amz2, Spata24, AK146979, 
Rbm38, Parp2, Foxk2, Rrn3, Hspe1, Pfkfb2, Tapt1, AK043804, Heatr3, AK144055, Tbc1d7, 
Pdlim1, Myo19, Tmem144, Bfsp1, Dennd4a, Hinfp, Nme4, Gatsl3, Pitx3, Tcerg1, BC029722, 
Acp5, Arhgap26, Cul3, Rbp7, Tnfrsf25, AK007460, Atxn3, Dyrk3, Vps37d, Mapkapk3, 
AK040873, AK053246, AK087382, Mex3d, Golga5, Gstm6, Zmat3, Ccdc21, Cks2, Slmap, 
Dusp4, BC038648, Asb4, Rnaseh2b, 2010107G12Rik, Plxnb1, Aen, Wipi2, Csrp2, Nek7, 
AK156148, Gstt1, Mina, Mospd4, 4930523C07Rik, Atf3, Gm10684, Mpp7, Cbwd1, Bend3, 
Mfsd10, Upb1, AI428936, Klhl29, Bbs7, Acadm, Spsb1, Ppm1k, Spg21, 1700012B15Rik, 
Mir3092, Maz, Wnt4, Nnt, Clcn6, Crkl, 4833442J19Rik, AK133793, Osbpl8, Ptrh1, Immp2l, 
Fam50b, Sox12, AY512912, Dfna5, Mir23a, 2310035K24Rik, Atp6v1h, Il12rb1, Glo1, Ift172, 
Rad51c, Abcc4, Mrpl54, AK085274, Rnd3, AK014798, Atp6v1g1, Prkaca, Csda, Rdh13, 
Mesp1, Mir17, Birc6, Lrrc8d, Sema4b, Smoc1, 4933427E11Rik, AK087736, Slc35c2, Kcns2, 
Lmna, Slc25a47, Gm16062, En1, Abcb4, Pde8a, AK165776, Paxip1, Prkaa1, Gpd1, 
BC057079, AK169507, Cstf1, Krtcap2, Nbeal2, Fam185a, Ahcyl2, Sos1, C1qtnf1, Rere, 
Gpr155, 2210015D19Rik, Taf4b, A630072M18Rik, AK145464, Trim29, Frat2, Armc8, 
Tmem104, Slc26a2, Ccnl1, 3110070M22Rik, Zhx2, Gamt, Gpx4, AI314180, Aim1l, Akt2, 
Kdm5b, Zfp639, Ppp3ca, Hgfac, Opn1sw, 2610035D17Rik, Ncoa4, BC029214, Cyp2j6, 
Kank2, 4933433P14Rik, Chst2, Gm7854, Snx1, 0610012H03Rik, B3gnt3, Get4, Impact, 
Prex2, BC055402, Gtf2a1, Clcc1, Akr1a4, Uspl1, Rassf7, Dot1l, Scarf2, C4b, AK041972, 
Stx4a, Mir1942, Fastkd3, Erf, Atg4c, AK017924, AI316807, Cpsf4l, Pdzd8, Itgal, Cyp2a5, 
Pgm1, Fam105b, Tnfrsf14, Fut10, Rnft2, Rab3il1, Fbxo9, Mettl14, Nol6, Snhg12, Copg, 
Myh9, Serac1, AK141725, AK017409, Depdc7, Shox2, Cyp3a11, Trim8, Ces1d, Plbd1, 
Isoc2b, Ccdc12, Stmn1, Cdx4, Ntrk2, Tmem37, Acvr1, Zc3h8, Plk3, Ung, Zfp958, Dhdds, 
2810004N23Rik, AK131895, Arhgef37, Srsf4, Gm12597, Mpa2l, Cobl, Ddx50, AK043964, 
Nuak2, Rasgef1b, Gpr98, Sh3bgrl2, Syne2, Afg3l2, Opn3, AK085768, Nceh1, Tceb3, Wdr62, 
Casp14, Opn4, AK080350, Matr3, Mcoln1, Nkx6-2, Vtn, Srcin1, Trim37, Galk1, Fam69b, 
Ces2a, Dll1, Tmem184a, Prok2, Slc30a9, Ube2t, Grik4, Etnk1, Xpo1, Akap10, AK138421, 
AK011498, AK146230, Cct8, Bad, 4930473A06Rik, Acvr2b, Akap12, Styx, Idh1, 
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2810006K23Rik, Gabarapl2, Coro6, Habp2, Utp14a, Gpr150, Snap29, St8sia1, Cyb5r3, 
Slc29a2, Mir128-2, Xirp1, Iqgap2, Ywhaz, AK036422, Fosb, Kdsr, Zc3h4, Zc3h18, Agtrap, 
Pcyt2, Eny2, 2500003M10Rik, 3110082I17Rik, Eif3b, Pla2g15, Smagp, Mtl5, Syf2, Spen, 
Naa25, Mtg1, Spcs3, Kcnk16, Dopey2, Ldb1, AK079280, 5031439G07Rik, Cyp2e1, Rnf14, 
Vstm2l, Kdm2b, Tulp4, AK039373, Capn1, Pitrm1, Cycs, Smad1, Trhde, AK154275, 
B4galnt4, Ppm1b, Tprkb, Zfp239, Omp, Dcun1d3, Glrx3, Cd164, AK145334, 
2010109K11Rik, Tcra, Scaf4, Vmn2r93, BC021953, Ispd, Vps13d, Prodh2, Polr3h, Mir2861, 
Etaa1, Aspscr1, Tifa, AK076685, Midn, Gabarap, Yars, Tacc1, Ankrd56, Zfp362, Baz1a, 
AK009785, Phyhd1, Zbtb43, H2afj, Cux1, 1810043G02Rik, Rab34, BC057022, Tab2, Cndp2, 
Ccng2, 1810029B16Rik, Vamp1, Nip7, Rnf141, Car8, Rtp4, Tuba1c, AK039577, Mir720, 
Rwdd4a, Prss48, Galnt10, D17Wsu104e, Thada, Sox7, Pold3, Polm, Fzd8, Zzz3, Col25a1, 
Tie1, Srp72, BC042727, Klf10, DQ714940, Gm2058, Cyb5b, Cep57l1, Kifc1, Pprc1, 
Gm3646, Pla2g2c, E2f8, Rab11a, AK085428, Spice1, Sgol1, Cxcr4, Prrc2b, Ube3c, Fosl2, 
AK015545, Fbln2, Bax, 4932414J04Rik, Atp5g1, Pygl, Pigp, Brd2, Rbm4b, Plekhg1, Bach2, 
Jag1, 1700057K13Rik, Dtx4, Fam159a, Ndufa4l2, Tmem64, 4930555I21Rik, Stk35, Mbtd1, 
Lgals8, DQ693081, Nup153, Adsl, Hiat1, Tgm1, AK035687, Trim47, Hat1, Msx1, Fam173b, 
Zadh2, Nup93, Nme6, AK046786, Tmem86b, Tpst2, Hus1, Pbx4, Plekha7, AK048595, 
Fam102a, Prrg4, Dhrs3, 1810013D10Rik, Cnbp, Nup210, Insc, AK006239, D16Ertd472e, 
Hps1, 2700078E11Rik, Dusp10, Hdc, Far2, Pnpla2, 4931428F04Rik, Fam54a, Rnd2, Sdc1, 
Cetn3, Grid1, Socs5, Asb13, Mir684-1, Tmem177, Mfsd4, Acss2, Ece2, Peo1, Osm, Hlcs, 
Nr2f6, Aldh3b1, Dst, Set, Mir3109, Eif2b5, Uhrf1, Wdr36, BC100494, AK020061, Mt1, 
Fnip1, Otof, Msx1as, Lin54, AK036547, Nnmt, Wdr61, Ccdc109a, 1300014I06Rik, S100a10, 
Spcs2, Cenpn, Socs7, Pnldc1, Arhgap32, Bcl10, Emx1, Olfm2, Ublcp1, Baalc, Prr5, 
AK085609, Bloc1s1, Fbxo33, Fam134b, Cdk18, Oxt, Tgm2, Snapin, Tmem55a, AK007223, 
Sh2d6, Isy1, Ctdsp2, Nme2, Bik, Igsf11, Thoc1, Fhod3, 4921504E06Rik, Ctcfl, Pklr, Lsm10, 
Ccar1, 2310003H01Rik, Calm1, Dock5, Acap2, AK133038, AK033147, 1810009A15Rik, 
Psmg4, Cdk5r1, Mthfd2, Csk, Zfhx3, Peli2, Hn1l, Cd160, Heatr2, AK050516, Adamts4, 
4833439L19Rik, E030010A14Rik, Fas, Jph1, Klf7, SH3d19, Letm2, AK007545, Iqch, 
Ctnna1, Map2k5, AK033049, Grin3b, Fam108a, Akap11, Fgf21, AK144388, AW549877, 
AK047030, Gm1661, Maml2, E130317F20Rik, Kif1c, Rps6ka4, Ino80d, Apcs, AK144798, 
Eya3, Nudt9, Hscb, Eln, Hspb1, Mgll, Nfrkb, Pde7b, Mon2, Mmd, Lasp1, Pcnx, Tmem171, 
Cenpj, Dis3, Yaf2, 9430023L20Rik, Rxrb, Lhfpl1, Shroom2, Auh, Vps26a, Kl, 
2700060E02Rik, Mir1962, Adam19, AK141540, Cyp2c55, Lnx1, Aldh1l2, AK039053, Nrn1, 
Atp6v1e2, Mbl2, Hsp90aa1, Igfn1, Chadl, Slc19a2, AK016837, Papd7, AK085943, Dapp1, 
1810046K07Rik, Oit3, Tmpo, Uqcr10, Gpld1, Gart, Mfsd6, Xkr8, Pdk4, Mir139, 
1110004F10Rik, Egln1, Apon, Erbb3, B3galnt2, Tert, Rnf19a, Litaf, Klhl24, Olfm1, 
AK139864, 2010000I03Rik, Rbm19, Ppp2cb, Dnm2, Glyctk, Polr3k, Fubp1, Lingo2, 
2610002J02Rik, 4831440E17Rik, AK016046, AK131759, D10920, Mars2, Zfp664, Galc, 
Tubb2a, Cul4a, Capn7, Tmc6, Ssr1, Wdr43, Ydjc, Robo3, Rheb, Eif2b4, Snai3, Sep-07, 
AK078931, Metrnl, Zfp277, Ankrd46, Syp, Ing5, Snora65, 0610011L14Rik, Sepsecs, Plcxd1, 
Smurf1, Pvrl2, Fsd2, AK154190, Ddx6, Snrpf, Fn3k, Lrrc9, Slc25a48, Mast4, Hnrnpa1, 
Gpr156, Mir99a, Plod3, Ccl2, AK012387, Prr3, Arhgef18, Celf1, C030039L03Rik, 
AK041339, Serpina1e, Hnrnpa0, Prpf19, AK018156, Barx2, Ankrd9, BC030050, Rela, Negr1, 
Id3, AK042124, Serpina1b, Ptch1, Tdh, Pop1, Zfp791, Fpgs, Pafah2, Fbxo8, Serpina9, Cd46, 
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2010016I18Rik, Faf1, AK079675, Polr1a, Lpar2, Herpud2, Msra, AK009639, Mmadhc, 
Cept1, AK005641, Hdhd3, Zc3h12a, Rab42-ps, AK006202, Usp12, Ctsc, Sox6, Zbtb2, Bbs10, 
Pex12, Rptor, 1110057K04Rik, Cd83, Tnfrsf19, Ebpl, Mapk14, Rdbp, AB350970, Hirip3, Dct, 
Pabpc2, Cebpe, Dtd1, Gm11968, Stk32a, Top2b, Kif14, AK046134, Rpl41, Idi1, Uba6, Gsr, 
Slc12a4, AK006037, Slc25a29, D0H4S114, Skor2, Spred1, BC062821, Lyl1, Atm, Nrbf2, 
LOC100045653, Pld6, 5430411K18Rik, Kalrn, Utp18, Nid2, Snai1, Mycbp, Rtp3, Jmjd6, 
Prkcd, Ppfia4, Vamp4, Hnf4a, Ctbs, Gm12633, BC063263, Bet1l, Stt3b, Smarcd2, Tomm20l, 
AB352963, Chkb, 9930021J03Rik, BC034090, Scand3, Lrrc42, Fbln5, 5330439B14Rik, 
Cog6, AK087045, Nr4a3, AK085891, AK077358, AK144984, Dpf2, AK138296, Ralgps1, 
Pmvk, Crcp, Sepw1, Fkbp8, Ier2, Hmg20a, Slc16a10, AK015520, AK016521, Cacna1h, 
Mdc1, Cdo1, Vmn2r121, Nek2, Slc35a3, Clock, Ccdc9, Aldh3a2, Vash1, Hrh2, Hrasls, Cpox, 
AK150559, Mir698, Myo1e, Ube2cbp, AK019365, Fry, 2700089E24Rik, Fxyd3, Cpeb1, 
9530008L14Rik, Tsc22d3, Cttn, Tnfrsf26, Nprl3, Plekha1, Psd3, Ces2g, Mir1930, Zap70, 
Bzw1, Dner, Gli2, BC006779, Tcea2, Tgfa, Cadm4, Capn12, Mmp15, Jam3, Poc1a, Tgfbr2, 
Hivep2, AK007947, Sectm1a, Nup155, Pgam1, Mid1ip1, Ctrc, Impdh2, Mllt10, Sec62, Asna1, 
Tbata, Slc9a3r1, Exosc2, 2310033E01Rik, Fam83a, Wdr26, Pou2af1, AK156967, Tmem200b, 
Man2a2, Guk1, Ildr2, Ptk6, 5430416N02Rik, Opcml, Clec10a, AK021004, Plin3, Frat1, 
Fdxacb1, Adat2, Gpr182, Aarsd1, Dysf, AK017331, Arl15, Ctsz, Gm5506, Capza3, Cdyl, 
AK087806, D4Wsu53e, Zxdc, Usp5, Ttc21a, Nr4a1, Rce1, Mtx3, Stard7, Slc35a2, Mesdc2, 
Cgnl1, Tmem14a, 0610007L01Rik, Chchd2, Entpd6, Prdm14, AK084494, Atp10d, Hsf5, 
BC065997, Tnfrsf18, BC006965, Abcb1a, 1190002N15Rik, Nags, AK080657, Slc35d1, Nat8, 
AK143760, Dnhd1, Taf5l, Ndrg2, A730085E03Rik, AK217854, Plscr3, Zbtb20, Cdh1, 
Caprin1, Prpsap1, Hmgcr, Ranbp3, Tmem120a, Top1, Acadl 
NPAS2 and CLOCK: Rcbtb2, Osbpl3, Krt23, AK048886, Hnrpll, AK132836, Eif2b3, 
AK142879, Psmd1, Cr2, Usp8, Fam63a, Dpyd, Cno, Slc25a36, Mafg, Slc45a2, Gm5468, Mpz, 
Ier5l, Dnajc5b, AK045932, Tgfbr1, AK019798, Aldh2, 2810007J24Rik, ORF61, Eea1, 
Phlda1, Mettl7b, Accn1, B130006D01Rik, C030044B11Rik, Fam172a, Ndrg1, Gtf2f1, Ndst1, 
AK019053, Efcab2, Ptgds, Dido1, Prmt6, Klhl9, Rlf, Errfi1, Galntl5, AK006930, Afp, Glt1d1, 
Chn2, Ccdc61, Tomm40, Saa1, Myo7a, Sbk1, Rbpms, Enpp6, Gcdh, Nlrc5, 1810063B05Rik, 
BC018242, Tmem25, G630090E17Rik, Lrrc48, Zfyve1, Nol8, Parp4, AK014089, Rfc4, Gp5, 
Snx4, Hgd, AK083150, Hdgfrp2, Map4k3, Tmem20, Gm7102, Slc10a3, Uchl5, 
C130074G19Rik, Ints7, 9430008C03Rik, Sox2ot, Asap3, Gm13011, Zfp513, Npffr2, 
Tmem106b, Creb5, Elmod3, Cic, Gm5595, Tsku, Tpte, Aprt, Birc3, Spc24, Ostb, Fam83b, 
Pbld2, Tmem220, 1810027O10Rik, Stat3, Hexim1, Fdxr, Arl4a, Scarna13, Cdca7l, Gpx5, 
Gas1, Rarb, AK015818, Mar-06, Rab40c, Runx2, Khsrp, Kcng3, Ttr, Diap1, AK086315, 
AK016444, AK075658,  
NPAS2 and BMAL1: Hmcn1, 0610007P14Rik, Kif12, Klhdc7b, Lipa, Elk4, Cd302, 
Tspan9, Ireb2, Usp20, Ptpmt1, Tmem53, Tgfbr3, Vkorc1l1, Fabp1, Lhfpl4, Abcb10, Gopc, 
Man1a, Eif1, Serpina11, BC024659, Mrpl15, Rab14, Dio1, Pcgf3, Uroc1, AK042445, Plxnd1, 
Zbtb32, Tmem86a, Dkk3, Cars2, Cln8, Clec18a, Zc3h12c, Fbxo22, Stmn1-rs1, Chac2, Ctage5, 
Smek1, AK076979, Ror2, Habp4, Kif13b, 9030625A04Rik, Ldhal6b, Sult1c2, Tmc1, Cnnm2, 
Mobkl3, Nrp2, Dnpep, Dnajb3, Cabc1, Trp53bp2, Il1f9, Gm13498, Fign, Ambra1, Cds2, 
Nfatc2, Fgg, Slc16a1, Osgin2, Aco1, Edn2, Fndc5, Slc30a2, Pax7, Abcf2, Tmed5, Ephb4, Met, 
AK080009, Atoh8, Mat2a, Magi1, A230083G16Rik, Bbc3, Lrrk1, Rnf169, St5, Pex11c, 
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Pde4c, Ces1g, Has3, Zfp872, Dlat, Kdelc2, Sin3a, Edc3, Pkm2, Skor1, Parp16, Manf, 
Zc3h12d, 2010003K15Rik, Prep, Arid3a, Rfx4, Gas2l3, Sec14l2, Smcr8, Dhrs7b, 
1810012P15Rik, Pigw, Akap1, Grb2, Nampt, Mir681, Hist1h2bh, Ankrd55, Dock9, Mir297-
1, Ank, Trio, Rnf139, AK020235, AB099516, Acvr1b, Eif4b, Itsn1, Lnpep, Slc22a7, Rasgrp3, 
Scarna17, Tjp2, Neurl1a, Gm5098 
CLOCK and BMAL1: Cdk4, 1700021K19Rik, Ddt, Fhit, Tbc1d15, Lonp1, 
AK138667, C1rl, Lama3, Pten, Dvl2, Gse1, Gtl3, Art2b, Nlrp6, Dap, Mirlet7a-1, AI462493, 
AK029768, Nelf, Top3a, Hspg2, 5830415F09Rik, Atf6b, AK146139, Slc25a13, AK168184, 
D5Ertd579e, Dbx1, Fam101a, 1700001C19Rik, Prhoxnb, Klb, Smad6, Tmem182, AK086793, 
Phb, Mir3075, Rab44, Celsr2, Sertad1, Irf1, Tmem55b, Gm16516, Cecr2, Rbm17, Fam189b, 
AK154735, Srbd1, Tmem106a, AK154225, Zbtb40, Elavl3, Cyp2u1, AK035211, Lrrc28, 
Ubr2, Vps37a, Cdv3, Bhlhe41, Gpx1, Mrpl23, Gpr135, Chd7, E2f2, Tpra1, Ets1, Tm4sf4, Gaa, 
Alkbh5, Arhgef26, Mettl4, Limd1, Pard3, Rnf43, Adck3, Nptn, Dcaf13, Gprc5c, Tbc1d9b, 
Ino80, Rpl14, Sc4mol, Tmem212, Nr1d2, Ing2, Arrdc4, Mxd4, Fam187b, Zc3h11a, Slc23a1, 
Mllt1, P2rx4, Zfp507, Fgb, 1810010H24Rik, 5930403L14Rik, Epn1, Hagh, AK019662, Ell, 
Bdh1, Ppa1, Angptl3, Wars2, D030047H15Rik, BC044868, Amigo2, 9530091C08Rik, 
Slc35d2, Tmem174, Myom3, Olfml2a, Tbl2, D10Wsu102e, AK089375, Sdad1, Zfp69, 
Tatdn2, Bcat2, Arrdc1, Hpn, Cltc, Frmd6, Cln6, Rab3gap2, Ctla4, Ccdc37, Hspa8, 
1300001I01Rik, Polr3a, Pmch, Rnf144a, AK046304, Zfp710, Nfib, 2400001E08Rik, Kif21a, 
Gnat2, Glrx5, Ccdc86, Fbxo30, AK079018, Slc38a3, Ptprj, AK153351, Pfkfb3, Derl3, Rrp8, 
Ccbp2, 4933439F18Rik, Dclre1a, Mknk2, AK134426, Tor1aip1, Vps37b, Hsd17b2, Sumo3, 
Gpt, AK017620, Polr2i, Pard6b, Comp, AK005707, Rnf38, Pnpla7, Zbtb17, Adam2, Zfp62, 
Acaa2, Slc16a12, Cat, Tada1, Cebpa, Mvd, 1810055G02Rik, 2310047M10Rik, Prlr, Tbl1xr1, 
Cfb, AK040741, Ltbr, 0610007C21Rik, Ccdc121, Yif1b, St13, Mst1, 
OTTMUSG00000024510, Kdm4b, Alg9, Fbxo31, Ralb, Narg2, Bat1a, Slc6a6, Tsc22d2, 
Ccdc3, Bcl7a, Mrpl36, Hspa9, Lztfl1, Lrtm1, AK047558, Ddi2, Kdm4a, Sqrdl, Atf7ip, 
BC031781, Cyp2d13, Chat, 2210417A02Rik, Psmd9, Ccdc132, Gast, Btd, Mtmr7, Foxa3, 
H47, Rcc2, Calr3, Grn, AK006039, Clcn7, Gm9159, Kifc5b, Hhex, Mobkl1a, Hnrnpu, Celf2, 
Igfbp5, Dntt, Psmb3, Narf, Dync2li1, Mir1901, Krcc1, Sertad2, Uqcrq, 9230116N13Rik, 
Tomm20, Bcas1, Shb, Raf1, Dync1li1, Bves, Ttll8, Zfp36l2, Ptprf, Chpt1, Wnt10a, Eif5a, 
Qtrtd1, 0610030E20Rik, Gzmk, Neu3, AK162599, Dyrk1a, Slc22a1, Cxcl12, Slc12a3, Polr2h, 
Tpd52l1, AK002663, Gmfb, F7, Hyal1, Pnrc1, Med11, Ptbp1, Mat1a, Pcsk9, Tjp3, Meig1, 
AK016682, Max, Aqp8, Sucla2, Slc19a1, Cyth1, Mtf1, Tnfaip8l2, Zfp933, Zfp292, Rhou, 
Lamc1, Fbxo46, Sgms1, BC024978, AK079377, Taf8, Spata2L, St3gal5, Pkp4, 
B230312A22Rik, BC055111, AK018302, Ubqln1, Nagpa, Atp1a1, Dhdh, Pip5k1c, 
AK076673, Lonrf1, Zfp457, Mettl13, Lrig2, AK006664, Zfp609, Myrip, AK014704, Edf1, 
Slco1b2, Atp8b1, Pdia4, AK029587, Naa10, Sucnr1, Birc5, 1700084E18Rik, Trp53inp1, 
Cdk7, Tnfrsf1a, Rin3, AK139806, Tcf7l2, Arid2, Dsp, 1700029F12Rik, Neil2, Tmem100, 
Qtrt1, Rab17, C4bp, Mical2, Mgat1, Fkbp5, Pdcd11, Prkca, AK155560, AK140161, 
AK006070, AK018984, Mcl1, Gcc2, Tubg1, Cdc42bpa, Apoc2, Rps14, BC024479, 
AK049871, Ddhd1, Ap1b1, ADAM22, Fbxl22, Wdr81, AK139053, Gtf2ird1, Dyrk1b, Tshz1, 
Rhof, Praf2, Mreg, AK010767, Parp11, Chrd, Casr, Pdp2, Dpy19l1, Hist1h1c, Ctsf, Egr1, 
Abtb1, Gtpbp2, E130203B14Rik, Niacr1, Prkag2, Trim56, Akr1c14, Agpat2, Krt18, Tarbp1, 
Phf15, Sec22a, Fzd1, Cadm1, Fgfr4, Bid, Tmed2, Rassf1, Znrf4, AK144632, Stxbp5l, Tpp2, 
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Snd1, AK014435, Arhgap12, Pikfyve, Ttpal, Mpzl2, AK021325, Nkx2-2, AK087755, Mtdh, 
Gcat, Tmem44, Cdh2, Eif6, Fam25c, Slc38a2, Ahsg, 2810055F11Rik, Slc38a9, Fam46c, 
Whamm, 2610101N10Rik, Pelo, Gpr110, Slc4a3, Gdpd4, Tmem126a, AK020861, Nolc1, 
A530013C23Rik, Utrn, 1810011O10Rik, Ercc6, Umps, Gtf2i, Entpd5, Igfals, Neurl2, 
2610002D18Rik, Lrp5, Ddb1, Pdgfa, Ppargc1a, 1600002H07Rik, Ywhae, Psapl1, Reep3, 
Hmx1, Shmt1, Idh3a, Ankrd28, Rnase10, BC016495, Klhdc3, Stab2, Ddx39, AK044432, 
E2f1, AK160416, AK141187, 1110003E01Rik, AK086149, Kbtbd11, Ocln, Atf7, AK010245, 
Nfix, Ndfip1, Nr4a2, Xylt1, Vprbp, Gm829, Adck4, Cyp4v3, Ticam1, Arhgef1, Scn3a, Egr3, 
Pnpla5, Ikbke, C330006K01Rik, Lipg, Slc26a1, AK043789, Rpp38, AK076318, Pvrl1, 
AK144897, Setd4, Engase, Sec31a, Cldn2, Gnl3, Commd8, Fa2h, Gm2a, Dnajb9, Txnip, 
Mcm7, AK015284, Ppp1r3g, Usp16, Pnpo, AK146386, Fam100a, Crybg3, Tmem183a, Pdhb, 
Nadk, AK039589, AK015526, Zfp91, Fdx1l, Sidt2, Rad9, AK205379, Agps, Rbms1, Rhobtb3, 
Ptp4a1, Wdfy3, Rpl29, Zfp827, Papola, Rnase13, Wfikkn1, Ak2, Vsig10l, Tet2, Wnt5b, 
Homer2, Fam81a, Ccdc148, Tnfsf10, Atg3, Ube2i, Ppp1r15b, Cnst, Exosc5, Ehhadh, 
AK085201, Lass2, Slc25a22, Prdm4, Daam1, AK044449, AK076253, Rrp12, Gtf3a, Bbox1, 
Cbfa2t2, Serbp1, Cdcp1, Tpo, Kdm3a, Fxn, Rasl11b, Mrps12, Sc5d, Nsd1, C030006K11Rik, 
Zfp174, AY512943, Epb4.1, Areg, Akr1b3, Tnpo2, Gng7, Bptf, Bfar, Agxt, Bmp8b, Cbr4, 
Plekhg3, 1110018J18Rik, B4galt5, Sec13, BC049352, Maml3, Alpk1, Cpsf4, Grlf1, 
AK021232, Fam50a, Tox, Bod1, AA388235, Irak1bp1, Slc35a4, BC002163, Cyp4f15, Pmpcb, 
Cry1, AK046160, Mki67ip, Bahcc1, AK039829, Ankrd33, Lyzl1, D19Ertd386e, Nudt16l1, 
Angptl4, Mtfr1, Fntb, AK044426, AK136047, Scarb2, Orai1, Ctse, Zfp750, Lin52, Ankrd23, 
AK046316, Glt28d2, Rrp9, H2afy2, AK050866, Atp5sl, Sacs, Frmd4b, 1810020D17Rik, 
Insig2, AK029599, Gpr84, AK017143, Foxk1, Foxq1, Synpo, Snx18, Mapkap1, Slc36a1, 
AK051055, Trip6, AK020095, Banp, Derl2, Acer2, Hs3st3b1, Nab1, Serf2, AK160548, Ptprg, 
Glt25d2, Zbtb34, Asgr2, Zfp36l1, Derl1, Cbs, AK142949, Pde1a, Pebp1, Hip1r, Snrnp27, 
Ceacam16, Ankrd27, Elovl5, Tmem17, Ehmt2, A1cf, Rmi1, Creg1, Acvr2a, BC020535, 
Pgpep1, AK044786, AK090213, Tnrc18, Anapc5, Fchsd2, Tex18, Fzd7, Cstad, AK013883, 
Dnmbp, Dusp12, Ttc23, Zfp143, Ankrd37, Snx33, AK196141, Bphl, 5730469M10Rik, Ehmt1, 
Ap1ar, Ncf1, Cdk8, Arhgap18, Armc2, Cdc42ep4, Igsf5, Dclre1c, Lepre1, Gfpt1, Mgmt, Fadd, 
Trip4, Ddc, Mir365-2, Tnfaip8l1, Fis1, Creb3l3, Slc12a7, Rsad1, Prr22, Dhcr24, Sqstm1, 
5730455O13Rik, Dtx2, AK084560, Chac1, Als2cr11, Phospho1, Chchd7, Dtx1, Coq7, Mfn1, 
4921507P07Rik, Usp10, Cdkn3, Aven, Gtf2ird2, 6430548M08Rik, BC096441, Kpna2, 
Tnrc6b, Itgb5, Pisd-ps2, Ncrna00085, Amdhd2, Alpk2, AA408296, Rfx5, Slc12a9, Adamts15, 
Nme1, Cnot4, Ptprd, Slc35e3, Senp7, Mgst2, Rbbp4, Asgr1, Ampd2, Mapk6, Fgfr2, Alg11, 
Dock4, Ercc6l, Gldc, Trak1, Dnajc12, Riok2, AK054493, Mrgprg, Pabpc1, Rnf149, Tm4sf1, 
Fga, AK006245, 8430408G22Rik, Icam1, Ube2b, D030028A08Rik, Phf2, Mrpl14, Foxn2, 
AK016120, Tmem2, BC114417, AK040090, 1810008A18Rik, Camk1d, Pmp2, Shfm1, Ahi1, 
Dctpp1, BC030398, Fos, Pdcd2, Tlr5, Mul1, Tpcn1, Kctd21, Nmnat3, Btbd2, Mir29b-1, Got2, 
Psma4, Myl7, Med31, Tnks1bp1, Tmem189, AK009335, Aars, Calm3, Bcl3, Sil1, Lamp1, 
AK032654, Eif2ak3, Acat2, Sar1b, Serpina10, Tcf3, Srebf1, Scap, Dhx9, AA881470, Capg, 
Xpo7, Zfp871, Zbtb10, Med13l, Hpgd, Dynlrb2, Gdnf, Fst, AK042990, BC035947, Spata5, 
Gstm1, Slc25a42, AK038627, Extl3, Tars, Etv5, Rps4x, Gpatch4, Taok3, Fkbp4, AK084599, 
Zfp566, Parva, AK215526, Mcph1, Mir3471-1, Zfyve26, Samd4, Mbnl2, Cuta, Fth1, Fmo5, 
Nit2, Ccdc85b, Vamp5, Dip2c, Farp1, Samm50, Parp9, BC024582, Mir148a, Socs3, Madd, 
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AK011482, Sntb1, Tnks, Serpina4-ps1, Cald1, Pcsk4, Slc1a4, Shank2, Hnrnpa3, Vav2, 
Ldlrad3, 3230401D17Rik, Mfsd1, Plk5, Myst4, Tsc1, Cisd2, Samd8, Trpc4ap, Snx14, Pias4, 
Mir183, Shkbp1, Cabyr, Prkaa2, A430107O13Rik, Arhgef7, Bag4, 9030617O03Rik, 
BC048601, 4933403F05Rik, A930007I19Rik, Kif26b, AK049838, Ilvbl, Ddit4l, Cidec, 
Hsbp1l1, Nnat, Tubb2c, Nmd3, Cxcl14, A630055G03Rik, Epc1, Golm1, Dclk3, Prf1, Agphd1, 
Hsd17b3, Spp2, 1700037H04Rik, Vps33a, Aqp11, Slc39a10, Igfbp2, Serpinc1, Gga2, Esrp2, 
Trcg1, Nktr, Esr1, 6720456H20Rik, Mcfd2, Tpst1, Cherp, Cdadc1, Ccdc112, 6330403A02Rik, 
Dusp23, Xrn2, Carhsp1, Shroom1, Tgds, Tmem175, Dedd2, Arap1, AK087886, P4hb, Aco2, 
Lrrc58, AK018858, Ddah1, Atf1, Stim2, AK053124, Cdc25a, H6pd, Ankrd12, Kcnh1, 
AK133032, Mapkapk2, Optc, Chd1l, Baiap2l1, Tjp1, AK019657, Acot4, 2010107H07Rik, 
AK132723, Clpp, Smap2, Pink1, Pgd, Aqp1, P2ry2, Zfp809, Trpv2, E130012A19Rik, 
Slc34a1, Slc25a30, Sec14l5, Crisp2, Banf1, Dtymk, Abhd11, Abcc12, AK039624, Pfkl, Elane, 
Itih1, Cyp4f17, A330023F24Rik, Arfgap2, Tmppe, B4galnt1, Rad50, Axin2, Klf11, Mir23b, 
Jak1, Chrna4, Tprgl, Rhbdd2, Spop, Bche, Tmem38b, Mir455, AK005667, Plscr2, Smcr7, 
4933426M11Rik, 4930539E08Rik, Ppic, AK082757, Dab2ip, Gpr88, Mir709, Smad3, 
Abca8a, Ubr5, Rab5a, Esco1, D1Bwg0212e, Traf3ip3, Ugdh, Spry2, Ola1, Zfp462, Dcp1b, 
Tecr, AK050336, Hdac5, Hes6, Qsox1, Rabgap1l, Fabp2, Ap1m1, Il34, Chchd10, Slc16a6, 
C1ql4, Ctdp1, Atrnl1, 6030422M02Rik, BC023483, Zmynd12, Ubp1, Jarid2, AK082325, 
Tcp11, Dusp1, Paqr7, Trpv4, Ntsr2, Mir582, Telo2, Gm4906, Ccdc25, Mrps9, Ubiad1, 
Dpy19l3, Pdgfrl, AK132865, Ube2ql1, St8sia3, Arhgef17, Fance, AK160850, Senp2, 
4930528F23Rik, Stard13, Mir203, Plxnb2, Rims1, Add2, Gemin4, Nrip1, Gnmt, Gchfr, Sox4, 
4930562C15Rik, 1190005I06Rik, Rangap1, Nedd4l, AK149321, AK144662, Gna14, 
Secisbp2l, Rtn4rl1, Mef2a, Map2k7, Ndufs7, Als2, Drd4, Arid5b, A330040F15Rik, Spag4, 
Itpripl1, EG232599, Plcg2, Gm6924, Rffl, Slc7a15, Gpbp1, St7, AK087264, AK085341, 
Pomc, Fam18a, Brpf3, AK046150, Snrk, Usp22, AK136034, Ganab, AK006712, Csrnp1, 
2610203C22Rik, 1700030F18Rik, Srm, Cacng1, Gpr68, Hnrnpm, Slc35f5, Iffo2, AK160141, 
Bcor, AK043922, Cisd1, Cxxc5, Tle4, Clint1, Mylk, Ccdc41, AK008767, Slc7a6, Nfic, Gas7, 
Ccdc114, Ttyh2, Gm5294, Ccnb2, Rrp1, Ap3m1, Rogdi, Irf2bp1, Dolk, Kcnv2, Enpp2, Ihh, 
Mansc1, Tfdp1, Pemt, Kcnj12, Sgpp1, Il15ra, Slc24a3, 2210403K04Rik, Usp6nl, Tmem50a, 
Cbx8, Hsd17b12, Arhgdia, AK019751, Zfhx2, Mir802, 2900079G21Rik, Lrp3, Gm628, 
Tmem56, Chchd4, Nhlrc2 
NPAS2, CLOCK and BMAL1: Per1, Dcun1d4, Myo10, Srd5a2, Nr1d1, Mpp6, Klf13, 
Thrsp, Upp2, BC037703, Tenc1, Chka, AK020914, Synj2, Inmt, AK036974, Nav2, Fads1, 
Phf17, Ubap1, Pitpnm2, Dbp, AK158188, Gm129, Fam47e, Pdk1, Decr1, Por, Anks4b, Eepd1, 
Tbcel, Tha1, Slc25a37, Furin, Usp36, Agxt2, Mgrn1, Hoga1, Hjurp, Mafb, Acot7, Nr3c2, 
Il17rd, AK086749, Ndufb9, Memo1, Pax2, Mir26b, Grem2, Cubn, Ccdc141, Cry2, Utp11l, 
Gys2, Xrcc1, Ccnd1, Hlf, Matn2, Eif4g1, Rtp1, ORF63, AK019601, Ppp2r5a, Mcm10, 
Rapgef1, 0610037L13Rik, Slc45a1, Wipf3, Prss8, Gpt2, St3gal4, Gnat1, Nfil3, Wdfy2, 
Gm7325, Cps1, A730008H23Rik, Per2, Aqp12, Atp1b1, Rapgef2, Col27a1, Prkg2, Herpud1, 
4931406C07Rik, Car12, Pctk2, Plk2, Abcd2, Ergic1, Fgd2, AK077157, Ugt1a1, Rgs8, Igsf8, 
Lrp4, AK042900, AU019990, Bcl2l1, Tshz2, Abcd3, Pla2g12a, Ppap2b, Adc, Nr0b2, Gpatch3, 
Gm16532, AK042797, Nup62, 2700029M09Rik, Maf, AK078316, Fdx1, Adarb1, Nudt4, 
Fam19a2, Igfbp4, AK136877, Gch1, 1700108F19Rik, Trib1, Slc38a4, Pim1, Ttc7, Ammecr1l, 
Ppargc1b, D18Ertd653e, Mamdc2, Gm815, AK171953, Etnk2, BC050122, AK053216, 
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Ralgapa2, Ahcy, AK027991, Cp, Ccrn4l, Ptgfr, Thrap3, Agmat, Atxn2, Smyd1, Kbtbd8, Itpr2, 
Stard5, Xpo6, Slc22a16, AK169506, Cnot8, Slc13a2, Map2k6, Hbp1, Gphb5, AK200600, Nln, 
AK016040, Gnpnat1, Azin1, Tef, Nup50, AK007854, AK050349, Eif1a, Zfp407, Cyp17a1, 
Il1r1, Dis3l2, Rgs16, Mir103-2, Nrsn2, Gclm, AK047309, Hyi, Padi1, Dnajc16, Afm, Bri3, 
Akr1d1, Plekha8, Znrf2, Itpr1, Clec2d, AK043814, Irgq, AK007376, Pcsk6, Trpc2, Psma1, 
Sephs2, Lhpp, AK021128, AK032387, Nudt7, Rab6b, Reep6, Tmem19, Tbc1d10a, Tmem93, 
Tob1, AK143961, 4831426I19Rik, Wrnip1, AK007100, Fam107a, Gjb2, Lifr, Pim3, Nr1i2, 
Prr18, Vegfa, Cfh, Prdx6, AK042551, Bend7, Plcb1, 0610008F07Rik, Zmynd8, Adh6b, Uox, 
B4galt1, Epb4.1l4b, Sgip1, AK144477, Pum1, Mtor, Cpeb2, Slc4a4, Alb, 2900026A02Rik, 
2410137F16Rik, D6Ertd527e, AK029023, Slco1a4, Ppfibp1, Zfp36, Fam196a, Tmem80, 
Tspan4, Hook3, Helt, 4930567H12Rik, Ldlr, Bmper, Usp2, Mfrp, Tle3, Trf, Alas1, 
AK006189, Arg1, Prdm1, Nap1l1, Sdr9c7, BC019819, Cyfip2, G3bp1, Trim11, Pipox, 
Slc35b1, Slc25a39, Tbc1d16, Id2, Tssc1, Sh3yl1, Arhgap5, AK034421, AK014028, Txndc5, 
9430083A17Rik, Smad5, Agtpbp1, Dmgdh, Scamp1, Chdh, Ctsb, Tmem184b, AK045688, 
1700001L05Rik, Nfe2, Nmral1, Vps8, 1110020A21Rik, Epas1, Rnf125, Lman1, Flrt1, 
Smarca2, Papss2, Ppp1r3c, Tectb, Gm8883, Agap1, Zcchc2, AK039419, Chit1, Fam20b, 
Mpzl1, Psen2, Mir1981, Plxna2, AK075572, Ass1, Abl1, Cobll1, D2Ertd750e, Sord, Slc27a2, 
Gm14164, Matn4, Fndc3b, Ensa, Adh5, Gabbr2, St3gal3, C77080, Klhdc7a, Epha2, Fhad1, 
Slc25a33, Arhgef16, Crot, Lgi2, 0610040J01Rik, Rbm47, Prkab1, Pptc7, Gpr146, Gna12, 
1700001J03Rik, Slc46a3, AK076827, AK008560, Snx10, 9130019P16Rik, Fam176a, Klf15, 
Hdac11, AK002866, Vgll4, Pik3c2g, Ehd2, Cblc, Mogat2, Wee1, Eps8l2, Odz3, Isyna1, Junb, 
Sall1, AK015712, Bcar1, Galnt2, AK041328, Apoa1, 1700017B05Rik, Ip6k2, Cnksr3, Cited2, 
DQ696813, Aifm2, Gstt2, AB251164, Pah, Plxnc1, Rdh9, Gm12034, Slit3, Wwc1, Vdac1, 
Rara, G6pc, Fam20a, Tk1, AK192194, 2310015A10Rik, Clmn, Aspg, Atp6ap1l, AK043460, 
AK087292, Anxa7, Pbrm1, Txndc16, 1700129C05Rik, Fdft1, Sorbs3, Mtss1, Asap1, Rbfox2, 
Ppara, Tymp, Krt8, Tbccd1, AI480653, Wdr4, Ddr1, Svil, Pcdh1, A930012L18Rik, Gm672, 
Acy3, Neat1, AK019124, AK039361, Blnk, Marveld1, Abcc2, AK087340, Tbl1x, Tram1, 
Hs6st1, Cnnm4, AK041998, Ptma, Rbm44, Epb4.1l5, Slc41a1, Plekha6, Ivns1abp, Adcy10, 
Gfi1b, AK011205, B3galt1, Dhrs9, Gorasp2, AK044780, Bmf, AK134652, Slc25a44, Efna1, 
Mrps21, Cnn3, Agxt2l1, Ripk2, Ifnk, Dnajb5, Tnfsf15, Fggy, Lepr, Dab1, Eif4g3, Camk2n1, 
Efhd2, AK135377, Hopx, Mn1, Pxn, AK162140, 0910001L09Rik, Cyp2w1, Gpr12, 
AK046388, Zfp467, Fam13a, Aldh1l1, Lpcat3, 4930417O13Rik, Etv6, Sox5, Zfp526, Lipe, 
Cyp2f2, Eif3k, 4930432E11Rik, AK149394, Akap13, Uvrag, AK016032, Irs2, Slc7a2, Mlf1ip, 
Myo9b, Prdx2, Ces1e, 4933407C03Rik, Car5a, Trhr2, Fanca, Sipa1l2, Irf2bp2, Rgl3, Imp3, 
Glce, Dapk2, AK076831, Uba7, 1700102P08Rik, P4htm, Acaa1b, Cyp8b1, AK008417, 
Supv3l1, Cdk1, 1110038D17Rik, Pttg1ip, Slc17a8, Dusp6, Tns3, Rnf145, Slc22a4, Larp1, 
Dhx33, Mnt, Med13, AK003943, Mir152, Nol11, 2900041M22Rik, AK089512, Lpin1, Egln3, 
Arid4a, 4930403N07Rik, Ttc8, Mir3073, Adssl1, Peci, AK155516, Gfod1, Thoc3, Dapk1, 
Slc30a5, Acox2, AK047978, Htr2a, Zfp622, Col22a1, Adcy6, Csad, Ap2m1, Gramd1c, Cd47, 
Gbe1, Urb1, Ifnar2, AK038602, Clic6, Ripk4, Arid1b, AK006572, Srsf3, Abcg1, AK080425, 
Man2a1, Tgif1, Ypel5, Haao, Abcg8, Onecut2, Mir122a, Fads2, Cyp26a1, Pik3ap1, Avpi1, 
Gm10768, Pdcd4, Acsl5, Prps1, Gsta3, Fzd5, Tns1, 2810459M11Rik, Lrrfip1, Tor3a, Dpt, 
Nos1ap, Hlx, Mir669i, Sardh, Wdr38, AK007819, Serping1, Fnbp4, Slc20a1, Hao1, Id1, 
Plcg1, Sgk2, Sdc4, Ptpn1, Pck1, Slc17a9, Slc2a2, Lekr1, Fnip2, Trim45, Sort1, 
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A930005H10Rik, Mir760, Elovl6, Hadh, Bdh2, Cyr61, AK077587, 2610301B20Rik, Ddx58, 
Nfx1, Aldob, Zfp618, Plin2, E130114P18Rik, Ak4, Slc6a9, Artn, Khdrbs1, Tmem222, Rpl11, 
Tmco4, B330016D10Rik, Slc25a34, Gm10565, AK147071, AK033051, Srpk2, Agbl5, Yes1, 
Tbc1d14, Slc2a9, Stbd1, Fras1, Fgfrl1, Slc24a6, Gpn3, Aacs, Gusb, Baz1b, Mepce, Cyp3a13, 
BC046508, Slc13a4, Hipk2, AK016225, Asprv1, Suclg2, Lmod3, AK039720, Oxtr, Adipor2, 
Mical3, Clstn3, BC048546, Leng9, Slc7a10, Fcgrt, Ftl1, AK085337, Abhd2, Mrpl48, Acsm5, 
Acsm3, Zfp747, AK041267, AK031861, Echs1, BC052524, F10, Zfp703, Irf2, Man2b1, Fto, 
Ranbp10, Taf1c, Klhl36, Gins2, Ilf3, Gm6484, Fam55b, Zbtb16, 1600029D21Rik, AK018968, 
BC031353, Eef1a1, Amotl2, Dusp7, Gpd1l, Acaa1a, Hhatl, Map3k5, Sesn1, 1700040L02Rik, 
AK046981, Dazap1, Rps15, 1190007I07Rik, Ccdc38, AK002250, Wif1, Rassf3, Xrcc6bp1, 
Inhbe, Nxph4, Sec14l4, Xbp1, Adra1b, Maml1, Clk4, B9d1, Kdm6b, Aldoc, Utp6, Acsf2, 
Pdk2, Arhgap23, Thra, Msl1, Dnmt3a, Cys1, Adi1, Efcab10, Ifrd1, Sos2, Dhrs7, AK085818, 
Hif1a, Foxn3, Ttc7b, Serpina6, Meg3, Dio3os, Dnahc11, AK046182, Gm11346, Slc22a23, 
Bmp6, Gm10790, Il6st, Mocs2, Abhd6, Ecd, Arhgef3, Il17rb, Tkt, Sfmbt1, Zfhx2as, Gucy1b2, 
Slc39a14, Lrrc63, Gpc6, Cox6c, Eppk1, Rbx1, Tob2, 2210021J22Rik, Rhebl1, Tmbim6, 
Lima1, Cbx5, BC046487, Fetub, AK018484, Fam43a, BC027231, Cryzl1, Ets2, 
B930003M22Rik, Hmga1, Cryaa, Plin5, Alk, Galm, Prkce, 3110002H16Rik, Npc1, Osbpl1a, 
Aqp4, Gm5820, Cabp4, Lrfn4, Pank1, 1500017E21Rik, Sorbs1, Cpn1, Pcgf6, Sh3pxd2a, 
Mxi1, Rbm20, Coq10b, Pinc, Ngef, Usp40, Phlpp1, Lax1, Adora1, Nr5a2, Nmnat2, 
AK154552, BC039791, Olfml2b, Ephx1, AK076929, Crat, Psmb7, Lass6, AK143789, Zfp106, 
Trpm7, Atrn, Bmp2, Rrbp1, Pax1, 1110008F13Rik, Sys1, A630075F10Rik, Osbpl2, Gm5148, 
Slc25a31, AK040671, Rnf13, Igsf10, Mbnl1, Mef2d, Tchhl1, Car14, Stxbp3a, Agl, Palmd, F3, 
Bcar3, AB351921, Lpar3, Ndufaf4, Susd1, Rgs3, Mpdz, Ttc39b, Podn, Btbd19, Ece1, Pqlc2, 
Aldh4a1, Arhgef10l, Tnfrsf1b, Slc2a5, Morn1, Akap9, Slc4a2, Fgfr3, Htra3, Med28, Sel1l3, 
Pds5a, AK078705, Paics, AK050091, Klhl8, Hsd17b13, C130026L21Rik, 2210016L21Rik, 
2410131K14Rik, Ncor2, Scarb1, Ubc, Slc15a4, Mlxipl, E130309D02Rik, AK038791, DMR, 
Mtif3, Hsph1, Aass, Gprin3, Rtkn, Bhlhe40, Irak2, Zfp422, Il17ra, Slc6a13, Gapdh, Lrp6, 
Hebp1, Slco1a1, Abcc9, Rassf8, LOC100303645, Rps9, Zfp446, Napa, Apoe, 
2210010C17Rik, Cyp2g1, Cebpg, E130304I02Rik, Ruvbl2, Sphk2, Saa3, Ldha, Mir211, 
Adamts17, Polg, Lrrc32, Dgat2, Slco2b1, Tmc7, Cln3, Bnip3, Syce1, Insr, AK047141, 
AK162519, Proz, Sfrp1, Ppp1r3b, 6430573F11Rik, Adam24, Mtus1, Klkb1, Chd9, Lcat, 
Ctrb1, AK085459, BC021891, Nrp1, Ecsit, C2cd2l, Nrg4, AK028224, Snx22, Aqp9, Nedd4, 
Onecut1, Ctgf, Wisp3, AI317395, Foxo3, Tmem26, AK143813, Pdxk, Jsrp1, Gadd45b, 
Slc41a2, Tcp11l2, Fgd6, Tmcc3, Acss3, Slc16a7, Ddit3, Rdh7, Gls2, Rps26, Lif, Znrf3, Igfbp1, 
Agxt2l2, Sec24a, Tom1l2, AK140192, Aldh3a1, Ube2g1, Tmem97, 1100001G20Rik, Hnf1b, 
Tex14, Dusp3, Snord104, Wipi1, 4933422H20Rik, Wbp2, AK084679, Hectd1, 
2310044G17Rik, Serpina3n, Hhipl1, B930059L03Rik, Inf2, Slc17a2, BC025054, Agtr1a, 
DQ685120, BB123696, Fbp1, Ctsl, Cdk20, Adcy2, Glrx, AK144545, 4833420G17Rik, Adk, 
AK016284, Dcp1a, Ubb, Atg14, Rabggta, Cbln3, Cryl1, Spata13, AK215081, Clu, 
1300010F03Rik, Sepp1, Rai14, Ext1, AK007154, Pla2g6, Atf4, Cyp2d10, Arsa, Lmbr1l, 
Zfp263, Ppl, Dexi, BC106179, Uts2d, Hes1, Tmem39a, AK165366, AK087725, Brp44l, 
AK015714, Igf2r, Tbc1d24, AK149278, Myom1, Prkd3, AK041408, Ttc39c, Stard4, 
AK158482, Ccdc68, Smad7, Cyb5, Pcx, Pacs1, Pga5, 1110059E24Rik, AK076909, Tnks2, 
Cyp2c44, Gpam, Fam160b1, Gfra1, Obfc2a, Pgap1, Trak2, Als2cr4, AK040166, Gm15456, 
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AK079660, Pid1, Dgkd, Ube2f, AK039635, Dbi, 3110009E18Rik, Dars, Zfp281, Abl2, Fmo3, 
Mgst3, Pfdn2, Mir350, Degs1, Mosc2, Hsd11b1, Phyh, 5430407P10Rik, Rexo4, Rxra, Tor1b, 
Lhx6, Nek6, Mettl8, AK079188, Chrna1, Nfe2l2, AK078367, F2, Nat10, Catsper2, Mall, 
Slc23a2, 1110034G24Rik, Foxa2, Ncoa3, Sulf2, Atp9a, Fabp4, Fabp12, Foxo1, Tlr2, 
D930015E06Rik, Fam160a1, Hdgf, AK007191, Rorc, AK052161, Hsd3b5, Slc22a15, Sars, 
S1pr1, Enpep, Papss1, BC046436, Adh1, AK029620, Dnajb4, Cth, Asph, Ttpa, Aptx, Gne, 
Abca1, AI427809, Akap2, E130308A19Rik, Pgm2, AK021368, Leprot, C8a, Ssbp3, Hectd3, 
Mfsd2a, Rragc, Fam76a, Wdtc1, Rps6ka1, Gale, Alpl, Fam131c, Tnfrsf8, Mthfr, Klhl21, Ski, 
Prkcz, Phtf2, 2900005J15Rik, Insig1, AK189432, Ywhah, Zfyve28, AK076853, Qdpr, Rell1, 
Klf3, AK007290, Gc, Rassf6, Cxcl1, Aff1, Ulk1, Tmem211, Fbxo21, Tctn2, Wbscr25, Stx1a, 
Serpine1, 4930432F04Rik, Pan3, Lrrc4, BC145649, AK020588, AK039826, Pcyox1, Eefsec, 
AK083777, AK154635, Foxp1, Pex26, Nop2, Ntf3, Pzp, Erp27, Plekha5, Aebp2, Ifltd1, 
Lypd4, Egln2, Snrpa, Blvrb, Dpf1, AK087850, Nudt19, Rras, Rps11, Abcc6, Csrp3, Mesp2, 
Anpep, Ap3s2, AK155169, Fah, Clpb, Gde1, Pdilt, Crym, Eef2k, Lcmt1, Zfp768, Tacc2, 
Fam53b, D7Ertd443e, Ppp2r2d, Olfr541, BC024386, Rplp2, Ctsd, Gas6, Rasa3, F11, Acsl1, 
Stox2, Eps15l1, 0610038B21Rik, Hook2, 9330175E14Rik, Slc38a7, Nol3, Mir3108, Hp, 
AK008488, Wwox, Sdr42e1, Osgin1, Crispld2, Fam92b, Zfpm1, AK040202, 2310022B05Rik, 
AK143934, Raver1, AK048946, Dcps, Oaf, AK143856, Slc37a4, Apoa5, AI118078, Cyp1a2, 
Rplp1, Myo6, Paqr9, Dnajc13, Tlr9, Abhd14a, Ifrd2, Ip6k1, Mtap4, Cmtm8, Gorasp1, Ctnnb1, 
Tspyl1, Ddo, Pbld1, Rtkn2, Rhobtb1, AK044689, Bcr, Col18a1, Ap3d1, Lmnb2, Nfyb, 
AK006461, Ric8b, Fhl4, Hsp90b1, 1700113H08Rik, Nr1h4, Krr1, AK089123, Cand1, Gns, 
R3hdm2, Lrp1, Hsd17b6, Pes1, Ugp2, Smek2, Snrnp25, Npm1, Mat2b, 3010026O09Rik, 
Slc22a5, Flcn, Map2k3, Chd3, Eif4a1, Senp3, Aspa, Dph1, Myo18a, Wsb1, AK019731, Ccl9, 
Dusp14, Aatf, Ypel2, 1700106J16Rik, Tns4, Stat5b, Dhx8, G6pc3, Abca8b, Cdk3, Cbx4, 
Actg1, Slc25a10, Gcgr, Atxn7l1, Snx13, Psma6, Mia2, Ppm1a, Fut8, Gphn, Actn1, 
1700052I22Rik, Mir3067, Dpf3, 6430527G18Rik, 3300002A11Rik, Slc17a3, Uqcrfs1, Mylk4, 
Gcnt2, AK006512, Atxn1, Fam120a, Gadd45g, Klhl3, AK038606, BC051665, Pcsk1, 
Col4a3bp, Utp15, Pik3r1, Adamts6, Zswim6, Actr8, Eaf1, Gm3219, AK020680, Zfp395, 
Reep4, Ghr, BC048765, BC048519, St3gal1, Plec, Adck5, Lrrc14, BC100417, Cdc42ep1, 
Ndufa6, Pnpla3, Atxn10, AK041762, 1300018J18Rik, Scaf11, Fkbp11, Gm10035, Adcy9, 
1810013L24Rik, AK028773, Txndc11, Mkl2, Bcl6, AK039760, AK053957, Gm1968, 
AK029404, Senp5, Pdia5, Plcxd2, Cblb, Mrpl39, Bach1, Dscr3, Cldn20, Plg, Dact2, Mapk13, 
Pknox1, Sik1, Brd4, Neu1, 2310039H08Rik, Mrps10, DQ716672, Dpp9, Twsg1, Lclat1, 
Fam98a, AK153584, Lrpprc, AK085972, AK016027, Fam59a, Mapre2, Nr3c1, Fech, Poli, 
AK036329, DQ548994, Pqlc1, Cpt1a, Gstp1, Esrra, Zfand5, Klf9, Mir101b, B430203M17Rik, 
Mir107, Hectd2, AK082813, Loxl4, As3mt, Nt5c2, Adra2a, AK045643 
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A.8 Software protocols for fear conditioning and latent 
inhibition 
These programs were used to run inputs and record lick data from the cages used for 
fear conditioning/latent inhibition investigation in Chapter 6. 
A.8.1 Pre-training 
\filename, cecilie_li_pretraining 
\the following test paradigm is divided into 4 parts: pre-
training, pre-exposure, conditioning and test. This part is the 
pre-training. It runs for 15 mins as follow: start program. 
Record time of first lick. Record total number of licks AND 
record number of licks every minute. 
 
\inputs 
^lick = 2  \lickometer 
 
\variables 
\L = lick_to  licks total 
\A = lick_a   lick array counting licks pr. minute 
\F = first_l  time of first lick 
\P = array minute timer 
\M = minutes 
\S = seconds 
\T = seconds counting until first lick 
\U = minutes counting until first lick 
\Q = count of licks in array 
 
\state sets 







DIM A = 14 
 
S.S.1 \start program and count response 
 
S1, 
#START: ---> S2 
 
S2, 
#R^lick: ADD L; ADD Q ---> S2 
 
\_______________________________________________ 




S.S.2 \session timing 
 
S1, 
#START: ---> S2  \the start command ensures that timing 
will begin concurrently with S.S.1 
 
S2, 
1": ADD S; IF S<60 [@sec, @min] \check every second for the 
count to 60 
 @sec: ---> S2 
 @min: ADD M; SET S = 0; IF M < 15 [@cont, @stop] 
 \after 60" count one minute and reset to zero. Session time 
is set for 15 minutes. 
 @cont: ---> S2 
 @stop: ---> S3 
 
S3, 




S.S.3 \Screen display 
S1, 
0.1": SHOW 1,lick_to,L,2, Mins,M, 3, Secs,S, 4,lick_a,P, 5, 




S.S.4 \Recording amount of licks pr. minute 
 
S1, 
#START: ---> S2 
 
S2, 




S.S.5 \time of first lick 
 
S1, 
#start: ---> S2 
 
S2, 
#R^lick: ---> S3   \when first lick, stop timing by jumping to 
S3 
 
1": ADD T; IF T<60 [@sec, @min] \check every second for the 
count to 60 
 @sec: ---> S2 
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 @min: ADD U; SET T = 0 ---> S2 
S3, 
0.1": ---> SX 
 





\the following test paradigm is divided into 4 parts: pre-
training, pre-exposure, conditioning and test. This part is the 
preexposure. A 
\stimulus is presented repeatedly without consequences.  Here, 
the 
\parameters are set to 60 pre-exposures (PEs) of 5 sec tones at 
an inter-stimulus interval 











^StimDuration = 5                         \Duration of each 
stimulus (5s) 
^ISI          = 15                        \inter-stimulus 
interval(15s) 
^PE           = 60                        \No. of PEs 
 
\----Descriptions of variables------------\ 
 
\S = number of stimuli (ss1) 
 




s.s.1,                                     \Delivers pre-
exposures and 
s1,                                        \starts and ends the 
program. 
#Start: ---> s2          
s2, 
^ISI": ON ^Tone; ADD S; show 1, NUM_PE, S ---> s3  \Waits 
for ISI, sounds tone, 
                                 \increments number of PEs and 
                                      \displays that on screen 
 
s3,                                \After stimulus duration has 
^StimDuration": OFF ^Tone ---> s4          \passed, switch off 
the tone. 
 




0.1": IF S = ^PE [@Finished, @Unfinished]  \If the required 
number of PEs 
         @Finished:  ---> s5               \have been given, 
jump to stop the 
         @Unfinished: ---> s2              \program end, otherwise 
loop back to 
                                           \give the next PE. 
s5, 
15": ---> STOPKILL                     \stop the program 
 
Note for NPE mice no outputs were used or inputs recorded so no script is used 
 





\date, august 17 2006 
\the following test paradigm is divided into 4 parts: pre-
training, pre-exposure, conditioning and test. This part is the 
conditioning phase. Two 
\stimulus-shock pairings are presented.  Here, the parameters 
are set to 
\5 sec tone followed immediately by 1 sec shock (0.5 mA), given 
5 and 7.5 mins into 





^tone = 1  \tone 
^shock = 8  \shock (check that this is the right output 
number) 
^shockmode = 2          \ delivers shock together with 8 
 
\----Definitions of other constants-------\ 
 
^StimDuration = 5                         \Duration of each 
stimulus (5s) 
^ShockDuration = 1                        \Duration of shock 
(1s) 
^ISI          = 150                       \Time between stimuli 
(2.5 min = 150s) 
^Conds        = 2                         \Number of stimulus-
shock pairings 
 
\----Descriptions of variables------------\ 
 
\S = number of stimuli (ss1) 
 




s.s.1,                                     \Delivers tone-shock 
pairings and 
s1,                                        \starts and ends the 
program. 
#Start: ---> s2                       \Waits for start signal 
 
s2, 
5': ON ^Tone; ADD S; show 1, NUM_PE, S ---> s3         
\Waits for ISI, sounds tone, 
                                             \increments 
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number of PEs and 
                                             \displays 
that on screen 
 
s3,                                          \After 
stimulus duration has 
^StimDuration": OFF ^Tone; ON ^Shock, ^shockmode ---> s4  
 \passed, switch off the tone 
                                             \and switch 
on the shock. 
 
s4, 
^ShockDuration": OFF ^Shock, ^shockmode ---> s5        \After 
shock duration has passed, 




0.1": IF S = ^Conds [@Finished, @Unfinished]  \If the required 
number of 
         @Finished: ---> s6                \pairings have been 
given, jump 
         @Unfinished: ---> s7              \to where the program 
will stop, 
                                           \otherwise loop back 
to give the 
                                           \next pairing. 
 
s6, 
5': ---> STOPKILL                         \after 5 minutes, stop 
the program. 
 
s7,      \if the required number of 
pairings are not given, go to ISI and do same procedure 
 
 
^ISI": ON ^Tone; ADD S; show 1, NUM_PE, S ---> s3        \Waits 
for ISI, sounds tone, 
                                             \increments 
number of PEs and 
                                             \displays 
that on screen 





\date, august 17 2006 
\the following test paradigm is divided into 4 parts: pre-
training, pre-exposure, conditioning and test. This part is the 
test phase.\ Licks are counted, 
\and after a set number of licks a conditioned stimulus (CS) is 
presented 
\until a certain number of licks have been completed. A keyboard 
signal is 
\given to stop the program. The time of every lick is recorded.  
Here, the parameters are set to 





^lick = 2  \lickometer 
 
\outputs 






\----Definitions of other constants-------\ 
 
^CSOn         = 90                       \Lick no. at which CS 
comes on (90) 
^CSStaysOn    = 10                        \No. of licks for 
which CS stays on 
 
\----Descriptions of variables------------\ 
 
\A = time A (10 licks) 
\B = time B  (10 licks) 
\H = lick number that is start of time A (i.e. ^CSOn minus 
^CSStaysOn) 
\D = lick number that is end of time B (i.e. ^CSOn plus 
^CSStaysOn) 
\E = time at which lick H is made 
\F = time at which lick ^CSOn is made 
\G = time at which lick D is made 
 
\T = total number of licks 
\R = suppression ratio (10 licks) 
 
\----Declarations of array variables------\ 









s.s.1,                                     \Delivers CS, counts 
licks and 
s1,                                        \starts and ends the 
program. 
#Start: SET H = ^CSOn - ^CSStaysOn;  
        SET D = ^CSOn + ^CSStaysOn ---> s2 
                                           \Waits for start and 
works out 
                                           \start of time A and 
end of time B 
                                           \for both lick 
periods 
s2, 
1#R^Lick: ADD T; SET C(T) = X/10; show 1, LICKS, T ---> s3 
                                 \Waits for a lick, 
                                 \records the time of the lick 
                         \increments and displays lick 
                         \total on screen 
s3,                                         
0.1": IF T = H [@TimeA,@NotTimeA]          \Check for start of 
time A 
        @TimeA: SET E = X/10 ---> s2 
        @NotTimeA: IF T = ^CSOn [@TimeB,@NotTimeB] 
                                               \If lick that 
starts CS 
         @TimeB: ON ^Tone; SET F = X/10 --->s2 \and time B has 
been 
                                                   \made, 
start the CS and 
                                              \record the time 
         @NotTimeB: IF T = D [@EndTimeB10, @NotEndTimeB10] 
           @EndTimeB10: OFF ̂ Tone; SET G = X/10; \If yes, switch 
off tone 
            SET A = F - E, B = G - F;          \calculate 10-
lick SR 
            SET R = A/(A + B);  
            SHOW 2, SR_10, R---> s2 
           @NotEndTimeB10:    ---> s2          \If no, go back 
and wait for next lick 
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#Start: ---> s2                            \Wait for start signal 
 
s2, 
#K2:  ---> s3                              \Wait for K2 signal 
                                           
s3, 
0.1": SET C(T+1) = -987.987 ---> STOPABORTFLUSH \Put stop value 
into array,  
                                           \stop program, 
writing data to disk. 
 




#Start: ---> s2                            \Wait for start signal 
 
s2, 
0.1": ADD X ---> s2                        \Every 10th of a 
second, 
                                           \increment a timer 
variable 
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A.9 PIP reflective statement 
Note to examiners: 
This statement is included as an appendix to the thesis in order that the thesis accurately 
captures the PhD training experienced by the candidate as a BBSRC Doctoral Training 
Partnership student. 
The Professional Internship for PhD Students is a compulsory 3-month placement which must 
be undertaken by DTP students. It is usually centred on a specific project and must not be 
related to the PhD project. This reflective statement is designed to capture the skills 
development which has taken place during the student’s placement and the impact on their 
career plans it has had. 
Phenotyping ZFHX3 mouse models 
From 30/08/2019 to 20/12/2020 I was on placement at MRC Harwell working with the 
Nolan group. My work was as part of a project investigating conditional deletion of the 
hypothalamic transcription factor ZFHX3 in mice. Previous work by the group had revealed 
an important role for the transcription factor ZFHX3 in circadian biology. A dominant missense 
mutation in the gene (Zfhx3Sci) results in a short circadian period in constant conditions and 
altered sleep homeostasis (Parsons et al., 2015, Balzani et al., 2016). Mice with an inducible 
ZFHX3 KO have been found to show acute shortening of circadian period and/or loss of 
rhythmicity in constant conditions (Wilcox et al., 2017). My work in the inducible ZFHX3 KO 
model was work in further characterisation of effects within these mice through Harwell’s 
phenotyping suite. 
My work identified an anxiety phenotype in the mice observed in open field exploration and a 
change in social dominance behaviour specifically within male mice assessed by dominance 
tube testing. I was also able to perform other assays which identified no effect of the gene KO 
in these trials. 
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During my time at Harwell, I was also able to shadow or assist in a variety of other procedures 
I would not have been exposed to over the course of my PhD including experience working at 
a world class animal facility. I was able to receive training and experience in various mouse 
assays as well as ex vivo brain slice culture in which live luminescence was followed. While 
at Harwell I was first trained on the ClockLab software which I then used in my own PhD work 
for the investigation of light pulse behavioural effects. I was fortunate enough to also join a 
LASA course led by scientists at Harwell on generation of transgenic mice and embryo 
electroporation.  
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